data_2krb_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2krb _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 . . . . . 0 N--CA 1.477 0.924 0 N-CA-C 115.669 1.729 . . . . 0.0 115.669 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.3 m -121.42 5.63 10.16 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 126.683 1.993 . . . . 0.0 113.676 -177.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.1 m -139.55 165.27 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 C-N-CA 124.342 1.057 . . . . 0.0 111.684 -172.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 22.7 pt -132.17 154.56 40.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-O 122.215 1.007 . . . . 0.0 110.497 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 60.9 t -139.96 144.74 27.6 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.482 0 C-N-CA 125.318 1.447 . . . . 0.0 108.764 178.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -124.96 152.66 31.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 124.756 1.223 . . . . 0.0 108.807 178.404 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -127.07 164.06 22.39 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.362 1.465 . . . . 0.0 110.41 178.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 30.5 m-20 60.24 35.26 20.9 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 126.471 1.908 . . . . 0.0 113.101 -175.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . 0.261 7.3 p -104.14 81.92 0.55 Allowed Pre-proline 0 N--CA 1.479 0.989 0 C-N-CA 125.966 1.707 . . . . 0.0 111.589 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_endo -69.96 158.36 56.96 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 122.044 1.83 . . . . 0.0 111.152 175.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.89 170.08 14.46 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 121.611 -0.681 . . . . 0.0 111.72 167.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 30.9 m -138.57 167.65 20.88 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 126.81 2.044 . . . . 0.0 109.719 176.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -71.48 -175.81 23.42 Favored Glycine 0 CA--C 1.544 1.882 0 C-N-CA 124.733 1.158 . . . . 0.0 114.578 178.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -62.2 168.32 9.51 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 123.595 2.863 . . . . 0.0 111.043 179.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 13.5 t70 62.66 7.14 2.34 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 125.151 1.381 . . . . 0.0 113.926 -178.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 6.1 ttt180 -148.25 -29.38 0.31 Allowed 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 127.203 2.201 . . . . 0.0 114.136 -178.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -51.29 -32.62 25.47 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 177.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -67.81 -49.04 64.45 Favored 'General case' 0 C--O 1.231 0.1 0 C-N-CA 125.639 1.576 . . . . 0.0 109.356 179.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -45.11 -41.27 7.72 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 127.37 2.268 . . . . 0.0 110.5 174.024 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -47.53 -56.21 7.57 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.067 1.347 . . . . 0.0 112.422 178.093 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.17 -30.11 28.07 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.493 1.117 . . . . 0.0 112.163 176.11 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -60.88 -57.84 10.96 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 118.397 -0.811 . . . . 0.0 111.803 177.293 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 19.0 m -54.27 -36.96 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 124.899 1.28 . . . . 0.0 110.987 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.1 mp -47.85 -52.68 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 125.347 1.459 . . . . 0.0 109.971 170.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 19.9 m-70 -63.83 -39.31 93.93 Favored 'General case' 0 N--CA 1.466 0.331 0 O-C-N 121.211 -0.93 . . . . 0.0 111.892 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.48 -51.02 39.9 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 119.062 0.846 . . . . 0.0 111.609 179.272 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -60.04 -42.34 89.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 CA-C-N 118.528 0.604 . . . . 0.0 111.785 179.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.557 ' HB3' ' HH ' ' A' ' 68' ' ' TYR . 33.6 m-85 -86.07 -2.94 58.79 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -175.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.73 -27.27 63.84 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.754 1.222 . . . . 0.0 112.97 178.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.32 -24.16 65.71 Favored 'General case' 0 N--CA 1.484 1.262 0 O-C-N 120.661 -1.274 . . . . 0.0 113.178 177.298 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -92.65 -16.02 26.09 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.437 1.095 . . . . 0.0 113.125 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 155.38 -147.82 17.25 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 124.505 1.05 . . . . 0.0 112.51 -174.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 23.4 tptt -128.64 124.17 35.11 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.93 1.292 . . . . 0.0 109.938 177.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 3.6 mp -71.8 135.02 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 123.801 0.84 . . . . 0.0 109.897 175.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.3 t -111.54 -25.61 9.49 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.611 1.564 . . . . 0.0 113.462 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 28.5 m-80 -129.97 138.68 50.97 Favored 'General case' 0 C--N 1.339 0.117 0 C-N-CA 125.108 1.363 . . . . 0.0 110.31 -178.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -152.7 121.15 6.35 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.554 1.142 . . . . 0.0 111.657 -176.147 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -134.37 132.07 39.0 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.519 1.128 . . . . 0.0 111.338 -178.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -121.02 83.48 37.93 Favored Pre-proline 0 CA--C 1.542 0.644 0 C-N-CA 126.3 1.84 . . . . 0.0 108.728 -177.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -68.69 168.36 20.27 Favored 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 122.995 2.463 . . . . 0.0 111.096 178.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -144.7 172.72 12.6 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.434 1.493 . . . . 0.0 111.357 177.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -114.12 108.93 17.65 Favored 'General case' 0 C--O 1.221 -0.411 0 C-N-CA 125.753 1.621 . . . . 0.0 109.803 178.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.1 t70 54.44 29.12 10.55 Favored 'General case' 0 CA--C 1.555 1.161 0 C-N-CA 124.424 1.09 . . . . 0.0 113.065 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 76.84 12.61 84.4 Favored Glycine 0 CA--C 1.537 1.468 0 O-C-N 120.748 -1.22 . . . . 0.0 114.205 -174.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 26.2 mtpt -109.2 180.0 4.0 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 127.008 2.123 . . . . 0.0 109.949 -178.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 20.5 p -53.02 117.09 2.73 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 127.072 2.149 . . . . 0.0 112.651 -173.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.9 pttt -68.64 176.42 2.97 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.139 0.976 . . . . 0.0 113.387 170.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -140.61 -0.35 1.81 Allowed Glycine 0 CA--C 1.54 1.631 0 C-N-CA 126.908 2.194 . . . . 0.0 115.48 171.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -146.8 154.08 40.94 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 119.586 1.693 . . . . 0.0 108.875 -174.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -136.6 165.18 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 125.535 1.534 . . . . 0.0 111.063 173.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 19.3 t80 -132.27 123.67 27.38 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.479 1.112 . . . . 0.0 109.385 -179.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -126.46 137.97 53.46 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.867 1.667 . . . . 0.0 109.862 179.055 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -125.12 134.08 52.59 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 122.133 0.968 . . . . 0.0 109.744 176.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.557 ' HH ' ' HB3' ' A' ' 42' ' ' PHE . 85.7 m-85 -94.53 164.55 12.94 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 122.202 1.001 . . . . 0.0 111.44 175.156 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -76.23 -4.9 44.37 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.667 1.187 . . . . 0.0 112.699 175.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -153.4 151.51 25.74 Favored Pre-proline 0 CA--C 1.546 0.81 0 O-C-N 121.052 -1.03 . . . . 0.0 111.874 -176.165 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -63.54 -47.05 8.07 Favored 'Trans proline' 0 C--N 1.355 0.88 0 C-N-CA 123.542 2.828 . . . . 0.0 111.096 177.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -55.19 -16.83 3.52 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.428 1.891 . . . . 0.0 113.938 178.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 14.5 m-70 -86.93 -48.53 8.07 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 119.902 1.228 . . . . 0.0 111.263 173.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -61.87 -56.86 14.94 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.387 1.075 . . . . 0.0 111.882 176.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 11.3 m -61.35 -26.68 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 123.331 0.652 . . . . 0.0 112.016 -177.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -77.64 -56.19 4.73 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.531 1.133 . . . . 0.0 110.641 172.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.64 -44.25 62.89 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.609 1.164 . . . . 0.0 112.881 -177.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 54.4 t -56.84 -37.72 55.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 123.897 0.879 . . . . 0.0 113.071 175.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.2 mttm -89.83 4.22 50.5 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 126.102 1.761 . . . . 0.0 113.445 179.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -121.36 -32.97 3.76 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 178.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -109.75 17.75 20.92 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.254 1.021 . . . . 0.0 113.294 -177.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -53.59 88.52 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.952 2.101 . . . . 0.0 112.306 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 89.66 106.31 1.17 Allowed Glycine 0 C--N 1.339 0.738 0 N-CA-C 110.736 -0.945 . . . . 0.0 110.736 -178.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -80.06 146.87 31.7 Favored 'General case' 0 CA--C 1.548 0.889 0 O-C-N 121.3 -1.118 . . . . 0.0 112.15 177.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 1.1 pttt . . . . . 0 N--CA 1.483 1.179 0 O-C-N 120.644 -1.285 . . . . 0.0 114.111 -179.898 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 . . . . . 0 N--CA 1.469 0.513 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 27.0 mmm-85 -139.04 91.46 2.52 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.107 0.963 . . . . 0.0 110.99 -178.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 27.0 t -78.41 118.9 26.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 54.9 m-80 . . . . . 0 CA--C 1.545 0.753 0 C-N-CA 126.111 1.764 . . . . 0.0 111.04 178.801 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 . . . . . 0 CA--C 1.546 0.808 0 N-CA-C 116.347 1.98 . . . . 0.0 116.347 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.9 t -125.81 9.3 7.58 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 126.673 1.989 . . . . 0.0 113.351 -175.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.9 m -141.99 165.46 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 124.125 0.97 . . . . 0.0 111.99 -174.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 21.1 pt -130.59 154.95 41.38 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 C-N-CA 124.206 1.003 . . . . 0.0 111.258 178.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 57.9 t -137.79 144.67 30.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 125.257 1.423 . . . . 0.0 109.266 176.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.599 ' CG1' ' HH ' ' A' ' 84' ' ' TYR . 0.8 OUTLIER -125.66 150.03 30.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 123.948 0.899 . . . . 0.0 108.924 178.559 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -125.17 172.9 9.13 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.848 1.259 . . . . 0.0 110.405 178.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 54.08 32.55 15.89 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.634 1.574 . . . . 0.0 113.97 -174.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.3 p -103.73 81.09 0.44 Allowed Pre-proline 0 N--CA 1.475 0.807 0 C-N-CA 124.352 1.061 . . . . 0.0 111.202 -179.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -66.82 145.76 75.94 Favored 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 121.735 1.623 . . . . 0.0 111.368 176.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.71 163.63 13.59 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 120.82 0.343 . . . . 0.0 111.462 172.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 35.0 m -134.55 165.2 32.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 124.089 0.955 . . . . 0.0 110.822 -173.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -76.4 -171.3 32.67 Favored Glycine 0 CA--C 1.543 1.785 0 CA-C-O 121.417 0.454 . . . . 0.0 113.853 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -64.17 168.05 13.24 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 123.032 2.488 . . . . 0.0 112.291 177.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 65.52 9.28 5.7 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.423 1.089 . . . . 0.0 112.341 -178.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 27.0 ttt180 -150.61 -29.64 0.2 Allowed 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.391 1.476 . . . . 0.0 113.902 -177.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -52.83 -30.45 33.55 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 178.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -69.49 -45.45 68.91 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 122.927 0.491 . . . . 0.0 110.708 177.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.47 -39.25 67.3 Favored 'General case' 0 C--O 1.215 -0.748 0 C-N-CA 125.877 1.671 . . . . 0.0 110.776 175.433 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -45.84 -54.31 8.31 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.871 1.269 . . . . 0.0 112.544 178.18 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.3 tmtt? -84.89 -27.38 26.68 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.096 0.958 . . . . 0.0 113.144 175.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -64.36 -56.01 17.26 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 117.942 -1.028 . . . . 0.0 112.629 174.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 32.8 m -52.84 -34.2 19.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-N 119.507 1.049 . . . . 0.0 111.38 -178.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.1 mp -49.54 -52.21 12.77 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 C-N-CA 124.707 1.203 . . . . 0.0 111.325 170.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 33.1 m-70 -66.59 -18.33 65.31 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 119.03 0.832 . . . . 0.0 113.082 177.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.73 -52.36 5.17 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 119.318 0.963 . . . . 0.0 111.351 178.083 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -59.09 -41.98 85.15 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-N 118.408 0.549 . . . . 0.0 111.874 177.102 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -84.6 -3.03 58.27 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 112.794 0.664 . . . . 0.0 112.794 -178.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -67.17 -30.75 70.8 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 119.618 1.099 . . . . 0.0 113.909 177.171 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.479 ' HE3' ' CZ ' ' A' ' 45' ' ' PHE . 18.2 pttt -65.56 -23.01 66.75 Favored 'General case' 0 N--CA 1.48 1.039 0 O-C-N 120.74 -1.225 . . . . 0.0 112.853 179.128 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.479 ' CZ ' ' HE3' ' A' ' 44' ' ' LYS . 9.8 m-85 -92.49 -14.96 27.67 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.446 0.699 . . . . 0.0 112.826 -179.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 149.59 -146.26 15.33 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 124.034 0.826 . . . . 0.0 111.93 -173.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 19.0 tptt -129.61 126.61 38.85 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.271 1.028 . . . . 0.0 110.72 178.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.5 mp -72.2 138.56 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 123.701 0.8 . . . . 0.0 110.193 177.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.0 t -112.72 -22.95 10.46 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.819 1.247 . . . . 0.0 113.539 179.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 28.9 m-80 -135.08 134.13 40.0 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 119.487 1.039 . . . . 0.0 109.801 -176.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -147.98 124.58 11.08 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.253 1.021 . . . . 0.0 111.844 -176.428 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -135.84 130.95 34.72 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.255 1.022 . . . . 0.0 111.449 -177.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -122.46 85.85 48.28 Favored Pre-proline 0 CA--C 1.536 0.44 0 C-N-CA 125.68 1.592 . . . . 0.0 109.196 -175.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -70.66 169.71 19.4 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.6 2.2 . . . . 0.0 110.933 179.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -145.27 172.74 12.71 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.186 0.995 . . . . 0.0 111.688 175.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -112.39 109.9 19.8 Favored 'General case' 0 C--O 1.222 -0.369 0 C-N-CA 124.155 0.982 . . . . 0.0 110.611 177.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 17.7 t70 54.32 21.23 3.06 Favored 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 -179.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 85.86 13.39 69.6 Favored Glycine 0 CA--C 1.536 1.353 0 O-C-N 121.045 -1.034 . . . . 0.0 113.832 -174.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 10.2 mmtm -108.07 -179.94 4.04 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 127.039 2.136 . . . . 0.0 110.342 -178.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 79.9 p -58.84 115.58 3.19 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.235 1.414 . . . . 0.0 113.149 -176.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 3.2 pttt -64.17 174.85 1.43 Allowed 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.802 1.641 . . . . 0.0 114.508 172.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -136.31 -2.95 2.54 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 125.902 1.715 . . . . 0.0 115.314 174.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -145.36 154.81 42.7 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.945 1.698 . . . . 0.0 109.744 -175.325 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.1 pp -135.96 163.45 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 124.812 1.245 . . . . 0.0 110.205 172.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -130.4 125.38 34.4 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.568 1.147 . . . . 0.0 109.688 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -128.58 139.8 52.1 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 124.486 1.114 . . . . 0.0 109.993 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -125.59 134.28 51.99 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 121.898 0.856 . . . . 0.0 110.51 176.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -95.84 162.5 13.56 Favored 'General case' 0 CA--C 1.528 0.118 0 CA-C-O 122.185 0.993 . . . . 0.0 111.587 176.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.56 -1.83 26.26 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.24 1.016 . . . . 0.0 113.287 176.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -157.52 150.46 18.39 Favored Pre-proline 0 CA--C 1.541 0.612 0 C-N-CA 124.643 1.177 . . . . 0.0 111.877 -178.267 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -62.97 -44.37 16.17 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 123.41 2.74 . . . . 0.0 111.981 177.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -57.74 -20.99 38.63 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.844 1.258 . . . . 0.0 113.36 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 20.1 m-70 -82.05 -46.2 14.24 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 119.29 0.95 . . . . 0.0 111.735 173.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -66.44 -52.72 43.38 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.43 0.692 . . . . 0.0 112.387 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 11.3 m -61.32 -28.79 44.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 122.623 0.369 . . . . 0.0 111.861 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -75.54 -55.96 5.16 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.894 0.878 . . . . 0.0 111.155 173.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -52.85 -42.0 64.79 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.296 1.038 . . . . 0.0 112.772 -176.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 53.8 t -60.6 -35.77 65.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 123.859 0.863 . . . . 0.0 112.94 175.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 6.7 mttp -89.17 2.65 53.88 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.192 1.397 . . . . 0.0 113.241 178.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -123.83 -23.79 4.6 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 113.723 1.008 . . . . 0.0 113.723 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -114.63 18.7 16.54 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.531 1.132 . . . . 0.0 113.008 -177.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -61.8 74.5 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.964 2.106 . . . . 0.0 114.34 -177.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 105.72 78.85 1.22 Allowed Glycine 0 CA--C 1.527 0.793 0 C-N-CA 124.592 1.091 . . . . 0.0 113.107 174.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.599 ' HH ' ' CG1' ' A' ' 20' ' ' VAL . 11.0 m-85 -51.89 148.59 5.68 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.979 2.112 . . . . 0.0 113.226 179.426 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 7.2 mmmt . . . . . 0 N--CA 1.476 0.826 0 O-C-N 120.904 -1.122 . . . . 0.0 112.7 -171.416 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 . . . . . 0 N--CA 1.464 0.241 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -135.0 95.97 3.42 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 122.999 0.52 . . . . 0.0 110.198 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 40.9 t -85.45 122.28 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 178.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 52.7 m-80 . . . . . 0 CA--C 1.542 0.653 0 C-N-CA 125.255 1.422 . . . . 0.0 110.715 -179.174 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . 0.259 1.9 m-20 . . . . . 0 CA--C 1.546 0.807 0 N-CA-C 116.779 2.141 . . . . 0.0 116.779 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -124.09 5.79 8.57 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 126.758 2.023 . . . . 0.0 113.472 -177.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.0 m -137.2 165.65 27.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 124.015 0.926 . . . . 0.0 112.395 -173.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 17.5 pt -132.64 154.15 39.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 C-N-CA 124.526 1.13 . . . . 0.0 110.476 179.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 60.8 t -137.98 144.74 30.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 C-N-CA 125.676 1.59 . . . . 0.0 108.678 176.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.427 ' CG1' ' HH ' ' A' ' 84' ' ' TYR . 0.8 OUTLIER -122.98 156.04 28.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 C-N-CA 123.56 0.744 . . . . 0.0 109.372 174.871 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -130.32 169.65 15.16 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.34 1.456 . . . . 0.0 110.677 176.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 31.2 m-20 56.12 34.02 23.06 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 126.38 1.872 . . . . 0.0 113.91 -174.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . 0.255 7.5 p -102.18 81.15 0.34 Allowed Pre-proline 0 N--CA 1.484 1.252 0 C-N-CA 124.92 1.288 . . . . 0.0 112.158 179.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -66.62 149.25 84.06 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 122.058 1.839 . . . . 0.0 110.961 174.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 38.2 tt0 -67.72 163.74 20.92 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 121.634 0.731 . . . . 0.0 110.635 169.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 31.2 m -135.88 165.79 28.82 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 126.835 2.054 . . . . 0.0 109.482 -177.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -73.51 -172.54 24.83 Favored Glycine 0 CA--C 1.539 1.572 0 C-N-CA 123.833 0.73 . . . . 0.0 114.505 -178.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -62.49 169.76 7.79 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 123.353 2.702 . . . . 0.0 111.256 178.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 42.9 m-20 60.24 8.42 1.55 Allowed 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 125.451 1.501 . . . . 0.0 114.316 -177.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -148.31 -29.57 0.3 Allowed 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 126.046 1.739 . . . . 0.0 113.063 -179.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -51.36 -32.9 27.36 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 115.324 1.601 . . . . 0.0 115.324 177.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -68.59 -47.32 67.04 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.454 1.102 . . . . 0.0 109.502 179.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.4 mptt -51.08 -34.91 32.28 Favored 'General case' 0 C--O 1.219 -0.503 0 C-N-CA 126.601 1.96 . . . . 0.0 111.395 173.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 13.0 tp -51.99 -51.18 58.96 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 119.804 1.184 . . . . 0.0 113.134 177.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.8 tmtt? -83.35 -32.27 26.34 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.767 0.827 . . . . 0.0 112.79 172.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -60.84 -57.26 13.42 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 118.042 -0.98 . . . . 0.0 112.107 177.254 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 16.8 m -53.94 -37.91 35.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 CA-C-N 119.405 1.002 . . . . 0.0 111.257 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.2 mp -53.54 -45.27 58.76 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 124.525 1.13 . . . . 0.0 111.676 170.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 15.5 m-70 -65.51 -40.43 92.98 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 120.052 1.296 . . . . 0.0 112.623 176.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -74.29 -49.53 22.67 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 118.857 0.753 . . . . 0.0 112.647 -179.608 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -55.26 -42.68 67.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-N 118.759 0.709 . . . . 0.0 111.807 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -83.19 -2.08 54.61 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 113.388 0.885 . . . . 0.0 113.388 -178.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.3 t -74.12 -25.29 59.69 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 179.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 17.5 pttt -66.55 -18.71 65.51 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 119.371 0.987 . . . . 0.0 113.005 174.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -101.51 -12.25 18.66 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.211 1.005 . . . . 0.0 113.16 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 156.27 -144.37 10.76 Favored Glycine 0 CA--C 1.529 0.957 0 CA-C-N 118.467 0.576 . . . . 0.0 112.525 -176.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 26.1 tptt -131.67 128.38 38.91 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.929 1.292 . . . . 0.0 108.766 175.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.0 mp -84.14 131.34 34.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 177.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.0 t -100.76 -31.74 11.04 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 178.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 51.1 m-80 -108.22 163.78 12.88 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 119.329 0.968 . . . . 0.0 112.171 178.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -170.05 116.74 0.54 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.306 1.042 . . . . 0.0 112.307 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -132.97 126.52 32.18 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 121.877 0.846 . . . . 0.0 111.591 -179.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -119.5 86.04 33.28 Favored Pre-proline 0 CA--C 1.542 0.656 0 C-N-CA 126.464 1.906 . . . . 0.0 108.32 -178.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -69.53 174.78 8.81 Favored 'Trans proline' 0 C--N 1.355 0.881 0 C-N-CA 123.346 2.697 . . . . 0.0 110.95 177.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -145.53 172.35 13.35 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.235 1.414 . . . . 0.0 111.494 176.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -113.58 110.85 20.9 Favored 'General case' 0 C--O 1.223 -0.324 0 C-N-CA 125.096 1.358 . . . . 0.0 110.24 175.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 54.24 21.19 2.97 Favored 'General case' 0 CA--C 1.554 1.131 0 N-CA-C 114.884 1.439 . . . . 0.0 114.884 179.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 86.33 17.1 61.23 Favored Glycine 0 CA--C 1.539 1.579 0 O-C-N 121.259 -0.9 . . . . 0.0 113.485 -173.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 27.7 mmmt -117.22 176.34 5.19 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 127.65 2.38 . . . . 0.0 110.091 -177.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 76.2 p -50.6 117.39 2.42 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 126.739 2.016 . . . . 0.0 112.86 -176.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -69.71 177.41 3.04 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.922 0.889 . . . . 0.0 112.769 175.52 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -138.98 -1.63 2.01 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 125.503 1.525 . . . . 0.0 115.254 173.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -146.93 155.27 42.15 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 119.627 1.713 . . . . 0.0 109.098 -174.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.1 pp -138.99 166.44 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 125.233 1.413 . . . . 0.0 110.424 173.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 26.7 t80 -135.43 126.91 28.66 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.141 0.976 . . . . 0.0 109.827 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -130.51 139.42 50.5 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.444 1.498 . . . . 0.0 110.186 179.216 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -127.3 125.81 41.5 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.858 1.263 . . . . 0.0 111.034 177.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -86.05 169.22 13.37 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 122.199 0.999 . . . . 0.0 111.769 176.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -77.51 -5.96 51.89 Favored 'General case' 0 CA--C 1.549 0.918 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 175.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -154.51 156.19 31.37 Favored Pre-proline 0 N--CA 1.473 0.721 0 C-N-CA 125.059 1.344 . . . . 0.0 112.83 -176.096 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -65.38 -48.67 3.13 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 123.646 2.897 . . . . 0.0 111.478 179.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -53.29 -18.32 2.36 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.387 1.875 . . . . 0.0 114.284 177.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 22.3 m170 -85.81 -48.29 8.92 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 119.146 0.884 . . . . 0.0 110.494 175.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -64.29 -54.7 29.09 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.892 1.277 . . . . 0.0 112.335 177.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 11.8 m -59.51 -31.73 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 123.034 0.533 . . . . 0.0 111.438 -177.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -73.28 -57.67 3.85 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.59 1.156 . . . . 0.0 111.286 172.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -50.22 -44.09 53.12 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.637 1.175 . . . . 0.0 113.595 -178.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 54.8 t -58.48 -43.03 85.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 174.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.0 -0.52 51.94 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.616 1.566 . . . . 0.0 112.852 -179.415 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -113.86 -44.68 3.15 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 124.189 0.996 . . . . 0.0 112.436 178.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -94.91 18.78 11.27 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 -178.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -56.87 83.21 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 126.271 1.828 . . . . 0.0 113.053 177.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 102.99 87.0 1.98 Allowed Glycine 0 CA--C 1.527 0.806 0 C-N-CA 124.852 1.215 . . . . 0.0 113.401 171.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.427 ' HH ' ' CG1' ' A' ' 20' ' ' VAL . 34.2 m-85 -66.47 143.51 57.05 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 -176.44 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.195 0 O-C-N 120.241 -1.537 . . . . 0.0 114.932 -176.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 . . . . . 0 N--CA 1.463 0.188 0 N-CA-C 110.151 -0.314 . . . . 0.0 110.151 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 15.8 mmm-85 -138.52 98.62 3.63 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.165 0.986 . . . . 0.0 109.603 -177.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 40.4 t -87.77 119.8 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 178.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 52.6 m-80 . . . . . 0 CA--C 1.545 0.765 0 C-N-CA 125.553 1.541 . . . . 0.0 110.852 -179.976 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . 0.323 4.7 p-10 . . . . . 0 CA--C 1.553 1.077 0 N-CA-C 117.81 2.522 . . . . 0.0 117.81 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 50.6 m -115.33 4.1 14.35 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 129.424 3.09 . . . . 0.0 114.001 -174.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.2 m -137.75 161.74 32.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 125.098 1.359 . . . . 0.0 111.985 -172.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 19.1 pt -130.76 152.88 38.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 CA-C-O 122.338 1.066 . . . . 0.0 110.256 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 61.3 t -137.8 142.28 36.64 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.334 0 C-N-CA 125.482 1.513 . . . . 0.0 108.751 176.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -122.44 151.37 26.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 125.002 1.321 . . . . 0.0 108.679 178.442 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -127.65 167.3 16.61 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.204 1.402 . . . . 0.0 110.897 178.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 38.4 m-20 59.04 31.53 21.42 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 126.64 1.976 . . . . 0.0 114.212 -173.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . 0.254 7.6 p -102.01 81.29 0.34 Allowed Pre-proline 0 N--CA 1.479 1.011 0 C-N-CA 125.847 1.659 . . . . 0.0 111.835 -179.169 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -67.51 159.65 51.53 Favored 'Trans proline' 0 C--N 1.356 0.952 0 C-N-CA 122.004 1.803 . . . . 0.0 110.895 175.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -75.83 167.57 21.63 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.785 170.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 31.8 m -136.99 166.45 25.72 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 C-N-CA 126.521 1.928 . . . . 0.0 109.272 -177.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -75.78 -173.24 34.21 Favored Glycine 0 CA--C 1.539 1.59 0 C-N-CA 124.341 0.972 . . . . 0.0 114.523 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -61.39 169.07 7.02 Favored 'Trans proline' 0 CA--C 1.536 0.614 0 C-N-CA 123.568 2.845 . . . . 0.0 111.019 177.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 61.69 9.6 2.91 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.843 1.657 . . . . 0.0 114.046 -178.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 43.4 ttt85 -150.66 -29.61 0.2 Allowed 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 127.031 2.132 . . . . 0.0 114.601 -178.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -51.7 -33.22 33.33 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 115.263 1.579 . . . . 0.0 115.263 177.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -66.29 -50.77 62.53 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 125.613 1.565 . . . . 0.0 109.315 178.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 5.8 mptt -49.76 -37.83 31.35 Favored 'General case' 0 C--N 1.345 0.408 0 C-N-CA 127.627 2.371 . . . . 0.0 110.379 175.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -47.36 -64.71 0.71 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.135 1.374 . . . . 0.0 111.361 177.047 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.91 -28.47 58.06 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.687 0.795 . . . . 0.0 112.472 176.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -60.33 -59.69 5.01 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 117.773 -1.108 . . . . 0.0 111.437 176.305 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 32.3 m -53.94 -33.78 24.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 125.1 1.36 . . . . 0.0 111.746 -177.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.2 mp -50.09 -48.49 23.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 124.381 1.072 . . . . 0.0 111.137 169.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 19.4 m-70 -67.55 -20.33 65.39 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 119.446 1.021 . . . . 0.0 113.544 179.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.28 -49.64 5.12 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.02 1.328 . . . . 0.0 111.498 -177.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -55.17 -43.87 72.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 124.581 1.152 . . . . 0.0 111.129 175.179 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 36.5 m-85 -87.22 -0.14 56.25 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 113.04 0.755 . . . . 0.0 113.04 -177.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -70.09 -35.29 74.07 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.094 1.358 . . . . 0.0 112.05 178.333 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.455 ' HE3' ' CZ ' ' A' ' 45' ' ' PHE . 20.7 pttt -61.82 -17.36 55.96 Favored 'General case' 0 N--CA 1.478 0.941 0 O-C-N 120.948 -1.095 . . . . 0.0 113.647 177.558 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.455 ' CZ ' ' HE3' ' A' ' 44' ' ' LYS . 9.2 m-85 -101.17 -10.99 19.91 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.881 1.272 . . . . 0.0 113.346 178.29 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 149.55 -149.31 21.24 Favored Glycine 0 CA--C 1.532 1.125 0 CA-C-N 119.182 0.901 . . . . 0.0 112.663 -174.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 21.3 tptt -127.47 124.64 38.86 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 124.405 1.082 . . . . 0.0 108.945 178.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.4 mp -79.61 130.37 36.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 123.672 0.789 . . . . 0.0 109.066 175.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 2.8 t -100.7 -30.62 11.63 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.754 1.222 . . . . 0.0 113.516 177.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 42.7 m-80 -113.15 154.11 27.18 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 119.647 1.112 . . . . 0.0 111.548 179.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -159.46 123.91 3.94 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.665 0.786 . . . . 0.0 110.759 176.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -134.83 129.81 35.07 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 123.678 0.791 . . . . 0.0 111.905 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -121.65 86.17 44.69 Favored Pre-proline 0 CA--C 1.538 0.508 0 C-N-CA 127.449 2.3 . . . . 0.0 108.442 -177.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -68.67 174.49 8.44 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 122.736 2.291 . . . . 0.0 110.929 174.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -146.04 172.53 13.25 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 126.548 1.939 . . . . 0.0 110.416 174.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -113.33 110.29 20.1 Favored 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 125.674 1.59 . . . . 0.0 109.049 175.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 57.18 20.17 5.44 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 124.686 1.194 . . . . 0.0 113.784 177.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 85.04 14.62 68.98 Favored Glycine 0 CA--C 1.537 1.467 0 O-C-N 121.025 -1.047 . . . . 0.0 114.002 -172.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 5.8 mmmt -114.64 171.1 7.84 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 128.368 2.667 . . . . 0.0 109.976 -178.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 4.0 t -40.85 115.5 0.59 Allowed 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 127.228 2.211 . . . . 0.0 112.632 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.0 pttp -62.91 -179.11 0.25 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.339 1.056 . . . . 0.0 112.628 168.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -142.69 0.19 1.39 Allowed Glycine 0 CA--C 1.531 1.086 0 C-N-CA 126.51 2.005 . . . . 0.0 115.441 170.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -146.6 154.52 41.58 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 119.957 1.879 . . . . 0.0 108.999 -174.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.1 pp -137.09 165.3 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 126.274 1.83 . . . . 0.0 110.834 172.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -135.66 126.2 26.95 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.2 1.4 . . . . 0.0 109.507 -177.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -131.1 141.12 50.11 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.816 1.646 . . . . 0.0 110.706 -178.534 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -129.69 127.29 40.21 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.635 0.774 . . . . 0.0 109.908 -179.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -88.99 167.21 13.37 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.968 0.89 . . . . 0.0 111.693 177.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.2 -4.0 36.33 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.099 0.959 . . . . 0.0 113.499 174.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -157.3 153.86 24.47 Favored Pre-proline 0 N--CA 1.474 0.727 0 C-N-CA 124.973 1.309 . . . . 0.0 112.717 -177.036 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -63.07 -47.69 7.81 Favored 'Trans proline' 0 C--N 1.354 0.816 0 C-N-CA 123.862 3.041 . . . . 0.0 110.877 177.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -55.69 -14.72 2.38 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.735 2.014 . . . . 0.0 114.624 178.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 54.2 m170 -88.46 -46.37 9.18 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 119.669 1.122 . . . . 0.0 110.609 171.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -66.42 -54.31 25.72 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 124.03 0.932 . . . . 0.0 111.465 -179.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 10.7 m -61.28 -26.16 38.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 124.013 0.925 . . . . 0.0 112.076 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -78.25 -56.91 4.08 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.823 1.249 . . . . 0.0 110.299 172.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -50.65 -43.73 57.31 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 119.705 1.139 . . . . 0.0 113.411 -179.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 61.2 t -57.91 -39.82 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 123.63 0.772 . . . . 0.0 112.907 175.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 7.2 mttt -90.18 4.69 49.75 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 126.095 1.758 . . . . 0.0 113.088 179.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -124.8 -20.5 5.0 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 115.147 1.536 . . . . 0.0 115.147 178.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -120.94 21.74 11.28 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 125.479 1.511 . . . . 0.0 112.287 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -56.54 79.74 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 127.586 2.354 . . . . 0.0 113.797 178.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 98.11 91.29 1.95 Allowed Glycine 0 C--N 1.341 0.86 0 C-N-CA 124.202 0.906 . . . . 0.0 111.955 174.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -67.33 150.13 49.4 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.449 1.1 . . . . 0.0 113.704 -177.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . 0.273 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.219 0 N-CA-C 115.266 1.58 . . . . 0.0 115.266 -178.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 . . . . . 0 N--CA 1.464 0.227 0 CA-C-O 121.0 0.429 . . . . 0.0 111.293 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 23.3 mmm180 -137.59 89.88 2.46 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.21 1.404 . . . . 0.0 110.705 -177.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 33.3 t -77.9 118.78 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 123.616 0.766 . . . . 0.0 109.43 176.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 55.6 m-80 . . . . . 0 CA--C 1.544 0.722 0 C-N-CA 125.768 1.627 . . . . 0.0 110.563 178.964 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 . . . . . 0 CA--C 1.55 0.943 0 N-CA-C 116.036 1.865 . . . . 0.0 116.036 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.6 m -121.53 1.52 10.09 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 126.532 1.933 . . . . 0.0 113.348 -174.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 26.8 m -144.89 167.72 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 124.386 1.075 . . . . 0.0 111.772 -169.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 21.0 pt -130.96 156.03 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 CA-C-O 121.401 0.619 . . . . 0.0 111.472 178.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 98.2 t -136.0 152.93 31.23 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.029 0 C-N-CA 125.286 1.434 . . . . 0.0 109.964 175.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.597 HG13 ' HH ' ' A' ' 84' ' ' TYR . 0.6 OUTLIER -130.43 149.78 33.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 N-CA-C 108.312 -0.995 . . . . 0.0 108.312 177.061 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -124.86 162.37 24.5 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 124.357 1.063 . . . . 0.0 110.59 176.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 12.9 t30 65.76 34.02 7.78 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.709 1.604 . . . . 0.0 113.405 -177.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.7 p -104.53 81.7 0.56 Allowed Pre-proline 0 N--CA 1.476 0.866 0 C-N-CA 125.572 1.549 . . . . 0.0 112.612 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -68.31 144.85 63.7 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.108 1.872 . . . . 0.0 111.84 177.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.93 163.55 14.28 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 120.915 0.388 . . . . 0.0 111.193 169.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 31.3 m -138.55 161.37 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 C-N-CA 125.294 1.438 . . . . 0.0 109.935 -174.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -70.47 -173.25 12.75 Favored Glycine 0 CA--C 1.546 2.021 0 N-CA-C 115.286 0.875 . . . . 0.0 115.286 -179.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -62.21 167.97 10.09 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 123.527 2.818 . . . . 0.0 111.493 179.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 19.2 t70 64.4 7.75 3.82 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.055 1.342 . . . . 0.0 113.126 -178.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.2 ttt-85 -150.36 -27.38 0.23 Allowed 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.566 1.546 . . . . 0.0 114.142 -179.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -52.02 -33.09 36.9 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 114.713 1.375 . . . . 0.0 114.713 176.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -65.34 -53.14 48.06 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 125.077 1.351 . . . . 0.0 108.844 177.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.79 -38.52 48.83 Favored 'General case' 0 C--O 1.219 -0.541 0 C-N-CA 126.623 1.969 . . . . 0.0 111.003 176.61 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -46.65 -59.59 2.92 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 119.406 1.003 . . . . 0.0 111.879 175.263 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -75.17 -32.79 61.37 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.762 0.825 . . . . 0.0 112.824 175.232 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.99 -55.42 25.85 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 117.659 -1.163 . . . . 0.0 111.835 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 15.6 m -55.14 -37.55 43.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 124.25 1.02 . . . . 0.0 110.838 179.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.1 mp -53.18 -47.62 55.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 124.81 1.244 . . . . 0.0 111.495 170.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 13.5 m-70 -65.37 -39.7 92.6 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 119.29 0.95 . . . . 0.0 112.644 178.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -72.77 -49.14 32.65 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 119.233 0.924 . . . . 0.0 112.669 177.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -57.03 -39.86 69.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 CA-C-N 119.378 0.99 . . . . 0.0 111.878 -177.468 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 35.3 m-85 -86.64 -1.03 57.35 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -178.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -75.78 -22.94 55.92 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 -179.369 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 3.4 pttm -68.56 -24.94 64.68 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 119.488 1.04 . . . . 0.0 112.367 175.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -92.16 -14.24 29.42 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.977 0.911 . . . . 0.0 112.825 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 156.59 -148.35 18.11 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 123.982 0.801 . . . . 0.0 112.361 -176.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 12.3 tptm -128.08 123.16 33.88 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.455 1.102 . . . . 0.0 109.463 176.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 1.7 mp -79.71 123.55 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 177.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.8 t -102.18 -11.57 18.69 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 117.697 -1.144 . . . . 0.0 114.061 -178.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 32.0 m-80 -121.91 165.7 15.55 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.057 1.343 . . . . 0.0 110.917 175.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -166.79 126.21 1.48 Allowed 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.811 0.845 . . . . 0.0 111.928 173.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -137.02 122.37 19.42 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.833 0.825 . . . . 0.0 111.478 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -119.92 86.58 36.69 Favored Pre-proline 0 CA--C 1.538 0.504 0 C-N-CA 126.086 1.754 . . . . 0.0 108.835 -178.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -70.33 174.79 9.49 Favored 'Trans proline' 0 CA--C 1.536 0.612 0 C-N-CA 123.069 2.513 . . . . 0.0 111.043 178.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -145.54 171.97 13.91 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.482 1.113 . . . . 0.0 111.753 173.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -111.97 109.87 19.88 Favored 'General case' 0 C--O 1.223 -0.309 0 C-N-CA 124.734 1.213 . . . . 0.0 109.639 176.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 54.26 24.96 5.4 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 125.054 1.342 . . . . 0.0 114.462 179.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 83.7 12.89 76.78 Favored Glycine 0 CA--C 1.539 1.534 0 O-C-N 121.494 -0.754 . . . . 0.0 113.666 -174.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.9 mtpp -114.79 179.32 3.98 Favored 'General case' 0 C--N 1.343 0.297 0 C-N-CA 126.604 1.961 . . . . 0.0 110.857 -177.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 65.6 p -54.46 110.92 0.69 Allowed 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.675 1.59 . . . . 0.0 113.556 -173.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.6 pttt -59.23 174.12 0.42 Allowed 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.86 1.664 . . . . 0.0 113.291 173.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -136.38 -3.38 2.44 Favored Glycine 0 CA--C 1.534 1.272 0 C-N-CA 125.265 1.412 . . . . 0.0 115.484 173.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -144.7 154.77 43.11 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 126.116 1.766 . . . . 0.0 109.009 -176.109 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.1 pp -137.06 168.66 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 125.671 1.588 . . . . 0.0 110.74 172.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -138.65 132.68 31.31 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.748 1.219 . . . . 0.0 110.102 -178.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 31.8 mt -136.45 147.1 47.03 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 125.04 1.336 . . . . 0.0 110.684 179.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -132.31 122.17 24.7 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 124.149 0.98 . . . . 0.0 109.848 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -83.29 170.86 14.16 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 121.933 0.873 . . . . 0.0 111.245 175.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -74.01 -3.53 29.82 Favored 'General case' 0 CA--C 1.549 0.904 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 173.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.3 p -161.1 156.08 20.41 Favored Pre-proline 0 CA--C 1.54 0.567 0 CA-C-N 119.561 1.073 . . . . 0.0 112.997 -175.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -65.73 -45.41 6.56 Favored 'Trans proline' 0 C--N 1.355 0.919 0 C-N-CA 123.363 2.708 . . . . 0.0 111.632 -178.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -55.42 -15.51 2.73 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.295 1.838 . . . . 0.0 114.028 177.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -90.44 -46.57 8.27 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 119.729 1.15 . . . . 0.0 110.817 174.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -60.2 -57.18 13.91 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.338 1.055 . . . . 0.0 112.452 173.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 10.4 m -61.69 -28.48 44.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -176.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -74.82 -56.29 4.93 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.455 1.102 . . . . 0.0 110.66 173.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.77 -41.55 61.72 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.165 0.986 . . . . 0.0 112.969 -176.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 78.8 t -58.02 -39.44 72.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 124.018 0.927 . . . . 0.0 113.167 174.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 3.2 mptt -88.32 3.75 48.58 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.075 1.35 . . . . 0.0 113.348 178.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -120.67 -31.11 4.34 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 179.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -110.12 21.18 17.09 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 119.251 0.932 . . . . 0.0 113.039 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -57.21 85.61 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.768 1.627 . . . . 0.0 113.076 178.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 97.56 79.28 1.45 Allowed Glycine 0 CA--C 1.53 0.989 0 C-N-CA 124.308 0.956 . . . . 0.0 113.304 173.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.597 ' HH ' HG13 ' A' ' 20' ' ' VAL . 12.6 m-85 -57.49 128.66 38.14 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.805 1.242 . . . . 0.0 112.941 -177.066 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.477 0.895 0 O-C-N 119.941 -1.724 . . . . 0.0 115.283 -176.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 . . . . . 0 N--CA 1.466 0.328 0 CA-C-O 120.648 0.261 . . . . 0.0 110.746 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 22.1 mmt180 -137.08 87.04 2.25 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.985 0.914 . . . . 0.0 110.673 -178.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 39.2 t -78.82 118.7 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 177.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 54.7 m-80 . . . . . 0 CA--C 1.538 0.493 0 C-N-CA 125.686 1.594 . . . . 0.0 110.006 -178.319 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 CA--C 1.547 0.829 0 N-CA-C 116.427 2.01 . . . . 0.0 116.427 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 68.4 m -118.73 8.41 11.85 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.859 1.664 . . . . 0.0 113.722 -177.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.5 m -142.62 164.6 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 C-N-CA 123.517 0.727 . . . . 0.0 111.432 -174.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 18.4 pt -129.63 148.4 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 123.063 0.545 . . . . 0.0 110.976 179.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 40.7 t -134.01 137.13 52.71 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.121 0 CA-C-O 122.318 1.056 . . . . 0.0 109.173 174.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.617 HG12 ' HH ' ' A' ' 84' ' ' TYR . 0.9 OUTLIER -109.61 154.23 11.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.054 -0.975 . . . . 0.0 109.27 179.371 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -129.77 158.38 39.58 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 123.263 0.625 . . . . 0.0 111.792 174.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 63.5 t30 61.58 40.1 13.9 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 126.009 1.724 . . . . 0.0 113.056 -178.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.7 m -99.82 83.28 0.34 Allowed Pre-proline 0 N--CA 1.483 1.18 0 C-N-CA 126.032 1.733 . . . . 0.0 112.434 174.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -65.21 140.14 63.47 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 121.759 1.64 . . . . 0.0 110.002 171.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.67 177.36 1.62 Allowed 'General case' 0 CA--C 1.541 0.596 0 CA-C-O 121.385 0.612 . . . . 0.0 112.136 170.363 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.3 m -135.47 162.77 36.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 C-N-CA 125.183 1.393 . . . . 0.0 110.557 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -66.56 -174.15 5.86 Favored Glycine 0 CA--C 1.544 1.849 0 C-N-CA 124.069 0.842 . . . . 0.0 114.989 -179.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -63.81 166.19 16.67 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 123.051 2.501 . . . . 0.0 111.661 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.6 t0 62.33 11.72 4.73 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 123.876 0.87 . . . . 0.0 112.725 -177.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 7.2 ttt180 -151.52 -26.55 0.19 Allowed 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.431 1.492 . . . . 0.0 113.922 177.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -51.6 -32.9 30.57 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 114.694 1.368 . . . . 0.0 114.694 179.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -66.98 -49.24 66.02 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 125.46 1.504 . . . . 0.0 109.694 179.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 8.3 mptt -49.65 -34.17 17.6 Favored 'General case' 0 C--O 1.219 -0.551 0 C-N-CA 126.601 1.961 . . . . 0.0 111.279 173.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -50.42 -63.49 1.1 Allowed 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 120.264 1.393 . . . . 0.0 110.875 177.269 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.91 -28.89 61.76 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 121.444 -0.785 . . . . 0.0 112.687 175.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.8 -56.7 15.07 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 118.016 -0.992 . . . . 0.0 112.164 177.108 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 19.0 m -55.61 -34.84 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 124.004 0.922 . . . . 0.0 110.983 -178.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.1 mp -49.41 -46.89 19.83 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 124.528 1.131 . . . . 0.0 111.462 171.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 18.8 m-70 -68.68 -16.73 63.92 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 113.542 0.942 . . . . 0.0 113.542 179.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -94.04 -51.44 4.85 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.528 1.131 . . . . 0.0 111.19 178.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -56.08 -37.23 48.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 CA-C-N 118.831 0.741 . . . . 0.0 111.742 177.165 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -91.12 -0.93 57.81 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -179.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -74.31 -27.01 60.51 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 178.441 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.487 ' HE3' ' CZ ' ' A' ' 45' ' ' PHE . 16.9 pttt -66.67 -22.08 66.09 Favored 'General case' 0 N--CA 1.48 1.071 0 O-C-N 120.536 -1.353 . . . . 0.0 113.188 176.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.487 ' CZ ' ' HE3' ' A' ' 44' ' ' LYS . 9.6 m-85 -94.95 -12.89 25.94 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.68 0.792 . . . . 0.0 113.001 -179.266 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 151.03 -152.18 24.03 Favored Glycine 0 CA--C 1.53 1.024 0 N-CA-C 111.668 -0.573 . . . . 0.0 111.668 -173.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 24.6 tptt -126.26 123.61 38.52 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.506 1.122 . . . . 0.0 110.067 177.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.4 mp -76.37 129.72 36.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 176.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 2.6 t -100.83 -30.48 11.66 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.551 0.74 . . . . 0.0 112.826 179.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 8.8 m-80 -109.88 162.73 14.22 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.39 1.076 . . . . 0.0 110.843 -179.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -165.52 125.67 1.82 Allowed 'General case' 0 N--CA 1.468 0.439 0 O-C-N 121.424 -0.797 . . . . 0.0 111.785 174.39 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -136.83 122.87 20.27 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.941 0.876 . . . . 0.0 111.577 -179.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -119.72 86.1 34.63 Favored Pre-proline 0 CA--C 1.537 0.461 0 C-N-CA 125.892 1.677 . . . . 0.0 109.11 -176.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -70.75 171.08 16.24 Favored 'Trans proline' 0 CA--C 1.534 0.511 0 C-N-CA 122.99 2.46 . . . . 0.0 111.426 178.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -145.67 173.78 11.77 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.282 1.033 . . . . 0.0 111.705 175.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -116.22 111.34 20.04 Favored 'General case' 0 C--O 1.223 -0.3 0 C-N-CA 124.771 1.228 . . . . 0.0 110.096 176.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 50.86 30.08 4.87 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 125.768 1.627 . . . . 0.0 113.911 -178.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 79.66 12.96 83.06 Favored Glycine 0 CA--C 1.534 1.24 0 O-C-N 121.163 -0.96 . . . . 0.0 113.042 -176.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 26.7 mtpt -111.41 -178.35 3.43 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.689 1.995 . . . . 0.0 109.85 -178.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 64.4 p -57.72 115.37 2.76 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 126.818 2.047 . . . . 0.0 112.98 -172.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.8 pttp -69.46 171.81 8.19 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.605 1.162 . . . . 0.0 113.96 171.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -138.29 3.77 3.05 Favored Glycine 0 CA--C 1.536 1.385 0 C-N-CA 126.848 2.166 . . . . 0.0 115.638 175.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -147.38 152.57 38.38 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 119.961 1.88 . . . . 0.0 109.542 -178.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -135.84 166.72 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 125.643 1.577 . . . . 0.0 111.098 172.331 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -134.72 126.09 28.31 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.223 1.409 . . . . 0.0 109.985 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 73.9 mt -127.72 149.62 50.14 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 124.593 1.157 . . . . 0.0 110.722 175.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -136.34 132.56 35.78 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-O 122.364 1.078 . . . . 0.0 110.253 178.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -94.82 167.97 11.1 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 114.762 -1.108 . . . . 0.0 111.186 177.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -80.51 10.24 4.97 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.944 0.898 . . . . 0.0 112.339 176.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 9.7 m -169.78 153.04 4.79 Favored Pre-proline 0 CA--C 1.54 0.592 0 CA-C-N 120.005 1.275 . . . . 0.0 112.583 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -64.09 -46.12 8.79 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 124.818 3.679 . . . . 0.0 111.865 -178.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -53.98 -20.8 6.78 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.725 1.61 . . . . 0.0 113.509 176.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 33.0 m170 -84.99 -47.87 9.81 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 119.778 1.172 . . . . 0.0 110.534 176.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -65.06 -51.86 59.08 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.099 0.96 . . . . 0.0 112.287 178.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 15.9 m -60.47 -34.06 56.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 122.664 0.386 . . . . 0.0 111.149 -179.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -68.36 -57.39 5.97 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 123.593 0.757 . . . . 0.0 110.463 172.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -55.7 -39.66 71.33 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 119.101 0.864 . . . . 0.0 112.748 -173.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 49.2 t -59.43 -42.2 86.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 123.971 0.908 . . . . 0.0 112.713 173.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.56 2.33 37.71 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.354 1.061 . . . . 0.0 113.463 177.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -115.67 -53.63 2.57 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 119.036 0.835 . . . . 0.0 111.409 179.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -88.11 19.18 3.79 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.021 0.928 . . . . 0.0 113.327 -176.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -52.33 86.44 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.518 1.927 . . . . 0.0 113.374 -179.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.64 95.49 0.77 Allowed Glycine 0 CA--C 1.531 1.075 0 C-N-CA 124.557 1.075 . . . . 0.0 111.495 -178.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.617 ' HH ' HG12 ' A' ' 20' ' ' VAL . 23.6 m-85 -59.59 156.25 13.88 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 122.14 0.972 . . . . 0.0 112.397 177.042 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.467 0.418 0 C-N-CA 124.445 1.098 . . . . 0.0 110.08 -172.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 . . . . . 0 N--CA 1.467 0.392 0 CA-C-O 120.408 0.147 . . . . 0.0 111.087 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 21.0 mmm180 -136.43 94.76 3.05 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.606 0.762 . . . . 0.0 110.648 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 60.4 t -89.55 109.88 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 123.64 0.776 . . . . 0.0 109.849 179.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 . . . . . 0 CA--C 1.546 0.796 0 C-N-CA 125.004 1.321 . . . . 0.0 111.356 179.639 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . 0.272 3.6 p30 . . . . . 0 N--CA 1.477 0.875 0 N-CA-C 115.955 1.835 . . . . 0.0 115.955 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 59.7 m -130.83 5.68 4.62 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 127.21 2.204 . . . . 0.0 113.132 -171.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.6 m -142.3 162.7 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 C-N-CA 125.211 1.404 . . . . 0.0 111.785 -173.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 16.7 pt -131.42 150.09 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 C-N-CA 123.874 0.87 . . . . 0.0 110.243 -178.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 44.5 t -136.08 132.44 50.04 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.175 0 C-N-CA 124.954 1.302 . . . . 0.0 109.004 175.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -107.01 151.55 8.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 124.544 1.138 . . . . 0.0 109.51 176.452 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -127.23 166.32 17.97 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.229 1.012 . . . . 0.0 111.309 175.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 66.4 t30 60.2 39.62 19.06 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 126.593 1.957 . . . . 0.0 113.057 -176.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . 0.26 7.2 p -109.0 80.44 1.31 Allowed Pre-proline 0 N--CA 1.476 0.865 0 C-N-CA 125.63 1.572 . . . . 0.0 112.019 179.629 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -66.89 142.29 62.08 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 121.986 1.791 . . . . 0.0 110.975 175.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.31 163.02 13.72 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 122.981 0.512 . . . . 0.0 111.62 170.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 33.2 m -133.42 173.0 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 124.913 1.285 . . . . 0.0 110.953 -174.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -74.22 -176.58 35.4 Favored Glycine 0 CA--C 1.543 1.783 0 N-CA-C 114.478 0.551 . . . . 0.0 114.478 178.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -62.34 168.98 8.67 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 123.49 2.794 . . . . 0.0 111.205 176.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.1 t70 64.07 2.63 1.47 Allowed 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.425 1.49 . . . . 0.0 113.53 -177.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 4.4 ttp180 -142.71 -28.6 0.58 Allowed 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 126.525 1.93 . . . . 0.0 113.77 179.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -51.46 -33.4 30.82 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 115.146 1.536 . . . . 0.0 115.146 179.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -68.81 -43.22 76.04 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 124.929 1.292 . . . . 0.0 110.474 178.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -51.52 -38.52 54.48 Favored 'General case' 0 C--O 1.221 -0.424 0 C-N-CA 126.052 1.741 . . . . 0.0 110.659 174.238 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 80.6 mt -52.71 -43.42 65.63 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 120.142 1.337 . . . . 0.0 113.692 178.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.1 tmtt? -91.88 -28.07 17.53 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.726 0.811 . . . . 0.0 112.103 176.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -62.12 -61.79 2.23 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 118.864 -0.588 . . . . 0.0 111.557 173.501 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 28.0 m -54.04 -34.95 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 124.936 1.294 . . . . 0.0 111.42 -174.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.1 mp -46.92 -55.74 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.335 0 C-N-CA 125.582 1.553 . . . . 0.0 109.955 169.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 29.2 m-70 -63.39 -34.08 76.93 Favored 'General case' 0 C--O 1.223 -0.295 0 CA-C-O 118.203 -0.903 . . . . 0.0 112.275 -178.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.7 -54.12 11.35 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 118.877 0.762 . . . . 0.0 111.366 178.234 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -58.28 -42.13 82.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-N 118.42 0.555 . . . . 0.0 111.441 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.568 ' HB3' ' HH ' ' A' ' 68' ' ' TYR . 34.0 m-85 -84.43 -1.31 55.41 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 113.626 0.972 . . . . 0.0 113.626 -177.144 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.77 -27.32 61.09 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.534 1.133 . . . . 0.0 113.174 179.038 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 2.7 pttm -67.69 -24.78 65.44 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 119.794 1.179 . . . . 0.0 112.892 177.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -93.33 -10.39 35.55 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.28 1.032 . . . . 0.0 113.014 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 149.15 -142.67 10.05 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.046 0.831 . . . . 0.0 112.356 -176.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.5 tppt? -134.69 130.91 37.02 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 124.574 1.15 . . . . 0.0 109.766 177.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.9 mp -81.9 127.09 39.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 124.686 1.194 . . . . 0.0 108.46 175.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.2 t -97.86 -33.28 11.3 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.472 1.109 . . . . 0.0 113.089 178.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 8.7 m-80 -104.26 165.13 11.26 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.928 1.291 . . . . 0.0 111.162 179.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -167.78 126.16 1.24 Allowed 'General case' 0 N--CA 1.469 0.494 0 O-C-N 121.244 -0.91 . . . . 0.0 111.915 174.124 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -137.0 118.43 14.73 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-O 121.566 0.698 . . . . 0.0 111.366 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -116.46 86.75 18.73 Favored Pre-proline 0 CA--C 1.539 0.553 0 C-N-CA 126.136 1.774 . . . . 0.0 108.583 -179.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -69.29 174.61 8.85 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 123.249 2.632 . . . . 0.0 111.234 178.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -145.38 172.68 12.83 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.855 1.262 . . . . 0.0 111.94 174.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -113.76 108.25 16.85 Favored 'General case' 0 C--O 1.224 -0.275 0 C-N-CA 125.339 1.456 . . . . 0.0 109.508 178.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 53.96 26.73 6.58 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.289 1.435 . . . . 0.0 114.021 -179.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.58 11.69 82.73 Favored Glycine 0 CA--C 1.532 1.14 0 O-C-N 121.352 -0.842 . . . . 0.0 113.493 -174.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.5 mtpp -111.56 178.86 4.19 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 126.648 1.979 . . . . 0.0 110.252 178.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 44.0 p -48.71 106.43 0.1 Allowed 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 127.68 2.392 . . . . 0.0 115.013 -176.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.7 pttt -58.77 172.03 0.58 Allowed 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.026 1.33 . . . . 0.0 112.127 173.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -132.01 -2.81 4.16 Favored Glycine 0 CA--C 1.538 1.53 0 C-N-CA 127.364 2.412 . . . . 0.0 116.149 173.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -145.82 155.15 42.72 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 119.796 1.798 . . . . 0.0 109.249 -175.057 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -136.52 164.6 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 125.672 1.589 . . . . 0.0 111.34 170.574 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -134.32 127.81 32.47 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 125.671 1.588 . . . . 0.0 109.917 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 69.8 mt -130.22 149.78 51.77 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 124.775 1.23 . . . . 0.0 110.658 176.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -134.74 134.87 41.45 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 124.93 1.292 . . . . 0.0 110.148 178.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.568 ' HH ' ' HB3' ' A' ' 42' ' ' PHE . 93.5 m-85 -94.93 169.67 9.97 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 121.979 0.895 . . . . 0.0 111.461 176.131 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -74.81 -3.69 33.28 Favored 'General case' 0 CA--C 1.55 0.968 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 174.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.4 p -163.06 155.47 15.84 Favored Pre-proline 0 CA--C 1.541 0.6 0 C-N-CA 124.222 1.009 . . . . 0.0 113.369 -173.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -65.5 -47.95 3.71 Favored 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 123.848 3.032 . . . . 0.0 111.482 -176.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -53.08 -21.76 5.18 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.411 1.884 . . . . 0.0 113.776 178.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 24.6 m170 -83.5 -46.13 12.81 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 119.338 0.972 . . . . 0.0 110.799 175.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -68.05 -50.93 52.17 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.014 0.926 . . . . 0.0 112.846 179.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 17.9 m -60.9 -31.09 48.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 123.7 0.8 . . . . 0.0 111.734 -178.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -70.44 -62.8 1.25 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.795 1.638 . . . . 0.0 109.402 169.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -50.65 -41.76 55.68 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.177 1.391 . . . . 0.0 114.052 -175.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 23.6 t -52.86 -49.53 47.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 123.492 0.717 . . . . 0.0 111.806 173.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -91.95 19.94 6.21 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 126.45 1.9 . . . . 0.0 112.124 178.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -132.54 -3.22 3.36 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 125.459 1.504 . . . . 0.0 114.228 174.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -137.65 19.34 2.88 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.381 1.072 . . . . 0.0 112.623 178.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -61.36 79.47 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 126.109 1.764 . . . . 0.0 112.308 -178.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 103.06 87.29 2.0 Allowed Glycine 0 CA--C 1.527 0.841 0 C-N-CA 125.08 1.324 . . . . 0.0 113.758 172.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -66.08 145.09 56.25 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.833 1.253 . . . . 0.0 114.35 -179.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.474 0.749 0 C-N-CA 124.863 1.265 . . . . 0.0 114.198 177.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 . . . . . 0 N--CA 1.468 0.47 0 CA-C-O 120.579 0.228 . . . . 0.0 110.871 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 16.1 mmm180 -136.45 95.55 3.19 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.677 1.191 . . . . 0.0 109.717 -178.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 40.6 t -89.38 116.13 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 123.679 0.792 . . . . 0.0 109.411 178.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 35.9 m-80 . . . . . 0 CA--C 1.545 0.766 0 C-N-CA 124.423 1.089 . . . . 0.0 110.429 178.157 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 . . . . . 0 CA--C 1.548 0.889 0 N-CA-C 115.551 1.685 . . . . 0.0 115.551 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -121.26 2.2 10.3 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 127.42 2.288 . . . . 0.0 113.839 -175.559 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.1 m -139.78 162.58 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 124.203 1.001 . . . . 0.0 110.456 -172.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 14.7 pt -133.19 155.28 40.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 124.438 1.095 . . . . 0.0 110.718 -178.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -144.47 162.39 14.43 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.483 0 C-N-CA 125.207 1.403 . . . . 0.0 110.011 178.21 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.493 HG21 ' HH ' ' A' ' 84' ' ' TYR . 27.1 t -137.8 127.38 35.11 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.192 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 -176.114 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -96.26 163.13 13.22 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.313 1.045 . . . . 0.0 112.032 169.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 16.0 m-20 62.12 43.79 8.44 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 129.059 2.944 . . . . 0.0 114.199 -178.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.4 p -111.34 84.25 4.68 Favored Pre-proline 0 N--CA 1.485 1.286 0 C-N-CA 124.973 1.309 . . . . 0.0 111.957 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -66.69 145.88 77.09 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 122.064 1.843 . . . . 0.0 110.796 172.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -65.1 159.62 22.95 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 121.51 0.672 . . . . 0.0 110.941 169.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 35.0 m -130.95 166.01 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 C-N-CA 126.373 1.869 . . . . 0.0 109.043 -176.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -74.62 -173.6 31.03 Favored Glycine 0 CA--C 1.543 1.794 0 C-N-CA 124.175 0.893 . . . . 0.0 114.493 -179.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -62.23 168.15 9.82 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 123.435 2.757 . . . . 0.0 110.839 177.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.3 t70 65.93 2.63 2.28 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 125.385 1.474 . . . . 0.0 113.448 -177.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 9.6 tpt180 -145.83 -28.83 0.43 Allowed 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.661 1.584 . . . . 0.0 114.555 -177.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -52.31 -32.68 38.94 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 114.861 1.43 . . . . 0.0 114.861 177.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -69.58 -50.32 45.75 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.991 1.316 . . . . 0.0 109.542 179.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -47.84 -41.07 23.06 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 127.127 2.171 . . . . 0.0 109.827 175.206 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.6 tp -47.79 -47.9 30.6 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.567 1.547 . . . . 0.0 114.147 179.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -91.32 -31.48 16.07 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.478 1.111 . . . . 0.0 112.086 173.466 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -57.91 -59.17 5.67 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 118.102 -0.951 . . . . 0.0 111.461 175.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 15.4 m -53.38 -35.9 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 124.826 1.25 . . . . 0.0 110.829 178.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.1 mp -53.1 -44.99 52.99 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-N 118.859 0.754 . . . . 0.0 111.408 171.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 22.5 m-70 -66.8 -36.15 81.73 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 120.9 -1.125 . . . . 0.0 112.138 178.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -76.21 -50.24 15.02 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 118.716 0.689 . . . . 0.0 111.803 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -55.43 -40.04 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 124.404 1.082 . . . . 0.0 112.032 -179.112 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.557 ' HB3' ' HH ' ' A' ' 68' ' ' TYR . 31.6 m-85 -88.38 -6.04 57.93 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -177.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -68.1 -26.34 65.76 Favored 'General case' 0 C--N 1.343 0.305 0 C-N-CA 124.687 1.195 . . . . 0.0 111.96 -178.163 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 9.6 pttt -68.43 -19.34 64.58 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 175.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -100.2 -12.67 19.37 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.144 0.978 . . . . 0.0 112.79 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 153.14 -144.82 11.83 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 123.971 0.796 . . . . 0.0 111.722 -175.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 21.0 tptt -130.55 125.66 34.81 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.375 1.47 . . . . 0.0 109.082 178.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.2 mp -72.94 141.39 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 123.376 0.67 . . . . 0.0 109.802 173.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.6 t -114.51 -28.99 6.99 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 125.453 1.501 . . . . 0.0 113.235 178.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 24.1 m-80 -132.56 136.09 46.37 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 119.071 0.851 . . . . 0.0 109.338 -176.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -152.03 122.45 7.3 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.706 1.602 . . . . 0.0 112.195 -176.019 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -139.74 136.17 33.89 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.97 1.308 . . . . 0.0 111.084 -178.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -119.96 76.02 21.73 Favored Pre-proline 0 N--CA 1.47 0.569 0 C-N-CA 124.715 1.206 . . . . 0.0 109.453 -175.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -68.17 141.52 52.64 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.582 2.188 . . . . 0.0 111.531 -174.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -117.24 168.66 10.11 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.652 1.581 . . . . 0.0 111.512 -177.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -113.18 117.17 31.17 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 125.168 1.387 . . . . 0.0 109.397 179.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 51.45 24.26 2.13 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.034 1.333 . . . . 0.0 114.479 -177.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 79.84 17.77 74.25 Favored Glycine 0 CA--C 1.542 1.763 0 O-C-N 121.101 -1.0 . . . . 0.0 113.758 -176.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 5.4 mtpp -112.83 -178.04 3.29 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 127.647 2.379 . . . . 0.0 110.098 -176.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 82.3 p -49.33 114.5 1.04 Allowed 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.496 1.119 . . . . 0.0 111.158 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.9 170.5 0.42 Allowed 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.293 1.037 . . . . 0.0 113.571 171.249 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -133.71 -8.97 2.08 Favored Glycine 0 CA--C 1.529 0.935 0 CA-C-O 117.87 -1.517 . . . . 0.0 114.52 173.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -143.43 161.73 37.64 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 119.939 1.87 . . . . 0.0 109.98 175.323 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.1 pp -124.41 161.2 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 C-N-CA 125.533 1.533 . . . . 0.0 111.224 169.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -134.01 119.01 18.46 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.053 1.741 . . . . 0.0 110.358 179.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -123.69 147.09 47.75 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.589 1.555 . . . . 0.0 110.293 177.344 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -131.51 135.95 47.49 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 122.486 1.136 . . . . 0.0 110.271 175.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.557 ' HH ' ' HB3' ' A' ' 42' ' ' PHE . 77.1 m-85 -96.33 163.76 12.94 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 122.536 1.16 . . . . 0.0 111.587 175.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.28 -8.92 57.95 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.521 1.128 . . . . 0.0 113.001 177.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -153.66 152.1 26.52 Favored Pre-proline 0 CA--C 1.542 0.663 0 C-N-CA 125.759 1.624 . . . . 0.0 113.127 -177.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -63.7 -45.41 11.13 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 123.927 3.085 . . . . 0.0 111.258 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -53.83 -21.56 7.79 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.064 1.745 . . . . 0.0 113.505 177.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 21.8 m170 -84.38 -49.04 9.06 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 119.465 1.03 . . . . 0.0 110.229 175.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -60.14 -55.21 36.7 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.584 1.154 . . . . 0.0 111.689 177.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 15.2 m -60.76 -31.42 49.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 123.831 0.852 . . . . 0.0 111.892 -176.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -76.06 -55.46 5.57 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.587 1.155 . . . . 0.0 110.854 174.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -53.24 -42.88 66.87 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.639 1.176 . . . . 0.0 112.641 -177.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 50.2 t -55.62 -48.64 77.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 C-N-CA 123.861 0.865 . . . . 0.0 111.504 175.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -76.48 2.82 12.69 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 126.635 1.974 . . . . 0.0 114.368 178.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -117.53 -45.91 2.69 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.685 0.794 . . . . 0.0 112.337 177.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -93.74 23.0 5.03 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.066 0.946 . . . . 0.0 113.204 -178.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -49.11 80.95 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 127.941 2.496 . . . . 0.0 113.785 178.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 84.75 106.24 0.63 Allowed Glycine 0 CA--C 1.533 1.193 0 C-N-CA 125.641 1.591 . . . . 0.0 111.796 -179.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.493 ' HH ' HG21 ' A' ' 20' ' ' VAL . 15.9 m-85 -67.95 161.28 26.86 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 121.65 -0.912 . . . . 0.0 111.985 176.157 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.845 0 C-N-CA 124.943 1.297 . . . . 0.0 113.995 -170.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 . . . . . 0 CA--C 1.537 0.477 0 CA-C-O 120.827 0.346 . . . . 0.0 111.579 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 38.2 mmm-85 -135.73 88.13 2.38 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.774 0.83 . . . . 0.0 112.639 -178.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 24.2 t -75.74 116.21 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 124.12 0.968 . . . . 0.0 110.96 178.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 44.3 m-80 . . . . . 0 CA--C 1.549 0.92 0 C-N-CA 125.122 1.369 . . . . 0.0 111.392 -179.872 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . 0.301 5.4 p-10 . . . . . 0 N--CA 1.478 0.935 0 N-CA-C 116.639 2.089 . . . . 0.0 116.639 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -124.38 7.05 8.36 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 127.209 2.204 . . . . 0.0 113.93 -170.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.4 m -132.04 166.02 30.27 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 O-C-N 120.576 -1.328 . . . . 0.0 113.469 -171.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 16.0 pt -136.23 153.66 31.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 C-N-CA 124.498 1.119 . . . . 0.0 110.84 178.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 73.7 t -137.7 151.37 25.89 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.227 0 C-N-CA 125.957 1.703 . . . . 0.0 108.672 175.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -131.08 154.32 40.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 C-N-CA 124.73 1.212 . . . . 0.0 108.481 177.351 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -127.69 169.55 13.68 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.662 1.585 . . . . 0.0 110.719 176.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 13.8 m-20 59.08 29.82 19.47 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 126.284 1.834 . . . . 0.0 114.393 -174.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . 0.265 6.9 p -100.59 84.98 0.5 Allowed Pre-proline 0 N--CA 1.481 1.096 0 C-N-CA 125.156 1.382 . . . . 0.0 112.113 -177.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -69.45 160.08 51.18 Favored 'Trans proline' 0 C--N 1.354 0.864 0 C-N-CA 122.235 1.956 . . . . 0.0 111.345 175.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.5 168.1 20.3 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.649 170.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 30.9 m -140.25 168.42 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 125.743 1.617 . . . . 0.0 110.119 -175.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -76.85 -173.37 37.88 Favored Glycine 0 CA--C 1.544 1.891 0 C-N-CA 123.722 0.677 . . . . 0.0 114.244 178.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -61.54 172.05 3.88 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 123.307 2.672 . . . . 0.0 111.406 177.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 62.17 6.24 1.75 Allowed 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 126.116 1.766 . . . . 0.0 114.353 -178.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.1 ttt85 -151.58 -25.82 0.19 Allowed 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 126.985 2.114 . . . . 0.0 114.184 -177.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -49.69 -36.24 24.48 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 114.97 1.47 . . . . 0.0 114.97 175.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -64.7 -54.23 34.79 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 125.019 1.327 . . . . 0.0 108.747 178.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.9 -38.88 17.42 Favored 'General case' 0 C--O 1.219 -0.545 0 C-N-CA 127.344 2.258 . . . . 0.0 110.705 174.221 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -48.99 -55.52 11.68 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 119.744 1.156 . . . . 0.0 112.309 177.199 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.2 tmtt? -84.62 -27.29 27.3 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.753 0.821 . . . . 0.0 112.499 175.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -63.84 -53.65 47.34 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 117.286 -1.34 . . . . 0.0 111.597 176.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 30.2 m -52.32 -32.22 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 125.36 1.464 . . . . 0.0 112.768 -177.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.2 mp -50.58 -51.82 18.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 C-N-CA 124.482 1.113 . . . . 0.0 110.685 169.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 33.4 m-70 -64.67 -40.89 96.21 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 119.658 1.117 . . . . 0.0 112.098 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.39 -51.23 54.54 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.044 0.938 . . . . 0.0 111.087 179.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -61.4 -43.95 97.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-N 118.552 0.614 . . . . 0.0 111.154 179.069 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.555 ' HB3' ' HH ' ' A' ' 68' ' ' TYR . 37.8 m-85 -82.47 -6.36 59.26 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -176.1 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.57 -29.66 70.88 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.053 1.341 . . . . 0.0 113.337 177.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.4 pttm -65.95 -23.07 66.53 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 119.709 1.14 . . . . 0.0 112.952 177.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -96.97 -10.09 26.97 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.501 1.12 . . . . 0.0 113.069 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 149.46 -137.8 6.46 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 124.309 0.957 . . . . 0.0 112.623 -178.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.9 tppt? -135.83 137.8 41.88 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 124.655 1.182 . . . . 0.0 109.105 177.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.5 mp -95.53 128.13 46.97 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 C-N-CA 124.171 0.988 . . . . 0.0 108.717 179.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.9 t -96.17 -29.19 14.19 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.798 1.239 . . . . 0.0 113.911 178.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 47.2 m-80 -112.13 158.03 20.12 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.468 1.107 . . . . 0.0 111.562 178.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -163.16 125.33 2.57 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.761 0.824 . . . . 0.0 111.249 173.247 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -134.55 126.78 30.0 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 123.704 0.802 . . . . 0.0 111.843 -178.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -120.5 86.48 39.53 Favored Pre-proline 0 CA--C 1.542 0.641 0 C-N-CA 127.266 2.226 . . . . 0.0 108.909 -177.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -70.26 173.1 11.91 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 123.129 2.552 . . . . 0.0 111.033 175.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -145.41 172.89 12.54 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.55 1.54 . . . . 0.0 111.24 175.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -113.71 109.56 18.77 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 125.488 1.515 . . . . 0.0 109.276 177.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 22.2 t0 53.07 26.53 4.93 Favored 'General case' 0 CA--C 1.552 1.033 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 178.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 82.52 12.41 80.36 Favored Glycine 0 CA--C 1.537 1.463 0 O-C-N 120.998 -1.064 . . . . 0.0 113.957 -175.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 29.6 mtpt -112.17 -179.74 3.77 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 127.4 2.28 . . . . 0.0 110.148 -178.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 39.2 p -54.29 119.02 4.59 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.927 1.691 . . . . 0.0 113.517 -174.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.8 pttt -67.6 178.3 1.7 Allowed 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.399 1.08 . . . . 0.0 113.417 175.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -139.36 -4.82 1.4 Allowed Glycine 0 CA--C 1.537 1.415 0 C-N-CA 125.502 1.525 . . . . 0.0 115.561 172.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -145.88 156.17 43.37 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 119.444 1.622 . . . . 0.0 109.647 -174.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.1 pp -138.62 166.59 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 C-N-CA 125.674 1.59 . . . . 0.0 110.851 173.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 29.1 t80 -136.75 129.71 30.9 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.549 1.14 . . . . 0.0 110.114 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -131.94 146.56 52.17 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.791 1.636 . . . . 0.0 110.284 179.5 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -132.87 127.21 33.91 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.846 1.258 . . . . 0.0 110.577 177.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.555 ' HH ' ' HB3' ' A' ' 42' ' ' PHE . 86.3 m-85 -86.87 168.16 13.68 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.826 0.851 . . . . 0.0 111.73 175.518 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -74.07 -5.71 43.19 Favored 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 124.42 1.088 . . . . 0.0 113.539 173.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -161.57 153.21 15.95 Favored Pre-proline 0 N--CA 1.473 0.703 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 -171.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -67.45 -48.27 1.73 Allowed 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 123.224 2.616 . . . . 0.0 111.072 -173.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -53.45 -18.24 2.56 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.373 1.869 . . . . 0.0 114.244 176.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 20.6 m170 -85.8 -48.32 8.9 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 119.49 1.041 . . . . 0.0 110.348 175.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -65.06 -54.42 30.47 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.482 1.113 . . . . 0.0 112.826 176.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 12.9 m -57.66 -35.29 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 123.131 0.572 . . . . 0.0 111.344 -177.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -66.92 -63.84 0.98 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 126.046 1.739 . . . . 0.0 110.045 170.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -50.02 -41.03 46.5 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.892 1.277 . . . . 0.0 114.308 -176.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 40.4 t -56.21 -50.46 70.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 123.548 0.739 . . . . 0.0 111.854 173.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 11.4 tmtt? -82.87 -4.93 58.72 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.501 1.92 . . . . 0.0 112.599 -177.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -112.75 -19.78 11.89 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.558 1.543 . . . . 0.0 113.901 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -118.65 18.75 13.39 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 120.756 1.617 . . . . 0.0 113.22 177.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -54.96 85.19 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 126.222 1.809 . . . . 0.0 112.773 178.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 96.46 91.26 1.82 Allowed Glycine 0 C--N 1.338 0.662 0 C-N-CA 125.0 1.286 . . . . 0.0 112.9 174.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -66.55 147.47 53.24 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.477 0.893 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 178.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 . . . . . 0 N--CA 1.465 0.309 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 2.8 mmm180 -136.35 96.03 3.29 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.754 0.822 . . . . 0.0 110.179 -179.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 39.1 t -85.15 119.36 33.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 57.5 m-80 . . . . . 0 CA--C 1.54 0.56 0 C-N-CA 125.148 1.379 . . . . 0.0 110.269 178.254 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . 0.258 3.8 p30 . . . . . 0 CA--C 1.549 0.93 0 N-CA-C 117.668 2.47 . . . . 0.0 117.668 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.3 m -114.73 2.38 14.42 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 129.335 3.054 . . . . 0.0 113.034 -175.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.0 m -136.53 168.39 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 O-C-N 121.471 -0.768 . . . . 0.0 111.517 -174.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 21.0 pt -134.31 155.12 38.71 Favored 'Isoleucine or valine' 0 C--O 1.24 0.572 0 CA-C-O 121.797 0.808 . . . . 0.0 111.478 176.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 29.6 t -137.84 154.07 28.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 125.962 1.705 . . . . 0.0 109.036 177.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -131.69 156.33 42.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 C-N-CA 125.116 1.366 . . . . 0.0 109.05 177.38 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -128.94 165.87 20.24 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 124.338 1.055 . . . . 0.0 110.077 175.625 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 19.4 m-20 58.56 35.99 24.91 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 126.333 1.853 . . . . 0.0 113.776 -174.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.3 p -102.74 83.91 0.59 Allowed Pre-proline 0 N--CA 1.48 1.044 0 C-N-CA 124.886 1.275 . . . . 0.0 112.287 178.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -68.92 155.72 67.64 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 122.675 2.25 . . . . 0.0 111.774 175.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -76.67 166.75 22.95 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.355 170.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.8 m -135.64 166.36 27.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 C-N-CA 126.61 1.964 . . . . 0.0 109.687 -177.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -75.77 -171.08 30.23 Favored Glycine 0 CA--C 1.539 1.594 0 C-N-CA 123.267 0.461 . . . . 0.0 114.097 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -63.67 169.03 10.62 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 123.549 2.833 . . . . 0.0 111.692 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.1 t0 62.12 11.39 4.31 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.295 1.038 . . . . 0.0 113.12 -178.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 5.7 ttt180 -153.64 -28.34 0.13 Allowed 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 126.362 1.865 . . . . 0.0 113.426 -178.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -51.33 -33.17 28.1 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 177.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -66.86 -47.54 71.6 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 125.019 1.327 . . . . 0.0 109.696 178.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 8.5 mmtm -52.9 -36.06 58.92 Favored 'General case' 0 C--O 1.218 -0.563 0 C-N-CA 125.381 1.472 . . . . 0.0 110.235 176.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.9 tp -48.31 -49.48 33.81 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.875 1.27 . . . . 0.0 113.086 178.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.27 -28.71 17.6 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.955 0.902 . . . . 0.0 112.37 175.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -59.42 -57.54 12.55 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 118.289 -0.862 . . . . 0.0 111.534 174.016 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 17.9 m -51.4 -36.83 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 125.049 1.34 . . . . 0.0 110.998 -179.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.1 mp -54.43 -47.88 69.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 124.603 1.161 . . . . 0.0 110.681 173.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 20.8 m-70 -65.36 -31.04 71.95 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 118.16 -0.924 . . . . 0.0 113.079 178.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.19 -49.75 9.14 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 118.865 0.757 . . . . 0.0 112.025 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -56.76 -37.88 55.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 CA-C-N 118.832 0.742 . . . . 0.0 112.4 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -91.16 0.76 57.47 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -178.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.9 t -70.12 -37.72 75.4 Favored 'General case' 0 C--N 1.342 0.265 0 C-N-CA 125.957 1.703 . . . . 0.0 111.569 178.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.57 -24.54 63.83 Favored 'General case' 0 N--CA 1.478 0.951 0 O-C-N 121.047 -1.033 . . . . 0.0 112.856 179.188 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -92.37 -7.22 48.39 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.443 1.097 . . . . 0.0 112.795 177.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 139.52 -144.93 15.83 Favored Glycine 0 CA--C 1.537 1.423 0 C-N-CA 124.92 1.247 . . . . 0.0 112.876 -177.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 13.9 tptt -120.63 138.2 54.04 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 120.781 -1.423 . . . . 0.0 111.193 175.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.7 mp -90.75 135.83 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 124.085 0.954 . . . . 0.0 109.253 174.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.9 t -108.02 -16.66 14.23 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 116.603 -1.665 . . . . 0.0 114.837 178.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 52.2 m-80 -125.9 157.33 37.97 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 120.385 1.448 . . . . 0.0 111.137 176.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -165.1 115.68 1.12 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.263 0.625 . . . . 0.0 112.499 -177.243 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 51.4 m-85 -131.43 129.25 41.0 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 121.894 0.854 . . . . 0.0 111.792 -179.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -120.38 86.42 38.8 Favored Pre-proline 0 CA--C 1.539 0.552 0 C-N-CA 126.148 1.779 . . . . 0.0 108.914 -178.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -69.79 173.73 10.57 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 122.692 2.262 . . . . 0.0 111.196 177.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -144.59 173.75 11.54 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.285 1.434 . . . . 0.0 111.583 175.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -115.4 107.91 15.83 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 124.453 1.101 . . . . 0.0 110.65 177.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 19.0 t70 55.48 24.46 6.83 Favored 'General case' 0 CA--C 1.549 0.917 0 N-CA-C 113.777 1.028 . . . . 0.0 113.777 -178.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 85.5 11.3 75.16 Favored Glycine 0 CA--C 1.539 1.563 0 CA-C-O 118.815 -0.992 . . . . 0.0 113.284 -174.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 30.1 mtpt -114.09 171.31 7.68 Favored 'General case' 0 C--N 1.345 0.398 0 C-N-CA 126.788 2.035 . . . . 0.0 110.763 -178.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 70.8 p -44.98 116.84 1.17 Allowed 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 126.954 2.102 . . . . 0.0 112.387 -176.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 3.7 pttt -67.78 178.02 1.87 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 126.601 1.96 . . . . 0.0 112.743 174.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -139.99 -1.77 1.74 Allowed Glycine 0 CA--C 1.542 1.739 0 C-N-CA 125.875 1.702 . . . . 0.0 115.317 174.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -148.4 151.66 35.66 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 126.622 1.969 . . . . 0.0 109.14 -173.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -135.44 164.61 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 125.714 1.605 . . . . 0.0 110.907 174.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -134.98 125.27 26.28 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.208 1.003 . . . . 0.0 109.686 -178.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -129.82 139.88 51.13 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.283 1.433 . . . . 0.0 110.453 -179.399 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -128.62 124.72 36.52 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.218 0.607 . . . . 0.0 110.584 -179.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -88.23 173.86 8.54 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 122.072 0.939 . . . . 0.0 111.53 178.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -84.38 -0.84 54.2 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.661 0.784 . . . . 0.0 113.031 176.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.2 p -158.2 161.26 29.02 Favored Pre-proline 0 CA--C 1.541 0.63 0 CA-C-N 120.037 1.29 . . . . 0.0 112.88 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -68.05 -49.86 0.92 Allowed 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 123.086 2.524 . . . . 0.0 111.276 176.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -51.88 -30.17 22.85 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.764 1.226 . . . . 0.0 112.602 178.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -74.11 -47.11 38.45 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.19 0.996 . . . . 0.0 112.112 176.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -64.71 -54.34 33.14 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.772 1.229 . . . . 0.0 112.195 176.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 10.3 m -59.41 -35.95 61.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 122.881 0.473 . . . . 0.0 111.486 -177.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -66.05 -56.47 11.38 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 118.415 -0.802 . . . . 0.0 111.174 172.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.97 -43.99 63.81 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 119.274 0.943 . . . . 0.0 112.681 -177.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 79.5 t -59.65 -33.0 50.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 175.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.75 6.87 46.94 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.052 1.341 . . . . 0.0 112.039 -179.2 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 8.2 m-80 -125.94 -28.33 3.2 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 179.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -114.62 23.02 13.06 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.597 0.759 . . . . 0.0 112.15 -176.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -59.91 54.95 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 130.609 3.564 . . . . 0.0 115.771 -178.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 124.91 82.82 0.52 Allowed Glycine 0 CA--C 1.533 1.172 0 C-N-CA 125.182 1.372 . . . . 0.0 113.125 174.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -58.01 148.03 27.46 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.921 1.688 . . . . 0.0 113.865 -176.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.84 0 O-C-N 120.546 -1.346 . . . . 0.0 113.797 -177.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 . . . . . 0 N--CA 1.466 0.34 0 CA-C-O 120.743 0.306 . . . . 0.0 110.754 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 5.3 mmm180 -136.25 84.99 2.12 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.704 0.802 . . . . 0.0 111.932 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 27.4 t -72.94 121.78 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 122.772 0.429 . . . . 0.0 109.888 177.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 58.0 m-80 . . . . . 0 CA--C 1.545 0.772 0 C-N-CA 125.834 1.653 . . . . 0.0 111.09 -179.838 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 . . . . . 0 N--CA 1.477 0.924 0 N-CA-C 115.669 1.729 . . . . 0.0 115.669 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.3 m -121.42 5.63 10.16 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 126.683 1.993 . . . . 0.0 113.676 -177.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.1 m -139.55 165.27 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 C-N-CA 124.342 1.057 . . . . 0.0 111.684 -172.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 22.7 pt -132.17 154.56 40.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-O 122.215 1.007 . . . . 0.0 110.497 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 60.9 t -139.96 144.74 27.6 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.482 0 C-N-CA 125.318 1.447 . . . . 0.0 108.764 178.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -124.96 152.66 31.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 124.756 1.223 . . . . 0.0 108.807 178.404 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -127.07 164.06 22.39 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.362 1.465 . . . . 0.0 110.41 178.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 30.5 m-20 60.24 35.26 20.9 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 126.471 1.908 . . . . 0.0 113.101 -175.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . 0.261 7.3 p -104.14 81.92 0.55 Allowed Pre-proline 0 N--CA 1.479 0.989 0 C-N-CA 125.966 1.707 . . . . 0.0 111.589 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_endo -69.96 158.36 56.96 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 122.044 1.83 . . . . 0.0 111.152 175.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.89 170.08 14.46 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 121.611 -0.681 . . . . 0.0 111.72 167.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 30.9 m -138.57 167.65 20.88 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 126.81 2.044 . . . . 0.0 109.719 176.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -71.48 -175.81 23.42 Favored Glycine 0 CA--C 1.544 1.882 0 C-N-CA 124.733 1.158 . . . . 0.0 114.578 178.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -62.2 168.32 9.51 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 123.595 2.863 . . . . 0.0 111.043 179.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 13.5 t70 62.66 7.14 2.34 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 125.151 1.381 . . . . 0.0 113.926 -178.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 6.1 ttt180 -148.25 -29.38 0.31 Allowed 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 127.203 2.201 . . . . 0.0 114.136 -178.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -51.29 -32.62 25.47 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 177.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -67.81 -49.04 64.45 Favored 'General case' 0 C--O 1.231 0.1 0 C-N-CA 125.639 1.576 . . . . 0.0 109.356 179.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -45.11 -41.27 7.72 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 127.37 2.268 . . . . 0.0 110.5 174.024 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -47.53 -56.21 7.57 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.067 1.347 . . . . 0.0 112.422 178.093 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.17 -30.11 28.07 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.493 1.117 . . . . 0.0 112.163 176.11 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -60.88 -57.84 10.96 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 118.397 -0.811 . . . . 0.0 111.803 177.293 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 19.0 m -54.27 -36.96 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 124.899 1.28 . . . . 0.0 110.987 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.1 mp -47.85 -52.68 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 125.347 1.459 . . . . 0.0 109.971 170.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 19.9 m-70 -63.83 -39.31 93.93 Favored 'General case' 0 N--CA 1.466 0.331 0 O-C-N 121.211 -0.93 . . . . 0.0 111.892 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.48 -51.02 39.9 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 119.062 0.846 . . . . 0.0 111.609 179.272 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -60.04 -42.34 89.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 CA-C-N 118.528 0.604 . . . . 0.0 111.785 179.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.557 ' HB3' ' HH ' ' A' ' 68' ' ' TYR . 33.6 m-85 -86.07 -2.94 58.79 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -175.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.73 -27.27 63.84 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.754 1.222 . . . . 0.0 112.97 178.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.32 -24.16 65.71 Favored 'General case' 0 N--CA 1.484 1.262 0 O-C-N 120.661 -1.274 . . . . 0.0 113.178 177.298 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -92.65 -16.02 26.09 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.437 1.095 . . . . 0.0 113.125 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 155.38 -147.82 17.25 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 124.505 1.05 . . . . 0.0 112.51 -174.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 23.4 tptt -128.64 124.17 35.11 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.93 1.292 . . . . 0.0 109.938 177.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 3.6 mp -71.8 135.02 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 123.801 0.84 . . . . 0.0 109.897 175.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.3 t -111.54 -25.61 9.49 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.611 1.564 . . . . 0.0 113.462 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 28.5 m-80 -129.97 138.68 50.97 Favored 'General case' 0 C--N 1.339 0.117 0 C-N-CA 125.108 1.363 . . . . 0.0 110.31 -178.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -152.7 121.15 6.35 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.554 1.142 . . . . 0.0 111.657 -176.147 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -134.37 132.07 39.0 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.519 1.128 . . . . 0.0 111.338 -178.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -121.02 83.48 37.93 Favored Pre-proline 0 CA--C 1.542 0.644 0 C-N-CA 126.3 1.84 . . . . 0.0 108.728 -177.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -68.69 168.36 20.27 Favored 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 122.995 2.463 . . . . 0.0 111.096 178.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -144.7 172.72 12.6 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.434 1.493 . . . . 0.0 111.357 177.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -114.12 108.93 17.65 Favored 'General case' 0 C--O 1.221 -0.411 0 C-N-CA 125.753 1.621 . . . . 0.0 109.803 178.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.1 t70 54.44 29.12 10.55 Favored 'General case' 0 CA--C 1.555 1.161 0 C-N-CA 124.424 1.09 . . . . 0.0 113.065 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 76.84 12.61 84.4 Favored Glycine 0 CA--C 1.537 1.468 0 O-C-N 120.748 -1.22 . . . . 0.0 114.205 -174.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 26.2 mtpt -109.2 180.0 4.0 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 127.008 2.123 . . . . 0.0 109.949 -178.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 20.5 p -53.02 117.09 2.73 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 127.072 2.149 . . . . 0.0 112.651 -173.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.9 pttt -68.64 176.42 2.97 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.139 0.976 . . . . 0.0 113.387 170.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -140.61 -0.35 1.81 Allowed Glycine 0 CA--C 1.54 1.631 0 C-N-CA 126.908 2.194 . . . . 0.0 115.48 171.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -146.8 154.08 40.94 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 119.586 1.693 . . . . 0.0 108.875 -174.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -136.6 165.18 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 125.535 1.534 . . . . 0.0 111.063 173.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 19.3 t80 -132.27 123.67 27.38 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.479 1.112 . . . . 0.0 109.385 -179.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -126.46 137.97 53.46 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.867 1.667 . . . . 0.0 109.862 179.055 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -125.12 134.08 52.59 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 122.133 0.968 . . . . 0.0 109.744 176.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.557 ' HH ' ' HB3' ' A' ' 42' ' ' PHE . 85.7 m-85 -94.53 164.55 12.94 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 122.202 1.001 . . . . 0.0 111.44 175.156 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -76.23 -4.9 44.37 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.667 1.187 . . . . 0.0 112.699 175.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -153.4 151.51 25.74 Favored Pre-proline 0 CA--C 1.546 0.81 0 O-C-N 121.052 -1.03 . . . . 0.0 111.874 -176.165 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -63.54 -47.05 8.07 Favored 'Trans proline' 0 C--N 1.355 0.88 0 C-N-CA 123.542 2.828 . . . . 0.0 111.096 177.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -55.19 -16.83 3.52 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.428 1.891 . . . . 0.0 113.938 178.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 14.5 m-70 -86.93 -48.53 8.07 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 119.902 1.228 . . . . 0.0 111.263 173.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -61.87 -56.86 14.94 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.387 1.075 . . . . 0.0 111.882 176.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 11.3 m -61.35 -26.68 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 123.331 0.652 . . . . 0.0 112.016 -177.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -77.64 -56.19 4.73 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.531 1.133 . . . . 0.0 110.641 172.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.64 -44.25 62.89 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.609 1.164 . . . . 0.0 112.881 -177.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 54.4 t -56.84 -37.72 55.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 123.897 0.879 . . . . 0.0 113.071 175.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.2 mttm -89.83 4.22 50.5 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 126.102 1.761 . . . . 0.0 113.445 179.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -121.36 -32.97 3.76 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 178.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -109.75 17.75 20.92 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.254 1.021 . . . . 0.0 113.294 -177.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -53.59 88.52 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.952 2.101 . . . . 0.0 112.306 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 89.66 106.31 1.17 Allowed Glycine 0 C--N 1.339 0.738 0 N-CA-C 110.736 -0.945 . . . . 0.0 110.736 -178.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.429 ' CD2' ' CZ2' ' B' ' 52' ' ' TRP . 10.8 m-85 -80.06 146.87 31.7 Favored 'General case' 0 CA--C 1.548 0.889 0 O-C-N 121.3 -1.118 . . . . 0.0 112.15 177.514 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 1.1 pttt -98.88 59.64 1.21 Allowed 'General case' 0 N--CA 1.483 1.179 0 O-C-N 120.644 -1.285 . . . . 0.0 114.111 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.14 -10.28 14.26 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 178.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 26.1 t70 55.84 65.27 1.5 Allowed 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 125.156 1.383 . . . . 0.0 112.896 -178.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -128.25 -76.26 0.56 Allowed 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 -177.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -146.14 -69.86 0.26 Allowed 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.296 1.438 . . . . 0.0 111.14 179.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 -116.01 146.69 41.94 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.007 1.323 . . . . 0.0 110.371 -177.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.54 162.74 28.91 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 124.328 1.051 . . . . 0.0 111.66 176.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -90.54 172.42 8.72 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 126.285 1.834 . . . . 0.0 110.163 176.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 27.0 mmm-85 -139.04 91.46 2.52 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.107 0.963 . . . . 0.0 110.99 -178.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 27.0 t -78.41 118.9 26.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 54.9 m-80 . . . . . 0 CA--C 1.545 0.753 0 C-N-CA 126.111 1.764 . . . . 0.0 111.04 178.801 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 24.2 t70 . . . . . 0 CA--C 1.537 0.461 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -112.1 -178.9 3.54 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.397 1.479 . . . . 0.0 111.14 -178.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 47' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -68.55 73.51 0.24 Allowed 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.491 1.516 . . . . 0.0 112.444 174.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 12.5 m -138.44 177.95 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 126.771 2.028 . . . . 0.0 110.974 173.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 2.5 ttmt -50.15 133.76 23.02 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 126.553 1.941 . . . . 0.0 110.075 172.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -68.31 57.34 0.08 Allowed 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 125.835 1.654 . . . . 0.0 111.933 173.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -73.29 47.91 0.22 Allowed 'General case' 0 CA--C 1.549 0.913 0 O-C-N 119.957 -1.714 . . . . 0.0 112.888 177.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 52' ' ' TRP . . . . . 0.429 ' CZ2' ' CD2' ' A' ' 84' ' ' TYR . 64.4 t-105 -154.62 27.74 0.44 Allowed 'General case' 0 CA--C 1.557 1.238 0 C-N-CA 125.068 1.347 . . . . 0.0 112.949 -178.151 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -168.36 94.52 0.37 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 119.834 -1.791 . . . . 0.0 113.395 177.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -71.47 117.3 12.85 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 121.469 -0.77 . . . . 0.0 110.871 -178.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 . . . . . 0 CA--C 1.541 0.617 0 C-N-CA 126.098 1.759 . . . . 0.0 112.643 -177.803 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 . . . . . 0 CA--C 1.546 0.808 0 N-CA-C 116.347 1.98 . . . . 0.0 116.347 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.9 t -125.81 9.3 7.58 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 126.673 1.989 . . . . 0.0 113.351 -175.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.9 m -141.99 165.46 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 124.125 0.97 . . . . 0.0 111.99 -174.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 21.1 pt -130.59 154.95 41.38 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 C-N-CA 124.206 1.003 . . . . 0.0 111.258 178.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 57.9 t -137.79 144.67 30.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 125.257 1.423 . . . . 0.0 109.266 176.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.599 ' CG1' ' HH ' ' A' ' 84' ' ' TYR . 0.8 OUTLIER -125.66 150.03 30.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 123.948 0.899 . . . . 0.0 108.924 178.559 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -125.17 172.9 9.13 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.848 1.259 . . . . 0.0 110.405 178.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 54.08 32.55 15.89 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.634 1.574 . . . . 0.0 113.97 -174.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.3 p -103.73 81.09 0.44 Allowed Pre-proline 0 N--CA 1.475 0.807 0 C-N-CA 124.352 1.061 . . . . 0.0 111.202 -179.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -66.82 145.76 75.94 Favored 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 121.735 1.623 . . . . 0.0 111.368 176.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.71 163.63 13.59 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 120.82 0.343 . . . . 0.0 111.462 172.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 35.0 m -134.55 165.2 32.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 124.089 0.955 . . . . 0.0 110.822 -173.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -76.4 -171.3 32.67 Favored Glycine 0 CA--C 1.543 1.785 0 CA-C-O 121.417 0.454 . . . . 0.0 113.853 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -64.17 168.05 13.24 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 123.032 2.488 . . . . 0.0 112.291 177.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 65.52 9.28 5.7 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.423 1.089 . . . . 0.0 112.341 -178.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 27.0 ttt180 -150.61 -29.64 0.2 Allowed 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.391 1.476 . . . . 0.0 113.902 -177.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -52.83 -30.45 33.55 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 178.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -69.49 -45.45 68.91 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 122.927 0.491 . . . . 0.0 110.708 177.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.47 -39.25 67.3 Favored 'General case' 0 C--O 1.215 -0.748 0 C-N-CA 125.877 1.671 . . . . 0.0 110.776 175.433 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -45.84 -54.31 8.31 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.871 1.269 . . . . 0.0 112.544 178.18 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.3 tmtt? -84.89 -27.38 26.68 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.096 0.958 . . . . 0.0 113.144 175.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -64.36 -56.01 17.26 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 117.942 -1.028 . . . . 0.0 112.629 174.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 32.8 m -52.84 -34.2 19.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-N 119.507 1.049 . . . . 0.0 111.38 -178.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.1 mp -49.54 -52.21 12.77 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 C-N-CA 124.707 1.203 . . . . 0.0 111.325 170.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 33.1 m-70 -66.59 -18.33 65.31 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 119.03 0.832 . . . . 0.0 113.082 177.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.73 -52.36 5.17 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 119.318 0.963 . . . . 0.0 111.351 178.083 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -59.09 -41.98 85.15 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-N 118.408 0.549 . . . . 0.0 111.874 177.102 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -84.6 -3.03 58.27 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 112.794 0.664 . . . . 0.0 112.794 -178.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -67.17 -30.75 70.8 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 119.618 1.099 . . . . 0.0 113.909 177.171 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.479 ' HE3' ' CZ ' ' A' ' 45' ' ' PHE . 18.2 pttt -65.56 -23.01 66.75 Favored 'General case' 0 N--CA 1.48 1.039 0 O-C-N 120.74 -1.225 . . . . 0.0 112.853 179.128 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.479 ' CZ ' ' HE3' ' A' ' 44' ' ' LYS . 9.8 m-85 -92.49 -14.96 27.67 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.446 0.699 . . . . 0.0 112.826 -179.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 149.59 -146.26 15.33 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 124.034 0.826 . . . . 0.0 111.93 -173.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 19.0 tptt -129.61 126.61 38.85 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.271 1.028 . . . . 0.0 110.72 178.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.5 mp -72.2 138.56 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 123.701 0.8 . . . . 0.0 110.193 177.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.0 t -112.72 -22.95 10.46 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.819 1.247 . . . . 0.0 113.539 179.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 28.9 m-80 -135.08 134.13 40.0 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 119.487 1.039 . . . . 0.0 109.801 -176.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -147.98 124.58 11.08 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.253 1.021 . . . . 0.0 111.844 -176.428 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -135.84 130.95 34.72 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.255 1.022 . . . . 0.0 111.449 -177.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -122.46 85.85 48.28 Favored Pre-proline 0 CA--C 1.536 0.44 0 C-N-CA 125.68 1.592 . . . . 0.0 109.196 -175.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -70.66 169.71 19.4 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.6 2.2 . . . . 0.0 110.933 179.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -145.27 172.74 12.71 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.186 0.995 . . . . 0.0 111.688 175.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -112.39 109.9 19.8 Favored 'General case' 0 C--O 1.222 -0.369 0 C-N-CA 124.155 0.982 . . . . 0.0 110.611 177.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 17.7 t70 54.32 21.23 3.06 Favored 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 -179.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 85.86 13.39 69.6 Favored Glycine 0 CA--C 1.536 1.353 0 O-C-N 121.045 -1.034 . . . . 0.0 113.832 -174.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 10.2 mmtm -108.07 -179.94 4.04 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 127.039 2.136 . . . . 0.0 110.342 -178.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 79.9 p -58.84 115.58 3.19 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.235 1.414 . . . . 0.0 113.149 -176.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 3.2 pttt -64.17 174.85 1.43 Allowed 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.802 1.641 . . . . 0.0 114.508 172.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -136.31 -2.95 2.54 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 125.902 1.715 . . . . 0.0 115.314 174.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -145.36 154.81 42.7 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.945 1.698 . . . . 0.0 109.744 -175.325 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.1 pp -135.96 163.45 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 124.812 1.245 . . . . 0.0 110.205 172.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -130.4 125.38 34.4 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.568 1.147 . . . . 0.0 109.688 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -128.58 139.8 52.1 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 124.486 1.114 . . . . 0.0 109.993 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -125.59 134.28 51.99 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 121.898 0.856 . . . . 0.0 110.51 176.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -95.84 162.5 13.56 Favored 'General case' 0 CA--C 1.528 0.118 0 CA-C-O 122.185 0.993 . . . . 0.0 111.587 176.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.56 -1.83 26.26 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.24 1.016 . . . . 0.0 113.287 176.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -157.52 150.46 18.39 Favored Pre-proline 0 CA--C 1.541 0.612 0 C-N-CA 124.643 1.177 . . . . 0.0 111.877 -178.267 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -62.97 -44.37 16.17 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 123.41 2.74 . . . . 0.0 111.981 177.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -57.74 -20.99 38.63 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.844 1.258 . . . . 0.0 113.36 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 20.1 m-70 -82.05 -46.2 14.24 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 119.29 0.95 . . . . 0.0 111.735 173.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -66.44 -52.72 43.38 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.43 0.692 . . . . 0.0 112.387 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 11.3 m -61.32 -28.79 44.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 122.623 0.369 . . . . 0.0 111.861 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -75.54 -55.96 5.16 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.894 0.878 . . . . 0.0 111.155 173.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -52.85 -42.0 64.79 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.296 1.038 . . . . 0.0 112.772 -176.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 53.8 t -60.6 -35.77 65.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 123.859 0.863 . . . . 0.0 112.94 175.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 6.7 mttp -89.17 2.65 53.88 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.192 1.397 . . . . 0.0 113.241 178.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -123.83 -23.79 4.6 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 113.723 1.008 . . . . 0.0 113.723 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -114.63 18.7 16.54 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.531 1.132 . . . . 0.0 113.008 -177.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -61.8 74.5 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.964 2.106 . . . . 0.0 114.34 -177.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 105.72 78.85 1.22 Allowed Glycine 0 CA--C 1.527 0.793 0 C-N-CA 124.592 1.091 . . . . 0.0 113.107 174.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.599 ' HH ' ' CG1' ' A' ' 20' ' ' VAL . 11.0 m-85 -51.89 148.59 5.68 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.979 2.112 . . . . 0.0 113.226 179.426 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 7.2 mmmt -94.19 60.79 2.8 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 120.904 -1.122 . . . . 0.0 112.7 -171.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -39.91 -49.04 2.42 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 124.711 1.204 . . . . 0.0 112.901 -170.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -145.72 -66.49 0.3 Allowed 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 127.993 2.517 . . . . 0.0 109.268 169.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -159.27 -56.79 0.06 Allowed 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.647 0.779 . . . . 0.0 112.252 -178.207 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.41 -32.29 22.43 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.134 0.974 . . . . 0.0 112.894 -174.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -75.63 111.68 11.2 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.73 1.612 . . . . 0.0 109.864 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.9 m -127.13 149.51 49.92 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.248 1.019 . . . . 0.0 110.73 -177.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -114.62 176.54 5.0 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 124.982 1.313 . . . . 0.0 110.284 -174.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -135.0 95.97 3.42 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 122.999 0.52 . . . . 0.0 110.198 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 40.9 t -85.45 122.28 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 178.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 52.7 m-80 . . . . . 0 CA--C 1.542 0.653 0 C-N-CA 125.255 1.422 . . . . 0.0 110.715 -179.174 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 . . . . . 0 CA--C 1.535 0.366 0 CA-C-O 121.373 0.606 . . . . 0.0 111.769 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -80.57 64.15 5.26 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.836 0.854 . . . . 0.0 111.738 -179.441 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 47' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -123.41 -35.38 2.95 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 -178.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 15.8 m -110.11 -174.48 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 124.61 1.164 . . . . 0.0 110.806 178.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 11.1 mtpp -52.71 161.8 0.68 Allowed 'General case' 0 C--N 1.346 0.433 0 CA-C-O 122.101 0.953 . . . . 0.0 111.143 171.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 50' ' ' ASP . . . . . 0.44 ' C ' ' H ' ' B' ' 52' ' ' TRP . 0.8 OUTLIER -76.79 58.74 1.48 Allowed 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.685 1.194 . . . . 0.0 112.056 -172.936 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -61.33 6.86 0.05 OUTLIER 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 126.319 1.847 . . . . 0.0 114.519 176.165 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 52' ' ' TRP . . . . . 0.44 ' H ' ' C ' ' B' ' 50' ' ' ASP . 62.0 t-105 -138.83 17.52 2.67 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 125.375 1.47 . . . . 0.0 112.713 177.129 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -128.11 118.24 23.08 Favored 'General case' 0 N--CA 1.478 0.95 0 O-C-N 120.226 -1.546 . . . . 0.0 113.632 -177.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -50.08 139.39 14.28 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 122.313 1.054 . . . . 0.0 113.683 178.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.533 0.303 0 C-N-CA 125.805 1.642 . . . . 0.0 110.55 -177.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . 0.259 1.9 m-20 . . . . . 0 CA--C 1.546 0.807 0 N-CA-C 116.779 2.141 . . . . 0.0 116.779 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -124.09 5.79 8.57 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 126.758 2.023 . . . . 0.0 113.472 -177.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.0 m -137.2 165.65 27.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 124.015 0.926 . . . . 0.0 112.395 -173.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 17.5 pt -132.64 154.15 39.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 C-N-CA 124.526 1.13 . . . . 0.0 110.476 179.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 60.8 t -137.98 144.74 30.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 C-N-CA 125.676 1.59 . . . . 0.0 108.678 176.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.427 ' CG1' ' HH ' ' A' ' 84' ' ' TYR . 0.8 OUTLIER -122.98 156.04 28.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 C-N-CA 123.56 0.744 . . . . 0.0 109.372 174.871 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -130.32 169.65 15.16 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.34 1.456 . . . . 0.0 110.677 176.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 31.2 m-20 56.12 34.02 23.06 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 126.38 1.872 . . . . 0.0 113.91 -174.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . 0.255 7.5 p -102.18 81.15 0.34 Allowed Pre-proline 0 N--CA 1.484 1.252 0 C-N-CA 124.92 1.288 . . . . 0.0 112.158 179.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -66.62 149.25 84.06 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 122.058 1.839 . . . . 0.0 110.961 174.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 38.2 tt0 -67.72 163.74 20.92 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 121.634 0.731 . . . . 0.0 110.635 169.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 31.2 m -135.88 165.79 28.82 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 126.835 2.054 . . . . 0.0 109.482 -177.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -73.51 -172.54 24.83 Favored Glycine 0 CA--C 1.539 1.572 0 C-N-CA 123.833 0.73 . . . . 0.0 114.505 -178.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -62.49 169.76 7.79 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 123.353 2.702 . . . . 0.0 111.256 178.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 42.9 m-20 60.24 8.42 1.55 Allowed 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 125.451 1.501 . . . . 0.0 114.316 -177.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -148.31 -29.57 0.3 Allowed 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 126.046 1.739 . . . . 0.0 113.063 -179.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -51.36 -32.9 27.36 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 115.324 1.601 . . . . 0.0 115.324 177.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -68.59 -47.32 67.04 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.454 1.102 . . . . 0.0 109.502 179.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.4 mptt -51.08 -34.91 32.28 Favored 'General case' 0 C--O 1.219 -0.503 0 C-N-CA 126.601 1.96 . . . . 0.0 111.395 173.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 13.0 tp -51.99 -51.18 58.96 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 119.804 1.184 . . . . 0.0 113.134 177.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.8 tmtt? -83.35 -32.27 26.34 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.767 0.827 . . . . 0.0 112.79 172.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -60.84 -57.26 13.42 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 118.042 -0.98 . . . . 0.0 112.107 177.254 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 16.8 m -53.94 -37.91 35.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 CA-C-N 119.405 1.002 . . . . 0.0 111.257 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.2 mp -53.54 -45.27 58.76 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 124.525 1.13 . . . . 0.0 111.676 170.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 15.5 m-70 -65.51 -40.43 92.98 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 120.052 1.296 . . . . 0.0 112.623 176.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -74.29 -49.53 22.67 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 118.857 0.753 . . . . 0.0 112.647 -179.608 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -55.26 -42.68 67.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-N 118.759 0.709 . . . . 0.0 111.807 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -83.19 -2.08 54.61 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 113.388 0.885 . . . . 0.0 113.388 -178.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.3 t -74.12 -25.29 59.69 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 179.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 17.5 pttt -66.55 -18.71 65.51 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 119.371 0.987 . . . . 0.0 113.005 174.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -101.51 -12.25 18.66 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.211 1.005 . . . . 0.0 113.16 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 156.27 -144.37 10.76 Favored Glycine 0 CA--C 1.529 0.957 0 CA-C-N 118.467 0.576 . . . . 0.0 112.525 -176.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 26.1 tptt -131.67 128.38 38.91 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.929 1.292 . . . . 0.0 108.766 175.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.0 mp -84.14 131.34 34.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 177.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.0 t -100.76 -31.74 11.04 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 178.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 51.1 m-80 -108.22 163.78 12.88 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 119.329 0.968 . . . . 0.0 112.171 178.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -170.05 116.74 0.54 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.306 1.042 . . . . 0.0 112.307 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -132.97 126.52 32.18 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 121.877 0.846 . . . . 0.0 111.591 -179.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -119.5 86.04 33.28 Favored Pre-proline 0 CA--C 1.542 0.656 0 C-N-CA 126.464 1.906 . . . . 0.0 108.32 -178.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -69.53 174.78 8.81 Favored 'Trans proline' 0 C--N 1.355 0.881 0 C-N-CA 123.346 2.697 . . . . 0.0 110.95 177.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -145.53 172.35 13.35 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.235 1.414 . . . . 0.0 111.494 176.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -113.58 110.85 20.9 Favored 'General case' 0 C--O 1.223 -0.324 0 C-N-CA 125.096 1.358 . . . . 0.0 110.24 175.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 54.24 21.19 2.97 Favored 'General case' 0 CA--C 1.554 1.131 0 N-CA-C 114.884 1.439 . . . . 0.0 114.884 179.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 86.33 17.1 61.23 Favored Glycine 0 CA--C 1.539 1.579 0 O-C-N 121.259 -0.9 . . . . 0.0 113.485 -173.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 27.7 mmmt -117.22 176.34 5.19 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 127.65 2.38 . . . . 0.0 110.091 -177.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 76.2 p -50.6 117.39 2.42 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 126.739 2.016 . . . . 0.0 112.86 -176.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -69.71 177.41 3.04 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.922 0.889 . . . . 0.0 112.769 175.52 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -138.98 -1.63 2.01 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 125.503 1.525 . . . . 0.0 115.254 173.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -146.93 155.27 42.15 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 119.627 1.713 . . . . 0.0 109.098 -174.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.1 pp -138.99 166.44 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 125.233 1.413 . . . . 0.0 110.424 173.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 26.7 t80 -135.43 126.91 28.66 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.141 0.976 . . . . 0.0 109.827 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -130.51 139.42 50.5 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.444 1.498 . . . . 0.0 110.186 179.216 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -127.3 125.81 41.5 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.858 1.263 . . . . 0.0 111.034 177.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -86.05 169.22 13.37 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 122.199 0.999 . . . . 0.0 111.769 176.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -77.51 -5.96 51.89 Favored 'General case' 0 CA--C 1.549 0.918 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 175.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -154.51 156.19 31.37 Favored Pre-proline 0 N--CA 1.473 0.721 0 C-N-CA 125.059 1.344 . . . . 0.0 112.83 -176.096 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -65.38 -48.67 3.13 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 123.646 2.897 . . . . 0.0 111.478 179.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -53.29 -18.32 2.36 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.387 1.875 . . . . 0.0 114.284 177.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 22.3 m170 -85.81 -48.29 8.92 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 119.146 0.884 . . . . 0.0 110.494 175.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -64.29 -54.7 29.09 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.892 1.277 . . . . 0.0 112.335 177.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 11.8 m -59.51 -31.73 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 123.034 0.533 . . . . 0.0 111.438 -177.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -73.28 -57.67 3.85 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.59 1.156 . . . . 0.0 111.286 172.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -50.22 -44.09 53.12 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.637 1.175 . . . . 0.0 113.595 -178.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 54.8 t -58.48 -43.03 85.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 174.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.0 -0.52 51.94 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.616 1.566 . . . . 0.0 112.852 -179.415 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -113.86 -44.68 3.15 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 124.189 0.996 . . . . 0.0 112.436 178.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -94.91 18.78 11.27 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 -178.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -56.87 83.21 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 126.271 1.828 . . . . 0.0 113.053 177.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 102.99 87.0 1.98 Allowed Glycine 0 CA--C 1.527 0.806 0 C-N-CA 124.852 1.215 . . . . 0.0 113.401 171.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.427 ' HH ' ' CG1' ' A' ' 20' ' ' VAL . 34.2 m-85 -66.47 143.51 57.05 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 -176.44 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.26 49.12 1.37 Allowed 'General case' 0 N--CA 1.483 1.195 0 O-C-N 120.241 -1.537 . . . . 0.0 114.932 -176.215 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -58.85 -29.99 67.37 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.711 1.205 . . . . 0.0 113.915 -179.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 30.6 t70 67.56 91.84 0.08 Allowed 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 127.997 2.519 . . . . 0.0 113.671 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -149.28 -78.37 0.14 Allowed 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.383 1.073 . . . . 0.0 112.115 179.494 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -142.16 -69.14 0.36 Allowed 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 125.723 1.609 . . . . 0.0 110.384 -173.04 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 23.4 m80 -118.41 144.88 45.62 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 125.605 1.562 . . . . 0.0 110.4 177.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -73.34 166.74 22.61 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 125.11 1.364 . . . . 0.0 111.526 176.378 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -91.13 172.1 8.79 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 125.92 1.688 . . . . 0.0 110.151 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 15.8 mmm-85 -138.52 98.62 3.63 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.165 0.986 . . . . 0.0 109.603 -177.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 40.4 t -87.77 119.8 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 178.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 52.6 m-80 . . . . . 0 CA--C 1.545 0.765 0 C-N-CA 125.553 1.541 . . . . 0.0 110.852 -179.976 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 11.8 p30 . . . . . 0 CA--C 1.537 0.45 0 N-CA-C 115.039 1.496 . . . . 0.0 115.039 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 63.29 5.97 2.22 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 126.159 1.784 . . . . 0.0 114.486 -174.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 47' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -103.58 -63.05 1.22 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.59 1.156 . . . . 0.0 112.01 -175.607 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 35.0 m -97.8 -172.44 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 123.249 0.62 . . . . 0.0 111.013 -177.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.74 159.25 0.39 Allowed 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.418 1.087 . . . . 0.0 111.548 168.409 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 50' ' ' ASP . . . . . 0.472 ' C ' ' H ' ' B' ' 52' ' ' TRP . 4.3 m-20 -76.6 65.7 2.45 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-O 121.393 0.616 . . . . 0.0 112.197 -176.285 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -64.24 10.77 0.05 Allowed 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 126.036 1.734 . . . . 0.0 114.926 176.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 52' ' ' TRP . . . . . 0.472 ' H ' ' C ' ' B' ' 50' ' ' ASP . 58.4 t-105 -122.67 -50.89 1.95 Allowed 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 126.883 2.073 . . . . 0.0 110.65 176.488 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -146.94 127.24 13.91 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 122.613 2.461 . . . . 0.0 113.76 171.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -150.18 172.5 15.21 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.85 1.66 . . . . 0.0 108.771 -178.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 6.2 t0 . . . . . 0 CA--C 1.545 0.779 0 C-N-CA 125.549 1.539 . . . . 0.0 111.98 -175.583 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . 0.323 4.7 p-10 . . . . . 0 CA--C 1.553 1.077 0 N-CA-C 117.81 2.522 . . . . 0.0 117.81 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 50.6 m -115.33 4.1 14.35 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 129.424 3.09 . . . . 0.0 114.001 -174.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.2 m -137.75 161.74 32.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 125.098 1.359 . . . . 0.0 111.985 -172.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 19.1 pt -130.76 152.88 38.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 CA-C-O 122.338 1.066 . . . . 0.0 110.256 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 61.3 t -137.8 142.28 36.64 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.334 0 C-N-CA 125.482 1.513 . . . . 0.0 108.751 176.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -122.44 151.37 26.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 125.002 1.321 . . . . 0.0 108.679 178.442 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -127.65 167.3 16.61 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.204 1.402 . . . . 0.0 110.897 178.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 38.4 m-20 59.04 31.53 21.42 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 126.64 1.976 . . . . 0.0 114.212 -173.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . 0.254 7.6 p -102.01 81.29 0.34 Allowed Pre-proline 0 N--CA 1.479 1.011 0 C-N-CA 125.847 1.659 . . . . 0.0 111.835 -179.169 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -67.51 159.65 51.53 Favored 'Trans proline' 0 C--N 1.356 0.952 0 C-N-CA 122.004 1.803 . . . . 0.0 110.895 175.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -75.83 167.57 21.63 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.785 170.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 31.8 m -136.99 166.45 25.72 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 C-N-CA 126.521 1.928 . . . . 0.0 109.272 -177.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -75.78 -173.24 34.21 Favored Glycine 0 CA--C 1.539 1.59 0 C-N-CA 124.341 0.972 . . . . 0.0 114.523 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -61.39 169.07 7.02 Favored 'Trans proline' 0 CA--C 1.536 0.614 0 C-N-CA 123.568 2.845 . . . . 0.0 111.019 177.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 61.69 9.6 2.91 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.843 1.657 . . . . 0.0 114.046 -178.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 43.4 ttt85 -150.66 -29.61 0.2 Allowed 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 127.031 2.132 . . . . 0.0 114.601 -178.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -51.7 -33.22 33.33 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 115.263 1.579 . . . . 0.0 115.263 177.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -66.29 -50.77 62.53 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 125.613 1.565 . . . . 0.0 109.315 178.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 5.8 mptt -49.76 -37.83 31.35 Favored 'General case' 0 C--N 1.345 0.408 0 C-N-CA 127.627 2.371 . . . . 0.0 110.379 175.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -47.36 -64.71 0.71 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.135 1.374 . . . . 0.0 111.361 177.047 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.91 -28.47 58.06 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.687 0.795 . . . . 0.0 112.472 176.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -60.33 -59.69 5.01 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 117.773 -1.108 . . . . 0.0 111.437 176.305 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 32.3 m -53.94 -33.78 24.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 125.1 1.36 . . . . 0.0 111.746 -177.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.2 mp -50.09 -48.49 23.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 124.381 1.072 . . . . 0.0 111.137 169.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 19.4 m-70 -67.55 -20.33 65.39 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 119.446 1.021 . . . . 0.0 113.544 179.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.28 -49.64 5.12 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.02 1.328 . . . . 0.0 111.498 -177.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -55.17 -43.87 72.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 124.581 1.152 . . . . 0.0 111.129 175.179 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 36.5 m-85 -87.22 -0.14 56.25 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 113.04 0.755 . . . . 0.0 113.04 -177.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -70.09 -35.29 74.07 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.094 1.358 . . . . 0.0 112.05 178.333 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.455 ' HE3' ' CZ ' ' A' ' 45' ' ' PHE . 20.7 pttt -61.82 -17.36 55.96 Favored 'General case' 0 N--CA 1.478 0.941 0 O-C-N 120.948 -1.095 . . . . 0.0 113.647 177.558 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.455 ' CZ ' ' HE3' ' A' ' 44' ' ' LYS . 9.2 m-85 -101.17 -10.99 19.91 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.881 1.272 . . . . 0.0 113.346 178.29 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 149.55 -149.31 21.24 Favored Glycine 0 CA--C 1.532 1.125 0 CA-C-N 119.182 0.901 . . . . 0.0 112.663 -174.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 21.3 tptt -127.47 124.64 38.86 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 124.405 1.082 . . . . 0.0 108.945 178.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.4 mp -79.61 130.37 36.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 123.672 0.789 . . . . 0.0 109.066 175.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 2.8 t -100.7 -30.62 11.63 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.754 1.222 . . . . 0.0 113.516 177.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 42.7 m-80 -113.15 154.11 27.18 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 119.647 1.112 . . . . 0.0 111.548 179.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -159.46 123.91 3.94 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.665 0.786 . . . . 0.0 110.759 176.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -134.83 129.81 35.07 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 123.678 0.791 . . . . 0.0 111.905 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -121.65 86.17 44.69 Favored Pre-proline 0 CA--C 1.538 0.508 0 C-N-CA 127.449 2.3 . . . . 0.0 108.442 -177.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -68.67 174.49 8.44 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 122.736 2.291 . . . . 0.0 110.929 174.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -146.04 172.53 13.25 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 126.548 1.939 . . . . 0.0 110.416 174.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -113.33 110.29 20.1 Favored 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 125.674 1.59 . . . . 0.0 109.049 175.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 57.18 20.17 5.44 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 124.686 1.194 . . . . 0.0 113.784 177.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 85.04 14.62 68.98 Favored Glycine 0 CA--C 1.537 1.467 0 O-C-N 121.025 -1.047 . . . . 0.0 114.002 -172.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 5.8 mmmt -114.64 171.1 7.84 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 128.368 2.667 . . . . 0.0 109.976 -178.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 4.0 t -40.85 115.5 0.59 Allowed 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 127.228 2.211 . . . . 0.0 112.632 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.0 pttp -62.91 -179.11 0.25 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.339 1.056 . . . . 0.0 112.628 168.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -142.69 0.19 1.39 Allowed Glycine 0 CA--C 1.531 1.086 0 C-N-CA 126.51 2.005 . . . . 0.0 115.441 170.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -146.6 154.52 41.58 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 119.957 1.879 . . . . 0.0 108.999 -174.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.1 pp -137.09 165.3 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 126.274 1.83 . . . . 0.0 110.834 172.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -135.66 126.2 26.95 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.2 1.4 . . . . 0.0 109.507 -177.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -131.1 141.12 50.11 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.816 1.646 . . . . 0.0 110.706 -178.534 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -129.69 127.29 40.21 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.635 0.774 . . . . 0.0 109.908 -179.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -88.99 167.21 13.37 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.968 0.89 . . . . 0.0 111.693 177.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.2 -4.0 36.33 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.099 0.959 . . . . 0.0 113.499 174.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -157.3 153.86 24.47 Favored Pre-proline 0 N--CA 1.474 0.727 0 C-N-CA 124.973 1.309 . . . . 0.0 112.717 -177.036 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -63.07 -47.69 7.81 Favored 'Trans proline' 0 C--N 1.354 0.816 0 C-N-CA 123.862 3.041 . . . . 0.0 110.877 177.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -55.69 -14.72 2.38 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.735 2.014 . . . . 0.0 114.624 178.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 54.2 m170 -88.46 -46.37 9.18 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 119.669 1.122 . . . . 0.0 110.609 171.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -66.42 -54.31 25.72 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 124.03 0.932 . . . . 0.0 111.465 -179.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 10.7 m -61.28 -26.16 38.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 124.013 0.925 . . . . 0.0 112.076 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -78.25 -56.91 4.08 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.823 1.249 . . . . 0.0 110.299 172.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -50.65 -43.73 57.31 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 119.705 1.139 . . . . 0.0 113.411 -179.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 61.2 t -57.91 -39.82 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 123.63 0.772 . . . . 0.0 112.907 175.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 7.2 mttt -90.18 4.69 49.75 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 126.095 1.758 . . . . 0.0 113.088 179.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -124.8 -20.5 5.0 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 115.147 1.536 . . . . 0.0 115.147 178.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -120.94 21.74 11.28 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 125.479 1.511 . . . . 0.0 112.287 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -56.54 79.74 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 127.586 2.354 . . . . 0.0 113.797 178.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 98.11 91.29 1.95 Allowed Glycine 0 C--N 1.341 0.86 0 C-N-CA 124.202 0.906 . . . . 0.0 111.955 174.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.426 ' CE2' ' CZ2' ' B' ' 52' ' ' TRP . 11.2 m-85 -67.33 150.13 49.4 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.449 1.1 . . . . 0.0 113.704 -177.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . 0.273 0.0 OUTLIER -93.58 51.57 1.6 Allowed 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 115.266 1.58 . . . . 0.0 115.266 -178.977 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.52 22.26 0.06 Allowed 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 125.69 1.596 . . . . 0.0 114.171 176.589 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 24.6 t70 56.37 -88.91 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 125.519 1.528 . . . . 0.0 111.579 -168.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 45.2 -142.9 0.23 Allowed 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 127.985 2.514 . . . . 0.0 113.478 -177.32 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -115.49 -41.59 3.24 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 126.311 1.844 . . . . 0.0 112.187 172.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 8.1 m80 -126.41 139.23 53.42 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.99 1.716 . . . . 0.0 108.911 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.04 166.41 18.14 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.6 1.56 . . . . 0.0 111.726 177.532 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -88.39 170.77 10.65 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 126.665 1.986 . . . . 0.0 111.293 176.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 23.3 mmm180 -137.59 89.88 2.46 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.21 1.404 . . . . 0.0 110.705 -177.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 33.3 t -77.9 118.78 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 123.616 0.766 . . . . 0.0 109.43 176.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 55.6 m-80 . . . . . 0 CA--C 1.544 0.722 0 C-N-CA 125.768 1.627 . . . . 0.0 110.563 178.964 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 . . . . . 0 CA--C 1.539 0.521 0 N-CA-C 114.152 1.167 . . . . 0.0 114.152 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 50.5 mm-40 47.29 59.61 3.97 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 126.04 1.736 . . . . 0.0 113.01 -170.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.76 74.72 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.852 0 CA-C-O 122.412 1.101 . . . . 0.0 112.529 174.004 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 2.4 p -165.54 -49.98 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 127.764 2.425 . . . . 0.0 111.104 -178.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 1.8 ttpt -172.95 -176.48 1.42 Allowed 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 125.84 1.656 . . . . 0.0 111.447 -171.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -98.03 42.61 1.09 Allowed 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 127.52 2.328 . . . . 0.0 112.046 -169.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 12.4 t30 -55.3 -6.71 0.17 Allowed 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 126.666 1.986 . . . . 0.0 114.884 176.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 52' ' ' TRP . . . . . 0.426 ' CZ2' ' CE2' ' A' ' 84' ' ' TYR . 72.2 t-105 -130.84 3.83 4.49 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.345 1.458 . . . . 0.0 113.152 173.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -80.13 -165.48 0.85 Allowed 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 120.876 1.671 . . . . 0.0 111.272 177.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 32.1 t0 -140.59 33.06 1.83 Allowed 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 127.867 2.467 . . . . 0.0 112.267 172.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 28.8 t70 . . . . . 0 N--CA 1.469 0.488 0 C-N-CA 124.982 1.313 . . . . 0.0 109.275 175.821 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 . . . . . 0 CA--C 1.55 0.943 0 N-CA-C 116.036 1.865 . . . . 0.0 116.036 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.6 m -121.53 1.52 10.09 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 126.532 1.933 . . . . 0.0 113.348 -174.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 26.8 m -144.89 167.72 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 124.386 1.075 . . . . 0.0 111.772 -169.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 21.0 pt -130.96 156.03 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 CA-C-O 121.401 0.619 . . . . 0.0 111.472 178.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 98.2 t -136.0 152.93 31.23 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.029 0 C-N-CA 125.286 1.434 . . . . 0.0 109.964 175.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.597 HG13 ' HH ' ' A' ' 84' ' ' TYR . 0.6 OUTLIER -130.43 149.78 33.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 N-CA-C 108.312 -0.995 . . . . 0.0 108.312 177.061 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -124.86 162.37 24.5 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 124.357 1.063 . . . . 0.0 110.59 176.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 12.9 t30 65.76 34.02 7.78 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.709 1.604 . . . . 0.0 113.405 -177.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.7 p -104.53 81.7 0.56 Allowed Pre-proline 0 N--CA 1.476 0.866 0 C-N-CA 125.572 1.549 . . . . 0.0 112.612 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -68.31 144.85 63.7 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.108 1.872 . . . . 0.0 111.84 177.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.93 163.55 14.28 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 120.915 0.388 . . . . 0.0 111.193 169.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 31.3 m -138.55 161.37 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 C-N-CA 125.294 1.438 . . . . 0.0 109.935 -174.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -70.47 -173.25 12.75 Favored Glycine 0 CA--C 1.546 2.021 0 N-CA-C 115.286 0.875 . . . . 0.0 115.286 -179.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -62.21 167.97 10.09 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 123.527 2.818 . . . . 0.0 111.493 179.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 19.2 t70 64.4 7.75 3.82 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.055 1.342 . . . . 0.0 113.126 -178.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.2 ttt-85 -150.36 -27.38 0.23 Allowed 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.566 1.546 . . . . 0.0 114.142 -179.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -52.02 -33.09 36.9 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 114.713 1.375 . . . . 0.0 114.713 176.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -65.34 -53.14 48.06 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 125.077 1.351 . . . . 0.0 108.844 177.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.79 -38.52 48.83 Favored 'General case' 0 C--O 1.219 -0.541 0 C-N-CA 126.623 1.969 . . . . 0.0 111.003 176.61 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -46.65 -59.59 2.92 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 119.406 1.003 . . . . 0.0 111.879 175.263 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -75.17 -32.79 61.37 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.762 0.825 . . . . 0.0 112.824 175.232 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.99 -55.42 25.85 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 117.659 -1.163 . . . . 0.0 111.835 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 15.6 m -55.14 -37.55 43.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 124.25 1.02 . . . . 0.0 110.838 179.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.1 mp -53.18 -47.62 55.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 124.81 1.244 . . . . 0.0 111.495 170.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 13.5 m-70 -65.37 -39.7 92.6 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 119.29 0.95 . . . . 0.0 112.644 178.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -72.77 -49.14 32.65 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 119.233 0.924 . . . . 0.0 112.669 177.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -57.03 -39.86 69.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 CA-C-N 119.378 0.99 . . . . 0.0 111.878 -177.468 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 35.3 m-85 -86.64 -1.03 57.35 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -178.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -75.78 -22.94 55.92 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 -179.369 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 3.4 pttm -68.56 -24.94 64.68 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 119.488 1.04 . . . . 0.0 112.367 175.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -92.16 -14.24 29.42 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.977 0.911 . . . . 0.0 112.825 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 156.59 -148.35 18.11 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 123.982 0.801 . . . . 0.0 112.361 -176.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 12.3 tptm -128.08 123.16 33.88 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.455 1.102 . . . . 0.0 109.463 176.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 1.7 mp -79.71 123.55 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 177.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.8 t -102.18 -11.57 18.69 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 117.697 -1.144 . . . . 0.0 114.061 -178.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 32.0 m-80 -121.91 165.7 15.55 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.057 1.343 . . . . 0.0 110.917 175.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -166.79 126.21 1.48 Allowed 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.811 0.845 . . . . 0.0 111.928 173.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -137.02 122.37 19.42 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.833 0.825 . . . . 0.0 111.478 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -119.92 86.58 36.69 Favored Pre-proline 0 CA--C 1.538 0.504 0 C-N-CA 126.086 1.754 . . . . 0.0 108.835 -178.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -70.33 174.79 9.49 Favored 'Trans proline' 0 CA--C 1.536 0.612 0 C-N-CA 123.069 2.513 . . . . 0.0 111.043 178.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -145.54 171.97 13.91 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.482 1.113 . . . . 0.0 111.753 173.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -111.97 109.87 19.88 Favored 'General case' 0 C--O 1.223 -0.309 0 C-N-CA 124.734 1.213 . . . . 0.0 109.639 176.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 54.26 24.96 5.4 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 125.054 1.342 . . . . 0.0 114.462 179.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 83.7 12.89 76.78 Favored Glycine 0 CA--C 1.539 1.534 0 O-C-N 121.494 -0.754 . . . . 0.0 113.666 -174.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.9 mtpp -114.79 179.32 3.98 Favored 'General case' 0 C--N 1.343 0.297 0 C-N-CA 126.604 1.961 . . . . 0.0 110.857 -177.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 65.6 p -54.46 110.92 0.69 Allowed 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.675 1.59 . . . . 0.0 113.556 -173.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.6 pttt -59.23 174.12 0.42 Allowed 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.86 1.664 . . . . 0.0 113.291 173.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -136.38 -3.38 2.44 Favored Glycine 0 CA--C 1.534 1.272 0 C-N-CA 125.265 1.412 . . . . 0.0 115.484 173.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -144.7 154.77 43.11 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 126.116 1.766 . . . . 0.0 109.009 -176.109 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.1 pp -137.06 168.66 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 125.671 1.588 . . . . 0.0 110.74 172.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -138.65 132.68 31.31 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.748 1.219 . . . . 0.0 110.102 -178.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 31.8 mt -136.45 147.1 47.03 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 125.04 1.336 . . . . 0.0 110.684 179.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -132.31 122.17 24.7 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 124.149 0.98 . . . . 0.0 109.848 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -83.29 170.86 14.16 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 121.933 0.873 . . . . 0.0 111.245 175.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -74.01 -3.53 29.82 Favored 'General case' 0 CA--C 1.549 0.904 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 173.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.3 p -161.1 156.08 20.41 Favored Pre-proline 0 CA--C 1.54 0.567 0 CA-C-N 119.561 1.073 . . . . 0.0 112.997 -175.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -65.73 -45.41 6.56 Favored 'Trans proline' 0 C--N 1.355 0.919 0 C-N-CA 123.363 2.708 . . . . 0.0 111.632 -178.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -55.42 -15.51 2.73 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.295 1.838 . . . . 0.0 114.028 177.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -90.44 -46.57 8.27 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 119.729 1.15 . . . . 0.0 110.817 174.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -60.2 -57.18 13.91 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.338 1.055 . . . . 0.0 112.452 173.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 10.4 m -61.69 -28.48 44.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -176.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -74.82 -56.29 4.93 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.455 1.102 . . . . 0.0 110.66 173.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.77 -41.55 61.72 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.165 0.986 . . . . 0.0 112.969 -176.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 78.8 t -58.02 -39.44 72.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 124.018 0.927 . . . . 0.0 113.167 174.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 3.2 mptt -88.32 3.75 48.58 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.075 1.35 . . . . 0.0 113.348 178.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -120.67 -31.11 4.34 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 179.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -110.12 21.18 17.09 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 119.251 0.932 . . . . 0.0 113.039 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -57.21 85.61 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.768 1.627 . . . . 0.0 113.076 178.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 97.56 79.28 1.45 Allowed Glycine 0 CA--C 1.53 0.989 0 C-N-CA 124.308 0.956 . . . . 0.0 113.304 173.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.597 ' HH ' HG13 ' A' ' 20' ' ' VAL . 12.6 m-85 -57.49 128.66 38.14 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.805 1.242 . . . . 0.0 112.941 -177.066 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.65 55.81 2.09 Favored 'General case' 0 N--CA 1.477 0.895 0 O-C-N 119.941 -1.724 . . . . 0.0 115.283 -176.371 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 50.6 tp -57.02 -26.92 61.11 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.927 1.291 . . . . 0.0 113.797 178.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 14.0 t70 60.52 75.36 0.41 Allowed 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.739 1.616 . . . . 0.0 111.475 -177.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 7.8 ttmt -142.3 -64.94 0.41 Allowed 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 -174.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -151.68 -74.38 0.15 Allowed 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.077 1.351 . . . . 0.0 110.966 178.221 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 56.8 m80 -114.64 145.5 41.94 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.119 1.368 . . . . 0.0 110.761 178.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.91 163.96 27.37 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 125.249 1.42 . . . . 0.0 111.818 177.1 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -90.42 173.42 8.11 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 125.061 1.345 . . . . 0.0 110.746 177.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 22.1 mmt180 -137.08 87.04 2.25 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.985 0.914 . . . . 0.0 110.673 -178.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 39.2 t -78.82 118.7 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 177.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 54.7 m-80 . . . . . 0 CA--C 1.538 0.493 0 C-N-CA 125.686 1.594 . . . . 0.0 110.006 -178.319 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 16.1 t0 . . . . . 0 CA--C 1.55 0.971 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -67.75 53.21 0.06 Allowed 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 128.062 2.545 . . . . 0.0 113.7 -179.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 47' ' ' ASP . . . . . . . . . . . . . 31.8 t0 53.72 63.15 2.3 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 127.821 2.448 . . . . 0.0 113.329 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 15.8 m -130.29 59.02 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 124.891 1.276 . . . . 0.0 113.003 -174.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.26 -161.07 0.3 Allowed 'General case' 0 N--CA 1.473 0.679 0 O-C-N 121.458 -0.776 . . . . 0.0 110.262 -174.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 50' ' ' ASP . . . . . 0.444 ' C ' ' H ' ' B' ' 52' ' ' TRP . 9.0 m-20 -114.61 41.28 2.37 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.999 1.319 . . . . 0.0 111.505 -177.581 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -61.05 12.19 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 116.34 1.978 . . . . 0.0 116.34 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 52' ' ' TRP . . . . . 0.444 ' H ' ' C ' ' B' ' 50' ' ' ASP . 66.2 t-105 -141.27 2.83 1.71 Allowed 'General case' 0 CA--C 1.555 1.156 0 C-N-CA 127.289 2.235 . . . . 0.0 112.222 177.468 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -112.18 109.21 18.77 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-N 121.214 1.824 . . . . 0.0 112.471 178.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -48.12 133.38 15.18 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.817 1.247 . . . . 0.0 111.477 172.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 . . . . . 0 CA--C 1.538 0.502 0 C-N-CA 124.153 0.981 . . . . 0.0 111.779 -176.825 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 CA--C 1.547 0.829 0 N-CA-C 116.427 2.01 . . . . 0.0 116.427 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 68.4 m -118.73 8.41 11.85 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.859 1.664 . . . . 0.0 113.722 -177.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.5 m -142.62 164.6 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 C-N-CA 123.517 0.727 . . . . 0.0 111.432 -174.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 18.4 pt -129.63 148.4 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 123.063 0.545 . . . . 0.0 110.976 179.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 40.7 t -134.01 137.13 52.71 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.121 0 CA-C-O 122.318 1.056 . . . . 0.0 109.173 174.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.617 HG12 ' HH ' ' A' ' 84' ' ' TYR . 0.9 OUTLIER -109.61 154.23 11.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.054 -0.975 . . . . 0.0 109.27 179.371 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -129.77 158.38 39.58 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 123.263 0.625 . . . . 0.0 111.792 174.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 63.5 t30 61.58 40.1 13.9 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 126.009 1.724 . . . . 0.0 113.056 -178.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.7 m -99.82 83.28 0.34 Allowed Pre-proline 0 N--CA 1.483 1.18 0 C-N-CA 126.032 1.733 . . . . 0.0 112.434 174.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -65.21 140.14 63.47 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 121.759 1.64 . . . . 0.0 110.002 171.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.67 177.36 1.62 Allowed 'General case' 0 CA--C 1.541 0.596 0 CA-C-O 121.385 0.612 . . . . 0.0 112.136 170.363 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.3 m -135.47 162.77 36.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 C-N-CA 125.183 1.393 . . . . 0.0 110.557 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -66.56 -174.15 5.86 Favored Glycine 0 CA--C 1.544 1.849 0 C-N-CA 124.069 0.842 . . . . 0.0 114.989 -179.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -63.81 166.19 16.67 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 123.051 2.501 . . . . 0.0 111.661 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.6 t0 62.33 11.72 4.73 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 123.876 0.87 . . . . 0.0 112.725 -177.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 7.2 ttt180 -151.52 -26.55 0.19 Allowed 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.431 1.492 . . . . 0.0 113.922 177.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -51.6 -32.9 30.57 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 114.694 1.368 . . . . 0.0 114.694 179.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -66.98 -49.24 66.02 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 125.46 1.504 . . . . 0.0 109.694 179.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 8.3 mptt -49.65 -34.17 17.6 Favored 'General case' 0 C--O 1.219 -0.551 0 C-N-CA 126.601 1.961 . . . . 0.0 111.279 173.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -50.42 -63.49 1.1 Allowed 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 120.264 1.393 . . . . 0.0 110.875 177.269 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.91 -28.89 61.76 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 121.444 -0.785 . . . . 0.0 112.687 175.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.8 -56.7 15.07 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 118.016 -0.992 . . . . 0.0 112.164 177.108 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 19.0 m -55.61 -34.84 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 124.004 0.922 . . . . 0.0 110.983 -178.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.1 mp -49.41 -46.89 19.83 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 124.528 1.131 . . . . 0.0 111.462 171.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 18.8 m-70 -68.68 -16.73 63.92 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 113.542 0.942 . . . . 0.0 113.542 179.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -94.04 -51.44 4.85 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.528 1.131 . . . . 0.0 111.19 178.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -56.08 -37.23 48.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 CA-C-N 118.831 0.741 . . . . 0.0 111.742 177.165 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -91.12 -0.93 57.81 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -179.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -74.31 -27.01 60.51 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 178.441 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.487 ' HE3' ' CZ ' ' A' ' 45' ' ' PHE . 16.9 pttt -66.67 -22.08 66.09 Favored 'General case' 0 N--CA 1.48 1.071 0 O-C-N 120.536 -1.353 . . . . 0.0 113.188 176.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.487 ' CZ ' ' HE3' ' A' ' 44' ' ' LYS . 9.6 m-85 -94.95 -12.89 25.94 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.68 0.792 . . . . 0.0 113.001 -179.266 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 151.03 -152.18 24.03 Favored Glycine 0 CA--C 1.53 1.024 0 N-CA-C 111.668 -0.573 . . . . 0.0 111.668 -173.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 24.6 tptt -126.26 123.61 38.52 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.506 1.122 . . . . 0.0 110.067 177.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.4 mp -76.37 129.72 36.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 176.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 2.6 t -100.83 -30.48 11.66 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.551 0.74 . . . . 0.0 112.826 179.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 8.8 m-80 -109.88 162.73 14.22 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.39 1.076 . . . . 0.0 110.843 -179.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -165.52 125.67 1.82 Allowed 'General case' 0 N--CA 1.468 0.439 0 O-C-N 121.424 -0.797 . . . . 0.0 111.785 174.39 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -136.83 122.87 20.27 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.941 0.876 . . . . 0.0 111.577 -179.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -119.72 86.1 34.63 Favored Pre-proline 0 CA--C 1.537 0.461 0 C-N-CA 125.892 1.677 . . . . 0.0 109.11 -176.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -70.75 171.08 16.24 Favored 'Trans proline' 0 CA--C 1.534 0.511 0 C-N-CA 122.99 2.46 . . . . 0.0 111.426 178.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -145.67 173.78 11.77 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.282 1.033 . . . . 0.0 111.705 175.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -116.22 111.34 20.04 Favored 'General case' 0 C--O 1.223 -0.3 0 C-N-CA 124.771 1.228 . . . . 0.0 110.096 176.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 50.86 30.08 4.87 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 125.768 1.627 . . . . 0.0 113.911 -178.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 79.66 12.96 83.06 Favored Glycine 0 CA--C 1.534 1.24 0 O-C-N 121.163 -0.96 . . . . 0.0 113.042 -176.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 26.7 mtpt -111.41 -178.35 3.43 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.689 1.995 . . . . 0.0 109.85 -178.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 64.4 p -57.72 115.37 2.76 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 126.818 2.047 . . . . 0.0 112.98 -172.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.8 pttp -69.46 171.81 8.19 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.605 1.162 . . . . 0.0 113.96 171.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -138.29 3.77 3.05 Favored Glycine 0 CA--C 1.536 1.385 0 C-N-CA 126.848 2.166 . . . . 0.0 115.638 175.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -147.38 152.57 38.38 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 119.961 1.88 . . . . 0.0 109.542 -178.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -135.84 166.72 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 125.643 1.577 . . . . 0.0 111.098 172.331 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -134.72 126.09 28.31 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.223 1.409 . . . . 0.0 109.985 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 73.9 mt -127.72 149.62 50.14 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 124.593 1.157 . . . . 0.0 110.722 175.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -136.34 132.56 35.78 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-O 122.364 1.078 . . . . 0.0 110.253 178.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -94.82 167.97 11.1 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 114.762 -1.108 . . . . 0.0 111.186 177.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -80.51 10.24 4.97 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.944 0.898 . . . . 0.0 112.339 176.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 9.7 m -169.78 153.04 4.79 Favored Pre-proline 0 CA--C 1.54 0.592 0 CA-C-N 120.005 1.275 . . . . 0.0 112.583 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -64.09 -46.12 8.79 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 124.818 3.679 . . . . 0.0 111.865 -178.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -53.98 -20.8 6.78 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.725 1.61 . . . . 0.0 113.509 176.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 33.0 m170 -84.99 -47.87 9.81 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 119.778 1.172 . . . . 0.0 110.534 176.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -65.06 -51.86 59.08 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.099 0.96 . . . . 0.0 112.287 178.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 15.9 m -60.47 -34.06 56.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 122.664 0.386 . . . . 0.0 111.149 -179.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -68.36 -57.39 5.97 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 123.593 0.757 . . . . 0.0 110.463 172.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -55.7 -39.66 71.33 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 119.101 0.864 . . . . 0.0 112.748 -173.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 49.2 t -59.43 -42.2 86.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 123.971 0.908 . . . . 0.0 112.713 173.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.56 2.33 37.71 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.354 1.061 . . . . 0.0 113.463 177.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -115.67 -53.63 2.57 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 119.036 0.835 . . . . 0.0 111.409 179.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -88.11 19.18 3.79 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.021 0.928 . . . . 0.0 113.327 -176.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -52.33 86.44 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.518 1.927 . . . . 0.0 113.374 -179.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.64 95.49 0.77 Allowed Glycine 0 CA--C 1.531 1.075 0 C-N-CA 124.557 1.075 . . . . 0.0 111.495 -178.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.617 ' HH ' HG12 ' A' ' 20' ' ' VAL . 23.6 m-85 -59.59 156.25 13.88 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 122.14 0.972 . . . . 0.0 112.397 177.042 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.7 64.77 0.61 Allowed 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.445 1.098 . . . . 0.0 110.08 -172.089 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 44.5 tp -62.89 -4.19 2.02 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 126.18 1.792 . . . . 0.0 113.369 173.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.1 t0 61.68 32.11 18.47 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.44 1.096 . . . . 0.0 111.677 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.0 171.11 7.8 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 127.54 2.336 . . . . 0.0 111.523 -177.263 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 5.2 mp0 -69.85 -27.77 65.12 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -175.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 7.0 m80 -116.6 132.12 56.77 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.241 1.416 . . . . 0.0 109.615 -178.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.2 m -97.65 164.96 12.2 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.383 1.073 . . . . 0.0 110.911 -178.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -95.71 173.02 7.68 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 125.563 1.545 . . . . 0.0 111.087 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 21.0 mmm180 -136.43 94.76 3.05 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.606 0.762 . . . . 0.0 110.648 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 60.4 t -89.55 109.88 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 123.64 0.776 . . . . 0.0 109.849 179.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 . . . . . 0 CA--C 1.546 0.796 0 C-N-CA 125.004 1.321 . . . . 0.0 111.356 179.639 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 18.8 t70 . . . . . 0 CA--C 1.535 0.397 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 66.5 mm-40 -153.05 -73.08 0.14 Allowed 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 119.418 1.008 . . . . 0.0 109.446 176.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 47' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -81.56 -179.5 7.4 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.278 1.031 . . . . 0.0 111.459 175.17 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 8.6 t 79.47 160.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 127.523 2.329 . . . . 0.0 110.354 -174.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.91 179.01 0.3 Allowed 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 122.796 1.284 . . . . 0.0 111.482 168.373 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -67.42 59.73 0.06 Allowed 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 125.989 1.716 . . . . 0.0 112.233 173.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -64.46 -7.91 11.7 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.586 1.554 . . . . 0.0 113.168 174.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 52' ' ' TRP . . . . . . . . . . . . . 57.1 t-105 -137.77 -21.57 1.12 Allowed 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.074 1.35 . . . . 0.0 112.752 176.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -97.54 168.6 10.27 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.359 1.864 . . . . 0.0 112.141 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 -65.74 119.61 11.52 Favored 'General case' 0 C--N 1.327 -0.396 0 O-C-N 120.792 -1.193 . . . . 0.0 110.418 174.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 27.5 t70 . . . . . 0 CA--C 1.533 0.305 0 C-N-CA 124.613 1.165 . . . . 0.0 112.619 -173.075 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . 0.272 3.6 p30 . . . . . 0 N--CA 1.477 0.875 0 N-CA-C 115.955 1.835 . . . . 0.0 115.955 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 59.7 m -130.83 5.68 4.62 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 127.21 2.204 . . . . 0.0 113.132 -171.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.6 m -142.3 162.7 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 C-N-CA 125.211 1.404 . . . . 0.0 111.785 -173.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 16.7 pt -131.42 150.09 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 C-N-CA 123.874 0.87 . . . . 0.0 110.243 -178.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 44.5 t -136.08 132.44 50.04 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.175 0 C-N-CA 124.954 1.302 . . . . 0.0 109.004 175.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -107.01 151.55 8.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 124.544 1.138 . . . . 0.0 109.51 176.452 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -127.23 166.32 17.97 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.229 1.012 . . . . 0.0 111.309 175.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 66.4 t30 60.2 39.62 19.06 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 126.593 1.957 . . . . 0.0 113.057 -176.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . 0.26 7.2 p -109.0 80.44 1.31 Allowed Pre-proline 0 N--CA 1.476 0.865 0 C-N-CA 125.63 1.572 . . . . 0.0 112.019 179.629 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -66.89 142.29 62.08 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 121.986 1.791 . . . . 0.0 110.975 175.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.31 163.02 13.72 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 122.981 0.512 . . . . 0.0 111.62 170.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 33.2 m -133.42 173.0 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 124.913 1.285 . . . . 0.0 110.953 -174.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -74.22 -176.58 35.4 Favored Glycine 0 CA--C 1.543 1.783 0 N-CA-C 114.478 0.551 . . . . 0.0 114.478 178.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -62.34 168.98 8.67 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 123.49 2.794 . . . . 0.0 111.205 176.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.1 t70 64.07 2.63 1.47 Allowed 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.425 1.49 . . . . 0.0 113.53 -177.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 4.4 ttp180 -142.71 -28.6 0.58 Allowed 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 126.525 1.93 . . . . 0.0 113.77 179.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -51.46 -33.4 30.82 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 115.146 1.536 . . . . 0.0 115.146 179.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -68.81 -43.22 76.04 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 124.929 1.292 . . . . 0.0 110.474 178.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -51.52 -38.52 54.48 Favored 'General case' 0 C--O 1.221 -0.424 0 C-N-CA 126.052 1.741 . . . . 0.0 110.659 174.238 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 80.6 mt -52.71 -43.42 65.63 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 120.142 1.337 . . . . 0.0 113.692 178.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.1 tmtt? -91.88 -28.07 17.53 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.726 0.811 . . . . 0.0 112.103 176.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -62.12 -61.79 2.23 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 118.864 -0.588 . . . . 0.0 111.557 173.501 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 28.0 m -54.04 -34.95 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 124.936 1.294 . . . . 0.0 111.42 -174.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.1 mp -46.92 -55.74 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.335 0 C-N-CA 125.582 1.553 . . . . 0.0 109.955 169.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 29.2 m-70 -63.39 -34.08 76.93 Favored 'General case' 0 C--O 1.223 -0.295 0 CA-C-O 118.203 -0.903 . . . . 0.0 112.275 -178.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.7 -54.12 11.35 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 118.877 0.762 . . . . 0.0 111.366 178.234 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -58.28 -42.13 82.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-N 118.42 0.555 . . . . 0.0 111.441 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.568 ' HB3' ' HH ' ' A' ' 68' ' ' TYR . 34.0 m-85 -84.43 -1.31 55.41 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 113.626 0.972 . . . . 0.0 113.626 -177.144 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.77 -27.32 61.09 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.534 1.133 . . . . 0.0 113.174 179.038 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 2.7 pttm -67.69 -24.78 65.44 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 119.794 1.179 . . . . 0.0 112.892 177.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -93.33 -10.39 35.55 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.28 1.032 . . . . 0.0 113.014 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 149.15 -142.67 10.05 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.046 0.831 . . . . 0.0 112.356 -176.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.5 tppt? -134.69 130.91 37.02 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 124.574 1.15 . . . . 0.0 109.766 177.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.9 mp -81.9 127.09 39.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 124.686 1.194 . . . . 0.0 108.46 175.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.2 t -97.86 -33.28 11.3 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.472 1.109 . . . . 0.0 113.089 178.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 8.7 m-80 -104.26 165.13 11.26 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.928 1.291 . . . . 0.0 111.162 179.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -167.78 126.16 1.24 Allowed 'General case' 0 N--CA 1.469 0.494 0 O-C-N 121.244 -0.91 . . . . 0.0 111.915 174.124 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -137.0 118.43 14.73 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-O 121.566 0.698 . . . . 0.0 111.366 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -116.46 86.75 18.73 Favored Pre-proline 0 CA--C 1.539 0.553 0 C-N-CA 126.136 1.774 . . . . 0.0 108.583 -179.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -69.29 174.61 8.85 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 123.249 2.632 . . . . 0.0 111.234 178.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -145.38 172.68 12.83 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.855 1.262 . . . . 0.0 111.94 174.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -113.76 108.25 16.85 Favored 'General case' 0 C--O 1.224 -0.275 0 C-N-CA 125.339 1.456 . . . . 0.0 109.508 178.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 53.96 26.73 6.58 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.289 1.435 . . . . 0.0 114.021 -179.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.58 11.69 82.73 Favored Glycine 0 CA--C 1.532 1.14 0 O-C-N 121.352 -0.842 . . . . 0.0 113.493 -174.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.5 mtpp -111.56 178.86 4.19 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 126.648 1.979 . . . . 0.0 110.252 178.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 44.0 p -48.71 106.43 0.1 Allowed 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 127.68 2.392 . . . . 0.0 115.013 -176.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.7 pttt -58.77 172.03 0.58 Allowed 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.026 1.33 . . . . 0.0 112.127 173.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -132.01 -2.81 4.16 Favored Glycine 0 CA--C 1.538 1.53 0 C-N-CA 127.364 2.412 . . . . 0.0 116.149 173.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -145.82 155.15 42.72 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 119.796 1.798 . . . . 0.0 109.249 -175.057 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -136.52 164.6 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 125.672 1.589 . . . . 0.0 111.34 170.574 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -134.32 127.81 32.47 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 125.671 1.588 . . . . 0.0 109.917 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 69.8 mt -130.22 149.78 51.77 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 124.775 1.23 . . . . 0.0 110.658 176.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -134.74 134.87 41.45 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 124.93 1.292 . . . . 0.0 110.148 178.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.568 ' HH ' ' HB3' ' A' ' 42' ' ' PHE . 93.5 m-85 -94.93 169.67 9.97 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 121.979 0.895 . . . . 0.0 111.461 176.131 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -74.81 -3.69 33.28 Favored 'General case' 0 CA--C 1.55 0.968 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 174.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.4 p -163.06 155.47 15.84 Favored Pre-proline 0 CA--C 1.541 0.6 0 C-N-CA 124.222 1.009 . . . . 0.0 113.369 -173.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -65.5 -47.95 3.71 Favored 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 123.848 3.032 . . . . 0.0 111.482 -176.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -53.08 -21.76 5.18 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.411 1.884 . . . . 0.0 113.776 178.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 24.6 m170 -83.5 -46.13 12.81 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 119.338 0.972 . . . . 0.0 110.799 175.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -68.05 -50.93 52.17 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.014 0.926 . . . . 0.0 112.846 179.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 17.9 m -60.9 -31.09 48.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 123.7 0.8 . . . . 0.0 111.734 -178.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -70.44 -62.8 1.25 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.795 1.638 . . . . 0.0 109.402 169.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -50.65 -41.76 55.68 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.177 1.391 . . . . 0.0 114.052 -175.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 23.6 t -52.86 -49.53 47.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 123.492 0.717 . . . . 0.0 111.806 173.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -91.95 19.94 6.21 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 126.45 1.9 . . . . 0.0 112.124 178.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -132.54 -3.22 3.36 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 125.459 1.504 . . . . 0.0 114.228 174.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -137.65 19.34 2.88 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.381 1.072 . . . . 0.0 112.623 178.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -61.36 79.47 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 126.109 1.764 . . . . 0.0 112.308 -178.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 103.06 87.29 2.0 Allowed Glycine 0 CA--C 1.527 0.841 0 C-N-CA 125.08 1.324 . . . . 0.0 113.758 172.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -66.08 145.09 56.25 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.833 1.253 . . . . 0.0 114.35 -179.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.64 65.12 8.32 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.863 1.265 . . . . 0.0 114.198 177.253 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 64.2 tp -58.83 -10.76 2.61 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 172.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.3 t70 75.55 25.38 1.22 Allowed 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 126.311 1.844 . . . . 0.0 112.226 -178.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -105.64 172.42 6.81 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 128.047 2.539 . . . . 0.0 111.734 -178.187 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 5.7 mp0 -70.41 -28.39 65.02 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 114.241 1.201 . . . . 0.0 114.241 -177.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 3.6 m80 -123.14 143.97 49.64 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.321 1.448 . . . . 0.0 109.329 -178.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -95.14 170.04 9.68 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.543 1.137 . . . . 0.0 111.063 -177.323 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -91.28 172.08 8.78 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 125.368 1.467 . . . . 0.0 110.871 176.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 16.1 mmm180 -136.45 95.55 3.19 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.677 1.191 . . . . 0.0 109.717 -178.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 40.6 t -89.38 116.13 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 123.679 0.792 . . . . 0.0 109.411 178.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 35.9 m-80 . . . . . 0 CA--C 1.545 0.766 0 C-N-CA 124.423 1.089 . . . . 0.0 110.429 178.157 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 . . . . . 0 CA--C 1.546 0.803 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -174.99 -177.54 1.1 Allowed 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 128.046 2.538 . . . . 0.0 109.055 -178.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 47' ' ' ASP . . . . . . . . . . . . . 18.5 t70 57.82 21.65 7.73 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.923 1.689 . . . . 0.0 114.388 175.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 7.9 p -146.39 156.65 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 128.117 2.567 . . . . 0.0 109.092 -178.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 41.6 mtmt -56.65 -70.74 0.11 Allowed 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.873 1.269 . . . . 0.0 110.607 171.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 4.9 p30 177.86 77.73 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.827 2.051 . . . . 0.0 110.51 -173.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 11.6 t30 -68.01 2.69 1.93 Allowed 'General case' 0 CA--C 1.55 0.967 0 O-C-N 120.635 -1.291 . . . . 0.0 112.569 168.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 52' ' ' TRP . . . . . . . . . . . . . 48.0 t-105 -154.03 89.48 1.3 Allowed 'General case' 0 N--CA 1.451 -0.387 0 O-C-N 120.24 -1.538 . . . . 0.0 108.572 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -166.84 -172.22 2.04 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 127.892 2.477 . . . . 0.0 111.579 170.036 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -144.25 155.88 44.05 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.005 0.922 . . . . 0.0 109.094 163.721 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 . . . . . 0 N--CA 1.466 0.369 0 C-N-CA 124.847 1.259 . . . . 0.0 110.899 178.423 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 . . . . . 0 CA--C 1.548 0.889 0 N-CA-C 115.551 1.685 . . . . 0.0 115.551 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -121.26 2.2 10.3 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 127.42 2.288 . . . . 0.0 113.839 -175.559 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.1 m -139.78 162.58 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 124.203 1.001 . . . . 0.0 110.456 -172.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 14.7 pt -133.19 155.28 40.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 124.438 1.095 . . . . 0.0 110.718 -178.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -144.47 162.39 14.43 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.483 0 C-N-CA 125.207 1.403 . . . . 0.0 110.011 178.21 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.493 HG21 ' HH ' ' A' ' 84' ' ' TYR . 27.1 t -137.8 127.38 35.11 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.192 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 -176.114 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -96.26 163.13 13.22 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.313 1.045 . . . . 0.0 112.032 169.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 16.0 m-20 62.12 43.79 8.44 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 129.059 2.944 . . . . 0.0 114.199 -178.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.4 p -111.34 84.25 4.68 Favored Pre-proline 0 N--CA 1.485 1.286 0 C-N-CA 124.973 1.309 . . . . 0.0 111.957 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -66.69 145.88 77.09 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 122.064 1.843 . . . . 0.0 110.796 172.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -65.1 159.62 22.95 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 121.51 0.672 . . . . 0.0 110.941 169.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 35.0 m -130.95 166.01 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 C-N-CA 126.373 1.869 . . . . 0.0 109.043 -176.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -74.62 -173.6 31.03 Favored Glycine 0 CA--C 1.543 1.794 0 C-N-CA 124.175 0.893 . . . . 0.0 114.493 -179.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -62.23 168.15 9.82 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 123.435 2.757 . . . . 0.0 110.839 177.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.3 t70 65.93 2.63 2.28 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 125.385 1.474 . . . . 0.0 113.448 -177.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 9.6 tpt180 -145.83 -28.83 0.43 Allowed 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.661 1.584 . . . . 0.0 114.555 -177.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -52.31 -32.68 38.94 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 114.861 1.43 . . . . 0.0 114.861 177.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -69.58 -50.32 45.75 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.991 1.316 . . . . 0.0 109.542 179.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -47.84 -41.07 23.06 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 127.127 2.171 . . . . 0.0 109.827 175.206 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.6 tp -47.79 -47.9 30.6 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.567 1.547 . . . . 0.0 114.147 179.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -91.32 -31.48 16.07 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.478 1.111 . . . . 0.0 112.086 173.466 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -57.91 -59.17 5.67 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 118.102 -0.951 . . . . 0.0 111.461 175.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 15.4 m -53.38 -35.9 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 124.826 1.25 . . . . 0.0 110.829 178.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.1 mp -53.1 -44.99 52.99 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-N 118.859 0.754 . . . . 0.0 111.408 171.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 22.5 m-70 -66.8 -36.15 81.73 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 120.9 -1.125 . . . . 0.0 112.138 178.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -76.21 -50.24 15.02 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 118.716 0.689 . . . . 0.0 111.803 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -55.43 -40.04 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 124.404 1.082 . . . . 0.0 112.032 -179.112 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.557 ' HB3' ' HH ' ' A' ' 68' ' ' TYR . 31.6 m-85 -88.38 -6.04 57.93 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -177.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -68.1 -26.34 65.76 Favored 'General case' 0 C--N 1.343 0.305 0 C-N-CA 124.687 1.195 . . . . 0.0 111.96 -178.163 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 9.6 pttt -68.43 -19.34 64.58 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 175.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -100.2 -12.67 19.37 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.144 0.978 . . . . 0.0 112.79 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 153.14 -144.82 11.83 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 123.971 0.796 . . . . 0.0 111.722 -175.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 21.0 tptt -130.55 125.66 34.81 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.375 1.47 . . . . 0.0 109.082 178.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.2 mp -72.94 141.39 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 123.376 0.67 . . . . 0.0 109.802 173.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.6 t -114.51 -28.99 6.99 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 125.453 1.501 . . . . 0.0 113.235 178.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 24.1 m-80 -132.56 136.09 46.37 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 119.071 0.851 . . . . 0.0 109.338 -176.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -152.03 122.45 7.3 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.706 1.602 . . . . 0.0 112.195 -176.019 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -139.74 136.17 33.89 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.97 1.308 . . . . 0.0 111.084 -178.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -119.96 76.02 21.73 Favored Pre-proline 0 N--CA 1.47 0.569 0 C-N-CA 124.715 1.206 . . . . 0.0 109.453 -175.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -68.17 141.52 52.64 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.582 2.188 . . . . 0.0 111.531 -174.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -117.24 168.66 10.11 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.652 1.581 . . . . 0.0 111.512 -177.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -113.18 117.17 31.17 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 125.168 1.387 . . . . 0.0 109.397 179.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 51.45 24.26 2.13 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.034 1.333 . . . . 0.0 114.479 -177.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 79.84 17.77 74.25 Favored Glycine 0 CA--C 1.542 1.763 0 O-C-N 121.101 -1.0 . . . . 0.0 113.758 -176.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 5.4 mtpp -112.83 -178.04 3.29 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 127.647 2.379 . . . . 0.0 110.098 -176.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 82.3 p -49.33 114.5 1.04 Allowed 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.496 1.119 . . . . 0.0 111.158 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.9 170.5 0.42 Allowed 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.293 1.037 . . . . 0.0 113.571 171.249 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -133.71 -8.97 2.08 Favored Glycine 0 CA--C 1.529 0.935 0 CA-C-O 117.87 -1.517 . . . . 0.0 114.52 173.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -143.43 161.73 37.64 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 119.939 1.87 . . . . 0.0 109.98 175.323 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.1 pp -124.41 161.2 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 C-N-CA 125.533 1.533 . . . . 0.0 111.224 169.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -134.01 119.01 18.46 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.053 1.741 . . . . 0.0 110.358 179.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -123.69 147.09 47.75 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.589 1.555 . . . . 0.0 110.293 177.344 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -131.51 135.95 47.49 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 122.486 1.136 . . . . 0.0 110.271 175.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.557 ' HH ' ' HB3' ' A' ' 42' ' ' PHE . 77.1 m-85 -96.33 163.76 12.94 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 122.536 1.16 . . . . 0.0 111.587 175.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.28 -8.92 57.95 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.521 1.128 . . . . 0.0 113.001 177.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -153.66 152.1 26.52 Favored Pre-proline 0 CA--C 1.542 0.663 0 C-N-CA 125.759 1.624 . . . . 0.0 113.127 -177.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -63.7 -45.41 11.13 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 123.927 3.085 . . . . 0.0 111.258 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -53.83 -21.56 7.79 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.064 1.745 . . . . 0.0 113.505 177.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 21.8 m170 -84.38 -49.04 9.06 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 119.465 1.03 . . . . 0.0 110.229 175.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -60.14 -55.21 36.7 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.584 1.154 . . . . 0.0 111.689 177.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 15.2 m -60.76 -31.42 49.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 123.831 0.852 . . . . 0.0 111.892 -176.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -76.06 -55.46 5.57 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.587 1.155 . . . . 0.0 110.854 174.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -53.24 -42.88 66.87 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.639 1.176 . . . . 0.0 112.641 -177.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 50.2 t -55.62 -48.64 77.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 C-N-CA 123.861 0.865 . . . . 0.0 111.504 175.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -76.48 2.82 12.69 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 126.635 1.974 . . . . 0.0 114.368 178.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -117.53 -45.91 2.69 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.685 0.794 . . . . 0.0 112.337 177.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -93.74 23.0 5.03 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.066 0.946 . . . . 0.0 113.204 -178.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -49.11 80.95 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 127.941 2.496 . . . . 0.0 113.785 178.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 84.75 106.24 0.63 Allowed Glycine 0 CA--C 1.533 1.193 0 C-N-CA 125.641 1.591 . . . . 0.0 111.796 -179.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.493 ' HH ' HG21 ' A' ' 20' ' ' VAL . 15.9 m-85 -67.95 161.28 26.86 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 121.65 -0.912 . . . . 0.0 111.985 176.157 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.445 ' HE3' ' HA ' ' B' ' 54' ' ' ASP . 0.0 OUTLIER -117.23 48.73 1.28 Allowed 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.943 1.297 . . . . 0.0 113.995 -170.835 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 39.9 tp -38.46 -61.55 0.68 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 128.353 2.661 . . . . 0.0 112.817 -171.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 19.6 t70 162.91 -49.53 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 130.003 3.321 . . . . 0.0 111.11 -176.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.84 166.09 22.79 Favored 'General case' 0 N--CA 1.479 1.007 0 O-C-N 121.362 -0.836 . . . . 0.0 112.358 -178.182 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 5.9 mp0 -61.66 -42.64 99.19 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.318 1.447 . . . . 0.0 111.565 -176.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 74.4 m80 -62.97 102.15 0.33 Allowed 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 127.075 2.15 . . . . 0.0 110.845 -177.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.85 154.42 19.51 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 122.841 1.305 . . . . 0.0 112.439 -179.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -86.44 169.06 13.21 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 126.623 1.969 . . . . 0.0 111.579 -178.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 38.2 mmm-85 -135.73 88.13 2.38 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.774 0.83 . . . . 0.0 112.639 -178.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 24.2 t -75.74 116.21 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 124.12 0.968 . . . . 0.0 110.96 178.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 44.3 m-80 . . . . . 0 CA--C 1.549 0.92 0 C-N-CA 125.122 1.369 . . . . 0.0 111.392 -179.872 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 1.1 p30 . . . . . 0 N--CA 1.469 0.512 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 168.69 -42.96 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 128.929 2.892 . . . . 0.0 111.236 -177.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 47' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -126.94 -169.7 2.08 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.201 1.4 . . . . 0.0 110.785 -177.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 2.7 t 69.67 44.13 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 125.637 1.575 . . . . 0.0 110.861 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 43.6 mtmt 55.87 -147.27 0.53 Allowed 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.996 1.318 . . . . 0.0 109.456 -177.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 60.0 m-20 -111.72 59.91 0.62 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.577 1.551 . . . . 0.0 109.582 -179.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -63.0 -0.53 0.71 Allowed 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 114.795 1.406 . . . . 0.0 114.795 177.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 52' ' ' TRP . . . . . . . . . . . . . 26.2 t-105 -136.87 -14.76 1.59 Allowed 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 126.113 1.765 . . . . 0.0 113.518 176.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -103.88 111.27 23.73 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 120.111 1.323 . . . . 0.0 110.535 -169.211 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . 0.445 ' HA ' ' HE3' ' A' ' 85' ' ' LYS . 17.2 t70 -91.88 152.65 19.98 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 121.743 0.782 . . . . 0.0 111.371 174.602 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 . . . . . 0 CA--C 1.541 0.599 0 C-N-CA 127.592 2.357 . . . . 0.0 109.044 171.936 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . 0.301 5.4 p-10 . . . . . 0 N--CA 1.478 0.935 0 N-CA-C 116.639 2.089 . . . . 0.0 116.639 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -124.38 7.05 8.36 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 127.209 2.204 . . . . 0.0 113.93 -170.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.4 m -132.04 166.02 30.27 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 O-C-N 120.576 -1.328 . . . . 0.0 113.469 -171.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 16.0 pt -136.23 153.66 31.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 C-N-CA 124.498 1.119 . . . . 0.0 110.84 178.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 73.7 t -137.7 151.37 25.89 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.227 0 C-N-CA 125.957 1.703 . . . . 0.0 108.672 175.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -131.08 154.32 40.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 C-N-CA 124.73 1.212 . . . . 0.0 108.481 177.351 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -127.69 169.55 13.68 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.662 1.585 . . . . 0.0 110.719 176.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 13.8 m-20 59.08 29.82 19.47 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 126.284 1.834 . . . . 0.0 114.393 -174.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . 0.265 6.9 p -100.59 84.98 0.5 Allowed Pre-proline 0 N--CA 1.481 1.096 0 C-N-CA 125.156 1.382 . . . . 0.0 112.113 -177.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -69.45 160.08 51.18 Favored 'Trans proline' 0 C--N 1.354 0.864 0 C-N-CA 122.235 1.956 . . . . 0.0 111.345 175.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.5 168.1 20.3 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.649 170.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 30.9 m -140.25 168.42 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 125.743 1.617 . . . . 0.0 110.119 -175.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -76.85 -173.37 37.88 Favored Glycine 0 CA--C 1.544 1.891 0 C-N-CA 123.722 0.677 . . . . 0.0 114.244 178.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -61.54 172.05 3.88 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 123.307 2.672 . . . . 0.0 111.406 177.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 62.17 6.24 1.75 Allowed 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 126.116 1.766 . . . . 0.0 114.353 -178.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.1 ttt85 -151.58 -25.82 0.19 Allowed 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 126.985 2.114 . . . . 0.0 114.184 -177.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -49.69 -36.24 24.48 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 114.97 1.47 . . . . 0.0 114.97 175.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -64.7 -54.23 34.79 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 125.019 1.327 . . . . 0.0 108.747 178.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.9 -38.88 17.42 Favored 'General case' 0 C--O 1.219 -0.545 0 C-N-CA 127.344 2.258 . . . . 0.0 110.705 174.221 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -48.99 -55.52 11.68 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 119.744 1.156 . . . . 0.0 112.309 177.199 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.2 tmtt? -84.62 -27.29 27.3 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.753 0.821 . . . . 0.0 112.499 175.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -63.84 -53.65 47.34 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 117.286 -1.34 . . . . 0.0 111.597 176.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 30.2 m -52.32 -32.22 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 125.36 1.464 . . . . 0.0 112.768 -177.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.2 mp -50.58 -51.82 18.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 C-N-CA 124.482 1.113 . . . . 0.0 110.685 169.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 33.4 m-70 -64.67 -40.89 96.21 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 119.658 1.117 . . . . 0.0 112.098 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.39 -51.23 54.54 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.044 0.938 . . . . 0.0 111.087 179.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -61.4 -43.95 97.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-N 118.552 0.614 . . . . 0.0 111.154 179.069 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.555 ' HB3' ' HH ' ' A' ' 68' ' ' TYR . 37.8 m-85 -82.47 -6.36 59.26 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -176.1 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.57 -29.66 70.88 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.053 1.341 . . . . 0.0 113.337 177.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.4 pttm -65.95 -23.07 66.53 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 119.709 1.14 . . . . 0.0 112.952 177.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -96.97 -10.09 26.97 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.501 1.12 . . . . 0.0 113.069 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 149.46 -137.8 6.46 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 124.309 0.957 . . . . 0.0 112.623 -178.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.9 tppt? -135.83 137.8 41.88 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 124.655 1.182 . . . . 0.0 109.105 177.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.5 mp -95.53 128.13 46.97 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 C-N-CA 124.171 0.988 . . . . 0.0 108.717 179.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.9 t -96.17 -29.19 14.19 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.798 1.239 . . . . 0.0 113.911 178.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 47.2 m-80 -112.13 158.03 20.12 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.468 1.107 . . . . 0.0 111.562 178.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -163.16 125.33 2.57 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.761 0.824 . . . . 0.0 111.249 173.247 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -134.55 126.78 30.0 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 123.704 0.802 . . . . 0.0 111.843 -178.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -120.5 86.48 39.53 Favored Pre-proline 0 CA--C 1.542 0.641 0 C-N-CA 127.266 2.226 . . . . 0.0 108.909 -177.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -70.26 173.1 11.91 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 123.129 2.552 . . . . 0.0 111.033 175.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -145.41 172.89 12.54 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.55 1.54 . . . . 0.0 111.24 175.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -113.71 109.56 18.77 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 125.488 1.515 . . . . 0.0 109.276 177.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 22.2 t0 53.07 26.53 4.93 Favored 'General case' 0 CA--C 1.552 1.033 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 178.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 82.52 12.41 80.36 Favored Glycine 0 CA--C 1.537 1.463 0 O-C-N 120.998 -1.064 . . . . 0.0 113.957 -175.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 29.6 mtpt -112.17 -179.74 3.77 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 127.4 2.28 . . . . 0.0 110.148 -178.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 39.2 p -54.29 119.02 4.59 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.927 1.691 . . . . 0.0 113.517 -174.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.8 pttt -67.6 178.3 1.7 Allowed 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.399 1.08 . . . . 0.0 113.417 175.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -139.36 -4.82 1.4 Allowed Glycine 0 CA--C 1.537 1.415 0 C-N-CA 125.502 1.525 . . . . 0.0 115.561 172.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -145.88 156.17 43.37 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 119.444 1.622 . . . . 0.0 109.647 -174.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.1 pp -138.62 166.59 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 C-N-CA 125.674 1.59 . . . . 0.0 110.851 173.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 29.1 t80 -136.75 129.71 30.9 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.549 1.14 . . . . 0.0 110.114 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -131.94 146.56 52.17 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.791 1.636 . . . . 0.0 110.284 179.5 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -132.87 127.21 33.91 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.846 1.258 . . . . 0.0 110.577 177.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.555 ' HH ' ' HB3' ' A' ' 42' ' ' PHE . 86.3 m-85 -86.87 168.16 13.68 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.826 0.851 . . . . 0.0 111.73 175.518 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -74.07 -5.71 43.19 Favored 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 124.42 1.088 . . . . 0.0 113.539 173.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -161.57 153.21 15.95 Favored Pre-proline 0 N--CA 1.473 0.703 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 -171.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -67.45 -48.27 1.73 Allowed 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 123.224 2.616 . . . . 0.0 111.072 -173.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -53.45 -18.24 2.56 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.373 1.869 . . . . 0.0 114.244 176.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 20.6 m170 -85.8 -48.32 8.9 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 119.49 1.041 . . . . 0.0 110.348 175.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -65.06 -54.42 30.47 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.482 1.113 . . . . 0.0 112.826 176.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 12.9 m -57.66 -35.29 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 123.131 0.572 . . . . 0.0 111.344 -177.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -66.92 -63.84 0.98 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 126.046 1.739 . . . . 0.0 110.045 170.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -50.02 -41.03 46.5 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.892 1.277 . . . . 0.0 114.308 -176.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 40.4 t -56.21 -50.46 70.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 123.548 0.739 . . . . 0.0 111.854 173.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 11.4 tmtt? -82.87 -4.93 58.72 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.501 1.92 . . . . 0.0 112.599 -177.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -112.75 -19.78 11.89 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.558 1.543 . . . . 0.0 113.901 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -118.65 18.75 13.39 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 120.756 1.617 . . . . 0.0 113.22 177.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -54.96 85.19 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 126.222 1.809 . . . . 0.0 112.773 178.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 96.46 91.26 1.82 Allowed Glycine 0 C--N 1.338 0.662 0 C-N-CA 125.0 1.286 . . . . 0.0 112.9 174.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -66.55 147.47 53.24 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.493 ' HE3' ' O ' ' B' ' 54' ' ' ASP . 0.0 OUTLIER -92.58 69.31 4.86 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 178.674 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 56.3 tp -44.88 -45.24 10.19 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.716 1.206 . . . . 0.0 113.096 -177.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -148.13 -66.46 0.25 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 127.327 2.251 . . . . 0.0 109.138 171.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -158.65 -58.39 0.07 Allowed 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.677 1.191 . . . . 0.0 112.192 -178.107 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -87.92 -29.61 20.7 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 125.488 1.515 . . . . 0.0 114.209 -174.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 10.4 m80 -82.84 110.61 18.0 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 125.162 1.385 . . . . 0.0 109.568 -178.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.32 160.3 29.63 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.967 1.307 . . . . 0.0 111.366 -175.035 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 -126.93 176.44 7.31 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 125.969 1.708 . . . . 0.0 109.661 -171.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 2.8 mmm180 -136.35 96.03 3.29 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.754 0.822 . . . . 0.0 110.179 -179.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 39.1 t -85.15 119.36 33.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 57.5 m-80 . . . . . 0 CA--C 1.54 0.56 0 C-N-CA 125.148 1.379 . . . . 0.0 110.269 178.254 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 . . . . . 0 CA--C 1.543 0.688 0 N-CA-C 112.786 0.661 . . . . 0.0 112.786 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 62.78 10.55 4.32 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.987 1.315 . . . . 0.0 113.475 178.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 47' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -63.68 -24.71 67.89 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 126.533 1.933 . . . . 0.0 114.458 -174.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 6.0 m -118.28 62.68 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 125.874 1.67 . . . . 0.0 110.962 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? 54.41 -86.17 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 126.672 1.989 . . . . 0.0 109.867 -164.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 50' ' ' ASP . . . . . 0.462 ' C ' ' H ' ' B' ' 52' ' ' TRP . 1.7 p30 -175.07 63.74 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 126.081 1.753 . . . . 0.0 113.649 -169.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -65.11 24.4 0.02 OUTLIER 'General case' 0 CA--C 1.562 1.424 0 C-N-CA 125.817 1.647 . . . . 0.0 115.411 174.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 52' ' ' TRP . . . . . 0.462 ' H ' ' C ' ' B' ' 50' ' ' ASP . 54.7 t-105 -146.99 4.39 0.83 Allowed 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 126.916 2.086 . . . . 0.0 113.553 176.187 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -66.97 -165.79 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.253 0 CA-C-N 121.24 1.836 . . . . 0.0 114.305 174.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . 0.493 ' O ' ' HE3' ' A' ' 85' ' ' LYS . 2.1 p-10 -100.79 153.6 19.33 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 121.186 -0.946 . . . . 0.0 112.498 170.572 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.539 0.556 0 C-N-CA 124.148 0.979 . . . . 0.0 110.942 172.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . 0.258 3.8 p30 . . . . . 0 CA--C 1.549 0.93 0 N-CA-C 117.668 2.47 . . . . 0.0 117.668 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.3 m -114.73 2.38 14.42 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 129.335 3.054 . . . . 0.0 113.034 -175.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.0 m -136.53 168.39 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 O-C-N 121.471 -0.768 . . . . 0.0 111.517 -174.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 21.0 pt -134.31 155.12 38.71 Favored 'Isoleucine or valine' 0 C--O 1.24 0.572 0 CA-C-O 121.797 0.808 . . . . 0.0 111.478 176.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 29.6 t -137.84 154.07 28.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 125.962 1.705 . . . . 0.0 109.036 177.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -131.69 156.33 42.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 C-N-CA 125.116 1.366 . . . . 0.0 109.05 177.38 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -128.94 165.87 20.24 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 124.338 1.055 . . . . 0.0 110.077 175.625 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 19.4 m-20 58.56 35.99 24.91 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 126.333 1.853 . . . . 0.0 113.776 -174.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.3 p -102.74 83.91 0.59 Allowed Pre-proline 0 N--CA 1.48 1.044 0 C-N-CA 124.886 1.275 . . . . 0.0 112.287 178.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -68.92 155.72 67.64 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 122.675 2.25 . . . . 0.0 111.774 175.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -76.67 166.75 22.95 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.355 170.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.8 m -135.64 166.36 27.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 C-N-CA 126.61 1.964 . . . . 0.0 109.687 -177.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -75.77 -171.08 30.23 Favored Glycine 0 CA--C 1.539 1.594 0 C-N-CA 123.267 0.461 . . . . 0.0 114.097 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -63.67 169.03 10.62 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 123.549 2.833 . . . . 0.0 111.692 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.1 t0 62.12 11.39 4.31 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.295 1.038 . . . . 0.0 113.12 -178.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 5.7 ttt180 -153.64 -28.34 0.13 Allowed 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 126.362 1.865 . . . . 0.0 113.426 -178.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -51.33 -33.17 28.1 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 177.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -66.86 -47.54 71.6 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 125.019 1.327 . . . . 0.0 109.696 178.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 8.5 mmtm -52.9 -36.06 58.92 Favored 'General case' 0 C--O 1.218 -0.563 0 C-N-CA 125.381 1.472 . . . . 0.0 110.235 176.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.9 tp -48.31 -49.48 33.81 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.875 1.27 . . . . 0.0 113.086 178.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.27 -28.71 17.6 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.955 0.902 . . . . 0.0 112.37 175.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -59.42 -57.54 12.55 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 118.289 -0.862 . . . . 0.0 111.534 174.016 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 17.9 m -51.4 -36.83 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 125.049 1.34 . . . . 0.0 110.998 -179.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.1 mp -54.43 -47.88 69.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 124.603 1.161 . . . . 0.0 110.681 173.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 20.8 m-70 -65.36 -31.04 71.95 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 118.16 -0.924 . . . . 0.0 113.079 178.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.19 -49.75 9.14 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 118.865 0.757 . . . . 0.0 112.025 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -56.76 -37.88 55.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 CA-C-N 118.832 0.742 . . . . 0.0 112.4 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -91.16 0.76 57.47 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -178.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.9 t -70.12 -37.72 75.4 Favored 'General case' 0 C--N 1.342 0.265 0 C-N-CA 125.957 1.703 . . . . 0.0 111.569 178.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.57 -24.54 63.83 Favored 'General case' 0 N--CA 1.478 0.951 0 O-C-N 121.047 -1.033 . . . . 0.0 112.856 179.188 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -92.37 -7.22 48.39 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.443 1.097 . . . . 0.0 112.795 177.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 139.52 -144.93 15.83 Favored Glycine 0 CA--C 1.537 1.423 0 C-N-CA 124.92 1.247 . . . . 0.0 112.876 -177.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 13.9 tptt -120.63 138.2 54.04 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 120.781 -1.423 . . . . 0.0 111.193 175.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.7 mp -90.75 135.83 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 124.085 0.954 . . . . 0.0 109.253 174.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.9 t -108.02 -16.66 14.23 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 116.603 -1.665 . . . . 0.0 114.837 178.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 52.2 m-80 -125.9 157.33 37.97 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 120.385 1.448 . . . . 0.0 111.137 176.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -165.1 115.68 1.12 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.263 0.625 . . . . 0.0 112.499 -177.243 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 51.4 m-85 -131.43 129.25 41.0 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 121.894 0.854 . . . . 0.0 111.792 -179.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -120.38 86.42 38.8 Favored Pre-proline 0 CA--C 1.539 0.552 0 C-N-CA 126.148 1.779 . . . . 0.0 108.914 -178.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -69.79 173.73 10.57 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 122.692 2.262 . . . . 0.0 111.196 177.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -144.59 173.75 11.54 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.285 1.434 . . . . 0.0 111.583 175.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -115.4 107.91 15.83 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 124.453 1.101 . . . . 0.0 110.65 177.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 19.0 t70 55.48 24.46 6.83 Favored 'General case' 0 CA--C 1.549 0.917 0 N-CA-C 113.777 1.028 . . . . 0.0 113.777 -178.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 85.5 11.3 75.16 Favored Glycine 0 CA--C 1.539 1.563 0 CA-C-O 118.815 -0.992 . . . . 0.0 113.284 -174.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 30.1 mtpt -114.09 171.31 7.68 Favored 'General case' 0 C--N 1.345 0.398 0 C-N-CA 126.788 2.035 . . . . 0.0 110.763 -178.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 70.8 p -44.98 116.84 1.17 Allowed 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 126.954 2.102 . . . . 0.0 112.387 -176.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 3.7 pttt -67.78 178.02 1.87 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 126.601 1.96 . . . . 0.0 112.743 174.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -139.99 -1.77 1.74 Allowed Glycine 0 CA--C 1.542 1.739 0 C-N-CA 125.875 1.702 . . . . 0.0 115.317 174.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -148.4 151.66 35.66 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 126.622 1.969 . . . . 0.0 109.14 -173.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -135.44 164.61 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 125.714 1.605 . . . . 0.0 110.907 174.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -134.98 125.27 26.28 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.208 1.003 . . . . 0.0 109.686 -178.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -129.82 139.88 51.13 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.283 1.433 . . . . 0.0 110.453 -179.399 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -128.62 124.72 36.52 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.218 0.607 . . . . 0.0 110.584 -179.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -88.23 173.86 8.54 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 122.072 0.939 . . . . 0.0 111.53 178.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -84.38 -0.84 54.2 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.661 0.784 . . . . 0.0 113.031 176.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.2 p -158.2 161.26 29.02 Favored Pre-proline 0 CA--C 1.541 0.63 0 CA-C-N 120.037 1.29 . . . . 0.0 112.88 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -68.05 -49.86 0.92 Allowed 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 123.086 2.524 . . . . 0.0 111.276 176.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -51.88 -30.17 22.85 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.764 1.226 . . . . 0.0 112.602 178.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -74.11 -47.11 38.45 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.19 0.996 . . . . 0.0 112.112 176.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -64.71 -54.34 33.14 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.772 1.229 . . . . 0.0 112.195 176.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 10.3 m -59.41 -35.95 61.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 122.881 0.473 . . . . 0.0 111.486 -177.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -66.05 -56.47 11.38 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 118.415 -0.802 . . . . 0.0 111.174 172.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.97 -43.99 63.81 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 119.274 0.943 . . . . 0.0 112.681 -177.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 79.5 t -59.65 -33.0 50.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 175.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.75 6.87 46.94 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.052 1.341 . . . . 0.0 112.039 -179.2 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 8.2 m-80 -125.94 -28.33 3.2 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 179.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -114.62 23.02 13.06 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.597 0.759 . . . . 0.0 112.15 -176.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -59.91 54.95 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 130.609 3.564 . . . . 0.0 115.771 -178.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 124.91 82.82 0.52 Allowed Glycine 0 CA--C 1.533 1.172 0 C-N-CA 125.182 1.372 . . . . 0.0 113.125 174.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -58.01 148.03 27.46 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.921 1.688 . . . . 0.0 113.865 -176.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.05 72.33 2.93 Favored 'General case' 0 N--CA 1.476 0.84 0 O-C-N 120.546 -1.346 . . . . 0.0 113.797 -177.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 26.1 tp -69.81 7.49 0.89 Allowed 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 125.443 1.497 . . . . 0.0 114.384 175.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.1 t70 67.09 47.69 1.33 Allowed 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.043 1.337 . . . . 0.0 112.117 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 18.9 mmtm -142.41 172.91 12.05 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.7 1.6 . . . . 0.0 112.407 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.55 -38.01 62.84 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.638 1.975 . . . . 0.0 113.333 179.327 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 27.6 m-70 -90.98 133.58 35.17 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 124.458 1.103 . . . . 0.0 109.443 177.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.7 m -112.02 162.63 15.17 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.331 1.053 . . . . 0.0 110.566 -176.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -86.26 170.96 11.62 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.139 0.976 . . . . 0.0 110.754 -178.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 5.3 mmm180 -136.25 84.99 2.12 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.704 0.802 . . . . 0.0 111.932 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 27.4 t -72.94 121.78 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 122.772 0.429 . . . . 0.0 109.888 177.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 58.0 m-80 . . . . . 0 CA--C 1.545 0.772 0 C-N-CA 125.834 1.653 . . . . 0.0 111.09 -179.838 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 10.8 t0 . . . . . 0 CA--C 1.537 0.457 0 CA-C-O 121.624 0.726 . . . . 0.0 111.191 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -169.55 174.42 5.9 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 128.598 2.759 . . . . 0.0 107.371 -176.186 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 47' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -65.94 -8.43 22.46 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 178.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 11.1 p -48.3 -45.02 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 125.94 1.696 . . . . 0.0 113.441 178.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 3.1 mtpp 169.43 170.97 0.05 OUTLIER 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 127.899 2.48 . . . . 0.0 110.883 -173.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 50' ' ' ASP . . . . . 0.401 ' C ' ' H ' ' B' ' 52' ' ' TRP . 0.0 OUTLIER -110.35 45.13 1.15 Allowed 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 126.699 2.0 . . . . 0.0 112.079 -169.28 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 17.7 t30 -58.75 2.62 0.04 OUTLIER 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 125.754 1.622 . . . . 0.0 114.744 176.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 52' ' ' TRP . . . . . 0.401 ' H ' ' C ' ' B' ' 50' ' ' ASP . 69.6 t-105 -139.25 7.41 2.4 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.084 1.354 . . . . 0.0 112.933 176.639 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -97.06 -138.86 0.28 Allowed 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 120.611 1.55 . . . . 0.0 111.119 -173.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -149.82 171.07 17.34 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 124.337 1.055 . . . . 0.0 110.679 173.145 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 3.9 t70 . . . . . 0 CA--C 1.545 0.754 0 C-N-CA 124.242 1.017 . . . . 0.0 110.16 170.728 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 . . . . . 0 N--CA 1.477 0.924 0 N-CA-C 115.669 1.729 . . . . 0.0 115.669 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.3 m -121.42 5.63 10.16 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 126.683 1.993 . . . . 0.0 113.676 -177.167 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.1 m -139.55 165.27 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 C-N-CA 124.342 1.057 . . . . 0.0 111.684 -172.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.59 HG22 HG23 ' A' ' 78' ' ' VAL . 22.7 pt -132.17 154.56 40.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-O 122.215 1.007 . . . . 0.0 110.497 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 60.9 t -139.96 144.74 27.6 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.482 0 C-N-CA 125.318 1.447 . . . . 0.0 108.764 178.349 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -124.96 152.66 31.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 124.756 1.223 . . . . 0.0 108.807 178.404 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -127.07 164.06 22.39 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.362 1.465 . . . . 0.0 110.41 178.789 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 30.5 m-20 60.24 35.26 20.9 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 126.471 1.908 . . . . 0.0 113.101 -175.413 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . 0.261 7.3 p -104.14 81.92 0.55 Allowed Pre-proline 0 N--CA 1.479 0.989 0 C-N-CA 125.966 1.707 . . . . 0.0 111.589 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_endo -69.96 158.36 56.96 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 122.044 1.83 . . . . 0.0 111.152 175.803 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.89 170.08 14.46 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 121.611 -0.681 . . . . 0.0 111.72 167.706 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.436 HG21 ' HG2' ' A' ' 30' ' ' ARG . 30.9 m -138.57 167.65 20.88 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 126.81 2.044 . . . . 0.0 109.719 176.097 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -71.48 -175.81 23.42 Favored Glycine 0 CA--C 1.544 1.882 0 C-N-CA 124.733 1.158 . . . . 0.0 114.578 178.372 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.549 ' HA ' HD22 ' A' ' 31' ' ' LEU . 64.9 Cg_endo -62.2 168.32 9.51 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 123.595 2.863 . . . . 0.0 111.043 179.027 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 13.5 t70 62.66 7.14 2.34 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 125.151 1.381 . . . . 0.0 113.926 -178.437 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.436 ' HG2' HG21 ' A' ' 26' ' ' VAL . 6.1 ttt180 -148.25 -29.38 0.31 Allowed 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 127.203 2.201 . . . . 0.0 114.136 -178.724 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.549 HD22 ' HA ' ' A' ' 28' ' ' PRO . 1.6 pt? -51.29 -32.62 25.47 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 177.792 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -67.81 -49.04 64.45 Favored 'General case' 0 C--O 1.231 0.1 0 C-N-CA 125.639 1.576 . . . . 0.0 109.356 179.309 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -45.11 -41.27 7.72 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 127.37 2.268 . . . . 0.0 110.5 174.024 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -47.53 -56.21 7.57 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.067 1.347 . . . . 0.0 112.422 178.093 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.17 -30.11 28.07 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.493 1.117 . . . . 0.0 112.163 176.11 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -60.88 -57.84 10.96 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 118.397 -0.811 . . . . 0.0 111.803 177.293 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 19.0 m -54.27 -36.96 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 124.899 1.28 . . . . 0.0 110.987 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.1 mp -47.85 -52.68 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 125.347 1.459 . . . . 0.0 109.971 170.565 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 19.9 m-70 -63.83 -39.31 93.93 Favored 'General case' 0 N--CA 1.466 0.331 0 O-C-N 121.211 -0.93 . . . . 0.0 111.892 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.48 -51.02 39.9 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 119.062 0.846 . . . . 0.0 111.609 179.272 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -60.04 -42.34 89.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 CA-C-N 118.528 0.604 . . . . 0.0 111.785 179.751 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.589 ' HB2' HD11 ' A' ' 48' ' ' ILE . 33.6 m-85 -86.07 -2.94 58.79 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -175.81 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.73 -27.27 63.84 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.754 1.222 . . . . 0.0 112.97 178.776 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.32 -24.16 65.71 Favored 'General case' 0 N--CA 1.484 1.262 0 O-C-N 120.661 -1.274 . . . . 0.0 113.178 177.298 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -92.65 -16.02 26.09 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.437 1.095 . . . . 0.0 113.125 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 155.38 -147.82 17.25 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 124.505 1.05 . . . . 0.0 112.51 -174.723 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 23.4 tptt -128.64 124.17 35.11 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.93 1.292 . . . . 0.0 109.938 177.709 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.589 HD11 ' HB2' ' A' ' 42' ' ' PHE . 3.6 mp -71.8 135.02 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 123.801 0.84 . . . . 0.0 109.897 175.094 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.3 t -111.54 -25.61 9.49 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.611 1.564 . . . . 0.0 113.462 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -129.97 138.68 50.97 Favored 'General case' 0 C--N 1.339 0.117 0 C-N-CA 125.108 1.363 . . . . 0.0 110.31 -178.452 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -152.7 121.15 6.35 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.554 1.142 . . . . 0.0 111.657 -176.147 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -134.37 132.07 39.0 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.519 1.128 . . . . 0.0 111.338 -178.584 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -121.02 83.48 37.93 Favored Pre-proline 0 CA--C 1.542 0.644 0 C-N-CA 126.3 1.84 . . . . 0.0 108.728 -177.175 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -68.69 168.36 20.27 Favored 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 122.995 2.463 . . . . 0.0 111.096 178.749 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -144.7 172.72 12.6 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.434 1.493 . . . . 0.0 111.357 177.559 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -114.12 108.93 17.65 Favored 'General case' 0 C--O 1.221 -0.411 0 C-N-CA 125.753 1.621 . . . . 0.0 109.803 178.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.1 t70 54.44 29.12 10.55 Favored 'General case' 0 CA--C 1.555 1.161 0 C-N-CA 124.424 1.09 . . . . 0.0 113.065 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 76.84 12.61 84.4 Favored Glycine 0 CA--C 1.537 1.468 0 O-C-N 120.748 -1.22 . . . . 0.0 114.205 -174.207 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 26.2 mtpt -109.2 180.0 4.0 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 127.008 2.123 . . . . 0.0 109.949 -178.555 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 20.5 p -53.02 117.09 2.73 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 127.072 2.149 . . . . 0.0 112.651 -173.384 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.9 pttt -68.64 176.42 2.97 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.139 0.976 . . . . 0.0 113.387 170.791 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -140.61 -0.35 1.81 Allowed Glycine 0 CA--C 1.54 1.631 0 C-N-CA 126.908 2.194 . . . . 0.0 115.48 171.026 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -146.8 154.08 40.94 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 119.586 1.693 . . . . 0.0 108.875 -174.655 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -136.6 165.18 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 125.535 1.534 . . . . 0.0 111.063 173.777 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 19.3 t80 -132.27 123.67 27.38 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.479 1.112 . . . . 0.0 109.385 -179.59 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -126.46 137.97 53.46 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.867 1.667 . . . . 0.0 109.862 179.055 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -125.12 134.08 52.59 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 122.133 0.968 . . . . 0.0 109.744 176.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -94.53 164.55 12.94 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 122.202 1.001 . . . . 0.0 111.44 175.156 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -76.23 -4.9 44.37 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.667 1.187 . . . . 0.0 112.699 175.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -153.4 151.51 25.74 Favored Pre-proline 0 CA--C 1.546 0.81 0 O-C-N 121.052 -1.03 . . . . 0.0 111.874 -176.165 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -63.54 -47.05 8.07 Favored 'Trans proline' 0 C--N 1.355 0.88 0 C-N-CA 123.542 2.828 . . . . 0.0 111.096 177.577 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -55.19 -16.83 3.52 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.428 1.891 . . . . 0.0 113.938 178.697 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 14.5 m-70 -86.93 -48.53 8.07 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 119.902 1.228 . . . . 0.0 111.263 173.658 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -61.87 -56.86 14.94 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.387 1.075 . . . . 0.0 111.882 176.689 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 11.3 m -61.35 -26.68 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 123.331 0.652 . . . . 0.0 112.016 -177.088 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -77.64 -56.19 4.73 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.531 1.133 . . . . 0.0 110.641 172.511 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.64 -44.25 62.89 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.609 1.164 . . . . 0.0 112.881 -177.433 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.59 HG23 HG22 ' A' ' 18' ' ' ILE . 54.4 t -56.84 -37.72 55.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 123.897 0.879 . . . . 0.0 113.071 175.024 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.2 mttm -89.83 4.22 50.5 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 126.102 1.761 . . . . 0.0 113.445 179.059 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -121.36 -32.97 3.76 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 178.651 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -109.75 17.75 20.92 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.254 1.021 . . . . 0.0 113.294 -177.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -53.59 88.52 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.952 2.101 . . . . 0.0 112.306 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 89.66 106.31 1.17 Allowed Glycine 0 C--N 1.339 0.738 0 N-CA-C 110.736 -0.945 . . . . 0.0 110.736 -178.656 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -80.06 146.87 31.7 Favored 'General case' 0 CA--C 1.548 0.889 0 O-C-N 121.3 -1.118 . . . . 0.0 112.15 177.514 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 1.1 pttt . . . . . 0 N--CA 1.483 1.179 0 O-C-N 120.644 -1.285 . . . . 0.0 114.111 -179.898 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 . . . . . 0 N--CA 1.469 0.513 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 27.0 mmm-85 -139.04 91.46 2.52 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.107 0.963 . . . . 0.0 110.99 -178.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 27.0 t -78.41 118.9 26.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.674 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 54.9 m-80 . . . . . 0 CA--C 1.545 0.753 0 C-N-CA 126.111 1.764 . . . . 0.0 111.04 178.801 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 . . . . . 0 CA--C 1.546 0.808 0 N-CA-C 116.347 1.98 . . . . 0.0 116.347 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.9 t -125.81 9.3 7.58 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 126.673 1.989 . . . . 0.0 113.351 -175.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.9 m -141.99 165.46 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 124.125 0.97 . . . . 0.0 111.99 -174.82 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.563 HG22 HG23 ' A' ' 78' ' ' VAL . 21.1 pt -130.59 154.95 41.38 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 C-N-CA 124.206 1.003 . . . . 0.0 111.258 178.815 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 57.9 t -137.79 144.67 30.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 125.257 1.423 . . . . 0.0 109.266 176.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -125.66 150.03 30.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 123.948 0.899 . . . . 0.0 108.924 178.559 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -125.17 172.9 9.13 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.848 1.259 . . . . 0.0 110.405 178.288 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 54.08 32.55 15.89 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.634 1.574 . . . . 0.0 113.97 -174.099 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.3 p -103.73 81.09 0.44 Allowed Pre-proline 0 N--CA 1.475 0.807 0 C-N-CA 124.352 1.061 . . . . 0.0 111.202 -179.594 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -66.82 145.76 75.94 Favored 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 121.735 1.623 . . . . 0.0 111.368 176.814 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.71 163.63 13.59 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 120.82 0.343 . . . . 0.0 111.462 172.463 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 35.0 m -134.55 165.2 32.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 124.089 0.955 . . . . 0.0 110.822 -173.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -76.4 -171.3 32.67 Favored Glycine 0 CA--C 1.543 1.785 0 CA-C-O 121.417 0.454 . . . . 0.0 113.853 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.536 ' HA ' HD22 ' A' ' 31' ' ' LEU . 61.4 Cg_endo -64.17 168.05 13.24 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 123.032 2.488 . . . . 0.0 112.291 177.888 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 65.52 9.28 5.7 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.423 1.089 . . . . 0.0 112.341 -178.733 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 27.0 ttt180 -150.61 -29.64 0.2 Allowed 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.391 1.476 . . . . 0.0 113.902 -177.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.536 HD22 ' HA ' ' A' ' 28' ' ' PRO . 1.6 pt? -52.83 -30.45 33.55 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 178.15 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -69.49 -45.45 68.91 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 122.927 0.491 . . . . 0.0 110.708 177.047 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.47 -39.25 67.3 Favored 'General case' 0 C--O 1.215 -0.748 0 C-N-CA 125.877 1.671 . . . . 0.0 110.776 175.433 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -45.84 -54.31 8.31 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.871 1.269 . . . . 0.0 112.544 178.18 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.3 tmtt? -84.89 -27.38 26.68 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.096 0.958 . . . . 0.0 113.144 175.679 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -64.36 -56.01 17.26 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 117.942 -1.028 . . . . 0.0 112.629 174.362 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 32.8 m -52.84 -34.2 19.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-N 119.507 1.049 . . . . 0.0 111.38 -178.439 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.1 mp -49.54 -52.21 12.77 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 C-N-CA 124.707 1.203 . . . . 0.0 111.325 170.294 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.429 ' HA ' HD13 ' A' ' 48' ' ' ILE . 33.1 m-70 -66.59 -18.33 65.31 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 119.03 0.832 . . . . 0.0 113.082 177.794 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.73 -52.36 5.17 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 119.318 0.963 . . . . 0.0 111.351 178.083 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -59.09 -41.98 85.15 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-N 118.408 0.549 . . . . 0.0 111.874 177.102 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.608 ' HB2' HD11 ' A' ' 48' ' ' ILE . 46.9 m-85 -84.6 -3.03 58.27 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 112.794 0.664 . . . . 0.0 112.794 -178.121 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -67.17 -30.75 70.8 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 119.618 1.099 . . . . 0.0 113.909 177.171 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.481 ' HE3' ' CZ ' ' A' ' 45' ' ' PHE . 18.2 pttt -65.56 -23.01 66.75 Favored 'General case' 0 N--CA 1.48 1.039 0 O-C-N 120.74 -1.225 . . . . 0.0 112.853 179.128 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.481 ' CZ ' ' HE3' ' A' ' 44' ' ' LYS . 9.8 m-85 -92.49 -14.96 27.67 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.446 0.699 . . . . 0.0 112.826 -179.664 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 149.59 -146.26 15.33 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 124.034 0.826 . . . . 0.0 111.93 -173.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 19.0 tptt -129.61 126.61 38.85 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.271 1.028 . . . . 0.0 110.72 178.468 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.608 HD11 ' HB2' ' A' ' 42' ' ' PHE . 4.5 mp -72.2 138.56 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 123.701 0.8 . . . . 0.0 110.193 177.097 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.0 t -112.72 -22.95 10.46 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.819 1.247 . . . . 0.0 113.539 179.503 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -135.08 134.13 40.0 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 119.487 1.039 . . . . 0.0 109.801 -176.729 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -147.98 124.58 11.08 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.253 1.021 . . . . 0.0 111.844 -176.428 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -135.84 130.95 34.72 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.255 1.022 . . . . 0.0 111.449 -177.02 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -122.46 85.85 48.28 Favored Pre-proline 0 CA--C 1.536 0.44 0 C-N-CA 125.68 1.592 . . . . 0.0 109.196 -175.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -70.66 169.71 19.4 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.6 2.2 . . . . 0.0 110.933 179.068 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -145.27 172.74 12.71 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.186 0.995 . . . . 0.0 111.688 175.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -112.39 109.9 19.8 Favored 'General case' 0 C--O 1.222 -0.369 0 C-N-CA 124.155 0.982 . . . . 0.0 110.611 177.605 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 17.7 t70 54.32 21.23 3.06 Favored 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 -179.004 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 85.86 13.39 69.6 Favored Glycine 0 CA--C 1.536 1.353 0 O-C-N 121.045 -1.034 . . . . 0.0 113.832 -174.036 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 10.2 mmtm -108.07 -179.94 4.04 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 127.039 2.136 . . . . 0.0 110.342 -178.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 79.9 p -58.84 115.58 3.19 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.235 1.414 . . . . 0.0 113.149 -176.062 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 3.2 pttt -64.17 174.85 1.43 Allowed 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.802 1.641 . . . . 0.0 114.508 172.073 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -136.31 -2.95 2.54 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 125.902 1.715 . . . . 0.0 115.314 174.223 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -145.36 154.81 42.7 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.945 1.698 . . . . 0.0 109.744 -175.325 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.1 pp -135.96 163.45 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 124.812 1.245 . . . . 0.0 110.205 172.501 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -130.4 125.38 34.4 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.568 1.147 . . . . 0.0 109.688 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -128.58 139.8 52.1 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 124.486 1.114 . . . . 0.0 109.993 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -125.59 134.28 51.99 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 121.898 0.856 . . . . 0.0 110.51 176.795 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -95.84 162.5 13.56 Favored 'General case' 0 CA--C 1.528 0.118 0 CA-C-O 122.185 0.993 . . . . 0.0 111.587 176.484 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.56 -1.83 26.26 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.24 1.016 . . . . 0.0 113.287 176.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -157.52 150.46 18.39 Favored Pre-proline 0 CA--C 1.541 0.612 0 C-N-CA 124.643 1.177 . . . . 0.0 111.877 -178.267 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -62.97 -44.37 16.17 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 123.41 2.74 . . . . 0.0 111.981 177.222 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -57.74 -20.99 38.63 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.844 1.258 . . . . 0.0 113.36 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 20.1 m-70 -82.05 -46.2 14.24 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 119.29 0.95 . . . . 0.0 111.735 173.243 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -66.44 -52.72 43.38 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.43 0.692 . . . . 0.0 112.387 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 11.3 m -61.32 -28.79 44.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 122.623 0.369 . . . . 0.0 111.861 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -75.54 -55.96 5.16 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.894 0.878 . . . . 0.0 111.155 173.311 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -52.85 -42.0 64.79 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.296 1.038 . . . . 0.0 112.772 -176.682 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.563 HG23 HG22 ' A' ' 18' ' ' ILE . 53.8 t -60.6 -35.77 65.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 123.859 0.863 . . . . 0.0 112.94 175.109 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 6.7 mttp -89.17 2.65 53.88 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.192 1.397 . . . . 0.0 113.241 178.425 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -123.83 -23.79 4.6 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 113.723 1.008 . . . . 0.0 113.723 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -114.63 18.7 16.54 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.531 1.132 . . . . 0.0 113.008 -177.642 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -61.8 74.5 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.964 2.106 . . . . 0.0 114.34 -177.767 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 105.72 78.85 1.22 Allowed Glycine 0 CA--C 1.527 0.793 0 C-N-CA 124.592 1.091 . . . . 0.0 113.107 174.176 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -51.89 148.59 5.68 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.979 2.112 . . . . 0.0 113.226 179.426 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 7.2 mmmt . . . . . 0 N--CA 1.476 0.826 0 O-C-N 120.904 -1.122 . . . . 0.0 112.7 -171.416 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 . . . . . 0 N--CA 1.464 0.241 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -135.0 95.97 3.42 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 122.999 0.52 . . . . 0.0 110.198 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 40.9 t -85.45 122.28 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 178.771 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 52.7 m-80 . . . . . 0 CA--C 1.542 0.653 0 C-N-CA 125.255 1.422 . . . . 0.0 110.715 -179.174 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . 0.259 1.9 m-20 . . . . . 0 CA--C 1.546 0.807 0 N-CA-C 116.779 2.141 . . . . 0.0 116.779 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -124.09 5.79 8.57 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 126.758 2.023 . . . . 0.0 113.472 -177.647 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.0 m -137.2 165.65 27.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 124.015 0.926 . . . . 0.0 112.395 -173.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.604 HG22 HG23 ' A' ' 78' ' ' VAL . 17.5 pt -132.64 154.15 39.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 C-N-CA 124.526 1.13 . . . . 0.0 110.476 179.217 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 60.8 t -137.98 144.74 30.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 C-N-CA 125.676 1.59 . . . . 0.0 108.678 176.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -122.98 156.04 28.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 C-N-CA 123.56 0.744 . . . . 0.0 109.372 174.871 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -130.32 169.65 15.16 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.34 1.456 . . . . 0.0 110.677 176.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 31.2 m-20 56.12 34.02 23.06 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 126.38 1.872 . . . . 0.0 113.91 -174.271 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . 0.255 7.5 p -102.18 81.15 0.34 Allowed Pre-proline 0 N--CA 1.484 1.252 0 C-N-CA 124.92 1.288 . . . . 0.0 112.158 179.665 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -66.62 149.25 84.06 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 122.058 1.839 . . . . 0.0 110.961 174.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.422 ' HB3' HG22 ' A' ' 60' ' ' THR . 38.2 tt0 -67.72 163.74 20.92 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 121.634 0.731 . . . . 0.0 110.635 169.153 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.425 HG21 ' HG2' ' A' ' 30' ' ' ARG . 31.2 m -135.88 165.79 28.82 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 126.835 2.054 . . . . 0.0 109.482 -177.296 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -73.51 -172.54 24.83 Favored Glycine 0 CA--C 1.539 1.572 0 C-N-CA 123.833 0.73 . . . . 0.0 114.505 -178.72 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.578 ' HA ' HD22 ' A' ' 31' ' ' LEU . 66.3 Cg_endo -62.49 169.76 7.79 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 123.353 2.702 . . . . 0.0 111.256 178.291 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 42.9 m-20 60.24 8.42 1.55 Allowed 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 125.451 1.501 . . . . 0.0 114.316 -177.533 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.425 ' HG2' HG21 ' A' ' 26' ' ' VAL . 0.2 OUTLIER -148.31 -29.57 0.3 Allowed 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 126.046 1.739 . . . . 0.0 113.063 -179.56 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.578 HD22 ' HA ' ' A' ' 28' ' ' PRO . 1.7 pt? -51.36 -32.9 27.36 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 115.324 1.601 . . . . 0.0 115.324 177.812 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -68.59 -47.32 67.04 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.454 1.102 . . . . 0.0 109.502 179.203 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.4 mptt -51.08 -34.91 32.28 Favored 'General case' 0 C--O 1.219 -0.503 0 C-N-CA 126.601 1.96 . . . . 0.0 111.395 173.391 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 13.0 tp -51.99 -51.18 58.96 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 119.804 1.184 . . . . 0.0 113.134 177.164 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.8 tmtt? -83.35 -32.27 26.34 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.767 0.827 . . . . 0.0 112.79 172.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -60.84 -57.26 13.42 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 118.042 -0.98 . . . . 0.0 112.107 177.254 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 16.8 m -53.94 -37.91 35.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 CA-C-N 119.405 1.002 . . . . 0.0 111.257 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.2 mp -53.54 -45.27 58.76 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 124.525 1.13 . . . . 0.0 111.676 170.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.404 ' HA ' HD13 ' A' ' 48' ' ' ILE . 15.5 m-70 -65.51 -40.43 92.98 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 120.052 1.296 . . . . 0.0 112.623 176.695 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -74.29 -49.53 22.67 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 118.857 0.753 . . . . 0.0 112.647 -179.608 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -55.26 -42.68 67.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-N 118.759 0.709 . . . . 0.0 111.807 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.519 ' HB2' HD11 ' A' ' 48' ' ' ILE . 30.8 m-85 -83.19 -2.08 54.61 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 113.388 0.885 . . . . 0.0 113.388 -178.127 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.3 t -74.12 -25.29 59.69 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 179.392 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 17.5 pttt -66.55 -18.71 65.51 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 119.371 0.987 . . . . 0.0 113.005 174.201 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -101.51 -12.25 18.66 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.211 1.005 . . . . 0.0 113.16 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 156.27 -144.37 10.76 Favored Glycine 0 CA--C 1.529 0.957 0 CA-C-N 118.467 0.576 . . . . 0.0 112.525 -176.677 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 26.1 tptt -131.67 128.38 38.91 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.929 1.292 . . . . 0.0 108.766 175.192 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.519 HD11 ' HB2' ' A' ' 42' ' ' PHE . 2.0 mp -84.14 131.34 34.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 177.19 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.0 t -100.76 -31.74 11.04 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 178.413 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -108.22 163.78 12.88 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 119.329 0.968 . . . . 0.0 112.171 178.218 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -170.05 116.74 0.54 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.306 1.042 . . . . 0.0 112.307 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -132.97 126.52 32.18 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 121.877 0.846 . . . . 0.0 111.591 -179.205 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -119.5 86.04 33.28 Favored Pre-proline 0 CA--C 1.542 0.656 0 C-N-CA 126.464 1.906 . . . . 0.0 108.32 -178.285 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -69.53 174.78 8.81 Favored 'Trans proline' 0 C--N 1.355 0.881 0 C-N-CA 123.346 2.697 . . . . 0.0 110.95 177.481 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -145.53 172.35 13.35 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.235 1.414 . . . . 0.0 111.494 176.12 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -113.58 110.85 20.9 Favored 'General case' 0 C--O 1.223 -0.324 0 C-N-CA 125.096 1.358 . . . . 0.0 110.24 175.443 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 54.24 21.19 2.97 Favored 'General case' 0 CA--C 1.554 1.131 0 N-CA-C 114.884 1.439 . . . . 0.0 114.884 179.63 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 86.33 17.1 61.23 Favored Glycine 0 CA--C 1.539 1.579 0 O-C-N 121.259 -0.9 . . . . 0.0 113.485 -173.733 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 27.7 mmmt -117.22 176.34 5.19 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 127.65 2.38 . . . . 0.0 110.091 -177.446 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.422 HG22 ' HB3' ' A' ' 25' ' ' GLN . 76.2 p -50.6 117.39 2.42 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 126.739 2.016 . . . . 0.0 112.86 -176.233 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -69.71 177.41 3.04 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.922 0.889 . . . . 0.0 112.769 175.52 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -138.98 -1.63 2.01 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 125.503 1.525 . . . . 0.0 115.254 173.238 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -146.93 155.27 42.15 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 119.627 1.713 . . . . 0.0 109.098 -174.807 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.1 pp -138.99 166.44 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 125.233 1.413 . . . . 0.0 110.424 173.14 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 26.7 t80 -135.43 126.91 28.66 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.141 0.976 . . . . 0.0 109.827 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -130.51 139.42 50.5 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.444 1.498 . . . . 0.0 110.186 179.216 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -127.3 125.81 41.5 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.858 1.263 . . . . 0.0 111.034 177.793 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -86.05 169.22 13.37 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 122.199 0.999 . . . . 0.0 111.769 176.72 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -77.51 -5.96 51.89 Favored 'General case' 0 CA--C 1.549 0.918 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 175.482 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -154.51 156.19 31.37 Favored Pre-proline 0 N--CA 1.473 0.721 0 C-N-CA 125.059 1.344 . . . . 0.0 112.83 -176.096 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -65.38 -48.67 3.13 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 123.646 2.897 . . . . 0.0 111.478 179.023 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -53.29 -18.32 2.36 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.387 1.875 . . . . 0.0 114.284 177.817 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 22.3 m170 -85.81 -48.29 8.92 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 119.146 0.884 . . . . 0.0 110.494 175.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -64.29 -54.7 29.09 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.892 1.277 . . . . 0.0 112.335 177.478 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 11.8 m -59.51 -31.73 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 123.034 0.533 . . . . 0.0 111.438 -177.721 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -73.28 -57.67 3.85 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.59 1.156 . . . . 0.0 111.286 172.423 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -50.22 -44.09 53.12 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.637 1.175 . . . . 0.0 113.595 -178.317 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.604 HG23 HG22 ' A' ' 18' ' ' ILE . 54.8 t -58.48 -43.03 85.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 174.126 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.0 -0.52 51.94 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.616 1.566 . . . . 0.0 112.852 -179.415 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -113.86 -44.68 3.15 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 124.189 0.996 . . . . 0.0 112.436 178.428 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -94.91 18.78 11.27 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 -178.455 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -56.87 83.21 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 126.271 1.828 . . . . 0.0 113.053 177.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 102.99 87.0 1.98 Allowed Glycine 0 CA--C 1.527 0.806 0 C-N-CA 124.852 1.215 . . . . 0.0 113.401 171.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -66.47 143.51 57.05 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 -176.44 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.195 0 O-C-N 120.241 -1.537 . . . . 0.0 114.932 -176.215 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 . . . . . 0 N--CA 1.463 0.188 0 N-CA-C 110.151 -0.314 . . . . 0.0 110.151 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 15.8 mmm-85 -138.52 98.62 3.63 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.165 0.986 . . . . 0.0 109.603 -177.242 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 40.4 t -87.77 119.8 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 178.638 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 52.6 m-80 . . . . . 0 CA--C 1.545 0.765 0 C-N-CA 125.553 1.541 . . . . 0.0 110.852 -179.976 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . 0.323 4.7 p-10 . . . . . 0 CA--C 1.553 1.077 0 N-CA-C 117.81 2.522 . . . . 0.0 117.81 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 50.6 m -115.33 4.1 14.35 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 129.424 3.09 . . . . 0.0 114.001 -174.321 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.2 m -137.75 161.74 32.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 125.098 1.359 . . . . 0.0 111.985 -172.35 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.546 HG22 HG23 ' A' ' 78' ' ' VAL . 19.1 pt -130.76 152.88 38.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 CA-C-O 122.338 1.066 . . . . 0.0 110.256 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 61.3 t -137.8 142.28 36.64 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.334 0 C-N-CA 125.482 1.513 . . . . 0.0 108.751 176.739 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -122.44 151.37 26.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 125.002 1.321 . . . . 0.0 108.679 178.442 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -127.65 167.3 16.61 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.204 1.402 . . . . 0.0 110.897 178.568 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 38.4 m-20 59.04 31.53 21.42 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 126.64 1.976 . . . . 0.0 114.212 -173.217 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . 0.254 7.6 p -102.01 81.29 0.34 Allowed Pre-proline 0 N--CA 1.479 1.011 0 C-N-CA 125.847 1.659 . . . . 0.0 111.835 -179.169 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -67.51 159.65 51.53 Favored 'Trans proline' 0 C--N 1.356 0.952 0 C-N-CA 122.004 1.803 . . . . 0.0 110.895 175.325 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -75.83 167.57 21.63 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.785 170.319 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.421 HG21 ' HG2' ' A' ' 30' ' ' ARG . 31.8 m -136.99 166.45 25.72 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 C-N-CA 126.521 1.928 . . . . 0.0 109.272 -177.33 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -75.78 -173.24 34.21 Favored Glycine 0 CA--C 1.539 1.59 0 C-N-CA 124.341 0.972 . . . . 0.0 114.523 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.548 ' HA ' HD22 ' A' ' 31' ' ' LEU . 68.2 Cg_endo -61.39 169.07 7.02 Favored 'Trans proline' 0 CA--C 1.536 0.614 0 C-N-CA 123.568 2.845 . . . . 0.0 111.019 177.607 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 61.69 9.6 2.91 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.843 1.657 . . . . 0.0 114.046 -178.177 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.421 ' HG2' HG21 ' A' ' 26' ' ' VAL . 43.4 ttt85 -150.66 -29.61 0.2 Allowed 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 127.031 2.132 . . . . 0.0 114.601 -178.229 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.548 HD22 ' HA ' ' A' ' 28' ' ' PRO . 1.7 pt? -51.7 -33.22 33.33 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 115.263 1.579 . . . . 0.0 115.263 177.117 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -66.29 -50.77 62.53 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 125.613 1.565 . . . . 0.0 109.315 178.405 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 5.8 mptt -49.76 -37.83 31.35 Favored 'General case' 0 C--N 1.345 0.408 0 C-N-CA 127.627 2.371 . . . . 0.0 110.379 175.309 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -47.36 -64.71 0.71 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.135 1.374 . . . . 0.0 111.361 177.047 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.91 -28.47 58.06 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.687 0.795 . . . . 0.0 112.472 176.481 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -60.33 -59.69 5.01 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 117.773 -1.108 . . . . 0.0 111.437 176.305 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 32.3 m -53.94 -33.78 24.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 125.1 1.36 . . . . 0.0 111.746 -177.797 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.2 mp -50.09 -48.49 23.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 124.381 1.072 . . . . 0.0 111.137 169.22 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.418 ' HA ' HD13 ' A' ' 48' ' ' ILE . 19.4 m-70 -67.55 -20.33 65.39 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 119.446 1.021 . . . . 0.0 113.544 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.28 -49.64 5.12 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.02 1.328 . . . . 0.0 111.498 -177.817 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -55.17 -43.87 72.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 124.581 1.152 . . . . 0.0 111.129 175.179 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.517 ' HB2' HD11 ' A' ' 48' ' ' ILE . 36.5 m-85 -87.22 -0.14 56.25 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 113.04 0.755 . . . . 0.0 113.04 -177.898 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -70.09 -35.29 74.07 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.094 1.358 . . . . 0.0 112.05 178.333 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.442 ' HE3' ' CZ ' ' A' ' 45' ' ' PHE . 20.7 pttt -61.82 -17.36 55.96 Favored 'General case' 0 N--CA 1.478 0.941 0 O-C-N 120.948 -1.095 . . . . 0.0 113.647 177.558 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.442 ' CZ ' ' HE3' ' A' ' 44' ' ' LYS . 9.2 m-85 -101.17 -10.99 19.91 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.881 1.272 . . . . 0.0 113.346 178.29 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 149.55 -149.31 21.24 Favored Glycine 0 CA--C 1.532 1.125 0 CA-C-N 119.182 0.901 . . . . 0.0 112.663 -174.217 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 21.3 tptt -127.47 124.64 38.86 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 124.405 1.082 . . . . 0.0 108.945 178.16 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.517 HD11 ' HB2' ' A' ' 42' ' ' PHE . 2.4 mp -79.61 130.37 36.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 123.672 0.789 . . . . 0.0 109.066 175.82 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 2.8 t -100.7 -30.62 11.63 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.754 1.222 . . . . 0.0 113.516 177.721 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -113.15 154.11 27.18 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 119.647 1.112 . . . . 0.0 111.548 179.66 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -159.46 123.91 3.94 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.665 0.786 . . . . 0.0 110.759 176.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -134.83 129.81 35.07 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 123.678 0.791 . . . . 0.0 111.905 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -121.65 86.17 44.69 Favored Pre-proline 0 CA--C 1.538 0.508 0 C-N-CA 127.449 2.3 . . . . 0.0 108.442 -177.247 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -68.67 174.49 8.44 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 122.736 2.291 . . . . 0.0 110.929 174.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -146.04 172.53 13.25 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 126.548 1.939 . . . . 0.0 110.416 174.608 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -113.33 110.29 20.1 Favored 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 125.674 1.59 . . . . 0.0 109.049 175.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 57.18 20.17 5.44 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 124.686 1.194 . . . . 0.0 113.784 177.334 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 85.04 14.62 68.98 Favored Glycine 0 CA--C 1.537 1.467 0 O-C-N 121.025 -1.047 . . . . 0.0 114.002 -172.373 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 5.8 mmmt -114.64 171.1 7.84 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 128.368 2.667 . . . . 0.0 109.976 -178.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 4.0 t -40.85 115.5 0.59 Allowed 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 127.228 2.211 . . . . 0.0 112.632 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.0 pttp -62.91 -179.11 0.25 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.339 1.056 . . . . 0.0 112.628 168.204 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -142.69 0.19 1.39 Allowed Glycine 0 CA--C 1.531 1.086 0 C-N-CA 126.51 2.005 . . . . 0.0 115.441 170.147 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -146.6 154.52 41.58 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 119.957 1.879 . . . . 0.0 108.999 -174.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.1 pp -137.09 165.3 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 126.274 1.83 . . . . 0.0 110.834 172.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -135.66 126.2 26.95 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.2 1.4 . . . . 0.0 109.507 -177.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -131.1 141.12 50.11 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.816 1.646 . . . . 0.0 110.706 -178.534 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -129.69 127.29 40.21 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.635 0.774 . . . . 0.0 109.908 -179.535 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -88.99 167.21 13.37 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.968 0.89 . . . . 0.0 111.693 177.44 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.2 -4.0 36.33 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.099 0.959 . . . . 0.0 113.499 174.417 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -157.3 153.86 24.47 Favored Pre-proline 0 N--CA 1.474 0.727 0 C-N-CA 124.973 1.309 . . . . 0.0 112.717 -177.036 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -63.07 -47.69 7.81 Favored 'Trans proline' 0 C--N 1.354 0.816 0 C-N-CA 123.862 3.041 . . . . 0.0 110.877 177.571 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -55.69 -14.72 2.38 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.735 2.014 . . . . 0.0 114.624 178.528 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 54.2 m170 -88.46 -46.37 9.18 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 119.669 1.122 . . . . 0.0 110.609 171.453 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -66.42 -54.31 25.72 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 124.03 0.932 . . . . 0.0 111.465 -179.194 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 10.7 m -61.28 -26.16 38.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 124.013 0.925 . . . . 0.0 112.076 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -78.25 -56.91 4.08 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.823 1.249 . . . . 0.0 110.299 172.793 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -50.65 -43.73 57.31 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 119.705 1.139 . . . . 0.0 113.411 -179.358 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.546 HG23 HG22 ' A' ' 18' ' ' ILE . 61.2 t -57.91 -39.82 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 123.63 0.772 . . . . 0.0 112.907 175.276 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 7.2 mttt -90.18 4.69 49.75 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 126.095 1.758 . . . . 0.0 113.088 179.527 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -124.8 -20.5 5.0 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 115.147 1.536 . . . . 0.0 115.147 178.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -120.94 21.74 11.28 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 125.479 1.511 . . . . 0.0 112.287 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -56.54 79.74 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 127.586 2.354 . . . . 0.0 113.797 178.781 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 98.11 91.29 1.95 Allowed Glycine 0 C--N 1.341 0.86 0 C-N-CA 124.202 0.906 . . . . 0.0 111.955 174.163 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -67.33 150.13 49.4 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.449 1.1 . . . . 0.0 113.704 -177.505 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . 0.273 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.219 0 N-CA-C 115.266 1.58 . . . . 0.0 115.266 -178.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 . . . . . 0 N--CA 1.464 0.227 0 CA-C-O 121.0 0.429 . . . . 0.0 111.293 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 23.3 mmm180 -137.59 89.88 2.46 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.21 1.404 . . . . 0.0 110.705 -177.766 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 33.3 t -77.9 118.78 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 123.616 0.766 . . . . 0.0 109.43 176.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 55.6 m-80 . . . . . 0 CA--C 1.544 0.722 0 C-N-CA 125.768 1.627 . . . . 0.0 110.563 178.964 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 . . . . . 0 CA--C 1.55 0.943 0 N-CA-C 116.036 1.865 . . . . 0.0 116.036 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.6 m -121.53 1.52 10.09 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 126.532 1.933 . . . . 0.0 113.348 -174.849 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 26.8 m -144.89 167.72 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 124.386 1.075 . . . . 0.0 111.772 -169.093 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.535 HG22 HG23 ' A' ' 78' ' ' VAL . 21.0 pt -130.96 156.03 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 CA-C-O 121.401 0.619 . . . . 0.0 111.472 178.191 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 98.2 t -136.0 152.93 31.23 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.029 0 C-N-CA 125.286 1.434 . . . . 0.0 109.964 175.404 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -130.43 149.78 33.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 N-CA-C 108.312 -0.995 . . . . 0.0 108.312 177.061 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -124.86 162.37 24.5 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 124.357 1.063 . . . . 0.0 110.59 176.802 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 12.9 t30 65.76 34.02 7.78 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.709 1.604 . . . . 0.0 113.405 -177.821 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.7 p -104.53 81.7 0.56 Allowed Pre-proline 0 N--CA 1.476 0.866 0 C-N-CA 125.572 1.549 . . . . 0.0 112.612 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -68.31 144.85 63.7 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.108 1.872 . . . . 0.0 111.84 177.22 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.426 ' HB3' HG22 ' A' ' 60' ' ' THR . 0.0 OUTLIER -64.93 163.55 14.28 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 120.915 0.388 . . . . 0.0 111.193 169.79 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 31.3 m -138.55 161.37 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 C-N-CA 125.294 1.438 . . . . 0.0 109.935 -174.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -70.47 -173.25 12.75 Favored Glycine 0 CA--C 1.546 2.021 0 N-CA-C 115.286 0.875 . . . . 0.0 115.286 -179.526 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.559 ' HA ' HD22 ' A' ' 31' ' ' LEU . 59.3 Cg_endo -62.21 167.97 10.09 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 123.527 2.818 . . . . 0.0 111.493 179.247 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 19.2 t70 64.4 7.75 3.82 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.055 1.342 . . . . 0.0 113.126 -178.667 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.2 ttt-85 -150.36 -27.38 0.23 Allowed 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.566 1.546 . . . . 0.0 114.142 -179.238 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.559 HD22 ' HA ' ' A' ' 28' ' ' PRO . 1.6 pt? -52.02 -33.09 36.9 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 114.713 1.375 . . . . 0.0 114.713 176.386 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -65.34 -53.14 48.06 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 125.077 1.351 . . . . 0.0 108.844 177.502 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.79 -38.52 48.83 Favored 'General case' 0 C--O 1.219 -0.541 0 C-N-CA 126.623 1.969 . . . . 0.0 111.003 176.61 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -46.65 -59.59 2.92 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 119.406 1.003 . . . . 0.0 111.879 175.263 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -75.17 -32.79 61.37 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.762 0.825 . . . . 0.0 112.824 175.232 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.99 -55.42 25.85 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 117.659 -1.163 . . . . 0.0 111.835 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 15.6 m -55.14 -37.55 43.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 124.25 1.02 . . . . 0.0 110.838 179.345 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.1 mp -53.18 -47.62 55.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 124.81 1.244 . . . . 0.0 111.495 170.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 13.5 m-70 -65.37 -39.7 92.6 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 119.29 0.95 . . . . 0.0 112.644 178.519 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -72.77 -49.14 32.65 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 119.233 0.924 . . . . 0.0 112.669 177.722 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -57.03 -39.86 69.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 CA-C-N 119.378 0.99 . . . . 0.0 111.878 -177.468 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.537 ' HB2' HD11 ' A' ' 48' ' ' ILE . 35.3 m-85 -86.64 -1.03 57.35 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -178.684 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -75.78 -22.94 55.92 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 -179.369 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 3.4 pttm -68.56 -24.94 64.68 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 119.488 1.04 . . . . 0.0 112.367 175.091 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -92.16 -14.24 29.42 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.977 0.911 . . . . 0.0 112.825 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 156.59 -148.35 18.11 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 123.982 0.801 . . . . 0.0 112.361 -176.52 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 12.3 tptm -128.08 123.16 33.88 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.455 1.102 . . . . 0.0 109.463 176.472 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.537 HD11 ' HB2' ' A' ' 42' ' ' PHE . 1.7 mp -79.71 123.55 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 177.436 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.8 t -102.18 -11.57 18.69 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 117.697 -1.144 . . . . 0.0 114.061 -178.621 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -121.91 165.7 15.55 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.057 1.343 . . . . 0.0 110.917 175.452 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.505 ' HA ' HD23 ' A' ' 66' ' ' LEU . 0.2 OUTLIER -166.79 126.21 1.48 Allowed 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.811 0.845 . . . . 0.0 111.928 173.689 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -137.02 122.37 19.42 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.833 0.825 . . . . 0.0 111.478 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -119.92 86.58 36.69 Favored Pre-proline 0 CA--C 1.538 0.504 0 C-N-CA 126.086 1.754 . . . . 0.0 108.835 -178.508 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -70.33 174.79 9.49 Favored 'Trans proline' 0 CA--C 1.536 0.612 0 C-N-CA 123.069 2.513 . . . . 0.0 111.043 178.037 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -145.54 171.97 13.91 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.482 1.113 . . . . 0.0 111.753 173.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -111.97 109.87 19.88 Favored 'General case' 0 C--O 1.223 -0.309 0 C-N-CA 124.734 1.213 . . . . 0.0 109.639 176.642 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 54.26 24.96 5.4 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 125.054 1.342 . . . . 0.0 114.462 179.48 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 83.7 12.89 76.78 Favored Glycine 0 CA--C 1.539 1.534 0 O-C-N 121.494 -0.754 . . . . 0.0 113.666 -174.486 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.9 mtpp -114.79 179.32 3.98 Favored 'General case' 0 C--N 1.343 0.297 0 C-N-CA 126.604 1.961 . . . . 0.0 110.857 -177.653 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.426 HG22 ' HB3' ' A' ' 25' ' ' GLN . 65.6 p -54.46 110.92 0.69 Allowed 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.675 1.59 . . . . 0.0 113.556 -173.64 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.6 pttt -59.23 174.12 0.42 Allowed 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.86 1.664 . . . . 0.0 113.291 173.395 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -136.38 -3.38 2.44 Favored Glycine 0 CA--C 1.534 1.272 0 C-N-CA 125.265 1.412 . . . . 0.0 115.484 173.013 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -144.7 154.77 43.11 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 126.116 1.766 . . . . 0.0 109.009 -176.109 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.1 pp -137.06 168.66 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 125.671 1.588 . . . . 0.0 110.74 172.403 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -138.65 132.68 31.31 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.748 1.219 . . . . 0.0 110.102 -178.609 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.505 HD23 ' HA ' ' A' ' 51' ' ' ASP . 31.8 mt -136.45 147.1 47.03 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 125.04 1.336 . . . . 0.0 110.684 179.186 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -132.31 122.17 24.7 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 124.149 0.98 . . . . 0.0 109.848 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -83.29 170.86 14.16 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 121.933 0.873 . . . . 0.0 111.245 175.004 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -74.01 -3.53 29.82 Favored 'General case' 0 CA--C 1.549 0.904 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 173.746 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.3 p -161.1 156.08 20.41 Favored Pre-proline 0 CA--C 1.54 0.567 0 CA-C-N 119.561 1.073 . . . . 0.0 112.997 -175.754 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -65.73 -45.41 6.56 Favored 'Trans proline' 0 C--N 1.355 0.919 0 C-N-CA 123.363 2.708 . . . . 0.0 111.632 -178.556 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -55.42 -15.51 2.73 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.295 1.838 . . . . 0.0 114.028 177.271 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -90.44 -46.57 8.27 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 119.729 1.15 . . . . 0.0 110.817 174.379 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -60.2 -57.18 13.91 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.338 1.055 . . . . 0.0 112.452 173.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 10.4 m -61.69 -28.48 44.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -176.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -74.82 -56.29 4.93 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.455 1.102 . . . . 0.0 110.66 173.78 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.77 -41.55 61.72 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.165 0.986 . . . . 0.0 112.969 -176.485 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.535 HG23 HG22 ' A' ' 18' ' ' ILE . 78.8 t -58.02 -39.44 72.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 124.018 0.927 . . . . 0.0 113.167 174.375 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 3.2 mptt -88.32 3.75 48.58 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.075 1.35 . . . . 0.0 113.348 178.129 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -120.67 -31.11 4.34 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 179.341 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -110.12 21.18 17.09 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 119.251 0.932 . . . . 0.0 113.039 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -57.21 85.61 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.768 1.627 . . . . 0.0 113.076 178.444 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 97.56 79.28 1.45 Allowed Glycine 0 CA--C 1.53 0.989 0 C-N-CA 124.308 0.956 . . . . 0.0 113.304 173.146 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -57.49 128.66 38.14 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.805 1.242 . . . . 0.0 112.941 -177.066 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.477 0.895 0 O-C-N 119.941 -1.724 . . . . 0.0 115.283 -176.371 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 . . . . . 0 N--CA 1.466 0.328 0 CA-C-O 120.648 0.261 . . . . 0.0 110.746 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 22.1 mmt180 -137.08 87.04 2.25 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.985 0.914 . . . . 0.0 110.673 -178.687 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 39.2 t -78.82 118.7 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 177.165 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 54.7 m-80 . . . . . 0 CA--C 1.538 0.493 0 C-N-CA 125.686 1.594 . . . . 0.0 110.006 -178.319 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 CA--C 1.547 0.829 0 N-CA-C 116.427 2.01 . . . . 0.0 116.427 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 68.4 m -118.73 8.41 11.85 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.859 1.664 . . . . 0.0 113.722 -177.151 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.5 m -142.62 164.6 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 C-N-CA 123.517 0.727 . . . . 0.0 111.432 -174.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.578 HG22 HG23 ' A' ' 78' ' ' VAL . 18.4 pt -129.63 148.4 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 123.063 0.545 . . . . 0.0 110.976 179.552 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 40.7 t -134.01 137.13 52.71 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.121 0 CA-C-O 122.318 1.056 . . . . 0.0 109.173 174.312 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.489 HG22 HG13 ' A' ' 64' ' ' ILE . 0.9 OUTLIER -109.61 154.23 11.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.054 -0.975 . . . . 0.0 109.27 179.371 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -129.77 158.38 39.58 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 123.263 0.625 . . . . 0.0 111.792 174.713 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 63.5 t30 61.58 40.1 13.9 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 126.009 1.724 . . . . 0.0 113.056 -178.149 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.7 m -99.82 83.28 0.34 Allowed Pre-proline 0 N--CA 1.483 1.18 0 C-N-CA 126.032 1.733 . . . . 0.0 112.434 174.458 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -65.21 140.14 63.47 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 121.759 1.64 . . . . 0.0 110.002 171.162 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.67 177.36 1.62 Allowed 'General case' 0 CA--C 1.541 0.596 0 CA-C-O 121.385 0.612 . . . . 0.0 112.136 170.363 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.532 HG21 ' HG2' ' A' ' 30' ' ' ARG . 27.3 m -135.47 162.77 36.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 C-N-CA 125.183 1.393 . . . . 0.0 110.557 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -66.56 -174.15 5.86 Favored Glycine 0 CA--C 1.544 1.849 0 C-N-CA 124.069 0.842 . . . . 0.0 114.989 -179.542 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.5 ' HA ' HD22 ' A' ' 31' ' ' LEU . 61.0 Cg_endo -63.81 166.19 16.67 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 123.051 2.501 . . . . 0.0 111.661 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.6 t0 62.33 11.72 4.73 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 123.876 0.87 . . . . 0.0 112.725 -177.269 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.532 ' HG2' HG21 ' A' ' 26' ' ' VAL . 7.2 ttt180 -151.52 -26.55 0.19 Allowed 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.431 1.492 . . . . 0.0 113.922 177.89 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.5 HD22 ' HA ' ' A' ' 28' ' ' PRO . 1.7 pt? -51.6 -32.9 30.57 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 114.694 1.368 . . . . 0.0 114.694 179.56 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -66.98 -49.24 66.02 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 125.46 1.504 . . . . 0.0 109.694 179.234 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 8.3 mptt -49.65 -34.17 17.6 Favored 'General case' 0 C--O 1.219 -0.551 0 C-N-CA 126.601 1.961 . . . . 0.0 111.279 173.292 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -50.42 -63.49 1.1 Allowed 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 120.264 1.393 . . . . 0.0 110.875 177.269 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.91 -28.89 61.76 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 121.444 -0.785 . . . . 0.0 112.687 175.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.8 -56.7 15.07 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 118.016 -0.992 . . . . 0.0 112.164 177.108 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 19.0 m -55.61 -34.84 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 124.004 0.922 . . . . 0.0 110.983 -178.263 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.1 mp -49.41 -46.89 19.83 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 124.528 1.131 . . . . 0.0 111.462 171.627 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 18.8 m-70 -68.68 -16.73 63.92 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 113.542 0.942 . . . . 0.0 113.542 179.501 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -94.04 -51.44 4.85 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.528 1.131 . . . . 0.0 111.19 178.229 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -56.08 -37.23 48.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 CA-C-N 118.831 0.741 . . . . 0.0 111.742 177.165 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.54 ' HB2' HD11 ' A' ' 48' ' ' ILE . 37.2 m-85 -91.12 -0.93 57.81 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -179.292 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -74.31 -27.01 60.51 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 178.441 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.487 ' HE3' ' CZ ' ' A' ' 45' ' ' PHE . 16.9 pttt -66.67 -22.08 66.09 Favored 'General case' 0 N--CA 1.48 1.071 0 O-C-N 120.536 -1.353 . . . . 0.0 113.188 176.899 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.487 ' CZ ' ' HE3' ' A' ' 44' ' ' LYS . 9.6 m-85 -94.95 -12.89 25.94 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.68 0.792 . . . . 0.0 113.001 -179.266 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 151.03 -152.18 24.03 Favored Glycine 0 CA--C 1.53 1.024 0 N-CA-C 111.668 -0.573 . . . . 0.0 111.668 -173.073 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 24.6 tptt -126.26 123.61 38.52 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.506 1.122 . . . . 0.0 110.067 177.793 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.546 HG21 HD22 ' A' ' 66' ' ' LEU . 2.4 mp -76.37 129.72 36.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 176.369 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 2.6 t -100.83 -30.48 11.66 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.551 0.74 . . . . 0.0 112.826 179.565 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -109.88 162.73 14.22 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.39 1.076 . . . . 0.0 110.843 -179.464 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.536 ' HA ' HD23 ' A' ' 66' ' ' LEU . 0.3 OUTLIER -165.52 125.67 1.82 Allowed 'General case' 0 N--CA 1.468 0.439 0 O-C-N 121.424 -0.797 . . . . 0.0 111.785 174.39 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -136.83 122.87 20.27 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.941 0.876 . . . . 0.0 111.577 -179.161 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -119.72 86.1 34.63 Favored Pre-proline 0 CA--C 1.537 0.461 0 C-N-CA 125.892 1.677 . . . . 0.0 109.11 -176.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -70.75 171.08 16.24 Favored 'Trans proline' 0 CA--C 1.534 0.511 0 C-N-CA 122.99 2.46 . . . . 0.0 111.426 178.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -145.67 173.78 11.77 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.282 1.033 . . . . 0.0 111.705 175.47 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -116.22 111.34 20.04 Favored 'General case' 0 C--O 1.223 -0.3 0 C-N-CA 124.771 1.228 . . . . 0.0 110.096 176.734 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 50.86 30.08 4.87 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 125.768 1.627 . . . . 0.0 113.911 -178.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 79.66 12.96 83.06 Favored Glycine 0 CA--C 1.534 1.24 0 O-C-N 121.163 -0.96 . . . . 0.0 113.042 -176.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 26.7 mtpt -111.41 -178.35 3.43 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.689 1.995 . . . . 0.0 109.85 -178.59 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 64.4 p -57.72 115.37 2.76 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 126.818 2.047 . . . . 0.0 112.98 -172.272 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.8 pttp -69.46 171.81 8.19 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.605 1.162 . . . . 0.0 113.96 171.162 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -138.29 3.77 3.05 Favored Glycine 0 CA--C 1.536 1.385 0 C-N-CA 126.848 2.166 . . . . 0.0 115.638 175.842 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -147.38 152.57 38.38 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 119.961 1.88 . . . . 0.0 109.542 -178.751 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.489 HG13 HG22 ' A' ' 20' ' ' VAL . 1.0 OUTLIER -135.84 166.72 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 125.643 1.577 . . . . 0.0 111.098 172.331 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -134.72 126.09 28.31 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.223 1.409 . . . . 0.0 109.985 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.546 HD22 HG21 ' A' ' 48' ' ' ILE . 73.9 mt -127.72 149.62 50.14 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 124.593 1.157 . . . . 0.0 110.722 175.769 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -136.34 132.56 35.78 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-O 122.364 1.078 . . . . 0.0 110.253 178.097 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -94.82 167.97 11.1 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 114.762 -1.108 . . . . 0.0 111.186 177.732 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -80.51 10.24 4.97 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.944 0.898 . . . . 0.0 112.339 176.671 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 9.7 m -169.78 153.04 4.79 Favored Pre-proline 0 CA--C 1.54 0.592 0 CA-C-N 120.005 1.275 . . . . 0.0 112.583 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -64.09 -46.12 8.79 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 124.818 3.679 . . . . 0.0 111.865 -178.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -53.98 -20.8 6.78 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.725 1.61 . . . . 0.0 113.509 176.322 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 33.0 m170 -84.99 -47.87 9.81 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 119.778 1.172 . . . . 0.0 110.534 176.011 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -65.06 -51.86 59.08 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.099 0.96 . . . . 0.0 112.287 178.546 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 15.9 m -60.47 -34.06 56.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 122.664 0.386 . . . . 0.0 111.149 -179.235 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -68.36 -57.39 5.97 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 123.593 0.757 . . . . 0.0 110.463 172.624 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -55.7 -39.66 71.33 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 119.101 0.864 . . . . 0.0 112.748 -173.093 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.578 HG23 HG22 ' A' ' 18' ' ' ILE . 49.2 t -59.43 -42.2 86.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 123.971 0.908 . . . . 0.0 112.713 173.719 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.56 2.33 37.71 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.354 1.061 . . . . 0.0 113.463 177.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -115.67 -53.63 2.57 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 119.036 0.835 . . . . 0.0 111.409 179.496 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -88.11 19.18 3.79 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.021 0.928 . . . . 0.0 113.327 -176.142 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -52.33 86.44 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.518 1.927 . . . . 0.0 113.374 -179.201 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.64 95.49 0.77 Allowed Glycine 0 CA--C 1.531 1.075 0 C-N-CA 124.557 1.075 . . . . 0.0 111.495 -178.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 23.6 m-85 -59.59 156.25 13.88 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 122.14 0.972 . . . . 0.0 112.397 177.042 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.467 0.418 0 C-N-CA 124.445 1.098 . . . . 0.0 110.08 -172.089 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 . . . . . 0 N--CA 1.467 0.392 0 CA-C-O 120.408 0.147 . . . . 0.0 111.087 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 21.0 mmm180 -136.43 94.76 3.05 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.606 0.762 . . . . 0.0 110.648 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 60.4 t -89.55 109.88 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 123.64 0.776 . . . . 0.0 109.849 179.409 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.433 ' HA ' HG13 ' A' ' 78' ' ' VAL . 49.1 m-80 . . . . . 0 CA--C 1.546 0.796 0 C-N-CA 125.004 1.321 . . . . 0.0 111.356 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . 0.272 3.6 p30 . . . . . 0 N--CA 1.477 0.875 0 N-CA-C 115.955 1.835 . . . . 0.0 115.955 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 59.7 m -130.83 5.68 4.62 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 127.21 2.204 . . . . 0.0 113.132 -171.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.6 m -142.3 162.7 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 C-N-CA 125.211 1.404 . . . . 0.0 111.785 -173.725 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.662 HG22 HG23 ' A' ' 78' ' ' VAL . 16.7 pt -131.42 150.09 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 C-N-CA 123.874 0.87 . . . . 0.0 110.243 -178.597 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 44.5 t -136.08 132.44 50.04 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.175 0 C-N-CA 124.954 1.302 . . . . 0.0 109.004 175.349 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -107.01 151.55 8.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 124.544 1.138 . . . . 0.0 109.51 176.452 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -127.23 166.32 17.97 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.229 1.012 . . . . 0.0 111.309 175.46 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 66.4 t30 60.2 39.62 19.06 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 126.593 1.957 . . . . 0.0 113.057 -176.104 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . 0.26 7.2 p -109.0 80.44 1.31 Allowed Pre-proline 0 N--CA 1.476 0.865 0 C-N-CA 125.63 1.572 . . . . 0.0 112.019 179.629 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -66.89 142.29 62.08 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 121.986 1.791 . . . . 0.0 110.975 175.47 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.31 163.02 13.72 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 122.981 0.512 . . . . 0.0 111.62 170.483 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.575 HG22 HD11 ' A' ' 34' ' ' LEU . 33.2 m -133.42 173.0 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 124.913 1.285 . . . . 0.0 110.953 -174.123 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -74.22 -176.58 35.4 Favored Glycine 0 CA--C 1.543 1.783 0 N-CA-C 114.478 0.551 . . . . 0.0 114.478 178.134 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.533 ' HA ' HD22 ' A' ' 31' ' ' LEU . 61.8 Cg_endo -62.34 168.98 8.67 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 123.49 2.794 . . . . 0.0 111.205 176.92 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.1 t70 64.07 2.63 1.47 Allowed 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.425 1.49 . . . . 0.0 113.53 -177.242 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.501 ' HG2' HG21 ' A' ' 26' ' ' VAL . 4.4 ttp180 -142.71 -28.6 0.58 Allowed 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 126.525 1.93 . . . . 0.0 113.77 179.467 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.533 HD22 ' HA ' ' A' ' 28' ' ' PRO . 1.6 pt? -51.46 -33.4 30.82 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 115.146 1.536 . . . . 0.0 115.146 179.19 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -68.81 -43.22 76.04 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 124.929 1.292 . . . . 0.0 110.474 178.756 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -51.52 -38.52 54.48 Favored 'General case' 0 C--O 1.221 -0.424 0 C-N-CA 126.052 1.741 . . . . 0.0 110.659 174.238 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.575 HD11 HG22 ' A' ' 26' ' ' VAL . 80.6 mt -52.71 -43.42 65.63 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 120.142 1.337 . . . . 0.0 113.692 178.898 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.1 tmtt? -91.88 -28.07 17.53 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.726 0.811 . . . . 0.0 112.103 176.512 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -62.12 -61.79 2.23 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 118.864 -0.588 . . . . 0.0 111.557 173.501 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 28.0 m -54.04 -34.95 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 124.936 1.294 . . . . 0.0 111.42 -174.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.402 HD13 ' O ' ' A' ' 34' ' ' LEU . 1.1 mp -46.92 -55.74 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.335 0 C-N-CA 125.582 1.553 . . . . 0.0 109.955 169.415 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 29.2 m-70 -63.39 -34.08 76.93 Favored 'General case' 0 C--O 1.223 -0.295 0 CA-C-O 118.203 -0.903 . . . . 0.0 112.275 -178.342 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.7 -54.12 11.35 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 118.877 0.762 . . . . 0.0 111.366 178.234 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -58.28 -42.13 82.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-N 118.42 0.555 . . . . 0.0 111.441 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.548 ' HB2' HD11 ' A' ' 48' ' ' ILE . 34.0 m-85 -84.43 -1.31 55.41 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 113.626 0.972 . . . . 0.0 113.626 -177.144 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.77 -27.32 61.09 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.534 1.133 . . . . 0.0 113.174 179.038 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 2.7 pttm -67.69 -24.78 65.44 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 119.794 1.179 . . . . 0.0 112.892 177.656 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -93.33 -10.39 35.55 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.28 1.032 . . . . 0.0 113.014 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 149.15 -142.67 10.05 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.046 0.831 . . . . 0.0 112.356 -176.221 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.5 tppt? -134.69 130.91 37.02 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 124.574 1.15 . . . . 0.0 109.766 177.642 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.573 HG21 HD22 ' A' ' 66' ' ' LEU . 2.9 mp -81.9 127.09 39.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 124.686 1.194 . . . . 0.0 108.46 175.771 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.2 t -97.86 -33.28 11.3 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.472 1.109 . . . . 0.0 113.089 178.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -104.26 165.13 11.26 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.928 1.291 . . . . 0.0 111.162 179.39 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.54 ' HA ' HD23 ' A' ' 66' ' ' LEU . 0.3 OUTLIER -167.78 126.16 1.24 Allowed 'General case' 0 N--CA 1.469 0.494 0 O-C-N 121.244 -0.91 . . . . 0.0 111.915 174.124 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -137.0 118.43 14.73 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-O 121.566 0.698 . . . . 0.0 111.366 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -116.46 86.75 18.73 Favored Pre-proline 0 CA--C 1.539 0.553 0 C-N-CA 126.136 1.774 . . . . 0.0 108.583 -179.693 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -69.29 174.61 8.85 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 123.249 2.632 . . . . 0.0 111.234 178.072 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -145.38 172.68 12.83 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.855 1.262 . . . . 0.0 111.94 174.234 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -113.76 108.25 16.85 Favored 'General case' 0 C--O 1.224 -0.275 0 C-N-CA 125.339 1.456 . . . . 0.0 109.508 178.192 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 53.96 26.73 6.58 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.289 1.435 . . . . 0.0 114.021 -179.608 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.58 11.69 82.73 Favored Glycine 0 CA--C 1.532 1.14 0 O-C-N 121.352 -0.842 . . . . 0.0 113.493 -174.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.5 mtpp -111.56 178.86 4.19 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 126.648 1.979 . . . . 0.0 110.252 178.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 44.0 p -48.71 106.43 0.1 Allowed 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 127.68 2.392 . . . . 0.0 115.013 -176.337 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.7 pttt -58.77 172.03 0.58 Allowed 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.026 1.33 . . . . 0.0 112.127 173.058 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -132.01 -2.81 4.16 Favored Glycine 0 CA--C 1.538 1.53 0 C-N-CA 127.364 2.412 . . . . 0.0 116.149 173.157 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -145.82 155.15 42.72 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 119.796 1.798 . . . . 0.0 109.249 -175.057 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -136.52 164.6 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 125.672 1.589 . . . . 0.0 111.34 170.574 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -134.32 127.81 32.47 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 125.671 1.588 . . . . 0.0 109.917 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.573 HD22 HG21 ' A' ' 48' ' ' ILE . 69.8 mt -130.22 149.78 51.77 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 124.775 1.23 . . . . 0.0 110.658 176.455 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -134.74 134.87 41.45 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 124.93 1.292 . . . . 0.0 110.148 178.563 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -94.93 169.67 9.97 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 121.979 0.895 . . . . 0.0 111.461 176.131 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -74.81 -3.69 33.28 Favored 'General case' 0 CA--C 1.55 0.968 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 174.661 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.4 p -163.06 155.47 15.84 Favored Pre-proline 0 CA--C 1.541 0.6 0 C-N-CA 124.222 1.009 . . . . 0.0 113.369 -173.184 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -65.5 -47.95 3.71 Favored 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 123.848 3.032 . . . . 0.0 111.482 -176.612 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -53.08 -21.76 5.18 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.411 1.884 . . . . 0.0 113.776 178.481 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 24.6 m170 -83.5 -46.13 12.81 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 119.338 0.972 . . . . 0.0 110.799 175.678 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -68.05 -50.93 52.17 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.014 0.926 . . . . 0.0 112.846 179.454 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 17.9 m -60.9 -31.09 48.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 123.7 0.8 . . . . 0.0 111.734 -178.309 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -70.44 -62.8 1.25 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.795 1.638 . . . . 0.0 109.402 169.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -50.65 -41.76 55.68 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.177 1.391 . . . . 0.0 114.052 -175.319 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.662 HG23 HG22 ' A' ' 18' ' ' ILE . 23.6 t -52.86 -49.53 47.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 123.492 0.717 . . . . 0.0 111.806 173.03 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -91.95 19.94 6.21 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 126.45 1.9 . . . . 0.0 112.124 178.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -132.54 -3.22 3.36 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 125.459 1.504 . . . . 0.0 114.228 174.552 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -137.65 19.34 2.88 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.381 1.072 . . . . 0.0 112.623 178.382 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -61.36 79.47 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 126.109 1.764 . . . . 0.0 112.308 -178.642 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 103.06 87.29 2.0 Allowed Glycine 0 CA--C 1.527 0.841 0 C-N-CA 125.08 1.324 . . . . 0.0 113.758 172.576 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -66.08 145.09 56.25 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.833 1.253 . . . . 0.0 114.35 -179.51 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.474 0.749 0 C-N-CA 124.863 1.265 . . . . 0.0 114.198 177.253 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 . . . . . 0 N--CA 1.468 0.47 0 CA-C-O 120.579 0.228 . . . . 0.0 110.871 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 16.1 mmm180 -136.45 95.55 3.19 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.677 1.191 . . . . 0.0 109.717 -178.793 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 40.6 t -89.38 116.13 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 123.679 0.792 . . . . 0.0 109.411 178.262 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.467 ' HA ' HG13 ' A' ' 78' ' ' VAL . 35.9 m-80 . . . . . 0 CA--C 1.545 0.766 0 C-N-CA 124.423 1.089 . . . . 0.0 110.429 178.157 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 . . . . . 0 CA--C 1.548 0.889 0 N-CA-C 115.551 1.685 . . . . 0.0 115.551 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -121.26 2.2 10.3 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 127.42 2.288 . . . . 0.0 113.839 -175.559 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.1 m -139.78 162.58 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 124.203 1.001 . . . . 0.0 110.456 -172.674 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.445 HG22 HG23 ' A' ' 78' ' ' VAL . 14.7 pt -133.19 155.28 40.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 124.438 1.095 . . . . 0.0 110.718 -178.645 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -144.47 162.39 14.43 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.483 0 C-N-CA 125.207 1.403 . . . . 0.0 110.011 178.21 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.465 HG22 HG22 ' A' ' 94' ' ' VAL . 27.1 t -137.8 127.38 35.11 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.192 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 -176.114 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -96.26 163.13 13.22 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.313 1.045 . . . . 0.0 112.032 169.736 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 16.0 m-20 62.12 43.79 8.44 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 129.059 2.944 . . . . 0.0 114.199 -178.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.784 HG11 HG23 ' A' ' 64' ' ' ILE . 7.4 p -111.34 84.25 4.68 Favored Pre-proline 0 N--CA 1.485 1.286 0 C-N-CA 124.973 1.309 . . . . 0.0 111.957 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -66.69 145.88 77.09 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 122.064 1.843 . . . . 0.0 110.796 172.706 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.451 ' HB3' HG22 ' A' ' 60' ' ' THR . 15.6 tt0 -65.1 159.62 22.95 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 121.51 0.672 . . . . 0.0 110.941 169.386 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.421 HG21 ' HG3' ' A' ' 30' ' ' ARG . 35.0 m -130.95 166.01 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 C-N-CA 126.373 1.869 . . . . 0.0 109.043 -176.224 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -74.62 -173.6 31.03 Favored Glycine 0 CA--C 1.543 1.794 0 C-N-CA 124.175 0.893 . . . . 0.0 114.493 -179.231 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.558 ' HA ' HD22 ' A' ' 31' ' ' LEU . 63.0 Cg_endo -62.23 168.15 9.82 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 123.435 2.757 . . . . 0.0 110.839 177.798 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.3 t70 65.93 2.63 2.28 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 125.385 1.474 . . . . 0.0 113.448 -177.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.421 ' HG3' HG21 ' A' ' 26' ' ' VAL . 9.6 tpt180 -145.83 -28.83 0.43 Allowed 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.661 1.584 . . . . 0.0 114.555 -177.002 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.558 HD22 ' HA ' ' A' ' 28' ' ' PRO . 1.6 pt? -52.31 -32.68 38.94 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 114.861 1.43 . . . . 0.0 114.861 177.416 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -69.58 -50.32 45.75 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.991 1.316 . . . . 0.0 109.542 179.498 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -47.84 -41.07 23.06 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 127.127 2.171 . . . . 0.0 109.827 175.206 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.6 tp -47.79 -47.9 30.6 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.567 1.547 . . . . 0.0 114.147 179.486 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -91.32 -31.48 16.07 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.478 1.111 . . . . 0.0 112.086 173.466 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -57.91 -59.17 5.67 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 118.102 -0.951 . . . . 0.0 111.461 175.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 15.4 m -53.38 -35.9 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 124.826 1.25 . . . . 0.0 110.829 178.305 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.1 mp -53.1 -44.99 52.99 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-N 118.859 0.754 . . . . 0.0 111.408 171.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.462 ' HA ' HD13 ' A' ' 48' ' ' ILE . 22.5 m-70 -66.8 -36.15 81.73 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 120.9 -1.125 . . . . 0.0 112.138 178.425 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -76.21 -50.24 15.02 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 118.716 0.689 . . . . 0.0 111.803 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -55.43 -40.04 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 124.404 1.082 . . . . 0.0 112.032 -179.112 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.66 ' HB2' HD11 ' A' ' 48' ' ' ILE . 31.6 m-85 -88.38 -6.04 57.93 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -177.777 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -68.1 -26.34 65.76 Favored 'General case' 0 C--N 1.343 0.305 0 C-N-CA 124.687 1.195 . . . . 0.0 111.96 -178.163 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 9.6 pttt -68.43 -19.34 64.58 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 175.868 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -100.2 -12.67 19.37 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.144 0.978 . . . . 0.0 112.79 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 153.14 -144.82 11.83 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 123.971 0.796 . . . . 0.0 111.722 -175.797 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 21.0 tptt -130.55 125.66 34.81 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.375 1.47 . . . . 0.0 109.082 178.65 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.66 HD11 ' HB2' ' A' ' 42' ' ' PHE . 4.2 mp -72.94 141.39 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 123.376 0.67 . . . . 0.0 109.802 173.6 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.6 t -114.51 -28.99 6.99 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 125.453 1.501 . . . . 0.0 113.235 178.387 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -132.56 136.09 46.37 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 119.071 0.851 . . . . 0.0 109.338 -176.655 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -152.03 122.45 7.3 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.706 1.602 . . . . 0.0 112.195 -176.019 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -139.74 136.17 33.89 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.97 1.308 . . . . 0.0 111.084 -178.273 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -119.96 76.02 21.73 Favored Pre-proline 0 N--CA 1.47 0.569 0 C-N-CA 124.715 1.206 . . . . 0.0 109.453 -175.474 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -68.17 141.52 52.64 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.582 2.188 . . . . 0.0 111.531 -174.535 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -117.24 168.66 10.11 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.652 1.581 . . . . 0.0 111.512 -177.849 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -113.18 117.17 31.17 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 125.168 1.387 . . . . 0.0 109.397 179.083 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 51.45 24.26 2.13 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.034 1.333 . . . . 0.0 114.479 -177.722 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 79.84 17.77 74.25 Favored Glycine 0 CA--C 1.542 1.763 0 O-C-N 121.101 -1.0 . . . . 0.0 113.758 -176.626 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 5.4 mtpp -112.83 -178.04 3.29 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 127.647 2.379 . . . . 0.0 110.098 -176.015 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.451 HG22 ' HB3' ' A' ' 25' ' ' GLN . 82.3 p -49.33 114.5 1.04 Allowed 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.496 1.119 . . . . 0.0 111.158 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.9 170.5 0.42 Allowed 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.293 1.037 . . . . 0.0 113.571 171.249 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -133.71 -8.97 2.08 Favored Glycine 0 CA--C 1.529 0.935 0 CA-C-O 117.87 -1.517 . . . . 0.0 114.52 173.886 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -143.43 161.73 37.64 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 119.939 1.87 . . . . 0.0 109.98 175.323 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.784 HG23 HG11 ' A' ' 23' ' ' VAL . 1.1 pp -124.41 161.2 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 C-N-CA 125.533 1.533 . . . . 0.0 111.224 169.477 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -134.01 119.01 18.46 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.053 1.741 . . . . 0.0 110.358 179.562 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -123.69 147.09 47.75 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.589 1.555 . . . . 0.0 110.293 177.344 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -131.51 135.95 47.49 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 122.486 1.136 . . . . 0.0 110.271 175.061 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -96.33 163.76 12.94 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 122.536 1.16 . . . . 0.0 111.587 175.639 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.28 -8.92 57.95 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.521 1.128 . . . . 0.0 113.001 177.459 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -153.66 152.1 26.52 Favored Pre-proline 0 CA--C 1.542 0.663 0 C-N-CA 125.759 1.624 . . . . 0.0 113.127 -177.557 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -63.7 -45.41 11.13 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 123.927 3.085 . . . . 0.0 111.258 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -53.83 -21.56 7.79 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.064 1.745 . . . . 0.0 113.505 177.447 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 21.8 m170 -84.38 -49.04 9.06 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 119.465 1.03 . . . . 0.0 110.229 175.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -60.14 -55.21 36.7 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.584 1.154 . . . . 0.0 111.689 177.733 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 15.2 m -60.76 -31.42 49.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 123.831 0.852 . . . . 0.0 111.892 -176.314 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -76.06 -55.46 5.57 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.587 1.155 . . . . 0.0 110.854 174.251 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -53.24 -42.88 66.87 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.639 1.176 . . . . 0.0 112.641 -177.143 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.445 HG23 HG22 ' A' ' 18' ' ' ILE . 50.2 t -55.62 -48.64 77.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 C-N-CA 123.861 0.865 . . . . 0.0 111.504 175.573 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -76.48 2.82 12.69 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 126.635 1.974 . . . . 0.0 114.368 178.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -117.53 -45.91 2.69 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.685 0.794 . . . . 0.0 112.337 177.644 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -93.74 23.0 5.03 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.066 0.946 . . . . 0.0 113.204 -178.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -49.11 80.95 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 127.941 2.496 . . . . 0.0 113.785 178.28 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 84.75 106.24 0.63 Allowed Glycine 0 CA--C 1.533 1.193 0 C-N-CA 125.641 1.591 . . . . 0.0 111.796 -179.263 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -67.95 161.28 26.86 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 121.65 -0.912 . . . . 0.0 111.985 176.157 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.845 0 C-N-CA 124.943 1.297 . . . . 0.0 113.995 -170.835 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 . . . . . 0 CA--C 1.537 0.477 0 CA-C-O 120.827 0.346 . . . . 0.0 111.579 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 38.2 mmm-85 -135.73 88.13 2.38 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.774 0.83 . . . . 0.0 112.639 -178.563 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.465 HG22 HG22 ' A' ' 20' ' ' VAL . 24.2 t -75.74 116.21 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 124.12 0.968 . . . . 0.0 110.96 178.755 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 44.3 m-80 . . . . . 0 CA--C 1.549 0.92 0 C-N-CA 125.122 1.369 . . . . 0.0 111.392 -179.872 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . 0.301 5.4 p-10 . . . . . 0 N--CA 1.478 0.935 0 N-CA-C 116.639 2.089 . . . . 0.0 116.639 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -124.38 7.05 8.36 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 127.209 2.204 . . . . 0.0 113.93 -170.671 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.4 m -132.04 166.02 30.27 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 O-C-N 120.576 -1.328 . . . . 0.0 113.469 -171.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.63 HG22 HG23 ' A' ' 78' ' ' VAL . 16.0 pt -136.23 153.66 31.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 C-N-CA 124.498 1.119 . . . . 0.0 110.84 178.21 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 73.7 t -137.7 151.37 25.89 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.227 0 C-N-CA 125.957 1.703 . . . . 0.0 108.672 175.697 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -131.08 154.32 40.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 C-N-CA 124.73 1.212 . . . . 0.0 108.481 177.351 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -127.69 169.55 13.68 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.662 1.585 . . . . 0.0 110.719 176.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 13.8 m-20 59.08 29.82 19.47 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 126.284 1.834 . . . . 0.0 114.393 -174.241 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . 0.265 6.9 p -100.59 84.98 0.5 Allowed Pre-proline 0 N--CA 1.481 1.096 0 C-N-CA 125.156 1.382 . . . . 0.0 112.113 -177.742 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -69.45 160.08 51.18 Favored 'Trans proline' 0 C--N 1.354 0.864 0 C-N-CA 122.235 1.956 . . . . 0.0 111.345 175.757 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.56 ' HB3' HG22 ' A' ' 60' ' ' THR . 0.0 OUTLIER -78.5 168.1 20.3 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.649 170.763 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.405 HG21 ' HG2' ' A' ' 30' ' ' ARG . 30.9 m -140.25 168.42 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 125.743 1.617 . . . . 0.0 110.119 -175.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -76.85 -173.37 37.88 Favored Glycine 0 CA--C 1.544 1.891 0 C-N-CA 123.722 0.677 . . . . 0.0 114.244 178.604 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.539 ' HA ' HD22 ' A' ' 31' ' ' LEU . 67.0 Cg_endo -61.54 172.05 3.88 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 123.307 2.672 . . . . 0.0 111.406 177.486 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 62.17 6.24 1.75 Allowed 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 126.116 1.766 . . . . 0.0 114.353 -178.681 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.405 ' HG2' HG21 ' A' ' 26' ' ' VAL . 2.1 ttt85 -151.58 -25.82 0.19 Allowed 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 126.985 2.114 . . . . 0.0 114.184 -177.199 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.539 HD22 ' HA ' ' A' ' 28' ' ' PRO . 1.8 pt? -49.69 -36.24 24.48 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 114.97 1.47 . . . . 0.0 114.97 175.011 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -64.7 -54.23 34.79 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 125.019 1.327 . . . . 0.0 108.747 178.8 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.9 -38.88 17.42 Favored 'General case' 0 C--O 1.219 -0.545 0 C-N-CA 127.344 2.258 . . . . 0.0 110.705 174.221 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -48.99 -55.52 11.68 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 119.744 1.156 . . . . 0.0 112.309 177.199 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.2 tmtt? -84.62 -27.29 27.3 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.753 0.821 . . . . 0.0 112.499 175.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -63.84 -53.65 47.34 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 117.286 -1.34 . . . . 0.0 111.597 176.837 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 30.2 m -52.32 -32.22 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 125.36 1.464 . . . . 0.0 112.768 -177.541 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.2 mp -50.58 -51.82 18.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 C-N-CA 124.482 1.113 . . . . 0.0 110.685 169.279 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 33.4 m-70 -64.67 -40.89 96.21 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 119.658 1.117 . . . . 0.0 112.098 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.403 ' HD3' ' H ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -67.39 -51.23 54.54 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.044 0.938 . . . . 0.0 111.087 179.699 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -61.4 -43.95 97.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-N 118.552 0.614 . . . . 0.0 111.154 179.069 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.486 ' HB2' HD11 ' A' ' 48' ' ' ILE . 37.8 m-85 -82.47 -6.36 59.26 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -176.1 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.57 -29.66 70.88 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.053 1.341 . . . . 0.0 113.337 177.773 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.4 pttm -65.95 -23.07 66.53 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 119.709 1.14 . . . . 0.0 112.952 177.677 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -96.97 -10.09 26.97 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.501 1.12 . . . . 0.0 113.069 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 149.46 -137.8 6.46 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 124.309 0.957 . . . . 0.0 112.623 -178.511 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.9 tppt? -135.83 137.8 41.88 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 124.655 1.182 . . . . 0.0 109.105 177.321 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.486 HD11 ' HB2' ' A' ' 42' ' ' PHE . 2.5 mp -95.53 128.13 46.97 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 C-N-CA 124.171 0.988 . . . . 0.0 108.717 179.175 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.9 t -96.17 -29.19 14.19 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.798 1.239 . . . . 0.0 113.911 178.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 21.4 m120 -112.13 158.03 20.12 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.468 1.107 . . . . 0.0 111.562 178.343 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -163.16 125.33 2.57 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.761 0.824 . . . . 0.0 111.249 173.247 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -134.55 126.78 30.0 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 123.704 0.802 . . . . 0.0 111.843 -178.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.408 ' CE2' HG21 ' A' ' 64' ' ' ILE . 15.8 m-85 -120.5 86.48 39.53 Favored Pre-proline 0 CA--C 1.542 0.641 0 C-N-CA 127.266 2.226 . . . . 0.0 108.909 -177.78 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -70.26 173.1 11.91 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 123.129 2.552 . . . . 0.0 111.033 175.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -145.41 172.89 12.54 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.55 1.54 . . . . 0.0 111.24 175.445 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -113.71 109.56 18.77 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 125.488 1.515 . . . . 0.0 109.276 177.298 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 22.2 t0 53.07 26.53 4.93 Favored 'General case' 0 CA--C 1.552 1.033 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 178.773 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 82.52 12.41 80.36 Favored Glycine 0 CA--C 1.537 1.463 0 O-C-N 120.998 -1.064 . . . . 0.0 113.957 -175.219 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 29.6 mtpt -112.17 -179.74 3.77 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 127.4 2.28 . . . . 0.0 110.148 -178.108 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.56 HG22 ' HB3' ' A' ' 25' ' ' GLN . 39.2 p -54.29 119.02 4.59 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.927 1.691 . . . . 0.0 113.517 -174.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.8 pttt -67.6 178.3 1.7 Allowed 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.399 1.08 . . . . 0.0 113.417 175.081 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -139.36 -4.82 1.4 Allowed Glycine 0 CA--C 1.537 1.415 0 C-N-CA 125.502 1.525 . . . . 0.0 115.561 172.039 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -145.88 156.17 43.37 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 119.444 1.622 . . . . 0.0 109.647 -174.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.408 HG21 ' CE2' ' A' ' 53' ' ' TYR . 1.1 pp -138.62 166.59 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 C-N-CA 125.674 1.59 . . . . 0.0 110.851 173.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 29.1 t80 -136.75 129.71 30.9 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.549 1.14 . . . . 0.0 110.114 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.426 ' CD2' HG21 ' A' ' 48' ' ' ILE . 0.8 OUTLIER -131.94 146.56 52.17 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.791 1.636 . . . . 0.0 110.284 179.5 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -132.87 127.21 33.91 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.846 1.258 . . . . 0.0 110.577 177.786 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -86.87 168.16 13.68 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.826 0.851 . . . . 0.0 111.73 175.518 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -74.07 -5.71 43.19 Favored 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 124.42 1.088 . . . . 0.0 113.539 173.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -161.57 153.21 15.95 Favored Pre-proline 0 N--CA 1.473 0.703 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 -171.676 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -67.45 -48.27 1.73 Allowed 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 123.224 2.616 . . . . 0.0 111.072 -173.159 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -53.45 -18.24 2.56 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.373 1.869 . . . . 0.0 114.244 176.443 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 20.6 m170 -85.8 -48.32 8.9 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 119.49 1.041 . . . . 0.0 110.348 175.616 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -65.06 -54.42 30.47 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.482 1.113 . . . . 0.0 112.826 176.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 12.9 m -57.66 -35.29 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 123.131 0.572 . . . . 0.0 111.344 -177.244 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -66.92 -63.84 0.98 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 126.046 1.739 . . . . 0.0 110.045 170.51 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -50.02 -41.03 46.5 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.892 1.277 . . . . 0.0 114.308 -176.121 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.63 HG23 HG22 ' A' ' 18' ' ' ILE . 40.4 t -56.21 -50.46 70.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 123.548 0.739 . . . . 0.0 111.854 173.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 11.4 tmtt? -82.87 -4.93 58.72 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.501 1.92 . . . . 0.0 112.599 -177.523 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -112.75 -19.78 11.89 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.558 1.543 . . . . 0.0 113.901 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -118.65 18.75 13.39 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 120.756 1.617 . . . . 0.0 113.22 177.651 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -54.96 85.19 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 126.222 1.809 . . . . 0.0 112.773 178.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 96.46 91.26 1.82 Allowed Glycine 0 C--N 1.338 0.662 0 C-N-CA 125.0 1.286 . . . . 0.0 112.9 174.121 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -66.55 147.47 53.24 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.477 0.893 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 178.674 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 . . . . . 0 N--CA 1.465 0.309 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 2.8 mmm180 -136.35 96.03 3.29 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.754 0.822 . . . . 0.0 110.179 -179.315 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 39.1 t -85.15 119.36 33.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 57.5 m-80 . . . . . 0 CA--C 1.54 0.56 0 C-N-CA 125.148 1.379 . . . . 0.0 110.269 178.254 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . 0.258 3.8 p30 . . . . . 0 CA--C 1.549 0.93 0 N-CA-C 117.668 2.47 . . . . 0.0 117.668 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.3 m -114.73 2.38 14.42 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 129.335 3.054 . . . . 0.0 113.034 -175.008 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.0 m -136.53 168.39 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 O-C-N 121.471 -0.768 . . . . 0.0 111.517 -174.078 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.552 HG22 HG23 ' A' ' 78' ' ' VAL . 21.0 pt -134.31 155.12 38.71 Favored 'Isoleucine or valine' 0 C--O 1.24 0.572 0 CA-C-O 121.797 0.808 . . . . 0.0 111.478 176.871 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 29.6 t -137.84 154.07 28.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 125.962 1.705 . . . . 0.0 109.036 177.651 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -131.69 156.33 42.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 C-N-CA 125.116 1.366 . . . . 0.0 109.05 177.38 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -128.94 165.87 20.24 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 124.338 1.055 . . . . 0.0 110.077 175.625 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 19.4 m-20 58.56 35.99 24.91 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 126.333 1.853 . . . . 0.0 113.776 -174.721 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.3 p -102.74 83.91 0.59 Allowed Pre-proline 0 N--CA 1.48 1.044 0 C-N-CA 124.886 1.275 . . . . 0.0 112.287 178.822 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -68.92 155.72 67.64 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 122.675 2.25 . . . . 0.0 111.774 175.174 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.413 ' HB3' HG22 ' A' ' 60' ' ' THR . 8.9 tt0 -76.67 166.75 22.95 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.355 170.697 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.436 HG21 ' HG2' ' A' ' 30' ' ' ARG . 27.8 m -135.64 166.36 27.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 C-N-CA 126.61 1.964 . . . . 0.0 109.687 -177.653 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -75.77 -171.08 30.23 Favored Glycine 0 CA--C 1.539 1.594 0 C-N-CA 123.267 0.461 . . . . 0.0 114.097 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.542 ' HA ' HD22 ' A' ' 31' ' ' LEU . 59.5 Cg_endo -63.67 169.03 10.62 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 123.549 2.833 . . . . 0.0 111.692 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.1 t0 62.12 11.39 4.31 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.295 1.038 . . . . 0.0 113.12 -178.605 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.436 ' HG2' HG21 ' A' ' 26' ' ' VAL . 5.7 ttt180 -153.64 -28.34 0.13 Allowed 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 126.362 1.865 . . . . 0.0 113.426 -178.534 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.542 HD22 ' HA ' ' A' ' 28' ' ' PRO . 1.7 pt? -51.33 -33.17 28.1 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 177.653 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -66.86 -47.54 71.6 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 125.019 1.327 . . . . 0.0 109.696 178.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 8.5 mmtm -52.9 -36.06 58.92 Favored 'General case' 0 C--O 1.218 -0.563 0 C-N-CA 125.381 1.472 . . . . 0.0 110.235 176.165 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.9 tp -48.31 -49.48 33.81 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.875 1.27 . . . . 0.0 113.086 178.737 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.27 -28.71 17.6 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.955 0.902 . . . . 0.0 112.37 175.849 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -59.42 -57.54 12.55 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 118.289 -0.862 . . . . 0.0 111.534 174.016 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 17.9 m -51.4 -36.83 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 125.049 1.34 . . . . 0.0 110.998 -179.195 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.1 mp -54.43 -47.88 69.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 124.603 1.161 . . . . 0.0 110.681 173.796 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.448 ' HA ' HD13 ' A' ' 48' ' ' ILE . 20.8 m-70 -65.36 -31.04 71.95 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 118.16 -0.924 . . . . 0.0 113.079 178.715 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.19 -49.75 9.14 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 118.865 0.757 . . . . 0.0 112.025 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -56.76 -37.88 55.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 CA-C-N 118.832 0.742 . . . . 0.0 112.4 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.551 ' HB2' HD11 ' A' ' 48' ' ' ILE . 41.8 m-85 -91.16 0.76 57.47 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -178.632 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.9 t -70.12 -37.72 75.4 Favored 'General case' 0 C--N 1.342 0.265 0 C-N-CA 125.957 1.703 . . . . 0.0 111.569 178.306 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.57 -24.54 63.83 Favored 'General case' 0 N--CA 1.478 0.951 0 O-C-N 121.047 -1.033 . . . . 0.0 112.856 179.188 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -92.37 -7.22 48.39 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.443 1.097 . . . . 0.0 112.795 177.709 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 139.52 -144.93 15.83 Favored Glycine 0 CA--C 1.537 1.423 0 C-N-CA 124.92 1.247 . . . . 0.0 112.876 -177.691 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 13.9 tptt -120.63 138.2 54.04 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 120.781 -1.423 . . . . 0.0 111.193 175.876 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.551 HD11 ' HB2' ' A' ' 42' ' ' PHE . 2.7 mp -90.75 135.83 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 124.085 0.954 . . . . 0.0 109.253 174.854 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.9 t -108.02 -16.66 14.23 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 116.603 -1.665 . . . . 0.0 114.837 178.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 20.1 m120 -125.9 157.33 37.97 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 120.385 1.448 . . . . 0.0 111.137 176.831 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -165.1 115.68 1.12 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.263 0.625 . . . . 0.0 112.499 -177.243 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 51.4 m-85 -131.43 129.25 41.0 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 121.894 0.854 . . . . 0.0 111.792 -179.393 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -120.38 86.42 38.8 Favored Pre-proline 0 CA--C 1.539 0.552 0 C-N-CA 126.148 1.779 . . . . 0.0 108.914 -178.287 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -69.79 173.73 10.57 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 122.692 2.262 . . . . 0.0 111.196 177.207 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -144.59 173.75 11.54 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.285 1.434 . . . . 0.0 111.583 175.706 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -115.4 107.91 15.83 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 124.453 1.101 . . . . 0.0 110.65 177.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 19.0 t70 55.48 24.46 6.83 Favored 'General case' 0 CA--C 1.549 0.917 0 N-CA-C 113.777 1.028 . . . . 0.0 113.777 -178.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 85.5 11.3 75.16 Favored Glycine 0 CA--C 1.539 1.563 0 CA-C-O 118.815 -0.992 . . . . 0.0 113.284 -174.69 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 30.1 mtpt -114.09 171.31 7.68 Favored 'General case' 0 C--N 1.345 0.398 0 C-N-CA 126.788 2.035 . . . . 0.0 110.763 -178.153 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.413 HG22 ' HB3' ' A' ' 25' ' ' GLN . 70.8 p -44.98 116.84 1.17 Allowed 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 126.954 2.102 . . . . 0.0 112.387 -176.609 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 3.7 pttt -67.78 178.02 1.87 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 126.601 1.96 . . . . 0.0 112.743 174.009 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -139.99 -1.77 1.74 Allowed Glycine 0 CA--C 1.542 1.739 0 C-N-CA 125.875 1.702 . . . . 0.0 115.317 174.293 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -148.4 151.66 35.66 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 126.622 1.969 . . . . 0.0 109.14 -173.727 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -135.44 164.61 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 125.714 1.605 . . . . 0.0 110.907 174.657 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -134.98 125.27 26.28 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.208 1.003 . . . . 0.0 109.686 -178.159 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -129.82 139.88 51.13 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.283 1.433 . . . . 0.0 110.453 -179.399 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -128.62 124.72 36.52 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.218 0.607 . . . . 0.0 110.584 -179.488 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -88.23 173.86 8.54 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 122.072 0.939 . . . . 0.0 111.53 178.563 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -84.38 -0.84 54.2 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.661 0.784 . . . . 0.0 113.031 176.756 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.2 p -158.2 161.26 29.02 Favored Pre-proline 0 CA--C 1.541 0.63 0 CA-C-N 120.037 1.29 . . . . 0.0 112.88 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -68.05 -49.86 0.92 Allowed 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 123.086 2.524 . . . . 0.0 111.276 176.57 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -51.88 -30.17 22.85 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.764 1.226 . . . . 0.0 112.602 178.58 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -74.11 -47.11 38.45 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.19 0.996 . . . . 0.0 112.112 176.679 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -64.71 -54.34 33.14 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.772 1.229 . . . . 0.0 112.195 176.789 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 10.3 m -59.41 -35.95 61.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 122.881 0.473 . . . . 0.0 111.486 -177.684 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -66.05 -56.47 11.38 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 118.415 -0.802 . . . . 0.0 111.174 172.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.97 -43.99 63.81 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 119.274 0.943 . . . . 0.0 112.681 -177.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.552 HG23 HG22 ' A' ' 18' ' ' ILE . 79.5 t -59.65 -33.0 50.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 175.637 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.75 6.87 46.94 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.052 1.341 . . . . 0.0 112.039 -179.2 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 8.2 m-80 -125.94 -28.33 3.2 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 179.336 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -114.62 23.02 13.06 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.597 0.759 . . . . 0.0 112.15 -176.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -59.91 54.95 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 130.609 3.564 . . . . 0.0 115.771 -178.264 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 124.91 82.82 0.52 Allowed Glycine 0 CA--C 1.533 1.172 0 C-N-CA 125.182 1.372 . . . . 0.0 113.125 174.495 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -58.01 148.03 27.46 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.921 1.688 . . . . 0.0 113.865 -176.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.84 0 O-C-N 120.546 -1.346 . . . . 0.0 113.797 -177.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 . . . . . 0 N--CA 1.466 0.34 0 CA-C-O 120.743 0.306 . . . . 0.0 110.754 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 5.3 mmm180 -136.25 84.99 2.12 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.704 0.802 . . . . 0.0 111.932 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 27.4 t -72.94 121.78 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 122.772 0.429 . . . . 0.0 109.888 177.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 58.0 m-80 . . . . . 0 CA--C 1.545 0.772 0 C-N-CA 125.834 1.653 . . . . 0.0 111.09 -179.838 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 . . . . . 0 N--CA 1.477 0.924 0 N-CA-C 115.669 1.729 . . . . 0.0 115.669 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.3 m -121.42 5.63 10.16 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 126.683 1.993 . . . . 0.0 113.676 -177.167 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.1 m -139.55 165.27 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 C-N-CA 124.342 1.057 . . . . 0.0 111.684 -172.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.59 HG22 HG23 ' A' ' 78' ' ' VAL . 22.7 pt -132.17 154.56 40.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-O 122.215 1.007 . . . . 0.0 110.497 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 60.9 t -139.96 144.74 27.6 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.482 0 C-N-CA 125.318 1.447 . . . . 0.0 108.764 178.349 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -124.96 152.66 31.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 124.756 1.223 . . . . 0.0 108.807 178.404 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -127.07 164.06 22.39 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.362 1.465 . . . . 0.0 110.41 178.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 30.5 m-20 60.24 35.26 20.9 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 126.471 1.908 . . . . 0.0 113.101 -175.413 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . 0.261 7.3 p -104.14 81.92 0.55 Allowed Pre-proline 0 N--CA 1.479 0.989 0 C-N-CA 125.966 1.707 . . . . 0.0 111.589 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_endo -69.96 158.36 56.96 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 122.044 1.83 . . . . 0.0 111.152 175.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.89 170.08 14.46 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 121.611 -0.681 . . . . 0.0 111.72 167.706 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.436 HG21 ' HG2' ' A' ' 30' ' ' ARG . 30.9 m -138.57 167.65 20.88 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 126.81 2.044 . . . . 0.0 109.719 176.097 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -71.48 -175.81 23.42 Favored Glycine 0 CA--C 1.544 1.882 0 C-N-CA 124.733 1.158 . . . . 0.0 114.578 178.372 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.549 ' HA ' HD22 ' A' ' 31' ' ' LEU . 64.9 Cg_endo -62.2 168.32 9.51 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 123.595 2.863 . . . . 0.0 111.043 179.027 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 13.5 t70 62.66 7.14 2.34 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 125.151 1.381 . . . . 0.0 113.926 -178.437 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.436 ' HG2' HG21 ' A' ' 26' ' ' VAL . 6.1 ttt180 -148.25 -29.38 0.31 Allowed 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 127.203 2.201 . . . . 0.0 114.136 -178.724 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.549 HD22 ' HA ' ' A' ' 28' ' ' PRO . 1.6 pt? -51.29 -32.62 25.47 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 177.792 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -67.81 -49.04 64.45 Favored 'General case' 0 C--O 1.231 0.1 0 C-N-CA 125.639 1.576 . . . . 0.0 109.356 179.309 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -45.11 -41.27 7.72 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 127.37 2.268 . . . . 0.0 110.5 174.024 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -47.53 -56.21 7.57 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.067 1.347 . . . . 0.0 112.422 178.093 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.17 -30.11 28.07 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.493 1.117 . . . . 0.0 112.163 176.11 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -60.88 -57.84 10.96 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 118.397 -0.811 . . . . 0.0 111.803 177.293 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 19.0 m -54.27 -36.96 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 124.899 1.28 . . . . 0.0 110.987 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.1 mp -47.85 -52.68 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 125.347 1.459 . . . . 0.0 109.971 170.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 19.9 m-70 -63.83 -39.31 93.93 Favored 'General case' 0 N--CA 1.466 0.331 0 O-C-N 121.211 -0.93 . . . . 0.0 111.892 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.48 -51.02 39.9 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 119.062 0.846 . . . . 0.0 111.609 179.272 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -60.04 -42.34 89.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 CA-C-N 118.528 0.604 . . . . 0.0 111.785 179.751 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.589 ' HB2' HD11 ' A' ' 48' ' ' ILE . 33.6 m-85 -86.07 -2.94 58.79 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -175.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.73 -27.27 63.84 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.754 1.222 . . . . 0.0 112.97 178.776 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.32 -24.16 65.71 Favored 'General case' 0 N--CA 1.484 1.262 0 O-C-N 120.661 -1.274 . . . . 0.0 113.178 177.298 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -92.65 -16.02 26.09 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.437 1.095 . . . . 0.0 113.125 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 155.38 -147.82 17.25 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 124.505 1.05 . . . . 0.0 112.51 -174.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 23.4 tptt -128.64 124.17 35.11 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.93 1.292 . . . . 0.0 109.938 177.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.589 HD11 ' HB2' ' A' ' 42' ' ' PHE . 3.6 mp -71.8 135.02 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 123.801 0.84 . . . . 0.0 109.897 175.094 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.3 t -111.54 -25.61 9.49 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.611 1.564 . . . . 0.0 113.462 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -129.97 138.68 50.97 Favored 'General case' 0 C--N 1.339 0.117 0 C-N-CA 125.108 1.363 . . . . 0.0 110.31 -178.452 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -152.7 121.15 6.35 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.554 1.142 . . . . 0.0 111.657 -176.147 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -134.37 132.07 39.0 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.519 1.128 . . . . 0.0 111.338 -178.584 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -121.02 83.48 37.93 Favored Pre-proline 0 CA--C 1.542 0.644 0 C-N-CA 126.3 1.84 . . . . 0.0 108.728 -177.175 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -68.69 168.36 20.27 Favored 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 122.995 2.463 . . . . 0.0 111.096 178.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -144.7 172.72 12.6 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.434 1.493 . . . . 0.0 111.357 177.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -114.12 108.93 17.65 Favored 'General case' 0 C--O 1.221 -0.411 0 C-N-CA 125.753 1.621 . . . . 0.0 109.803 178.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.1 t70 54.44 29.12 10.55 Favored 'General case' 0 CA--C 1.555 1.161 0 C-N-CA 124.424 1.09 . . . . 0.0 113.065 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 76.84 12.61 84.4 Favored Glycine 0 CA--C 1.537 1.468 0 O-C-N 120.748 -1.22 . . . . 0.0 114.205 -174.207 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 26.2 mtpt -109.2 180.0 4.0 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 127.008 2.123 . . . . 0.0 109.949 -178.555 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 20.5 p -53.02 117.09 2.73 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 127.072 2.149 . . . . 0.0 112.651 -173.384 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.9 pttt -68.64 176.42 2.97 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.139 0.976 . . . . 0.0 113.387 170.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -140.61 -0.35 1.81 Allowed Glycine 0 CA--C 1.54 1.631 0 C-N-CA 126.908 2.194 . . . . 0.0 115.48 171.026 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -146.8 154.08 40.94 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 119.586 1.693 . . . . 0.0 108.875 -174.655 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -136.6 165.18 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 125.535 1.534 . . . . 0.0 111.063 173.777 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 19.3 t80 -132.27 123.67 27.38 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.479 1.112 . . . . 0.0 109.385 -179.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -126.46 137.97 53.46 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.867 1.667 . . . . 0.0 109.862 179.055 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -125.12 134.08 52.59 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 122.133 0.968 . . . . 0.0 109.744 176.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -94.53 164.55 12.94 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 122.202 1.001 . . . . 0.0 111.44 175.156 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -76.23 -4.9 44.37 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.667 1.187 . . . . 0.0 112.699 175.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -153.4 151.51 25.74 Favored Pre-proline 0 CA--C 1.546 0.81 0 O-C-N 121.052 -1.03 . . . . 0.0 111.874 -176.165 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -63.54 -47.05 8.07 Favored 'Trans proline' 0 C--N 1.355 0.88 0 C-N-CA 123.542 2.828 . . . . 0.0 111.096 177.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -55.19 -16.83 3.52 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.428 1.891 . . . . 0.0 113.938 178.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 14.5 m-70 -86.93 -48.53 8.07 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 119.902 1.228 . . . . 0.0 111.263 173.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -61.87 -56.86 14.94 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.387 1.075 . . . . 0.0 111.882 176.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 11.3 m -61.35 -26.68 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 123.331 0.652 . . . . 0.0 112.016 -177.088 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -77.64 -56.19 4.73 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.531 1.133 . . . . 0.0 110.641 172.511 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.64 -44.25 62.89 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.609 1.164 . . . . 0.0 112.881 -177.433 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.59 HG23 HG22 ' A' ' 18' ' ' ILE . 54.4 t -56.84 -37.72 55.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 123.897 0.879 . . . . 0.0 113.071 175.024 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.2 mttm -89.83 4.22 50.5 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 126.102 1.761 . . . . 0.0 113.445 179.059 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -121.36 -32.97 3.76 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 178.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -109.75 17.75 20.92 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.254 1.021 . . . . 0.0 113.294 -177.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -53.59 88.52 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.952 2.101 . . . . 0.0 112.306 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 89.66 106.31 1.17 Allowed Glycine 0 C--N 1.339 0.738 0 N-CA-C 110.736 -0.945 . . . . 0.0 110.736 -178.656 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.429 ' CD2' ' CZ2' ' B' ' 52' ' ' TRP . 10.8 m-85 -80.06 146.87 31.7 Favored 'General case' 0 CA--C 1.548 0.889 0 O-C-N 121.3 -1.118 . . . . 0.0 112.15 177.514 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 1.1 pttt -98.88 59.64 1.21 Allowed 'General case' 0 N--CA 1.483 1.179 0 O-C-N 120.644 -1.285 . . . . 0.0 114.111 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.14 -10.28 14.26 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 178.667 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 26.1 t70 55.84 65.27 1.5 Allowed 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 125.156 1.383 . . . . 0.0 112.896 -178.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -128.25 -76.26 0.56 Allowed 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 -177.563 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -146.14 -69.86 0.26 Allowed 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.296 1.438 . . . . 0.0 111.14 179.409 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 -116.01 146.69 41.94 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.007 1.323 . . . . 0.0 110.371 -177.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.54 162.74 28.91 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 124.328 1.051 . . . . 0.0 111.66 176.602 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -90.54 172.42 8.72 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 126.285 1.834 . . . . 0.0 110.163 176.528 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 27.0 mmm-85 -139.04 91.46 2.52 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.107 0.963 . . . . 0.0 110.99 -178.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 27.0 t -78.41 118.9 26.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 54.9 m-80 . . . . . 0 CA--C 1.545 0.753 0 C-N-CA 126.111 1.764 . . . . 0.0 111.04 178.801 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 24.2 t70 . . . . . 0 CA--C 1.537 0.461 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -112.1 -178.9 3.54 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.397 1.479 . . . . 0.0 111.14 -178.314 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 47' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -68.55 73.51 0.24 Allowed 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.491 1.516 . . . . 0.0 112.444 174.457 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 12.5 m -138.44 177.95 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 126.771 2.028 . . . . 0.0 110.974 173.301 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 2.5 ttmt -50.15 133.76 23.02 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 126.553 1.941 . . . . 0.0 110.075 172.507 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -68.31 57.34 0.08 Allowed 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 125.835 1.654 . . . . 0.0 111.933 173.1 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -73.29 47.91 0.22 Allowed 'General case' 0 CA--C 1.549 0.913 0 O-C-N 119.957 -1.714 . . . . 0.0 112.888 177.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 52' ' ' TRP . . . . . 0.429 ' CZ2' ' CD2' ' A' ' 84' ' ' TYR . 64.4 t-105 -154.62 27.74 0.44 Allowed 'General case' 0 CA--C 1.557 1.238 0 C-N-CA 125.068 1.347 . . . . 0.0 112.949 -178.151 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -168.36 94.52 0.37 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 119.834 -1.791 . . . . 0.0 113.395 177.122 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -71.47 117.3 12.85 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 121.469 -0.77 . . . . 0.0 110.871 -178.493 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 . . . . . 0 CA--C 1.541 0.617 0 C-N-CA 126.098 1.759 . . . . 0.0 112.643 -177.803 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 . . . . . 0 CA--C 1.546 0.808 0 N-CA-C 116.347 1.98 . . . . 0.0 116.347 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.9 t -125.81 9.3 7.58 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 126.673 1.989 . . . . 0.0 113.351 -175.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.9 m -141.99 165.46 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 124.125 0.97 . . . . 0.0 111.99 -174.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.563 HG22 HG23 ' A' ' 78' ' ' VAL . 21.1 pt -130.59 154.95 41.38 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 C-N-CA 124.206 1.003 . . . . 0.0 111.258 178.815 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 57.9 t -137.79 144.67 30.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 125.257 1.423 . . . . 0.0 109.266 176.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -125.66 150.03 30.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 123.948 0.899 . . . . 0.0 108.924 178.559 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -125.17 172.9 9.13 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.848 1.259 . . . . 0.0 110.405 178.288 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 54.08 32.55 15.89 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.634 1.574 . . . . 0.0 113.97 -174.099 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.3 p -103.73 81.09 0.44 Allowed Pre-proline 0 N--CA 1.475 0.807 0 C-N-CA 124.352 1.061 . . . . 0.0 111.202 -179.594 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -66.82 145.76 75.94 Favored 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 121.735 1.623 . . . . 0.0 111.368 176.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.71 163.63 13.59 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 120.82 0.343 . . . . 0.0 111.462 172.463 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 35.0 m -134.55 165.2 32.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 124.089 0.955 . . . . 0.0 110.822 -173.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -76.4 -171.3 32.67 Favored Glycine 0 CA--C 1.543 1.785 0 CA-C-O 121.417 0.454 . . . . 0.0 113.853 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.536 ' HA ' HD22 ' A' ' 31' ' ' LEU . 61.4 Cg_endo -64.17 168.05 13.24 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 123.032 2.488 . . . . 0.0 112.291 177.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 65.52 9.28 5.7 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.423 1.089 . . . . 0.0 112.341 -178.733 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 27.0 ttt180 -150.61 -29.64 0.2 Allowed 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.391 1.476 . . . . 0.0 113.902 -177.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.536 HD22 ' HA ' ' A' ' 28' ' ' PRO . 1.6 pt? -52.83 -30.45 33.55 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 178.15 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -69.49 -45.45 68.91 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 122.927 0.491 . . . . 0.0 110.708 177.047 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.47 -39.25 67.3 Favored 'General case' 0 C--O 1.215 -0.748 0 C-N-CA 125.877 1.671 . . . . 0.0 110.776 175.433 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -45.84 -54.31 8.31 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.871 1.269 . . . . 0.0 112.544 178.18 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.3 tmtt? -84.89 -27.38 26.68 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.096 0.958 . . . . 0.0 113.144 175.679 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -64.36 -56.01 17.26 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 117.942 -1.028 . . . . 0.0 112.629 174.362 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 32.8 m -52.84 -34.2 19.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-N 119.507 1.049 . . . . 0.0 111.38 -178.439 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.1 mp -49.54 -52.21 12.77 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 C-N-CA 124.707 1.203 . . . . 0.0 111.325 170.294 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.429 ' HA ' HD13 ' A' ' 48' ' ' ILE . 33.1 m-70 -66.59 -18.33 65.31 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 119.03 0.832 . . . . 0.0 113.082 177.794 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.73 -52.36 5.17 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 119.318 0.963 . . . . 0.0 111.351 178.083 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -59.09 -41.98 85.15 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-N 118.408 0.549 . . . . 0.0 111.874 177.102 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.608 ' HB2' HD11 ' A' ' 48' ' ' ILE . 46.9 m-85 -84.6 -3.03 58.27 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 112.794 0.664 . . . . 0.0 112.794 -178.121 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -67.17 -30.75 70.8 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 119.618 1.099 . . . . 0.0 113.909 177.171 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.481 ' HE3' ' CZ ' ' A' ' 45' ' ' PHE . 18.2 pttt -65.56 -23.01 66.75 Favored 'General case' 0 N--CA 1.48 1.039 0 O-C-N 120.74 -1.225 . . . . 0.0 112.853 179.128 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.481 ' CZ ' ' HE3' ' A' ' 44' ' ' LYS . 9.8 m-85 -92.49 -14.96 27.67 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.446 0.699 . . . . 0.0 112.826 -179.664 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 149.59 -146.26 15.33 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 124.034 0.826 . . . . 0.0 111.93 -173.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 19.0 tptt -129.61 126.61 38.85 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.271 1.028 . . . . 0.0 110.72 178.468 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.608 HD11 ' HB2' ' A' ' 42' ' ' PHE . 4.5 mp -72.2 138.56 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 123.701 0.8 . . . . 0.0 110.193 177.097 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.0 t -112.72 -22.95 10.46 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.819 1.247 . . . . 0.0 113.539 179.503 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -135.08 134.13 40.0 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 119.487 1.039 . . . . 0.0 109.801 -176.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -147.98 124.58 11.08 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.253 1.021 . . . . 0.0 111.844 -176.428 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -135.84 130.95 34.72 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.255 1.022 . . . . 0.0 111.449 -177.02 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -122.46 85.85 48.28 Favored Pre-proline 0 CA--C 1.536 0.44 0 C-N-CA 125.68 1.592 . . . . 0.0 109.196 -175.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -70.66 169.71 19.4 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.6 2.2 . . . . 0.0 110.933 179.068 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -145.27 172.74 12.71 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.186 0.995 . . . . 0.0 111.688 175.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -112.39 109.9 19.8 Favored 'General case' 0 C--O 1.222 -0.369 0 C-N-CA 124.155 0.982 . . . . 0.0 110.611 177.605 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 17.7 t70 54.32 21.23 3.06 Favored 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 -179.004 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 85.86 13.39 69.6 Favored Glycine 0 CA--C 1.536 1.353 0 O-C-N 121.045 -1.034 . . . . 0.0 113.832 -174.036 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 10.2 mmtm -108.07 -179.94 4.04 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 127.039 2.136 . . . . 0.0 110.342 -178.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 79.9 p -58.84 115.58 3.19 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.235 1.414 . . . . 0.0 113.149 -176.062 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 3.2 pttt -64.17 174.85 1.43 Allowed 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.802 1.641 . . . . 0.0 114.508 172.073 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -136.31 -2.95 2.54 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 125.902 1.715 . . . . 0.0 115.314 174.223 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -145.36 154.81 42.7 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.945 1.698 . . . . 0.0 109.744 -175.325 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.1 pp -135.96 163.45 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 124.812 1.245 . . . . 0.0 110.205 172.501 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -130.4 125.38 34.4 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.568 1.147 . . . . 0.0 109.688 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -128.58 139.8 52.1 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 124.486 1.114 . . . . 0.0 109.993 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -125.59 134.28 51.99 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 121.898 0.856 . . . . 0.0 110.51 176.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -95.84 162.5 13.56 Favored 'General case' 0 CA--C 1.528 0.118 0 CA-C-O 122.185 0.993 . . . . 0.0 111.587 176.484 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.56 -1.83 26.26 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.24 1.016 . . . . 0.0 113.287 176.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -157.52 150.46 18.39 Favored Pre-proline 0 CA--C 1.541 0.612 0 C-N-CA 124.643 1.177 . . . . 0.0 111.877 -178.267 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -62.97 -44.37 16.17 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 123.41 2.74 . . . . 0.0 111.981 177.222 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -57.74 -20.99 38.63 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.844 1.258 . . . . 0.0 113.36 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 20.1 m-70 -82.05 -46.2 14.24 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 119.29 0.95 . . . . 0.0 111.735 173.243 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -66.44 -52.72 43.38 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.43 0.692 . . . . 0.0 112.387 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 11.3 m -61.32 -28.79 44.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 122.623 0.369 . . . . 0.0 111.861 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -75.54 -55.96 5.16 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.894 0.878 . . . . 0.0 111.155 173.311 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -52.85 -42.0 64.79 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.296 1.038 . . . . 0.0 112.772 -176.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.563 HG23 HG22 ' A' ' 18' ' ' ILE . 53.8 t -60.6 -35.77 65.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 123.859 0.863 . . . . 0.0 112.94 175.109 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 6.7 mttp -89.17 2.65 53.88 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.192 1.397 . . . . 0.0 113.241 178.425 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -123.83 -23.79 4.6 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 113.723 1.008 . . . . 0.0 113.723 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -114.63 18.7 16.54 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.531 1.132 . . . . 0.0 113.008 -177.642 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -61.8 74.5 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.964 2.106 . . . . 0.0 114.34 -177.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 105.72 78.85 1.22 Allowed Glycine 0 CA--C 1.527 0.793 0 C-N-CA 124.592 1.091 . . . . 0.0 113.107 174.176 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.403 ' HB3' ' HA ' ' B' ' 52' ' ' TRP . 11.0 m-85 -51.89 148.59 5.68 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.979 2.112 . . . . 0.0 113.226 179.426 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 7.2 mmmt -94.19 60.79 2.8 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 120.904 -1.122 . . . . 0.0 112.7 -171.416 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -39.91 -49.04 2.42 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 124.711 1.204 . . . . 0.0 112.901 -170.574 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -145.72 -66.49 0.3 Allowed 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 127.993 2.517 . . . . 0.0 109.268 169.151 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -159.27 -56.79 0.06 Allowed 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.647 0.779 . . . . 0.0 112.252 -178.207 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.41 -32.29 22.43 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.134 0.974 . . . . 0.0 112.894 -174.733 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -75.63 111.68 11.2 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.73 1.612 . . . . 0.0 109.864 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.9 m -127.13 149.51 49.92 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.248 1.019 . . . . 0.0 110.73 -177.085 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -114.62 176.54 5.0 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 124.982 1.313 . . . . 0.0 110.284 -174.571 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -135.0 95.97 3.42 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 122.999 0.52 . . . . 0.0 110.198 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 40.9 t -85.45 122.28 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 178.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 52.7 m-80 . . . . . 0 CA--C 1.542 0.653 0 C-N-CA 125.255 1.422 . . . . 0.0 110.715 -179.174 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 . . . . . 0 CA--C 1.535 0.366 0 CA-C-O 121.373 0.606 . . . . 0.0 111.769 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -80.57 64.15 5.26 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.836 0.854 . . . . 0.0 111.738 -179.441 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 47' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -123.41 -35.38 2.95 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 -178.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 15.8 m -110.11 -174.48 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 124.61 1.164 . . . . 0.0 110.806 178.385 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 11.1 mtpp -52.71 161.8 0.68 Allowed 'General case' 0 C--N 1.346 0.433 0 CA-C-O 122.101 0.953 . . . . 0.0 111.143 171.158 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -76.79 58.74 1.48 Allowed 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.685 1.194 . . . . 0.0 112.056 -172.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -61.33 6.86 0.05 OUTLIER 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 126.319 1.847 . . . . 0.0 114.519 176.165 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 52' ' ' TRP . . . . . 0.403 ' HA ' ' HB3' ' A' ' 84' ' ' TYR . 62.0 t-105 -138.83 17.52 2.67 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 125.375 1.47 . . . . 0.0 112.713 177.129 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -128.11 118.24 23.08 Favored 'General case' 0 N--CA 1.478 0.95 0 O-C-N 120.226 -1.546 . . . . 0.0 113.632 -177.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -50.08 139.39 14.28 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 122.313 1.054 . . . . 0.0 113.683 178.548 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.533 0.303 0 C-N-CA 125.805 1.642 . . . . 0.0 110.55 -177.063 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . 0.259 1.9 m-20 . . . . . 0 CA--C 1.546 0.807 0 N-CA-C 116.779 2.141 . . . . 0.0 116.779 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -124.09 5.79 8.57 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 126.758 2.023 . . . . 0.0 113.472 -177.647 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.0 m -137.2 165.65 27.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 124.015 0.926 . . . . 0.0 112.395 -173.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.604 HG22 HG23 ' A' ' 78' ' ' VAL . 17.5 pt -132.64 154.15 39.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 C-N-CA 124.526 1.13 . . . . 0.0 110.476 179.217 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 60.8 t -137.98 144.74 30.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 C-N-CA 125.676 1.59 . . . . 0.0 108.678 176.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -122.98 156.04 28.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 C-N-CA 123.56 0.744 . . . . 0.0 109.372 174.871 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -130.32 169.65 15.16 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.34 1.456 . . . . 0.0 110.677 176.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 31.2 m-20 56.12 34.02 23.06 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 126.38 1.872 . . . . 0.0 113.91 -174.271 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . 0.255 7.5 p -102.18 81.15 0.34 Allowed Pre-proline 0 N--CA 1.484 1.252 0 C-N-CA 124.92 1.288 . . . . 0.0 112.158 179.665 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -66.62 149.25 84.06 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 122.058 1.839 . . . . 0.0 110.961 174.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.422 ' HB3' HG22 ' A' ' 60' ' ' THR . 38.2 tt0 -67.72 163.74 20.92 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 121.634 0.731 . . . . 0.0 110.635 169.153 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.425 HG21 ' HG2' ' A' ' 30' ' ' ARG . 31.2 m -135.88 165.79 28.82 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 126.835 2.054 . . . . 0.0 109.482 -177.296 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -73.51 -172.54 24.83 Favored Glycine 0 CA--C 1.539 1.572 0 C-N-CA 123.833 0.73 . . . . 0.0 114.505 -178.72 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.578 ' HA ' HD22 ' A' ' 31' ' ' LEU . 66.3 Cg_endo -62.49 169.76 7.79 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 123.353 2.702 . . . . 0.0 111.256 178.291 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 42.9 m-20 60.24 8.42 1.55 Allowed 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 125.451 1.501 . . . . 0.0 114.316 -177.533 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.425 ' HG2' HG21 ' A' ' 26' ' ' VAL . 0.2 OUTLIER -148.31 -29.57 0.3 Allowed 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 126.046 1.739 . . . . 0.0 113.063 -179.56 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.578 HD22 ' HA ' ' A' ' 28' ' ' PRO . 1.7 pt? -51.36 -32.9 27.36 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 115.324 1.601 . . . . 0.0 115.324 177.812 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -68.59 -47.32 67.04 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.454 1.102 . . . . 0.0 109.502 179.203 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.4 mptt -51.08 -34.91 32.28 Favored 'General case' 0 C--O 1.219 -0.503 0 C-N-CA 126.601 1.96 . . . . 0.0 111.395 173.391 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 13.0 tp -51.99 -51.18 58.96 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 119.804 1.184 . . . . 0.0 113.134 177.164 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.8 tmtt? -83.35 -32.27 26.34 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.767 0.827 . . . . 0.0 112.79 172.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -60.84 -57.26 13.42 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 118.042 -0.98 . . . . 0.0 112.107 177.254 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 16.8 m -53.94 -37.91 35.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 CA-C-N 119.405 1.002 . . . . 0.0 111.257 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.2 mp -53.54 -45.27 58.76 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 124.525 1.13 . . . . 0.0 111.676 170.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.404 ' HA ' HD13 ' A' ' 48' ' ' ILE . 15.5 m-70 -65.51 -40.43 92.98 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 120.052 1.296 . . . . 0.0 112.623 176.695 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -74.29 -49.53 22.67 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 118.857 0.753 . . . . 0.0 112.647 -179.608 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -55.26 -42.68 67.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-N 118.759 0.709 . . . . 0.0 111.807 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.519 ' HB2' HD11 ' A' ' 48' ' ' ILE . 30.8 m-85 -83.19 -2.08 54.61 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 113.388 0.885 . . . . 0.0 113.388 -178.127 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.3 t -74.12 -25.29 59.69 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 179.392 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 17.5 pttt -66.55 -18.71 65.51 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 119.371 0.987 . . . . 0.0 113.005 174.201 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -101.51 -12.25 18.66 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.211 1.005 . . . . 0.0 113.16 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 156.27 -144.37 10.76 Favored Glycine 0 CA--C 1.529 0.957 0 CA-C-N 118.467 0.576 . . . . 0.0 112.525 -176.677 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 26.1 tptt -131.67 128.38 38.91 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.929 1.292 . . . . 0.0 108.766 175.192 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.519 HD11 ' HB2' ' A' ' 42' ' ' PHE . 2.0 mp -84.14 131.34 34.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 177.19 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.0 t -100.76 -31.74 11.04 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 178.413 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -108.22 163.78 12.88 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 119.329 0.968 . . . . 0.0 112.171 178.218 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -170.05 116.74 0.54 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.306 1.042 . . . . 0.0 112.307 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -132.97 126.52 32.18 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 121.877 0.846 . . . . 0.0 111.591 -179.205 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -119.5 86.04 33.28 Favored Pre-proline 0 CA--C 1.542 0.656 0 C-N-CA 126.464 1.906 . . . . 0.0 108.32 -178.285 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -69.53 174.78 8.81 Favored 'Trans proline' 0 C--N 1.355 0.881 0 C-N-CA 123.346 2.697 . . . . 0.0 110.95 177.481 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -145.53 172.35 13.35 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.235 1.414 . . . . 0.0 111.494 176.12 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -113.58 110.85 20.9 Favored 'General case' 0 C--O 1.223 -0.324 0 C-N-CA 125.096 1.358 . . . . 0.0 110.24 175.443 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 54.24 21.19 2.97 Favored 'General case' 0 CA--C 1.554 1.131 0 N-CA-C 114.884 1.439 . . . . 0.0 114.884 179.63 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 86.33 17.1 61.23 Favored Glycine 0 CA--C 1.539 1.579 0 O-C-N 121.259 -0.9 . . . . 0.0 113.485 -173.733 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 27.7 mmmt -117.22 176.34 5.19 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 127.65 2.38 . . . . 0.0 110.091 -177.446 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.422 HG22 ' HB3' ' A' ' 25' ' ' GLN . 76.2 p -50.6 117.39 2.42 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 126.739 2.016 . . . . 0.0 112.86 -176.233 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -69.71 177.41 3.04 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.922 0.889 . . . . 0.0 112.769 175.52 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -138.98 -1.63 2.01 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 125.503 1.525 . . . . 0.0 115.254 173.238 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -146.93 155.27 42.15 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 119.627 1.713 . . . . 0.0 109.098 -174.807 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.1 pp -138.99 166.44 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 125.233 1.413 . . . . 0.0 110.424 173.14 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 26.7 t80 -135.43 126.91 28.66 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.141 0.976 . . . . 0.0 109.827 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -130.51 139.42 50.5 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.444 1.498 . . . . 0.0 110.186 179.216 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -127.3 125.81 41.5 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.858 1.263 . . . . 0.0 111.034 177.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -86.05 169.22 13.37 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 122.199 0.999 . . . . 0.0 111.769 176.72 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -77.51 -5.96 51.89 Favored 'General case' 0 CA--C 1.549 0.918 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 175.482 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -154.51 156.19 31.37 Favored Pre-proline 0 N--CA 1.473 0.721 0 C-N-CA 125.059 1.344 . . . . 0.0 112.83 -176.096 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -65.38 -48.67 3.13 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 123.646 2.897 . . . . 0.0 111.478 179.023 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -53.29 -18.32 2.36 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.387 1.875 . . . . 0.0 114.284 177.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 22.3 m170 -85.81 -48.29 8.92 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 119.146 0.884 . . . . 0.0 110.494 175.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -64.29 -54.7 29.09 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.892 1.277 . . . . 0.0 112.335 177.478 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 11.8 m -59.51 -31.73 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 123.034 0.533 . . . . 0.0 111.438 -177.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -73.28 -57.67 3.85 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.59 1.156 . . . . 0.0 111.286 172.423 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -50.22 -44.09 53.12 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.637 1.175 . . . . 0.0 113.595 -178.317 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.604 HG23 HG22 ' A' ' 18' ' ' ILE . 54.8 t -58.48 -43.03 85.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 174.126 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.0 -0.52 51.94 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.616 1.566 . . . . 0.0 112.852 -179.415 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -113.86 -44.68 3.15 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 124.189 0.996 . . . . 0.0 112.436 178.428 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -94.91 18.78 11.27 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 -178.455 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -56.87 83.21 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 126.271 1.828 . . . . 0.0 113.053 177.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 102.99 87.0 1.98 Allowed Glycine 0 CA--C 1.527 0.806 0 C-N-CA 124.852 1.215 . . . . 0.0 113.401 171.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -66.47 143.51 57.05 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 -176.44 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.26 49.12 1.37 Allowed 'General case' 0 N--CA 1.483 1.195 0 O-C-N 120.241 -1.537 . . . . 0.0 114.932 -176.215 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -58.85 -29.99 67.37 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.711 1.205 . . . . 0.0 113.915 -179.424 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 30.6 t70 67.56 91.84 0.08 Allowed 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 127.997 2.519 . . . . 0.0 113.671 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -149.28 -78.37 0.14 Allowed 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.383 1.073 . . . . 0.0 112.115 179.494 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -142.16 -69.14 0.36 Allowed 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 125.723 1.609 . . . . 0.0 110.384 -173.04 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 23.4 m80 -118.41 144.88 45.62 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 125.605 1.562 . . . . 0.0 110.4 177.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -73.34 166.74 22.61 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 125.11 1.364 . . . . 0.0 111.526 176.378 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -91.13 172.1 8.79 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 125.92 1.688 . . . . 0.0 110.151 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 15.8 mmm-85 -138.52 98.62 3.63 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.165 0.986 . . . . 0.0 109.603 -177.242 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 40.4 t -87.77 119.8 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 178.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 52.6 m-80 . . . . . 0 CA--C 1.545 0.765 0 C-N-CA 125.553 1.541 . . . . 0.0 110.852 -179.976 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 11.8 p30 . . . . . 0 CA--C 1.537 0.45 0 N-CA-C 115.039 1.496 . . . . 0.0 115.039 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 63.29 5.97 2.22 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 126.159 1.784 . . . . 0.0 114.486 -174.239 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 47' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -103.58 -63.05 1.22 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.59 1.156 . . . . 0.0 112.01 -175.607 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 35.0 m -97.8 -172.44 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 123.249 0.62 . . . . 0.0 111.013 -177.62 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.74 159.25 0.39 Allowed 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.418 1.087 . . . . 0.0 111.548 168.409 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -76.6 65.7 2.45 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-O 121.393 0.616 . . . . 0.0 112.197 -176.285 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -64.24 10.77 0.05 Allowed 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 126.036 1.734 . . . . 0.0 114.926 176.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 52' ' ' TRP . . . . . . . . . . . . . 58.4 t-105 -122.67 -50.89 1.95 Allowed 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 126.883 2.073 . . . . 0.0 110.65 176.488 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -146.94 127.24 13.91 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 122.613 2.461 . . . . 0.0 113.76 171.37 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -150.18 172.5 15.21 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.85 1.66 . . . . 0.0 108.771 -178.444 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 6.2 t0 . . . . . 0 CA--C 1.545 0.779 0 C-N-CA 125.549 1.539 . . . . 0.0 111.98 -175.583 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . 0.323 4.7 p-10 . . . . . 0 CA--C 1.553 1.077 0 N-CA-C 117.81 2.522 . . . . 0.0 117.81 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 50.6 m -115.33 4.1 14.35 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 129.424 3.09 . . . . 0.0 114.001 -174.321 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.2 m -137.75 161.74 32.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 125.098 1.359 . . . . 0.0 111.985 -172.35 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.546 HG22 HG23 ' A' ' 78' ' ' VAL . 19.1 pt -130.76 152.88 38.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 CA-C-O 122.338 1.066 . . . . 0.0 110.256 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 61.3 t -137.8 142.28 36.64 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.334 0 C-N-CA 125.482 1.513 . . . . 0.0 108.751 176.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -122.44 151.37 26.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 125.002 1.321 . . . . 0.0 108.679 178.442 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -127.65 167.3 16.61 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.204 1.402 . . . . 0.0 110.897 178.568 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 38.4 m-20 59.04 31.53 21.42 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 126.64 1.976 . . . . 0.0 114.212 -173.217 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . 0.254 7.6 p -102.01 81.29 0.34 Allowed Pre-proline 0 N--CA 1.479 1.011 0 C-N-CA 125.847 1.659 . . . . 0.0 111.835 -179.169 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -67.51 159.65 51.53 Favored 'Trans proline' 0 C--N 1.356 0.952 0 C-N-CA 122.004 1.803 . . . . 0.0 110.895 175.325 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -75.83 167.57 21.63 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.785 170.319 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.421 HG21 ' HG2' ' A' ' 30' ' ' ARG . 31.8 m -136.99 166.45 25.72 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 C-N-CA 126.521 1.928 . . . . 0.0 109.272 -177.33 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -75.78 -173.24 34.21 Favored Glycine 0 CA--C 1.539 1.59 0 C-N-CA 124.341 0.972 . . . . 0.0 114.523 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.548 ' HA ' HD22 ' A' ' 31' ' ' LEU . 68.2 Cg_endo -61.39 169.07 7.02 Favored 'Trans proline' 0 CA--C 1.536 0.614 0 C-N-CA 123.568 2.845 . . . . 0.0 111.019 177.607 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 61.69 9.6 2.91 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.843 1.657 . . . . 0.0 114.046 -178.177 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.421 ' HG2' HG21 ' A' ' 26' ' ' VAL . 43.4 ttt85 -150.66 -29.61 0.2 Allowed 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 127.031 2.132 . . . . 0.0 114.601 -178.229 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.548 HD22 ' HA ' ' A' ' 28' ' ' PRO . 1.7 pt? -51.7 -33.22 33.33 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 115.263 1.579 . . . . 0.0 115.263 177.117 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -66.29 -50.77 62.53 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 125.613 1.565 . . . . 0.0 109.315 178.405 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 5.8 mptt -49.76 -37.83 31.35 Favored 'General case' 0 C--N 1.345 0.408 0 C-N-CA 127.627 2.371 . . . . 0.0 110.379 175.309 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -47.36 -64.71 0.71 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.135 1.374 . . . . 0.0 111.361 177.047 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.91 -28.47 58.06 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.687 0.795 . . . . 0.0 112.472 176.481 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -60.33 -59.69 5.01 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 117.773 -1.108 . . . . 0.0 111.437 176.305 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 32.3 m -53.94 -33.78 24.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 125.1 1.36 . . . . 0.0 111.746 -177.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.2 mp -50.09 -48.49 23.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 124.381 1.072 . . . . 0.0 111.137 169.22 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.418 ' HA ' HD13 ' A' ' 48' ' ' ILE . 19.4 m-70 -67.55 -20.33 65.39 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 119.446 1.021 . . . . 0.0 113.544 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.28 -49.64 5.12 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.02 1.328 . . . . 0.0 111.498 -177.817 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -55.17 -43.87 72.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 124.581 1.152 . . . . 0.0 111.129 175.179 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.517 ' HB2' HD11 ' A' ' 48' ' ' ILE . 36.5 m-85 -87.22 -0.14 56.25 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 113.04 0.755 . . . . 0.0 113.04 -177.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -70.09 -35.29 74.07 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.094 1.358 . . . . 0.0 112.05 178.333 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.442 ' HE3' ' CZ ' ' A' ' 45' ' ' PHE . 20.7 pttt -61.82 -17.36 55.96 Favored 'General case' 0 N--CA 1.478 0.941 0 O-C-N 120.948 -1.095 . . . . 0.0 113.647 177.558 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.442 ' CZ ' ' HE3' ' A' ' 44' ' ' LYS . 9.2 m-85 -101.17 -10.99 19.91 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.881 1.272 . . . . 0.0 113.346 178.29 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 149.55 -149.31 21.24 Favored Glycine 0 CA--C 1.532 1.125 0 CA-C-N 119.182 0.901 . . . . 0.0 112.663 -174.217 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 21.3 tptt -127.47 124.64 38.86 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 124.405 1.082 . . . . 0.0 108.945 178.16 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.517 HD11 ' HB2' ' A' ' 42' ' ' PHE . 2.4 mp -79.61 130.37 36.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 123.672 0.789 . . . . 0.0 109.066 175.82 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 2.8 t -100.7 -30.62 11.63 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.754 1.222 . . . . 0.0 113.516 177.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -113.15 154.11 27.18 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 119.647 1.112 . . . . 0.0 111.548 179.66 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -159.46 123.91 3.94 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.665 0.786 . . . . 0.0 110.759 176.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -134.83 129.81 35.07 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 123.678 0.791 . . . . 0.0 111.905 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -121.65 86.17 44.69 Favored Pre-proline 0 CA--C 1.538 0.508 0 C-N-CA 127.449 2.3 . . . . 0.0 108.442 -177.247 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -68.67 174.49 8.44 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 122.736 2.291 . . . . 0.0 110.929 174.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -146.04 172.53 13.25 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 126.548 1.939 . . . . 0.0 110.416 174.608 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -113.33 110.29 20.1 Favored 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 125.674 1.59 . . . . 0.0 109.049 175.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 57.18 20.17 5.44 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 124.686 1.194 . . . . 0.0 113.784 177.334 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 85.04 14.62 68.98 Favored Glycine 0 CA--C 1.537 1.467 0 O-C-N 121.025 -1.047 . . . . 0.0 114.002 -172.373 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 5.8 mmmt -114.64 171.1 7.84 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 128.368 2.667 . . . . 0.0 109.976 -178.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 4.0 t -40.85 115.5 0.59 Allowed 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 127.228 2.211 . . . . 0.0 112.632 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.0 pttp -62.91 -179.11 0.25 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.339 1.056 . . . . 0.0 112.628 168.204 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -142.69 0.19 1.39 Allowed Glycine 0 CA--C 1.531 1.086 0 C-N-CA 126.51 2.005 . . . . 0.0 115.441 170.147 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -146.6 154.52 41.58 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 119.957 1.879 . . . . 0.0 108.999 -174.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.1 pp -137.09 165.3 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 126.274 1.83 . . . . 0.0 110.834 172.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -135.66 126.2 26.95 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.2 1.4 . . . . 0.0 109.507 -177.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -131.1 141.12 50.11 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.816 1.646 . . . . 0.0 110.706 -178.534 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -129.69 127.29 40.21 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.635 0.774 . . . . 0.0 109.908 -179.535 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -88.99 167.21 13.37 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.968 0.89 . . . . 0.0 111.693 177.44 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.2 -4.0 36.33 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.099 0.959 . . . . 0.0 113.499 174.417 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -157.3 153.86 24.47 Favored Pre-proline 0 N--CA 1.474 0.727 0 C-N-CA 124.973 1.309 . . . . 0.0 112.717 -177.036 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -63.07 -47.69 7.81 Favored 'Trans proline' 0 C--N 1.354 0.816 0 C-N-CA 123.862 3.041 . . . . 0.0 110.877 177.571 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -55.69 -14.72 2.38 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.735 2.014 . . . . 0.0 114.624 178.528 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 54.2 m170 -88.46 -46.37 9.18 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 119.669 1.122 . . . . 0.0 110.609 171.453 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -66.42 -54.31 25.72 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 124.03 0.932 . . . . 0.0 111.465 -179.194 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 10.7 m -61.28 -26.16 38.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 124.013 0.925 . . . . 0.0 112.076 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -78.25 -56.91 4.08 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.823 1.249 . . . . 0.0 110.299 172.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -50.65 -43.73 57.31 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 119.705 1.139 . . . . 0.0 113.411 -179.358 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.546 HG23 HG22 ' A' ' 18' ' ' ILE . 61.2 t -57.91 -39.82 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 123.63 0.772 . . . . 0.0 112.907 175.276 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 7.2 mttt -90.18 4.69 49.75 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 126.095 1.758 . . . . 0.0 113.088 179.527 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -124.8 -20.5 5.0 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 115.147 1.536 . . . . 0.0 115.147 178.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -120.94 21.74 11.28 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 125.479 1.511 . . . . 0.0 112.287 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -56.54 79.74 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 127.586 2.354 . . . . 0.0 113.797 178.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 98.11 91.29 1.95 Allowed Glycine 0 C--N 1.341 0.86 0 C-N-CA 124.202 0.906 . . . . 0.0 111.955 174.163 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.426 ' CE2' ' CZ2' ' B' ' 52' ' ' TRP . 11.2 m-85 -67.33 150.13 49.4 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.449 1.1 . . . . 0.0 113.704 -177.505 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . 0.273 0.0 OUTLIER -93.58 51.57 1.6 Allowed 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 115.266 1.58 . . . . 0.0 115.266 -178.977 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.52 22.26 0.06 Allowed 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 125.69 1.596 . . . . 0.0 114.171 176.589 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 24.6 t70 56.37 -88.91 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 125.519 1.528 . . . . 0.0 111.579 -168.486 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 45.2 -142.9 0.23 Allowed 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 127.985 2.514 . . . . 0.0 113.478 -177.32 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -115.49 -41.59 3.24 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 126.311 1.844 . . . . 0.0 112.187 172.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 8.1 m80 -126.41 139.23 53.42 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.99 1.716 . . . . 0.0 108.911 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.04 166.41 18.14 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.6 1.56 . . . . 0.0 111.726 177.532 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -88.39 170.77 10.65 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 126.665 1.986 . . . . 0.0 111.293 176.578 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 23.3 mmm180 -137.59 89.88 2.46 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.21 1.404 . . . . 0.0 110.705 -177.766 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 33.3 t -77.9 118.78 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 123.616 0.766 . . . . 0.0 109.43 176.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 55.6 m-80 . . . . . 0 CA--C 1.544 0.722 0 C-N-CA 125.768 1.627 . . . . 0.0 110.563 178.964 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 . . . . . 0 CA--C 1.539 0.521 0 N-CA-C 114.152 1.167 . . . . 0.0 114.152 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 50.5 mm-40 47.29 59.61 3.97 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 126.04 1.736 . . . . 0.0 113.01 -170.513 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.76 74.72 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.852 0 CA-C-O 122.412 1.101 . . . . 0.0 112.529 174.004 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 2.4 p -165.54 -49.98 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 127.764 2.425 . . . . 0.0 111.104 -178.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 1.8 ttpt -172.95 -176.48 1.42 Allowed 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 125.84 1.656 . . . . 0.0 111.447 -171.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -98.03 42.61 1.09 Allowed 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 127.52 2.328 . . . . 0.0 112.046 -169.674 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 12.4 t30 -55.3 -6.71 0.17 Allowed 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 126.666 1.986 . . . . 0.0 114.884 176.358 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 52' ' ' TRP . . . . . 0.426 ' CZ2' ' CE2' ' A' ' 84' ' ' TYR . 72.2 t-105 -130.84 3.83 4.49 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.345 1.458 . . . . 0.0 113.152 173.732 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -80.13 -165.48 0.85 Allowed 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 120.876 1.671 . . . . 0.0 111.272 177.11 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 32.1 t0 -140.59 33.06 1.83 Allowed 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 127.867 2.467 . . . . 0.0 112.267 172.499 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 28.8 t70 . . . . . 0 N--CA 1.469 0.488 0 C-N-CA 124.982 1.313 . . . . 0.0 109.275 175.821 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 . . . . . 0 CA--C 1.55 0.943 0 N-CA-C 116.036 1.865 . . . . 0.0 116.036 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.6 m -121.53 1.52 10.09 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 126.532 1.933 . . . . 0.0 113.348 -174.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 26.8 m -144.89 167.72 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 124.386 1.075 . . . . 0.0 111.772 -169.093 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.535 HG22 HG23 ' A' ' 78' ' ' VAL . 21.0 pt -130.96 156.03 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 CA-C-O 121.401 0.619 . . . . 0.0 111.472 178.191 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 98.2 t -136.0 152.93 31.23 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.029 0 C-N-CA 125.286 1.434 . . . . 0.0 109.964 175.404 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -130.43 149.78 33.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 N-CA-C 108.312 -0.995 . . . . 0.0 108.312 177.061 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -124.86 162.37 24.5 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 124.357 1.063 . . . . 0.0 110.59 176.802 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 12.9 t30 65.76 34.02 7.78 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.709 1.604 . . . . 0.0 113.405 -177.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.7 p -104.53 81.7 0.56 Allowed Pre-proline 0 N--CA 1.476 0.866 0 C-N-CA 125.572 1.549 . . . . 0.0 112.612 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -68.31 144.85 63.7 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.108 1.872 . . . . 0.0 111.84 177.22 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.426 ' HB3' HG22 ' A' ' 60' ' ' THR . 0.0 OUTLIER -64.93 163.55 14.28 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 120.915 0.388 . . . . 0.0 111.193 169.79 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 31.3 m -138.55 161.37 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 C-N-CA 125.294 1.438 . . . . 0.0 109.935 -174.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -70.47 -173.25 12.75 Favored Glycine 0 CA--C 1.546 2.021 0 N-CA-C 115.286 0.875 . . . . 0.0 115.286 -179.526 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.559 ' HA ' HD22 ' A' ' 31' ' ' LEU . 59.3 Cg_endo -62.21 167.97 10.09 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 123.527 2.818 . . . . 0.0 111.493 179.247 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 19.2 t70 64.4 7.75 3.82 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.055 1.342 . . . . 0.0 113.126 -178.667 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.2 ttt-85 -150.36 -27.38 0.23 Allowed 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.566 1.546 . . . . 0.0 114.142 -179.238 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.559 HD22 ' HA ' ' A' ' 28' ' ' PRO . 1.6 pt? -52.02 -33.09 36.9 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 114.713 1.375 . . . . 0.0 114.713 176.386 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -65.34 -53.14 48.06 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 125.077 1.351 . . . . 0.0 108.844 177.502 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.79 -38.52 48.83 Favored 'General case' 0 C--O 1.219 -0.541 0 C-N-CA 126.623 1.969 . . . . 0.0 111.003 176.61 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -46.65 -59.59 2.92 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 119.406 1.003 . . . . 0.0 111.879 175.263 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -75.17 -32.79 61.37 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.762 0.825 . . . . 0.0 112.824 175.232 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.99 -55.42 25.85 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 117.659 -1.163 . . . . 0.0 111.835 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.406 HG12 ' CB ' ' B' ' 45' ' ' ASP . 15.6 m -55.14 -37.55 43.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 124.25 1.02 . . . . 0.0 110.838 179.345 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.1 mp -53.18 -47.62 55.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 124.81 1.244 . . . . 0.0 111.495 170.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 13.5 m-70 -65.37 -39.7 92.6 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 119.29 0.95 . . . . 0.0 112.644 178.519 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -72.77 -49.14 32.65 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 119.233 0.924 . . . . 0.0 112.669 177.722 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -57.03 -39.86 69.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 CA-C-N 119.378 0.99 . . . . 0.0 111.878 -177.468 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.537 ' HB2' HD11 ' A' ' 48' ' ' ILE . 35.3 m-85 -86.64 -1.03 57.35 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -178.684 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -75.78 -22.94 55.92 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 -179.369 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 3.4 pttm -68.56 -24.94 64.68 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 119.488 1.04 . . . . 0.0 112.367 175.091 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -92.16 -14.24 29.42 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.977 0.911 . . . . 0.0 112.825 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 156.59 -148.35 18.11 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 123.982 0.801 . . . . 0.0 112.361 -176.52 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 12.3 tptm -128.08 123.16 33.88 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.455 1.102 . . . . 0.0 109.463 176.472 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.537 HD11 ' HB2' ' A' ' 42' ' ' PHE . 1.7 mp -79.71 123.55 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 177.436 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.8 t -102.18 -11.57 18.69 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 117.697 -1.144 . . . . 0.0 114.061 -178.621 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -121.91 165.7 15.55 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.057 1.343 . . . . 0.0 110.917 175.452 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.505 ' HA ' HD23 ' A' ' 66' ' ' LEU . 0.2 OUTLIER -166.79 126.21 1.48 Allowed 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.811 0.845 . . . . 0.0 111.928 173.689 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -137.02 122.37 19.42 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.833 0.825 . . . . 0.0 111.478 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -119.92 86.58 36.69 Favored Pre-proline 0 CA--C 1.538 0.504 0 C-N-CA 126.086 1.754 . . . . 0.0 108.835 -178.508 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -70.33 174.79 9.49 Favored 'Trans proline' 0 CA--C 1.536 0.612 0 C-N-CA 123.069 2.513 . . . . 0.0 111.043 178.037 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -145.54 171.97 13.91 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.482 1.113 . . . . 0.0 111.753 173.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -111.97 109.87 19.88 Favored 'General case' 0 C--O 1.223 -0.309 0 C-N-CA 124.734 1.213 . . . . 0.0 109.639 176.642 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 54.26 24.96 5.4 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 125.054 1.342 . . . . 0.0 114.462 179.48 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 83.7 12.89 76.78 Favored Glycine 0 CA--C 1.539 1.534 0 O-C-N 121.494 -0.754 . . . . 0.0 113.666 -174.486 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.9 mtpp -114.79 179.32 3.98 Favored 'General case' 0 C--N 1.343 0.297 0 C-N-CA 126.604 1.961 . . . . 0.0 110.857 -177.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.426 HG22 ' HB3' ' A' ' 25' ' ' GLN . 65.6 p -54.46 110.92 0.69 Allowed 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.675 1.59 . . . . 0.0 113.556 -173.64 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.6 pttt -59.23 174.12 0.42 Allowed 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.86 1.664 . . . . 0.0 113.291 173.395 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -136.38 -3.38 2.44 Favored Glycine 0 CA--C 1.534 1.272 0 C-N-CA 125.265 1.412 . . . . 0.0 115.484 173.013 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -144.7 154.77 43.11 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 126.116 1.766 . . . . 0.0 109.009 -176.109 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.1 pp -137.06 168.66 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 125.671 1.588 . . . . 0.0 110.74 172.403 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -138.65 132.68 31.31 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.748 1.219 . . . . 0.0 110.102 -178.609 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.505 HD23 ' HA ' ' A' ' 51' ' ' ASP . 31.8 mt -136.45 147.1 47.03 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 125.04 1.336 . . . . 0.0 110.684 179.186 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -132.31 122.17 24.7 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 124.149 0.98 . . . . 0.0 109.848 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -83.29 170.86 14.16 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 121.933 0.873 . . . . 0.0 111.245 175.004 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -74.01 -3.53 29.82 Favored 'General case' 0 CA--C 1.549 0.904 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 173.746 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.3 p -161.1 156.08 20.41 Favored Pre-proline 0 CA--C 1.54 0.567 0 CA-C-N 119.561 1.073 . . . . 0.0 112.997 -175.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -65.73 -45.41 6.56 Favored 'Trans proline' 0 C--N 1.355 0.919 0 C-N-CA 123.363 2.708 . . . . 0.0 111.632 -178.556 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -55.42 -15.51 2.73 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.295 1.838 . . . . 0.0 114.028 177.271 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -90.44 -46.57 8.27 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 119.729 1.15 . . . . 0.0 110.817 174.379 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -60.2 -57.18 13.91 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.338 1.055 . . . . 0.0 112.452 173.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 10.4 m -61.69 -28.48 44.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -176.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -74.82 -56.29 4.93 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.455 1.102 . . . . 0.0 110.66 173.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.77 -41.55 61.72 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.165 0.986 . . . . 0.0 112.969 -176.485 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.535 HG23 HG22 ' A' ' 18' ' ' ILE . 78.8 t -58.02 -39.44 72.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 124.018 0.927 . . . . 0.0 113.167 174.375 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 3.2 mptt -88.32 3.75 48.58 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.075 1.35 . . . . 0.0 113.348 178.129 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -120.67 -31.11 4.34 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 179.341 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -110.12 21.18 17.09 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 119.251 0.932 . . . . 0.0 113.039 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -57.21 85.61 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.768 1.627 . . . . 0.0 113.076 178.444 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 97.56 79.28 1.45 Allowed Glycine 0 CA--C 1.53 0.989 0 C-N-CA 124.308 0.956 . . . . 0.0 113.304 173.146 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -57.49 128.66 38.14 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.805 1.242 . . . . 0.0 112.941 -177.066 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.65 55.81 2.09 Favored 'General case' 0 N--CA 1.477 0.895 0 O-C-N 119.941 -1.724 . . . . 0.0 115.283 -176.371 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 50.6 tp -57.02 -26.92 61.11 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.927 1.291 . . . . 0.0 113.797 178.562 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 14.0 t70 60.52 75.36 0.41 Allowed 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.739 1.616 . . . . 0.0 111.475 -177.206 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 7.8 ttmt -142.3 -64.94 0.41 Allowed 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 -174.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -151.68 -74.38 0.15 Allowed 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.077 1.351 . . . . 0.0 110.966 178.221 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 56.8 m80 -114.64 145.5 41.94 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.119 1.368 . . . . 0.0 110.761 178.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.91 163.96 27.37 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 125.249 1.42 . . . . 0.0 111.818 177.1 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -90.42 173.42 8.11 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 125.061 1.345 . . . . 0.0 110.746 177.356 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 22.1 mmt180 -137.08 87.04 2.25 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.985 0.914 . . . . 0.0 110.673 -178.687 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 39.2 t -78.82 118.7 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 177.165 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 54.7 m-80 . . . . . 0 CA--C 1.538 0.493 0 C-N-CA 125.686 1.594 . . . . 0.0 110.006 -178.319 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 45' ' ' ASP . . . . . 0.406 ' CB ' HG12 ' A' ' 37' ' ' VAL . 16.1 t0 . . . . . 0 CA--C 1.55 0.971 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -67.75 53.21 0.06 Allowed 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 128.062 2.545 . . . . 0.0 113.7 -179.433 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 47' ' ' ASP . . . . . . . . . . . . . 31.8 t0 53.72 63.15 2.3 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 127.821 2.448 . . . . 0.0 113.329 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 15.8 m -130.29 59.02 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 124.891 1.276 . . . . 0.0 113.003 -174.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.26 -161.07 0.3 Allowed 'General case' 0 N--CA 1.473 0.679 0 O-C-N 121.458 -0.776 . . . . 0.0 110.262 -174.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -114.61 41.28 2.37 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.999 1.319 . . . . 0.0 111.505 -177.581 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -61.05 12.19 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 116.34 1.978 . . . . 0.0 116.34 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 52' ' ' TRP . . . . . . . . . . . . . 66.2 t-105 -141.27 2.83 1.71 Allowed 'General case' 0 CA--C 1.555 1.156 0 C-N-CA 127.289 2.235 . . . . 0.0 112.222 177.468 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -112.18 109.21 18.77 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-N 121.214 1.824 . . . . 0.0 112.471 178.565 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -48.12 133.38 15.18 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.817 1.247 . . . . 0.0 111.477 172.371 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 . . . . . 0 CA--C 1.538 0.502 0 C-N-CA 124.153 0.981 . . . . 0.0 111.779 -176.825 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 CA--C 1.547 0.829 0 N-CA-C 116.427 2.01 . . . . 0.0 116.427 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 68.4 m -118.73 8.41 11.85 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.859 1.664 . . . . 0.0 113.722 -177.151 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.5 m -142.62 164.6 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 C-N-CA 123.517 0.727 . . . . 0.0 111.432 -174.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.578 HG22 HG23 ' A' ' 78' ' ' VAL . 18.4 pt -129.63 148.4 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 123.063 0.545 . . . . 0.0 110.976 179.552 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 40.7 t -134.01 137.13 52.71 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.121 0 CA-C-O 122.318 1.056 . . . . 0.0 109.173 174.312 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.489 HG22 HG13 ' A' ' 64' ' ' ILE . 0.9 OUTLIER -109.61 154.23 11.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.054 -0.975 . . . . 0.0 109.27 179.371 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -129.77 158.38 39.58 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 123.263 0.625 . . . . 0.0 111.792 174.713 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 63.5 t30 61.58 40.1 13.9 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 126.009 1.724 . . . . 0.0 113.056 -178.149 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.7 m -99.82 83.28 0.34 Allowed Pre-proline 0 N--CA 1.483 1.18 0 C-N-CA 126.032 1.733 . . . . 0.0 112.434 174.458 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -65.21 140.14 63.47 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 121.759 1.64 . . . . 0.0 110.002 171.162 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.67 177.36 1.62 Allowed 'General case' 0 CA--C 1.541 0.596 0 CA-C-O 121.385 0.612 . . . . 0.0 112.136 170.363 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.532 HG21 ' HG2' ' A' ' 30' ' ' ARG . 27.3 m -135.47 162.77 36.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 C-N-CA 125.183 1.393 . . . . 0.0 110.557 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -66.56 -174.15 5.86 Favored Glycine 0 CA--C 1.544 1.849 0 C-N-CA 124.069 0.842 . . . . 0.0 114.989 -179.542 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.5 ' HA ' HD22 ' A' ' 31' ' ' LEU . 61.0 Cg_endo -63.81 166.19 16.67 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 123.051 2.501 . . . . 0.0 111.661 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.6 t0 62.33 11.72 4.73 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 123.876 0.87 . . . . 0.0 112.725 -177.269 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.532 ' HG2' HG21 ' A' ' 26' ' ' VAL . 7.2 ttt180 -151.52 -26.55 0.19 Allowed 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.431 1.492 . . . . 0.0 113.922 177.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.5 HD22 ' HA ' ' A' ' 28' ' ' PRO . 1.7 pt? -51.6 -32.9 30.57 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 114.694 1.368 . . . . 0.0 114.694 179.56 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -66.98 -49.24 66.02 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 125.46 1.504 . . . . 0.0 109.694 179.234 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 8.3 mptt -49.65 -34.17 17.6 Favored 'General case' 0 C--O 1.219 -0.551 0 C-N-CA 126.601 1.961 . . . . 0.0 111.279 173.292 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -50.42 -63.49 1.1 Allowed 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 120.264 1.393 . . . . 0.0 110.875 177.269 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.91 -28.89 61.76 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 121.444 -0.785 . . . . 0.0 112.687 175.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.8 -56.7 15.07 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 118.016 -0.992 . . . . 0.0 112.164 177.108 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.444 HG12 ' N ' ' B' ' 45' ' ' ASP . 19.0 m -55.61 -34.84 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 124.004 0.922 . . . . 0.0 110.983 -178.263 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.1 mp -49.41 -46.89 19.83 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 124.528 1.131 . . . . 0.0 111.462 171.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 18.8 m-70 -68.68 -16.73 63.92 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 113.542 0.942 . . . . 0.0 113.542 179.501 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -94.04 -51.44 4.85 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.528 1.131 . . . . 0.0 111.19 178.229 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -56.08 -37.23 48.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 CA-C-N 118.831 0.741 . . . . 0.0 111.742 177.165 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.54 ' HB2' HD11 ' A' ' 48' ' ' ILE . 37.2 m-85 -91.12 -0.93 57.81 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -179.292 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -74.31 -27.01 60.51 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 178.441 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.487 ' HE3' ' CZ ' ' A' ' 45' ' ' PHE . 16.9 pttt -66.67 -22.08 66.09 Favored 'General case' 0 N--CA 1.48 1.071 0 O-C-N 120.536 -1.353 . . . . 0.0 113.188 176.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.487 ' CZ ' ' HE3' ' A' ' 44' ' ' LYS . 9.6 m-85 -94.95 -12.89 25.94 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.68 0.792 . . . . 0.0 113.001 -179.266 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 151.03 -152.18 24.03 Favored Glycine 0 CA--C 1.53 1.024 0 N-CA-C 111.668 -0.573 . . . . 0.0 111.668 -173.073 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 24.6 tptt -126.26 123.61 38.52 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.506 1.122 . . . . 0.0 110.067 177.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.546 HG21 HD22 ' A' ' 66' ' ' LEU . 2.4 mp -76.37 129.72 36.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 176.369 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 2.6 t -100.83 -30.48 11.66 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.551 0.74 . . . . 0.0 112.826 179.565 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -109.88 162.73 14.22 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.39 1.076 . . . . 0.0 110.843 -179.464 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.536 ' HA ' HD23 ' A' ' 66' ' ' LEU . 0.3 OUTLIER -165.52 125.67 1.82 Allowed 'General case' 0 N--CA 1.468 0.439 0 O-C-N 121.424 -0.797 . . . . 0.0 111.785 174.39 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -136.83 122.87 20.27 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.941 0.876 . . . . 0.0 111.577 -179.161 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -119.72 86.1 34.63 Favored Pre-proline 0 CA--C 1.537 0.461 0 C-N-CA 125.892 1.677 . . . . 0.0 109.11 -176.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -70.75 171.08 16.24 Favored 'Trans proline' 0 CA--C 1.534 0.511 0 C-N-CA 122.99 2.46 . . . . 0.0 111.426 178.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -145.67 173.78 11.77 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.282 1.033 . . . . 0.0 111.705 175.47 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -116.22 111.34 20.04 Favored 'General case' 0 C--O 1.223 -0.3 0 C-N-CA 124.771 1.228 . . . . 0.0 110.096 176.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 50.86 30.08 4.87 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 125.768 1.627 . . . . 0.0 113.911 -178.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 79.66 12.96 83.06 Favored Glycine 0 CA--C 1.534 1.24 0 O-C-N 121.163 -0.96 . . . . 0.0 113.042 -176.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 26.7 mtpt -111.41 -178.35 3.43 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.689 1.995 . . . . 0.0 109.85 -178.59 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 64.4 p -57.72 115.37 2.76 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 126.818 2.047 . . . . 0.0 112.98 -172.272 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.8 pttp -69.46 171.81 8.19 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.605 1.162 . . . . 0.0 113.96 171.162 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -138.29 3.77 3.05 Favored Glycine 0 CA--C 1.536 1.385 0 C-N-CA 126.848 2.166 . . . . 0.0 115.638 175.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -147.38 152.57 38.38 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 119.961 1.88 . . . . 0.0 109.542 -178.751 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.489 HG13 HG22 ' A' ' 20' ' ' VAL . 1.0 OUTLIER -135.84 166.72 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 125.643 1.577 . . . . 0.0 111.098 172.331 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -134.72 126.09 28.31 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.223 1.409 . . . . 0.0 109.985 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.546 HD22 HG21 ' A' ' 48' ' ' ILE . 73.9 mt -127.72 149.62 50.14 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 124.593 1.157 . . . . 0.0 110.722 175.769 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -136.34 132.56 35.78 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-O 122.364 1.078 . . . . 0.0 110.253 178.097 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -94.82 167.97 11.1 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 114.762 -1.108 . . . . 0.0 111.186 177.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -80.51 10.24 4.97 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.944 0.898 . . . . 0.0 112.339 176.671 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 9.7 m -169.78 153.04 4.79 Favored Pre-proline 0 CA--C 1.54 0.592 0 CA-C-N 120.005 1.275 . . . . 0.0 112.583 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -64.09 -46.12 8.79 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 124.818 3.679 . . . . 0.0 111.865 -178.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -53.98 -20.8 6.78 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.725 1.61 . . . . 0.0 113.509 176.322 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 33.0 m170 -84.99 -47.87 9.81 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 119.778 1.172 . . . . 0.0 110.534 176.011 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -65.06 -51.86 59.08 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.099 0.96 . . . . 0.0 112.287 178.546 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 15.9 m -60.47 -34.06 56.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 122.664 0.386 . . . . 0.0 111.149 -179.235 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -68.36 -57.39 5.97 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 123.593 0.757 . . . . 0.0 110.463 172.624 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -55.7 -39.66 71.33 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 119.101 0.864 . . . . 0.0 112.748 -173.093 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.578 HG23 HG22 ' A' ' 18' ' ' ILE . 49.2 t -59.43 -42.2 86.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 123.971 0.908 . . . . 0.0 112.713 173.719 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.56 2.33 37.71 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.354 1.061 . . . . 0.0 113.463 177.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -115.67 -53.63 2.57 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 119.036 0.835 . . . . 0.0 111.409 179.496 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -88.11 19.18 3.79 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.021 0.928 . . . . 0.0 113.327 -176.142 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -52.33 86.44 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.518 1.927 . . . . 0.0 113.374 -179.201 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.64 95.49 0.77 Allowed Glycine 0 CA--C 1.531 1.075 0 C-N-CA 124.557 1.075 . . . . 0.0 111.495 -178.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 23.6 m-85 -59.59 156.25 13.88 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 122.14 0.972 . . . . 0.0 112.397 177.042 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.7 64.77 0.61 Allowed 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.445 1.098 . . . . 0.0 110.08 -172.089 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 44.5 tp -62.89 -4.19 2.02 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 126.18 1.792 . . . . 0.0 113.369 173.659 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.1 t0 61.68 32.11 18.47 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.44 1.096 . . . . 0.0 111.677 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.0 171.11 7.8 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 127.54 2.336 . . . . 0.0 111.523 -177.263 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 5.2 mp0 -69.85 -27.77 65.12 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -175.052 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 7.0 m80 -116.6 132.12 56.77 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.241 1.416 . . . . 0.0 109.615 -178.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.2 m -97.65 164.96 12.2 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.383 1.073 . . . . 0.0 110.911 -178.394 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -95.71 173.02 7.68 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 125.563 1.545 . . . . 0.0 111.087 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 21.0 mmm180 -136.43 94.76 3.05 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.606 0.762 . . . . 0.0 110.648 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 60.4 t -89.55 109.88 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 123.64 0.776 . . . . 0.0 109.849 179.409 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.433 ' HA ' HG13 ' A' ' 78' ' ' VAL . 49.1 m-80 . . . . . 0 CA--C 1.546 0.796 0 C-N-CA 125.004 1.321 . . . . 0.0 111.356 179.639 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 45' ' ' ASP . . . . . 0.444 ' N ' HG12 ' A' ' 37' ' ' VAL . 18.8 t70 . . . . . 0 CA--C 1.535 0.397 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 66.5 mm-40 -153.05 -73.08 0.14 Allowed 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 119.418 1.008 . . . . 0.0 109.446 176.425 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 47' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -81.56 -179.5 7.4 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.278 1.031 . . . . 0.0 111.459 175.17 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 8.6 t 79.47 160.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 127.523 2.329 . . . . 0.0 110.354 -174.406 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.91 179.01 0.3 Allowed 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 122.796 1.284 . . . . 0.0 111.482 168.373 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -67.42 59.73 0.06 Allowed 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 125.989 1.716 . . . . 0.0 112.233 173.37 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -64.46 -7.91 11.7 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.586 1.554 . . . . 0.0 113.168 174.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 52' ' ' TRP . . . . . . . . . . . . . 57.1 t-105 -137.77 -21.57 1.12 Allowed 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.074 1.35 . . . . 0.0 112.752 176.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -97.54 168.6 10.27 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.359 1.864 . . . . 0.0 112.141 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 -65.74 119.61 11.52 Favored 'General case' 0 C--N 1.327 -0.396 0 O-C-N 120.792 -1.193 . . . . 0.0 110.418 174.645 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 27.5 t70 . . . . . 0 CA--C 1.533 0.305 0 C-N-CA 124.613 1.165 . . . . 0.0 112.619 -173.075 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . 0.272 3.6 p30 . . . . . 0 N--CA 1.477 0.875 0 N-CA-C 115.955 1.835 . . . . 0.0 115.955 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 59.7 m -130.83 5.68 4.62 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 127.21 2.204 . . . . 0.0 113.132 -171.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.6 m -142.3 162.7 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 C-N-CA 125.211 1.404 . . . . 0.0 111.785 -173.725 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.662 HG22 HG23 ' A' ' 78' ' ' VAL . 16.7 pt -131.42 150.09 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 C-N-CA 123.874 0.87 . . . . 0.0 110.243 -178.597 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 44.5 t -136.08 132.44 50.04 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.175 0 C-N-CA 124.954 1.302 . . . . 0.0 109.004 175.349 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -107.01 151.55 8.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 124.544 1.138 . . . . 0.0 109.51 176.452 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -127.23 166.32 17.97 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.229 1.012 . . . . 0.0 111.309 175.46 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 66.4 t30 60.2 39.62 19.06 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 126.593 1.957 . . . . 0.0 113.057 -176.104 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . 0.26 7.2 p -109.0 80.44 1.31 Allowed Pre-proline 0 N--CA 1.476 0.865 0 C-N-CA 125.63 1.572 . . . . 0.0 112.019 179.629 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -66.89 142.29 62.08 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 121.986 1.791 . . . . 0.0 110.975 175.47 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.31 163.02 13.72 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 122.981 0.512 . . . . 0.0 111.62 170.483 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.575 HG22 HD11 ' A' ' 34' ' ' LEU . 33.2 m -133.42 173.0 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 124.913 1.285 . . . . 0.0 110.953 -174.123 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -74.22 -176.58 35.4 Favored Glycine 0 CA--C 1.543 1.783 0 N-CA-C 114.478 0.551 . . . . 0.0 114.478 178.134 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.533 ' HA ' HD22 ' A' ' 31' ' ' LEU . 61.8 Cg_endo -62.34 168.98 8.67 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 123.49 2.794 . . . . 0.0 111.205 176.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.1 t70 64.07 2.63 1.47 Allowed 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.425 1.49 . . . . 0.0 113.53 -177.242 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.501 ' HG2' HG21 ' A' ' 26' ' ' VAL . 4.4 ttp180 -142.71 -28.6 0.58 Allowed 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 126.525 1.93 . . . . 0.0 113.77 179.467 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.533 HD22 ' HA ' ' A' ' 28' ' ' PRO . 1.6 pt? -51.46 -33.4 30.82 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 115.146 1.536 . . . . 0.0 115.146 179.19 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -68.81 -43.22 76.04 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 124.929 1.292 . . . . 0.0 110.474 178.756 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -51.52 -38.52 54.48 Favored 'General case' 0 C--O 1.221 -0.424 0 C-N-CA 126.052 1.741 . . . . 0.0 110.659 174.238 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.575 HD11 HG22 ' A' ' 26' ' ' VAL . 80.6 mt -52.71 -43.42 65.63 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 120.142 1.337 . . . . 0.0 113.692 178.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.1 tmtt? -91.88 -28.07 17.53 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.726 0.811 . . . . 0.0 112.103 176.512 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -62.12 -61.79 2.23 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 118.864 -0.588 . . . . 0.0 111.557 173.501 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 28.0 m -54.04 -34.95 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 124.936 1.294 . . . . 0.0 111.42 -174.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.402 HD13 ' O ' ' A' ' 34' ' ' LEU . 1.1 mp -46.92 -55.74 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.335 0 C-N-CA 125.582 1.553 . . . . 0.0 109.955 169.415 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 29.2 m-70 -63.39 -34.08 76.93 Favored 'General case' 0 C--O 1.223 -0.295 0 CA-C-O 118.203 -0.903 . . . . 0.0 112.275 -178.342 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.7 -54.12 11.35 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 118.877 0.762 . . . . 0.0 111.366 178.234 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.402 HG13 ' HA ' ' B' ' 53' ' ' ASP . 0.0 OUTLIER -58.28 -42.13 82.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-N 118.42 0.555 . . . . 0.0 111.441 179.723 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.548 ' HB2' HD11 ' A' ' 48' ' ' ILE . 34.0 m-85 -84.43 -1.31 55.41 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 113.626 0.972 . . . . 0.0 113.626 -177.144 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.77 -27.32 61.09 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.534 1.133 . . . . 0.0 113.174 179.038 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 2.7 pttm -67.69 -24.78 65.44 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 119.794 1.179 . . . . 0.0 112.892 177.656 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -93.33 -10.39 35.55 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.28 1.032 . . . . 0.0 113.014 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 149.15 -142.67 10.05 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.046 0.831 . . . . 0.0 112.356 -176.221 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.5 tppt? -134.69 130.91 37.02 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 124.574 1.15 . . . . 0.0 109.766 177.642 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.573 HG21 HD22 ' A' ' 66' ' ' LEU . 2.9 mp -81.9 127.09 39.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 124.686 1.194 . . . . 0.0 108.46 175.771 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.2 t -97.86 -33.28 11.3 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.472 1.109 . . . . 0.0 113.089 178.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -104.26 165.13 11.26 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.928 1.291 . . . . 0.0 111.162 179.39 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.54 ' HA ' HD23 ' A' ' 66' ' ' LEU . 0.3 OUTLIER -167.78 126.16 1.24 Allowed 'General case' 0 N--CA 1.469 0.494 0 O-C-N 121.244 -0.91 . . . . 0.0 111.915 174.124 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -137.0 118.43 14.73 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-O 121.566 0.698 . . . . 0.0 111.366 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -116.46 86.75 18.73 Favored Pre-proline 0 CA--C 1.539 0.553 0 C-N-CA 126.136 1.774 . . . . 0.0 108.583 -179.693 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -69.29 174.61 8.85 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 123.249 2.632 . . . . 0.0 111.234 178.072 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -145.38 172.68 12.83 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.855 1.262 . . . . 0.0 111.94 174.234 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -113.76 108.25 16.85 Favored 'General case' 0 C--O 1.224 -0.275 0 C-N-CA 125.339 1.456 . . . . 0.0 109.508 178.192 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 53.96 26.73 6.58 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.289 1.435 . . . . 0.0 114.021 -179.608 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.58 11.69 82.73 Favored Glycine 0 CA--C 1.532 1.14 0 O-C-N 121.352 -0.842 . . . . 0.0 113.493 -174.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.5 mtpp -111.56 178.86 4.19 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 126.648 1.979 . . . . 0.0 110.252 178.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 44.0 p -48.71 106.43 0.1 Allowed 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 127.68 2.392 . . . . 0.0 115.013 -176.337 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.7 pttt -58.77 172.03 0.58 Allowed 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.026 1.33 . . . . 0.0 112.127 173.058 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -132.01 -2.81 4.16 Favored Glycine 0 CA--C 1.538 1.53 0 C-N-CA 127.364 2.412 . . . . 0.0 116.149 173.157 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -145.82 155.15 42.72 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 119.796 1.798 . . . . 0.0 109.249 -175.057 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -136.52 164.6 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 125.672 1.589 . . . . 0.0 111.34 170.574 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -134.32 127.81 32.47 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 125.671 1.588 . . . . 0.0 109.917 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.573 HD22 HG21 ' A' ' 48' ' ' ILE . 69.8 mt -130.22 149.78 51.77 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 124.775 1.23 . . . . 0.0 110.658 176.455 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -134.74 134.87 41.45 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 124.93 1.292 . . . . 0.0 110.148 178.563 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -94.93 169.67 9.97 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 121.979 0.895 . . . . 0.0 111.461 176.131 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -74.81 -3.69 33.28 Favored 'General case' 0 CA--C 1.55 0.968 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 174.661 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.4 p -163.06 155.47 15.84 Favored Pre-proline 0 CA--C 1.541 0.6 0 C-N-CA 124.222 1.009 . . . . 0.0 113.369 -173.184 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -65.5 -47.95 3.71 Favored 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 123.848 3.032 . . . . 0.0 111.482 -176.612 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -53.08 -21.76 5.18 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.411 1.884 . . . . 0.0 113.776 178.481 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 24.6 m170 -83.5 -46.13 12.81 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 119.338 0.972 . . . . 0.0 110.799 175.678 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -68.05 -50.93 52.17 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.014 0.926 . . . . 0.0 112.846 179.454 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 17.9 m -60.9 -31.09 48.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 123.7 0.8 . . . . 0.0 111.734 -178.309 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -70.44 -62.8 1.25 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.795 1.638 . . . . 0.0 109.402 169.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -50.65 -41.76 55.68 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.177 1.391 . . . . 0.0 114.052 -175.319 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.662 HG23 HG22 ' A' ' 18' ' ' ILE . 23.6 t -52.86 -49.53 47.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 123.492 0.717 . . . . 0.0 111.806 173.03 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -91.95 19.94 6.21 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 126.45 1.9 . . . . 0.0 112.124 178.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -132.54 -3.22 3.36 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 125.459 1.504 . . . . 0.0 114.228 174.552 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -137.65 19.34 2.88 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.381 1.072 . . . . 0.0 112.623 178.382 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -61.36 79.47 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 126.109 1.764 . . . . 0.0 112.308 -178.642 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 103.06 87.29 2.0 Allowed Glycine 0 CA--C 1.527 0.841 0 C-N-CA 125.08 1.324 . . . . 0.0 113.758 172.576 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -66.08 145.09 56.25 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.833 1.253 . . . . 0.0 114.35 -179.51 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.64 65.12 8.32 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.863 1.265 . . . . 0.0 114.198 177.253 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 64.2 tp -58.83 -10.76 2.61 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 172.64 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.3 t70 75.55 25.38 1.22 Allowed 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 126.311 1.844 . . . . 0.0 112.226 -178.048 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -105.64 172.42 6.81 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 128.047 2.539 . . . . 0.0 111.734 -178.187 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 5.7 mp0 -70.41 -28.39 65.02 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 114.241 1.201 . . . . 0.0 114.241 -177.646 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 3.6 m80 -123.14 143.97 49.64 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.321 1.448 . . . . 0.0 109.329 -178.193 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -95.14 170.04 9.68 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.543 1.137 . . . . 0.0 111.063 -177.323 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -91.28 172.08 8.78 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 125.368 1.467 . . . . 0.0 110.871 176.163 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 16.1 mmm180 -136.45 95.55 3.19 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.677 1.191 . . . . 0.0 109.717 -178.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 40.6 t -89.38 116.13 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 123.679 0.792 . . . . 0.0 109.411 178.262 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.467 ' HA ' HG13 ' A' ' 78' ' ' VAL . 35.9 m-80 . . . . . 0 CA--C 1.545 0.766 0 C-N-CA 124.423 1.089 . . . . 0.0 110.429 178.157 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 . . . . . 0 CA--C 1.546 0.803 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -174.99 -177.54 1.1 Allowed 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 128.046 2.538 . . . . 0.0 109.055 -178.035 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 47' ' ' ASP . . . . . . . . . . . . . 18.5 t70 57.82 21.65 7.73 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.923 1.689 . . . . 0.0 114.388 175.106 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 7.9 p -146.39 156.65 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 128.117 2.567 . . . . 0.0 109.092 -178.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 41.6 mtmt -56.65 -70.74 0.11 Allowed 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.873 1.269 . . . . 0.0 110.607 171.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 4.9 p30 177.86 77.73 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.827 2.051 . . . . 0.0 110.51 -173.016 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 11.6 t30 -68.01 2.69 1.93 Allowed 'General case' 0 CA--C 1.55 0.967 0 O-C-N 120.635 -1.291 . . . . 0.0 112.569 168.295 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 52' ' ' TRP . . . . . . . . . . . . . 48.0 t-105 -154.03 89.48 1.3 Allowed 'General case' 0 N--CA 1.451 -0.387 0 O-C-N 120.24 -1.538 . . . . 0.0 108.572 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 53' ' ' ASP . . . . . 0.402 ' HA ' HG13 ' A' ' 41' ' ' ILE . 0.6 OUTLIER -166.84 -172.22 2.04 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 127.892 2.477 . . . . 0.0 111.579 170.036 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -144.25 155.88 44.05 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.005 0.922 . . . . 0.0 109.094 163.721 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 . . . . . 0 N--CA 1.466 0.369 0 C-N-CA 124.847 1.259 . . . . 0.0 110.899 178.423 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 . . . . . 0 CA--C 1.548 0.889 0 N-CA-C 115.551 1.685 . . . . 0.0 115.551 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -121.26 2.2 10.3 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 127.42 2.288 . . . . 0.0 113.839 -175.559 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.1 m -139.78 162.58 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 124.203 1.001 . . . . 0.0 110.456 -172.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.445 HG22 HG23 ' A' ' 78' ' ' VAL . 14.7 pt -133.19 155.28 40.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 124.438 1.095 . . . . 0.0 110.718 -178.645 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -144.47 162.39 14.43 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.483 0 C-N-CA 125.207 1.403 . . . . 0.0 110.011 178.21 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.465 HG22 HG22 ' A' ' 94' ' ' VAL . 27.1 t -137.8 127.38 35.11 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.192 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 -176.114 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -96.26 163.13 13.22 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.313 1.045 . . . . 0.0 112.032 169.736 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 16.0 m-20 62.12 43.79 8.44 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 129.059 2.944 . . . . 0.0 114.199 -178.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.784 HG11 HG23 ' A' ' 64' ' ' ILE . 7.4 p -111.34 84.25 4.68 Favored Pre-proline 0 N--CA 1.485 1.286 0 C-N-CA 124.973 1.309 . . . . 0.0 111.957 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -66.69 145.88 77.09 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 122.064 1.843 . . . . 0.0 110.796 172.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.451 ' HB3' HG22 ' A' ' 60' ' ' THR . 15.6 tt0 -65.1 159.62 22.95 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 121.51 0.672 . . . . 0.0 110.941 169.386 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.421 HG21 ' HG3' ' A' ' 30' ' ' ARG . 35.0 m -130.95 166.01 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 C-N-CA 126.373 1.869 . . . . 0.0 109.043 -176.224 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -74.62 -173.6 31.03 Favored Glycine 0 CA--C 1.543 1.794 0 C-N-CA 124.175 0.893 . . . . 0.0 114.493 -179.231 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.558 ' HA ' HD22 ' A' ' 31' ' ' LEU . 63.0 Cg_endo -62.23 168.15 9.82 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 123.435 2.757 . . . . 0.0 110.839 177.798 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.3 t70 65.93 2.63 2.28 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 125.385 1.474 . . . . 0.0 113.448 -177.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.421 ' HG3' HG21 ' A' ' 26' ' ' VAL . 9.6 tpt180 -145.83 -28.83 0.43 Allowed 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.661 1.584 . . . . 0.0 114.555 -177.002 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.558 HD22 ' HA ' ' A' ' 28' ' ' PRO . 1.6 pt? -52.31 -32.68 38.94 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 114.861 1.43 . . . . 0.0 114.861 177.416 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -69.58 -50.32 45.75 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.991 1.316 . . . . 0.0 109.542 179.498 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -47.84 -41.07 23.06 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 127.127 2.171 . . . . 0.0 109.827 175.206 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.6 tp -47.79 -47.9 30.6 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.567 1.547 . . . . 0.0 114.147 179.486 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -91.32 -31.48 16.07 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.478 1.111 . . . . 0.0 112.086 173.466 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -57.91 -59.17 5.67 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 118.102 -0.951 . . . . 0.0 111.461 175.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 15.4 m -53.38 -35.9 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 124.826 1.25 . . . . 0.0 110.829 178.305 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.1 mp -53.1 -44.99 52.99 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-N 118.859 0.754 . . . . 0.0 111.408 171.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.462 ' HA ' HD13 ' A' ' 48' ' ' ILE . 22.5 m-70 -66.8 -36.15 81.73 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 120.9 -1.125 . . . . 0.0 112.138 178.425 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -76.21 -50.24 15.02 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 118.716 0.689 . . . . 0.0 111.803 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -55.43 -40.04 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 124.404 1.082 . . . . 0.0 112.032 -179.112 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.66 ' HB2' HD11 ' A' ' 48' ' ' ILE . 31.6 m-85 -88.38 -6.04 57.93 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -177.777 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -68.1 -26.34 65.76 Favored 'General case' 0 C--N 1.343 0.305 0 C-N-CA 124.687 1.195 . . . . 0.0 111.96 -178.163 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 9.6 pttt -68.43 -19.34 64.58 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 175.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -100.2 -12.67 19.37 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.144 0.978 . . . . 0.0 112.79 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 153.14 -144.82 11.83 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 123.971 0.796 . . . . 0.0 111.722 -175.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 21.0 tptt -130.55 125.66 34.81 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.375 1.47 . . . . 0.0 109.082 178.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.66 HD11 ' HB2' ' A' ' 42' ' ' PHE . 4.2 mp -72.94 141.39 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 123.376 0.67 . . . . 0.0 109.802 173.6 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.6 t -114.51 -28.99 6.99 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 125.453 1.501 . . . . 0.0 113.235 178.387 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -132.56 136.09 46.37 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 119.071 0.851 . . . . 0.0 109.338 -176.655 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -152.03 122.45 7.3 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.706 1.602 . . . . 0.0 112.195 -176.019 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -139.74 136.17 33.89 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.97 1.308 . . . . 0.0 111.084 -178.273 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -119.96 76.02 21.73 Favored Pre-proline 0 N--CA 1.47 0.569 0 C-N-CA 124.715 1.206 . . . . 0.0 109.453 -175.474 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -68.17 141.52 52.64 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.582 2.188 . . . . 0.0 111.531 -174.535 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -117.24 168.66 10.11 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.652 1.581 . . . . 0.0 111.512 -177.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -113.18 117.17 31.17 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 125.168 1.387 . . . . 0.0 109.397 179.083 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 51.45 24.26 2.13 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.034 1.333 . . . . 0.0 114.479 -177.722 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 79.84 17.77 74.25 Favored Glycine 0 CA--C 1.542 1.763 0 O-C-N 121.101 -1.0 . . . . 0.0 113.758 -176.626 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 5.4 mtpp -112.83 -178.04 3.29 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 127.647 2.379 . . . . 0.0 110.098 -176.015 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.451 HG22 ' HB3' ' A' ' 25' ' ' GLN . 82.3 p -49.33 114.5 1.04 Allowed 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.496 1.119 . . . . 0.0 111.158 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.9 170.5 0.42 Allowed 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.293 1.037 . . . . 0.0 113.571 171.249 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -133.71 -8.97 2.08 Favored Glycine 0 CA--C 1.529 0.935 0 CA-C-O 117.87 -1.517 . . . . 0.0 114.52 173.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -143.43 161.73 37.64 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 119.939 1.87 . . . . 0.0 109.98 175.323 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.784 HG23 HG11 ' A' ' 23' ' ' VAL . 1.1 pp -124.41 161.2 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 C-N-CA 125.533 1.533 . . . . 0.0 111.224 169.477 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -134.01 119.01 18.46 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.053 1.741 . . . . 0.0 110.358 179.562 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -123.69 147.09 47.75 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.589 1.555 . . . . 0.0 110.293 177.344 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -131.51 135.95 47.49 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 122.486 1.136 . . . . 0.0 110.271 175.061 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -96.33 163.76 12.94 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 122.536 1.16 . . . . 0.0 111.587 175.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.28 -8.92 57.95 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.521 1.128 . . . . 0.0 113.001 177.459 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -153.66 152.1 26.52 Favored Pre-proline 0 CA--C 1.542 0.663 0 C-N-CA 125.759 1.624 . . . . 0.0 113.127 -177.557 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -63.7 -45.41 11.13 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 123.927 3.085 . . . . 0.0 111.258 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -53.83 -21.56 7.79 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.064 1.745 . . . . 0.0 113.505 177.447 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 21.8 m170 -84.38 -49.04 9.06 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 119.465 1.03 . . . . 0.0 110.229 175.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -60.14 -55.21 36.7 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.584 1.154 . . . . 0.0 111.689 177.733 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 15.2 m -60.76 -31.42 49.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 123.831 0.852 . . . . 0.0 111.892 -176.314 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -76.06 -55.46 5.57 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.587 1.155 . . . . 0.0 110.854 174.251 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -53.24 -42.88 66.87 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.639 1.176 . . . . 0.0 112.641 -177.143 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.445 HG23 HG22 ' A' ' 18' ' ' ILE . 50.2 t -55.62 -48.64 77.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 C-N-CA 123.861 0.865 . . . . 0.0 111.504 175.573 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -76.48 2.82 12.69 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 126.635 1.974 . . . . 0.0 114.368 178.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -117.53 -45.91 2.69 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.685 0.794 . . . . 0.0 112.337 177.644 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -93.74 23.0 5.03 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.066 0.946 . . . . 0.0 113.204 -178.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -49.11 80.95 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 127.941 2.496 . . . . 0.0 113.785 178.28 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 84.75 106.24 0.63 Allowed Glycine 0 CA--C 1.533 1.193 0 C-N-CA 125.641 1.591 . . . . 0.0 111.796 -179.263 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -67.95 161.28 26.86 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 121.65 -0.912 . . . . 0.0 111.985 176.157 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.416 ' HE3' ' HA ' ' B' ' 54' ' ' ASP . 0.0 OUTLIER -117.23 48.73 1.28 Allowed 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.943 1.297 . . . . 0.0 113.995 -170.835 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 39.9 tp -38.46 -61.55 0.68 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 128.353 2.661 . . . . 0.0 112.817 -171.023 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 19.6 t70 162.91 -49.53 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 130.003 3.321 . . . . 0.0 111.11 -176.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.84 166.09 22.79 Favored 'General case' 0 N--CA 1.479 1.007 0 O-C-N 121.362 -0.836 . . . . 0.0 112.358 -178.182 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 5.9 mp0 -61.66 -42.64 99.19 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.318 1.447 . . . . 0.0 111.565 -176.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 74.4 m80 -62.97 102.15 0.33 Allowed 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 127.075 2.15 . . . . 0.0 110.845 -177.625 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.85 154.42 19.51 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 122.841 1.305 . . . . 0.0 112.439 -179.54 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -86.44 169.06 13.21 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 126.623 1.969 . . . . 0.0 111.579 -178.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 38.2 mmm-85 -135.73 88.13 2.38 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.774 0.83 . . . . 0.0 112.639 -178.563 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.465 HG22 HG22 ' A' ' 20' ' ' VAL . 24.2 t -75.74 116.21 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 124.12 0.968 . . . . 0.0 110.96 178.755 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 44.3 m-80 . . . . . 0 CA--C 1.549 0.92 0 C-N-CA 125.122 1.369 . . . . 0.0 111.392 -179.872 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 1.1 p30 . . . . . 0 N--CA 1.469 0.512 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 168.69 -42.96 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 128.929 2.892 . . . . 0.0 111.236 -177.033 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 47' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -126.94 -169.7 2.08 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.201 1.4 . . . . 0.0 110.785 -177.525 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 2.7 t 69.67 44.13 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 125.637 1.575 . . . . 0.0 110.861 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 43.6 mtmt 55.87 -147.27 0.53 Allowed 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.996 1.318 . . . . 0.0 109.456 -177.132 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 60.0 m-20 -111.72 59.91 0.62 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.577 1.551 . . . . 0.0 109.582 -179.166 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -63.0 -0.53 0.71 Allowed 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 114.795 1.406 . . . . 0.0 114.795 177.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 52' ' ' TRP . . . . . . . . . . . . . 26.2 t-105 -136.87 -14.76 1.59 Allowed 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 126.113 1.765 . . . . 0.0 113.518 176.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -103.88 111.27 23.73 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 120.111 1.323 . . . . 0.0 110.535 -169.211 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 54' ' ' ASP . . . . . 0.416 ' HA ' ' HE3' ' A' ' 85' ' ' LYS . 17.2 t70 -91.88 152.65 19.98 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 121.743 0.782 . . . . 0.0 111.371 174.602 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 . . . . . 0 CA--C 1.541 0.599 0 C-N-CA 127.592 2.357 . . . . 0.0 109.044 171.936 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . 0.301 5.4 p-10 . . . . . 0 N--CA 1.478 0.935 0 N-CA-C 116.639 2.089 . . . . 0.0 116.639 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -124.38 7.05 8.36 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 127.209 2.204 . . . . 0.0 113.93 -170.671 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.4 m -132.04 166.02 30.27 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 O-C-N 120.576 -1.328 . . . . 0.0 113.469 -171.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.63 HG22 HG23 ' A' ' 78' ' ' VAL . 16.0 pt -136.23 153.66 31.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 C-N-CA 124.498 1.119 . . . . 0.0 110.84 178.21 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 73.7 t -137.7 151.37 25.89 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.227 0 C-N-CA 125.957 1.703 . . . . 0.0 108.672 175.697 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -131.08 154.32 40.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 C-N-CA 124.73 1.212 . . . . 0.0 108.481 177.351 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -127.69 169.55 13.68 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.662 1.585 . . . . 0.0 110.719 176.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 13.8 m-20 59.08 29.82 19.47 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 126.284 1.834 . . . . 0.0 114.393 -174.241 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . 0.265 6.9 p -100.59 84.98 0.5 Allowed Pre-proline 0 N--CA 1.481 1.096 0 C-N-CA 125.156 1.382 . . . . 0.0 112.113 -177.742 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -69.45 160.08 51.18 Favored 'Trans proline' 0 C--N 1.354 0.864 0 C-N-CA 122.235 1.956 . . . . 0.0 111.345 175.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.56 ' HB3' HG22 ' A' ' 60' ' ' THR . 0.0 OUTLIER -78.5 168.1 20.3 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.649 170.763 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.405 HG21 ' HG2' ' A' ' 30' ' ' ARG . 30.9 m -140.25 168.42 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 125.743 1.617 . . . . 0.0 110.119 -175.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -76.85 -173.37 37.88 Favored Glycine 0 CA--C 1.544 1.891 0 C-N-CA 123.722 0.677 . . . . 0.0 114.244 178.604 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.539 ' HA ' HD22 ' A' ' 31' ' ' LEU . 67.0 Cg_endo -61.54 172.05 3.88 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 123.307 2.672 . . . . 0.0 111.406 177.486 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 62.17 6.24 1.75 Allowed 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 126.116 1.766 . . . . 0.0 114.353 -178.681 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.405 ' HG2' HG21 ' A' ' 26' ' ' VAL . 2.1 ttt85 -151.58 -25.82 0.19 Allowed 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 126.985 2.114 . . . . 0.0 114.184 -177.199 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.539 HD22 ' HA ' ' A' ' 28' ' ' PRO . 1.8 pt? -49.69 -36.24 24.48 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 114.97 1.47 . . . . 0.0 114.97 175.011 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -64.7 -54.23 34.79 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 125.019 1.327 . . . . 0.0 108.747 178.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.9 -38.88 17.42 Favored 'General case' 0 C--O 1.219 -0.545 0 C-N-CA 127.344 2.258 . . . . 0.0 110.705 174.221 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -48.99 -55.52 11.68 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 119.744 1.156 . . . . 0.0 112.309 177.199 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.2 tmtt? -84.62 -27.29 27.3 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.753 0.821 . . . . 0.0 112.499 175.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -63.84 -53.65 47.34 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 117.286 -1.34 . . . . 0.0 111.597 176.837 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 30.2 m -52.32 -32.22 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 125.36 1.464 . . . . 0.0 112.768 -177.541 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.2 mp -50.58 -51.82 18.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 C-N-CA 124.482 1.113 . . . . 0.0 110.685 169.279 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 33.4 m-70 -64.67 -40.89 96.21 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 119.658 1.117 . . . . 0.0 112.098 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.449 ' HZ1' ' N ' ' B' ' 45' ' ' ASP . 0.0 OUTLIER -67.39 -51.23 54.54 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.044 0.938 . . . . 0.0 111.087 179.699 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.427 HG13 ' HA ' ' B' ' 53' ' ' ASP . 0.0 OUTLIER -61.4 -43.95 97.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-N 118.552 0.614 . . . . 0.0 111.154 179.069 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.486 ' HB2' HD11 ' A' ' 48' ' ' ILE . 37.8 m-85 -82.47 -6.36 59.26 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -176.1 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.57 -29.66 70.88 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.053 1.341 . . . . 0.0 113.337 177.773 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.4 pttm -65.95 -23.07 66.53 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 119.709 1.14 . . . . 0.0 112.952 177.677 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -96.97 -10.09 26.97 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.501 1.12 . . . . 0.0 113.069 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 149.46 -137.8 6.46 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 124.309 0.957 . . . . 0.0 112.623 -178.511 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.9 tppt? -135.83 137.8 41.88 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 124.655 1.182 . . . . 0.0 109.105 177.321 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.486 HD11 ' HB2' ' A' ' 42' ' ' PHE . 2.5 mp -95.53 128.13 46.97 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 C-N-CA 124.171 0.988 . . . . 0.0 108.717 179.175 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.9 t -96.17 -29.19 14.19 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.798 1.239 . . . . 0.0 113.911 178.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 21.4 m120 -112.13 158.03 20.12 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.468 1.107 . . . . 0.0 111.562 178.343 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -163.16 125.33 2.57 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.761 0.824 . . . . 0.0 111.249 173.247 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -134.55 126.78 30.0 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 123.704 0.802 . . . . 0.0 111.843 -178.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.408 ' CE2' HG21 ' A' ' 64' ' ' ILE . 15.8 m-85 -120.5 86.48 39.53 Favored Pre-proline 0 CA--C 1.542 0.641 0 C-N-CA 127.266 2.226 . . . . 0.0 108.909 -177.78 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -70.26 173.1 11.91 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 123.129 2.552 . . . . 0.0 111.033 175.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -145.41 172.89 12.54 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.55 1.54 . . . . 0.0 111.24 175.445 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -113.71 109.56 18.77 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 125.488 1.515 . . . . 0.0 109.276 177.298 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 22.2 t0 53.07 26.53 4.93 Favored 'General case' 0 CA--C 1.552 1.033 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 178.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 82.52 12.41 80.36 Favored Glycine 0 CA--C 1.537 1.463 0 O-C-N 120.998 -1.064 . . . . 0.0 113.957 -175.219 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 29.6 mtpt -112.17 -179.74 3.77 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 127.4 2.28 . . . . 0.0 110.148 -178.108 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.56 HG22 ' HB3' ' A' ' 25' ' ' GLN . 39.2 p -54.29 119.02 4.59 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.927 1.691 . . . . 0.0 113.517 -174.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.8 pttt -67.6 178.3 1.7 Allowed 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.399 1.08 . . . . 0.0 113.417 175.081 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -139.36 -4.82 1.4 Allowed Glycine 0 CA--C 1.537 1.415 0 C-N-CA 125.502 1.525 . . . . 0.0 115.561 172.039 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -145.88 156.17 43.37 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 119.444 1.622 . . . . 0.0 109.647 -174.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.408 HG21 ' CE2' ' A' ' 53' ' ' TYR . 1.1 pp -138.62 166.59 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 C-N-CA 125.674 1.59 . . . . 0.0 110.851 173.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 29.1 t80 -136.75 129.71 30.9 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.549 1.14 . . . . 0.0 110.114 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.426 ' CD2' HG21 ' A' ' 48' ' ' ILE . 0.8 OUTLIER -131.94 146.56 52.17 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.791 1.636 . . . . 0.0 110.284 179.5 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -132.87 127.21 33.91 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.846 1.258 . . . . 0.0 110.577 177.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -86.87 168.16 13.68 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.826 0.851 . . . . 0.0 111.73 175.518 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -74.07 -5.71 43.19 Favored 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 124.42 1.088 . . . . 0.0 113.539 173.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -161.57 153.21 15.95 Favored Pre-proline 0 N--CA 1.473 0.703 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 -171.676 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -67.45 -48.27 1.73 Allowed 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 123.224 2.616 . . . . 0.0 111.072 -173.159 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -53.45 -18.24 2.56 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.373 1.869 . . . . 0.0 114.244 176.443 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 20.6 m170 -85.8 -48.32 8.9 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 119.49 1.041 . . . . 0.0 110.348 175.616 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -65.06 -54.42 30.47 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.482 1.113 . . . . 0.0 112.826 176.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 12.9 m -57.66 -35.29 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 123.131 0.572 . . . . 0.0 111.344 -177.244 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -66.92 -63.84 0.98 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 126.046 1.739 . . . . 0.0 110.045 170.51 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -50.02 -41.03 46.5 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.892 1.277 . . . . 0.0 114.308 -176.121 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.63 HG23 HG22 ' A' ' 18' ' ' ILE . 40.4 t -56.21 -50.46 70.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 123.548 0.739 . . . . 0.0 111.854 173.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 11.4 tmtt? -82.87 -4.93 58.72 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.501 1.92 . . . . 0.0 112.599 -177.523 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -112.75 -19.78 11.89 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.558 1.543 . . . . 0.0 113.901 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -118.65 18.75 13.39 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 120.756 1.617 . . . . 0.0 113.22 177.651 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -54.96 85.19 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 126.222 1.809 . . . . 0.0 112.773 178.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 96.46 91.26 1.82 Allowed Glycine 0 C--N 1.338 0.662 0 C-N-CA 125.0 1.286 . . . . 0.0 112.9 174.121 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -66.55 147.47 53.24 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.524 ' HE3' ' O ' ' B' ' 54' ' ' ASP . 0.0 OUTLIER -92.58 69.31 4.86 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 178.674 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 56.3 tp -44.88 -45.24 10.19 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.716 1.206 . . . . 0.0 113.096 -177.008 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -148.13 -66.46 0.25 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 127.327 2.251 . . . . 0.0 109.138 171.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -158.65 -58.39 0.07 Allowed 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.677 1.191 . . . . 0.0 112.192 -178.107 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -87.92 -29.61 20.7 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 125.488 1.515 . . . . 0.0 114.209 -174.782 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 10.4 m80 -82.84 110.61 18.0 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 125.162 1.385 . . . . 0.0 109.568 -178.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.32 160.3 29.63 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.967 1.307 . . . . 0.0 111.366 -175.035 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 -126.93 176.44 7.31 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 125.969 1.708 . . . . 0.0 109.661 -171.326 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 2.8 mmm180 -136.35 96.03 3.29 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.754 0.822 . . . . 0.0 110.179 -179.315 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 39.1 t -85.15 119.36 33.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 57.5 m-80 . . . . . 0 CA--C 1.54 0.56 0 C-N-CA 125.148 1.379 . . . . 0.0 110.269 178.254 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 45' ' ' ASP . . . . . 0.449 ' N ' ' HZ1' ' A' ' 40' ' ' LYS . 44.2 m-20 . . . . . 0 CA--C 1.543 0.688 0 N-CA-C 112.786 0.661 . . . . 0.0 112.786 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 62.78 10.55 4.32 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.987 1.315 . . . . 0.0 113.475 178.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 47' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -63.68 -24.71 67.89 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 126.533 1.933 . . . . 0.0 114.458 -174.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 6.0 m -118.28 62.68 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 125.874 1.67 . . . . 0.0 110.962 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? 54.41 -86.17 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 126.672 1.989 . . . . 0.0 109.867 -164.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -175.07 63.74 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 126.081 1.753 . . . . 0.0 113.649 -169.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -65.11 24.4 0.02 OUTLIER 'General case' 0 CA--C 1.562 1.424 0 C-N-CA 125.817 1.647 . . . . 0.0 115.411 174.296 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 52' ' ' TRP . . . . . . . . . . . . . 54.7 t-105 -146.99 4.39 0.83 Allowed 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 126.916 2.086 . . . . 0.0 113.553 176.187 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 53' ' ' ASP . . . . . 0.427 ' HA ' HG13 ' A' ' 41' ' ' ILE . 0.5 OUTLIER -66.97 -165.79 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.253 0 CA-C-N 121.24 1.836 . . . . 0.0 114.305 174.818 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 54' ' ' ASP . . . . . 0.524 ' O ' ' HE3' ' A' ' 85' ' ' LYS . 2.1 p-10 -100.79 153.6 19.33 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 121.186 -0.946 . . . . 0.0 112.498 170.572 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.539 0.556 0 C-N-CA 124.148 0.979 . . . . 0.0 110.942 172.487 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . 0.258 3.8 p30 . . . . . 0 CA--C 1.549 0.93 0 N-CA-C 117.668 2.47 . . . . 0.0 117.668 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.3 m -114.73 2.38 14.42 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 129.335 3.054 . . . . 0.0 113.034 -175.008 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.0 m -136.53 168.39 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 O-C-N 121.471 -0.768 . . . . 0.0 111.517 -174.078 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.552 HG22 HG23 ' A' ' 78' ' ' VAL . 21.0 pt -134.31 155.12 38.71 Favored 'Isoleucine or valine' 0 C--O 1.24 0.572 0 CA-C-O 121.797 0.808 . . . . 0.0 111.478 176.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 29.6 t -137.84 154.07 28.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 125.962 1.705 . . . . 0.0 109.036 177.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -131.69 156.33 42.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 C-N-CA 125.116 1.366 . . . . 0.0 109.05 177.38 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -128.94 165.87 20.24 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 124.338 1.055 . . . . 0.0 110.077 175.625 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 19.4 m-20 58.56 35.99 24.91 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 126.333 1.853 . . . . 0.0 113.776 -174.721 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.3 p -102.74 83.91 0.59 Allowed Pre-proline 0 N--CA 1.48 1.044 0 C-N-CA 124.886 1.275 . . . . 0.0 112.287 178.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -68.92 155.72 67.64 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 122.675 2.25 . . . . 0.0 111.774 175.174 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.413 ' HB3' HG22 ' A' ' 60' ' ' THR . 8.9 tt0 -76.67 166.75 22.95 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.355 170.697 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.436 HG21 ' HG2' ' A' ' 30' ' ' ARG . 27.8 m -135.64 166.36 27.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 C-N-CA 126.61 1.964 . . . . 0.0 109.687 -177.653 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -75.77 -171.08 30.23 Favored Glycine 0 CA--C 1.539 1.594 0 C-N-CA 123.267 0.461 . . . . 0.0 114.097 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.542 ' HA ' HD22 ' A' ' 31' ' ' LEU . 59.5 Cg_endo -63.67 169.03 10.62 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 123.549 2.833 . . . . 0.0 111.692 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.1 t0 62.12 11.39 4.31 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.295 1.038 . . . . 0.0 113.12 -178.605 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.436 ' HG2' HG21 ' A' ' 26' ' ' VAL . 5.7 ttt180 -153.64 -28.34 0.13 Allowed 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 126.362 1.865 . . . . 0.0 113.426 -178.534 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.542 HD22 ' HA ' ' A' ' 28' ' ' PRO . 1.7 pt? -51.33 -33.17 28.1 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 177.653 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -66.86 -47.54 71.6 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 125.019 1.327 . . . . 0.0 109.696 178.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 8.5 mmtm -52.9 -36.06 58.92 Favored 'General case' 0 C--O 1.218 -0.563 0 C-N-CA 125.381 1.472 . . . . 0.0 110.235 176.165 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.9 tp -48.31 -49.48 33.81 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.875 1.27 . . . . 0.0 113.086 178.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.27 -28.71 17.6 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.955 0.902 . . . . 0.0 112.37 175.849 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -59.42 -57.54 12.55 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 118.289 -0.862 . . . . 0.0 111.534 174.016 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.423 HG12 ' CB ' ' B' ' 45' ' ' ASP . 17.9 m -51.4 -36.83 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 125.049 1.34 . . . . 0.0 110.998 -179.195 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.1 mp -54.43 -47.88 69.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 124.603 1.161 . . . . 0.0 110.681 173.796 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.448 ' HA ' HD13 ' A' ' 48' ' ' ILE . 20.8 m-70 -65.36 -31.04 71.95 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 118.16 -0.924 . . . . 0.0 113.079 178.715 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.19 -49.75 9.14 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 118.865 0.757 . . . . 0.0 112.025 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.417 HG13 ' HA ' ' B' ' 53' ' ' ASP . 0.0 OUTLIER -56.76 -37.88 55.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 CA-C-N 118.832 0.742 . . . . 0.0 112.4 179.725 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.551 ' HB2' HD11 ' A' ' 48' ' ' ILE . 41.8 m-85 -91.16 0.76 57.47 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -178.632 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.9 t -70.12 -37.72 75.4 Favored 'General case' 0 C--N 1.342 0.265 0 C-N-CA 125.957 1.703 . . . . 0.0 111.569 178.306 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.57 -24.54 63.83 Favored 'General case' 0 N--CA 1.478 0.951 0 O-C-N 121.047 -1.033 . . . . 0.0 112.856 179.188 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -92.37 -7.22 48.39 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.443 1.097 . . . . 0.0 112.795 177.709 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 139.52 -144.93 15.83 Favored Glycine 0 CA--C 1.537 1.423 0 C-N-CA 124.92 1.247 . . . . 0.0 112.876 -177.691 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 13.9 tptt -120.63 138.2 54.04 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 120.781 -1.423 . . . . 0.0 111.193 175.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.551 HD11 ' HB2' ' A' ' 42' ' ' PHE . 2.7 mp -90.75 135.83 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 124.085 0.954 . . . . 0.0 109.253 174.854 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.9 t -108.02 -16.66 14.23 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 116.603 -1.665 . . . . 0.0 114.837 178.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 20.1 m120 -125.9 157.33 37.97 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 120.385 1.448 . . . . 0.0 111.137 176.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -165.1 115.68 1.12 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.263 0.625 . . . . 0.0 112.499 -177.243 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 51.4 m-85 -131.43 129.25 41.0 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 121.894 0.854 . . . . 0.0 111.792 -179.393 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -120.38 86.42 38.8 Favored Pre-proline 0 CA--C 1.539 0.552 0 C-N-CA 126.148 1.779 . . . . 0.0 108.914 -178.287 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -69.79 173.73 10.57 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 122.692 2.262 . . . . 0.0 111.196 177.207 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -144.59 173.75 11.54 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.285 1.434 . . . . 0.0 111.583 175.706 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -115.4 107.91 15.83 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 124.453 1.101 . . . . 0.0 110.65 177.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 19.0 t70 55.48 24.46 6.83 Favored 'General case' 0 CA--C 1.549 0.917 0 N-CA-C 113.777 1.028 . . . . 0.0 113.777 -178.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 85.5 11.3 75.16 Favored Glycine 0 CA--C 1.539 1.563 0 CA-C-O 118.815 -0.992 . . . . 0.0 113.284 -174.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 30.1 mtpt -114.09 171.31 7.68 Favored 'General case' 0 C--N 1.345 0.398 0 C-N-CA 126.788 2.035 . . . . 0.0 110.763 -178.153 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.413 HG22 ' HB3' ' A' ' 25' ' ' GLN . 70.8 p -44.98 116.84 1.17 Allowed 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 126.954 2.102 . . . . 0.0 112.387 -176.609 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 3.7 pttt -67.78 178.02 1.87 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 126.601 1.96 . . . . 0.0 112.743 174.009 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -139.99 -1.77 1.74 Allowed Glycine 0 CA--C 1.542 1.739 0 C-N-CA 125.875 1.702 . . . . 0.0 115.317 174.293 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -148.4 151.66 35.66 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 126.622 1.969 . . . . 0.0 109.14 -173.727 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -135.44 164.61 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 125.714 1.605 . . . . 0.0 110.907 174.657 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -134.98 125.27 26.28 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.208 1.003 . . . . 0.0 109.686 -178.159 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -129.82 139.88 51.13 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.283 1.433 . . . . 0.0 110.453 -179.399 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -128.62 124.72 36.52 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.218 0.607 . . . . 0.0 110.584 -179.488 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -88.23 173.86 8.54 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 122.072 0.939 . . . . 0.0 111.53 178.563 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -84.38 -0.84 54.2 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.661 0.784 . . . . 0.0 113.031 176.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.2 p -158.2 161.26 29.02 Favored Pre-proline 0 CA--C 1.541 0.63 0 CA-C-N 120.037 1.29 . . . . 0.0 112.88 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -68.05 -49.86 0.92 Allowed 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 123.086 2.524 . . . . 0.0 111.276 176.57 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -51.88 -30.17 22.85 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.764 1.226 . . . . 0.0 112.602 178.58 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -74.11 -47.11 38.45 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.19 0.996 . . . . 0.0 112.112 176.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -64.71 -54.34 33.14 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.772 1.229 . . . . 0.0 112.195 176.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 10.3 m -59.41 -35.95 61.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 122.881 0.473 . . . . 0.0 111.486 -177.684 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -66.05 -56.47 11.38 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 118.415 -0.802 . . . . 0.0 111.174 172.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.97 -43.99 63.81 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 119.274 0.943 . . . . 0.0 112.681 -177.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.552 HG23 HG22 ' A' ' 18' ' ' ILE . 79.5 t -59.65 -33.0 50.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 175.637 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.75 6.87 46.94 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.052 1.341 . . . . 0.0 112.039 -179.2 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 8.2 m-80 -125.94 -28.33 3.2 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 179.336 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -114.62 23.02 13.06 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.597 0.759 . . . . 0.0 112.15 -176.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -59.91 54.95 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 130.609 3.564 . . . . 0.0 115.771 -178.264 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 124.91 82.82 0.52 Allowed Glycine 0 CA--C 1.533 1.172 0 C-N-CA 125.182 1.372 . . . . 0.0 113.125 174.495 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -58.01 148.03 27.46 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.921 1.688 . . . . 0.0 113.865 -176.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.05 72.33 2.93 Favored 'General case' 0 N--CA 1.476 0.84 0 O-C-N 120.546 -1.346 . . . . 0.0 113.797 -177.832 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 26.1 tp -69.81 7.49 0.89 Allowed 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 125.443 1.497 . . . . 0.0 114.384 175.443 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.1 t70 67.09 47.69 1.33 Allowed 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.043 1.337 . . . . 0.0 112.117 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 18.9 mmtm -142.41 172.91 12.05 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.7 1.6 . . . . 0.0 112.407 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.55 -38.01 62.84 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.638 1.975 . . . . 0.0 113.333 179.327 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 27.6 m-70 -90.98 133.58 35.17 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 124.458 1.103 . . . . 0.0 109.443 177.121 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.7 m -112.02 162.63 15.17 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.331 1.053 . . . . 0.0 110.566 -176.757 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -86.26 170.96 11.62 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.139 0.976 . . . . 0.0 110.754 -178.539 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 5.3 mmm180 -136.25 84.99 2.12 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.704 0.802 . . . . 0.0 111.932 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 27.4 t -72.94 121.78 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 122.772 0.429 . . . . 0.0 109.888 177.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 58.0 m-80 . . . . . 0 CA--C 1.545 0.772 0 C-N-CA 125.834 1.653 . . . . 0.0 111.09 -179.838 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 45' ' ' ASP . . . . . 0.423 ' CB ' HG12 ' A' ' 37' ' ' VAL . 10.8 t0 . . . . . 0 CA--C 1.537 0.457 0 CA-C-O 121.624 0.726 . . . . 0.0 111.191 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -169.55 174.42 5.9 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 128.598 2.759 . . . . 0.0 107.371 -176.186 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 47' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -65.94 -8.43 22.46 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 178.276 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 11.1 p -48.3 -45.02 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 125.94 1.696 . . . . 0.0 113.441 178.322 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 3.1 mtpp 169.43 170.97 0.05 OUTLIER 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 127.899 2.48 . . . . 0.0 110.883 -173.721 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -110.35 45.13 1.15 Allowed 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 126.699 2.0 . . . . 0.0 112.079 -169.28 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 17.7 t30 -58.75 2.62 0.04 OUTLIER 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 125.754 1.622 . . . . 0.0 114.744 176.622 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 52' ' ' TRP . . . . . . . . . . . . . 69.6 t-105 -139.25 7.41 2.4 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.084 1.354 . . . . 0.0 112.933 176.639 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 53' ' ' ASP . . . . . 0.417 ' HA ' HG13 ' A' ' 41' ' ' ILE . 0.4 OUTLIER -97.06 -138.86 0.28 Allowed 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 120.611 1.55 . . . . 0.0 111.119 -173.793 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -149.82 171.07 17.34 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 124.337 1.055 . . . . 0.0 110.679 173.145 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 3.9 t70 . . . . . 0 CA--C 1.545 0.754 0 C-N-CA 124.242 1.017 . . . . 0.0 110.16 170.728 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 . . . . . 0 N--CA 1.477 0.924 0 N-CA-C 115.669 1.729 . . . . 0.0 115.669 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.3 m -121.42 5.63 10.16 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 126.683 1.993 . . . . 0.0 113.676 -177.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.1 m -139.55 165.27 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 C-N-CA 124.342 1.057 . . . . 0.0 111.684 -172.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.59 HG22 HG23 ' A' ' 78' ' ' VAL . 22.7 pt -132.17 154.56 40.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-O 122.215 1.007 . . . . 0.0 110.497 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 60.9 t -139.96 144.74 27.6 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.482 0 C-N-CA 125.318 1.447 . . . . 0.0 108.764 178.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -124.96 152.66 31.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 124.756 1.223 . . . . 0.0 108.807 178.404 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -127.07 164.06 22.39 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.362 1.465 . . . . 0.0 110.41 178.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 30.5 m-20 60.24 35.26 20.9 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 126.471 1.908 . . . . 0.0 113.101 -175.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . 0.261 7.3 p -104.14 81.92 0.55 Allowed Pre-proline 0 N--CA 1.479 0.989 0 C-N-CA 125.966 1.707 . . . . 0.0 111.589 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_endo -69.96 158.36 56.96 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 122.044 1.83 . . . . 0.0 111.152 175.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.89 170.08 14.46 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 121.611 -0.681 . . . . 0.0 111.72 167.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.436 HG21 ' HG2' ' A' ' 30' ' ' ARG . 30.9 m -138.57 167.65 20.88 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 126.81 2.044 . . . . 0.0 109.719 176.097 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -71.48 -175.81 23.42 Favored Glycine 0 CA--C 1.544 1.882 0 C-N-CA 124.733 1.158 . . . . 0.0 114.578 178.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.549 ' HA ' HD22 ' A' ' 31' ' ' LEU . 64.9 Cg_endo -62.2 168.32 9.51 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 123.595 2.863 . . . . 0.0 111.043 179.027 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 13.5 t70 62.66 7.14 2.34 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 125.151 1.381 . . . . 0.0 113.926 -178.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.436 ' HG2' HG21 ' A' ' 26' ' ' VAL . 6.1 ttt180 -148.25 -29.38 0.31 Allowed 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 127.203 2.201 . . . . 0.0 114.136 -178.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.549 HD22 ' HA ' ' A' ' 28' ' ' PRO . 1.6 pt? -51.29 -32.62 25.47 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 177.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -67.81 -49.04 64.45 Favored 'General case' 0 C--O 1.231 0.1 0 C-N-CA 125.639 1.576 . . . . 0.0 109.356 179.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -45.11 -41.27 7.72 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 127.37 2.268 . . . . 0.0 110.5 174.024 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -47.53 -56.21 7.57 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.067 1.347 . . . . 0.0 112.422 178.093 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.17 -30.11 28.07 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.493 1.117 . . . . 0.0 112.163 176.11 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -60.88 -57.84 10.96 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 118.397 -0.811 . . . . 0.0 111.803 177.293 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 19.0 m -54.27 -36.96 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 124.899 1.28 . . . . 0.0 110.987 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.1 mp -47.85 -52.68 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 125.347 1.459 . . . . 0.0 109.971 170.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 19.9 m-70 -63.83 -39.31 93.93 Favored 'General case' 0 N--CA 1.466 0.331 0 O-C-N 121.211 -0.93 . . . . 0.0 111.892 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.48 -51.02 39.9 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 119.062 0.846 . . . . 0.0 111.609 179.272 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -60.04 -42.34 89.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 CA-C-N 118.528 0.604 . . . . 0.0 111.785 179.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.589 ' HB2' HD11 ' A' ' 48' ' ' ILE . 33.6 m-85 -86.07 -2.94 58.79 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -175.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.73 -27.27 63.84 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.754 1.222 . . . . 0.0 112.97 178.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.32 -24.16 65.71 Favored 'General case' 0 N--CA 1.484 1.262 0 O-C-N 120.661 -1.274 . . . . 0.0 113.178 177.298 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -92.65 -16.02 26.09 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.437 1.095 . . . . 0.0 113.125 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 155.38 -147.82 17.25 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 124.505 1.05 . . . . 0.0 112.51 -174.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 23.4 tptt -128.64 124.17 35.11 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.93 1.292 . . . . 0.0 109.938 177.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.589 HD11 ' HB2' ' A' ' 42' ' ' PHE . 3.6 mp -71.8 135.02 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 123.801 0.84 . . . . 0.0 109.897 175.094 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.3 t -111.54 -25.61 9.49 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.611 1.564 . . . . 0.0 113.462 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 28.5 m-80 -129.97 138.68 50.97 Favored 'General case' 0 C--N 1.339 0.117 0 C-N-CA 125.108 1.363 . . . . 0.0 110.31 -178.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -152.7 121.15 6.35 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.554 1.142 . . . . 0.0 111.657 -176.147 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -134.37 132.07 39.0 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.519 1.128 . . . . 0.0 111.338 -178.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -121.02 83.48 37.93 Favored Pre-proline 0 CA--C 1.542 0.644 0 C-N-CA 126.3 1.84 . . . . 0.0 108.728 -177.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -68.69 168.36 20.27 Favored 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 122.995 2.463 . . . . 0.0 111.096 178.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -144.7 172.72 12.6 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.434 1.493 . . . . 0.0 111.357 177.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -114.12 108.93 17.65 Favored 'General case' 0 C--O 1.221 -0.411 0 C-N-CA 125.753 1.621 . . . . 0.0 109.803 178.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.1 t70 54.44 29.12 10.55 Favored 'General case' 0 CA--C 1.555 1.161 0 C-N-CA 124.424 1.09 . . . . 0.0 113.065 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 76.84 12.61 84.4 Favored Glycine 0 CA--C 1.537 1.468 0 O-C-N 120.748 -1.22 . . . . 0.0 114.205 -174.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 26.2 mtpt -109.2 180.0 4.0 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 127.008 2.123 . . . . 0.0 109.949 -178.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 20.5 p -53.02 117.09 2.73 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 127.072 2.149 . . . . 0.0 112.651 -173.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.9 pttt -68.64 176.42 2.97 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.139 0.976 . . . . 0.0 113.387 170.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -140.61 -0.35 1.81 Allowed Glycine 0 CA--C 1.54 1.631 0 C-N-CA 126.908 2.194 . . . . 0.0 115.48 171.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -146.8 154.08 40.94 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 119.586 1.693 . . . . 0.0 108.875 -174.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -136.6 165.18 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 125.535 1.534 . . . . 0.0 111.063 173.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 19.3 t80 -132.27 123.67 27.38 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.479 1.112 . . . . 0.0 109.385 -179.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -126.46 137.97 53.46 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.867 1.667 . . . . 0.0 109.862 179.055 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -125.12 134.08 52.59 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 122.133 0.968 . . . . 0.0 109.744 176.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -94.53 164.55 12.94 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 122.202 1.001 . . . . 0.0 111.44 175.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -76.23 -4.9 44.37 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.667 1.187 . . . . 0.0 112.699 175.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -153.4 151.51 25.74 Favored Pre-proline 0 CA--C 1.546 0.81 0 O-C-N 121.052 -1.03 . . . . 0.0 111.874 -176.165 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -63.54 -47.05 8.07 Favored 'Trans proline' 0 C--N 1.355 0.88 0 C-N-CA 123.542 2.828 . . . . 0.0 111.096 177.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -55.19 -16.83 3.52 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.428 1.891 . . . . 0.0 113.938 178.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 14.5 m-70 -86.93 -48.53 8.07 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 119.902 1.228 . . . . 0.0 111.263 173.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -61.87 -56.86 14.94 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.387 1.075 . . . . 0.0 111.882 176.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 11.3 m -61.35 -26.68 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 123.331 0.652 . . . . 0.0 112.016 -177.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -77.64 -56.19 4.73 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.531 1.133 . . . . 0.0 110.641 172.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.64 -44.25 62.89 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.609 1.164 . . . . 0.0 112.881 -177.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.59 HG23 HG22 ' A' ' 18' ' ' ILE . 54.4 t -56.84 -37.72 55.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 123.897 0.879 . . . . 0.0 113.071 175.024 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.2 mttm -89.83 4.22 50.5 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 126.102 1.761 . . . . 0.0 113.445 179.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -121.36 -32.97 3.76 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 178.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -109.75 17.75 20.92 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.254 1.021 . . . . 0.0 113.294 -177.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -53.59 88.52 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.952 2.101 . . . . 0.0 112.306 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 89.66 106.31 1.17 Allowed Glycine 0 C--N 1.339 0.738 0 N-CA-C 110.736 -0.945 . . . . 0.0 110.736 -178.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -80.06 146.87 31.7 Favored 'General case' 0 CA--C 1.548 0.889 0 O-C-N 121.3 -1.118 . . . . 0.0 112.15 177.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 1.1 pttt . . . . . 0 N--CA 1.483 1.179 0 O-C-N 120.644 -1.285 . . . . 0.0 114.111 -179.898 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 . . . . . 0 N--CA 1.469 0.513 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 27.0 mmm-85 -139.04 91.46 2.52 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.107 0.963 . . . . 0.0 110.99 -178.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 27.0 t -78.41 118.9 26.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 54.9 m-80 . . . . . 0 CA--C 1.545 0.753 0 C-N-CA 126.111 1.764 . . . . 0.0 111.04 178.801 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 . . . . . 0 CA--C 1.546 0.808 0 N-CA-C 116.347 1.98 . . . . 0.0 116.347 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.9 t -125.81 9.3 7.58 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 126.673 1.989 . . . . 0.0 113.351 -175.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.9 m -141.99 165.46 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 124.125 0.97 . . . . 0.0 111.99 -174.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.563 HG22 HG23 ' A' ' 78' ' ' VAL . 21.1 pt -130.59 154.95 41.38 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 C-N-CA 124.206 1.003 . . . . 0.0 111.258 178.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 57.9 t -137.79 144.67 30.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 125.257 1.423 . . . . 0.0 109.266 176.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -125.66 150.03 30.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 123.948 0.899 . . . . 0.0 108.924 178.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -125.17 172.9 9.13 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.848 1.259 . . . . 0.0 110.405 178.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 54.08 32.55 15.89 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.634 1.574 . . . . 0.0 113.97 -174.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.3 p -103.73 81.09 0.44 Allowed Pre-proline 0 N--CA 1.475 0.807 0 C-N-CA 124.352 1.061 . . . . 0.0 111.202 -179.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -66.82 145.76 75.94 Favored 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 121.735 1.623 . . . . 0.0 111.368 176.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.71 163.63 13.59 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 120.82 0.343 . . . . 0.0 111.462 172.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 35.0 m -134.55 165.2 32.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 124.089 0.955 . . . . 0.0 110.822 -173.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -76.4 -171.3 32.67 Favored Glycine 0 CA--C 1.543 1.785 0 CA-C-O 121.417 0.454 . . . . 0.0 113.853 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.536 ' HA ' HD22 ' A' ' 31' ' ' LEU . 61.4 Cg_endo -64.17 168.05 13.24 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 123.032 2.488 . . . . 0.0 112.291 177.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 65.52 9.28 5.7 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.423 1.089 . . . . 0.0 112.341 -178.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 27.0 ttt180 -150.61 -29.64 0.2 Allowed 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.391 1.476 . . . . 0.0 113.902 -177.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.536 HD22 ' HA ' ' A' ' 28' ' ' PRO . 1.6 pt? -52.83 -30.45 33.55 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 178.15 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -69.49 -45.45 68.91 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 122.927 0.491 . . . . 0.0 110.708 177.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.47 -39.25 67.3 Favored 'General case' 0 C--O 1.215 -0.748 0 C-N-CA 125.877 1.671 . . . . 0.0 110.776 175.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -45.84 -54.31 8.31 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.871 1.269 . . . . 0.0 112.544 178.18 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.3 tmtt? -84.89 -27.38 26.68 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.096 0.958 . . . . 0.0 113.144 175.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -64.36 -56.01 17.26 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 117.942 -1.028 . . . . 0.0 112.629 174.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 32.8 m -52.84 -34.2 19.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-N 119.507 1.049 . . . . 0.0 111.38 -178.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.1 mp -49.54 -52.21 12.77 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 C-N-CA 124.707 1.203 . . . . 0.0 111.325 170.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.429 ' HA ' HD13 ' A' ' 48' ' ' ILE . 33.1 m-70 -66.59 -18.33 65.31 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 119.03 0.832 . . . . 0.0 113.082 177.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.73 -52.36 5.17 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 119.318 0.963 . . . . 0.0 111.351 178.083 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -59.09 -41.98 85.15 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-N 118.408 0.549 . . . . 0.0 111.874 177.102 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.608 ' HB2' HD11 ' A' ' 48' ' ' ILE . 46.9 m-85 -84.6 -3.03 58.27 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 112.794 0.664 . . . . 0.0 112.794 -178.121 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -67.17 -30.75 70.8 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 119.618 1.099 . . . . 0.0 113.909 177.171 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.481 ' HE3' ' CZ ' ' A' ' 45' ' ' PHE . 18.2 pttt -65.56 -23.01 66.75 Favored 'General case' 0 N--CA 1.48 1.039 0 O-C-N 120.74 -1.225 . . . . 0.0 112.853 179.128 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.481 ' CZ ' ' HE3' ' A' ' 44' ' ' LYS . 9.8 m-85 -92.49 -14.96 27.67 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.446 0.699 . . . . 0.0 112.826 -179.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 149.59 -146.26 15.33 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 124.034 0.826 . . . . 0.0 111.93 -173.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 19.0 tptt -129.61 126.61 38.85 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.271 1.028 . . . . 0.0 110.72 178.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.608 HD11 ' HB2' ' A' ' 42' ' ' PHE . 4.5 mp -72.2 138.56 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 123.701 0.8 . . . . 0.0 110.193 177.097 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.0 t -112.72 -22.95 10.46 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.819 1.247 . . . . 0.0 113.539 179.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 28.9 m-80 -135.08 134.13 40.0 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 119.487 1.039 . . . . 0.0 109.801 -176.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -147.98 124.58 11.08 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.253 1.021 . . . . 0.0 111.844 -176.428 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -135.84 130.95 34.72 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.255 1.022 . . . . 0.0 111.449 -177.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -122.46 85.85 48.28 Favored Pre-proline 0 CA--C 1.536 0.44 0 C-N-CA 125.68 1.592 . . . . 0.0 109.196 -175.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -70.66 169.71 19.4 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.6 2.2 . . . . 0.0 110.933 179.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -145.27 172.74 12.71 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.186 0.995 . . . . 0.0 111.688 175.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -112.39 109.9 19.8 Favored 'General case' 0 C--O 1.222 -0.369 0 C-N-CA 124.155 0.982 . . . . 0.0 110.611 177.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 17.7 t70 54.32 21.23 3.06 Favored 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 -179.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 85.86 13.39 69.6 Favored Glycine 0 CA--C 1.536 1.353 0 O-C-N 121.045 -1.034 . . . . 0.0 113.832 -174.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 10.2 mmtm -108.07 -179.94 4.04 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 127.039 2.136 . . . . 0.0 110.342 -178.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 79.9 p -58.84 115.58 3.19 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.235 1.414 . . . . 0.0 113.149 -176.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 3.2 pttt -64.17 174.85 1.43 Allowed 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.802 1.641 . . . . 0.0 114.508 172.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -136.31 -2.95 2.54 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 125.902 1.715 . . . . 0.0 115.314 174.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -145.36 154.81 42.7 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.945 1.698 . . . . 0.0 109.744 -175.325 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.1 pp -135.96 163.45 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 124.812 1.245 . . . . 0.0 110.205 172.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -130.4 125.38 34.4 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.568 1.147 . . . . 0.0 109.688 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -128.58 139.8 52.1 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 124.486 1.114 . . . . 0.0 109.993 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -125.59 134.28 51.99 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 121.898 0.856 . . . . 0.0 110.51 176.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -95.84 162.5 13.56 Favored 'General case' 0 CA--C 1.528 0.118 0 CA-C-O 122.185 0.993 . . . . 0.0 111.587 176.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.56 -1.83 26.26 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.24 1.016 . . . . 0.0 113.287 176.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -157.52 150.46 18.39 Favored Pre-proline 0 CA--C 1.541 0.612 0 C-N-CA 124.643 1.177 . . . . 0.0 111.877 -178.267 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -62.97 -44.37 16.17 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 123.41 2.74 . . . . 0.0 111.981 177.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -57.74 -20.99 38.63 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.844 1.258 . . . . 0.0 113.36 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 20.1 m-70 -82.05 -46.2 14.24 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 119.29 0.95 . . . . 0.0 111.735 173.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -66.44 -52.72 43.38 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.43 0.692 . . . . 0.0 112.387 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 11.3 m -61.32 -28.79 44.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 122.623 0.369 . . . . 0.0 111.861 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -75.54 -55.96 5.16 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.894 0.878 . . . . 0.0 111.155 173.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -52.85 -42.0 64.79 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.296 1.038 . . . . 0.0 112.772 -176.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.563 HG23 HG22 ' A' ' 18' ' ' ILE . 53.8 t -60.6 -35.77 65.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 123.859 0.863 . . . . 0.0 112.94 175.109 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 6.7 mttp -89.17 2.65 53.88 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.192 1.397 . . . . 0.0 113.241 178.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -123.83 -23.79 4.6 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 113.723 1.008 . . . . 0.0 113.723 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -114.63 18.7 16.54 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.531 1.132 . . . . 0.0 113.008 -177.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -61.8 74.5 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.964 2.106 . . . . 0.0 114.34 -177.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 105.72 78.85 1.22 Allowed Glycine 0 CA--C 1.527 0.793 0 C-N-CA 124.592 1.091 . . . . 0.0 113.107 174.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -51.89 148.59 5.68 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.979 2.112 . . . . 0.0 113.226 179.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 7.2 mmmt . . . . . 0 N--CA 1.476 0.826 0 O-C-N 120.904 -1.122 . . . . 0.0 112.7 -171.416 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 . . . . . 0 N--CA 1.464 0.241 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -135.0 95.97 3.42 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 122.999 0.52 . . . . 0.0 110.198 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 40.9 t -85.45 122.28 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 178.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 52.7 m-80 . . . . . 0 CA--C 1.542 0.653 0 C-N-CA 125.255 1.422 . . . . 0.0 110.715 -179.174 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . 0.259 1.9 m-20 . . . . . 0 CA--C 1.546 0.807 0 N-CA-C 116.779 2.141 . . . . 0.0 116.779 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -124.09 5.79 8.57 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 126.758 2.023 . . . . 0.0 113.472 -177.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.0 m -137.2 165.65 27.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 124.015 0.926 . . . . 0.0 112.395 -173.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.604 HG22 HG23 ' A' ' 78' ' ' VAL . 17.5 pt -132.64 154.15 39.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 C-N-CA 124.526 1.13 . . . . 0.0 110.476 179.217 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 60.8 t -137.98 144.74 30.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 C-N-CA 125.676 1.59 . . . . 0.0 108.678 176.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -122.98 156.04 28.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 C-N-CA 123.56 0.744 . . . . 0.0 109.372 174.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -130.32 169.65 15.16 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.34 1.456 . . . . 0.0 110.677 176.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 31.2 m-20 56.12 34.02 23.06 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 126.38 1.872 . . . . 0.0 113.91 -174.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . 0.255 7.5 p -102.18 81.15 0.34 Allowed Pre-proline 0 N--CA 1.484 1.252 0 C-N-CA 124.92 1.288 . . . . 0.0 112.158 179.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -66.62 149.25 84.06 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 122.058 1.839 . . . . 0.0 110.961 174.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.422 ' HB3' HG22 ' A' ' 60' ' ' THR . 38.2 tt0 -67.72 163.74 20.92 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 121.634 0.731 . . . . 0.0 110.635 169.153 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.425 HG21 ' HG2' ' A' ' 30' ' ' ARG . 31.2 m -135.88 165.79 28.82 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 126.835 2.054 . . . . 0.0 109.482 -177.296 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -73.51 -172.54 24.83 Favored Glycine 0 CA--C 1.539 1.572 0 C-N-CA 123.833 0.73 . . . . 0.0 114.505 -178.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.578 ' HA ' HD22 ' A' ' 31' ' ' LEU . 66.3 Cg_endo -62.49 169.76 7.79 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 123.353 2.702 . . . . 0.0 111.256 178.291 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 42.9 m-20 60.24 8.42 1.55 Allowed 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 125.451 1.501 . . . . 0.0 114.316 -177.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.425 ' HG2' HG21 ' A' ' 26' ' ' VAL . 0.2 OUTLIER -148.31 -29.57 0.3 Allowed 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 126.046 1.739 . . . . 0.0 113.063 -179.56 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.578 HD22 ' HA ' ' A' ' 28' ' ' PRO . 1.7 pt? -51.36 -32.9 27.36 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 115.324 1.601 . . . . 0.0 115.324 177.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -68.59 -47.32 67.04 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.454 1.102 . . . . 0.0 109.502 179.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.4 mptt -51.08 -34.91 32.28 Favored 'General case' 0 C--O 1.219 -0.503 0 C-N-CA 126.601 1.96 . . . . 0.0 111.395 173.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 13.0 tp -51.99 -51.18 58.96 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 119.804 1.184 . . . . 0.0 113.134 177.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.8 tmtt? -83.35 -32.27 26.34 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.767 0.827 . . . . 0.0 112.79 172.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -60.84 -57.26 13.42 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 118.042 -0.98 . . . . 0.0 112.107 177.254 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 16.8 m -53.94 -37.91 35.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 CA-C-N 119.405 1.002 . . . . 0.0 111.257 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.2 mp -53.54 -45.27 58.76 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 124.525 1.13 . . . . 0.0 111.676 170.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.404 ' HA ' HD13 ' A' ' 48' ' ' ILE . 15.5 m-70 -65.51 -40.43 92.98 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 120.052 1.296 . . . . 0.0 112.623 176.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -74.29 -49.53 22.67 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 118.857 0.753 . . . . 0.0 112.647 -179.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -55.26 -42.68 67.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-N 118.759 0.709 . . . . 0.0 111.807 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.519 ' HB2' HD11 ' A' ' 48' ' ' ILE . 30.8 m-85 -83.19 -2.08 54.61 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 113.388 0.885 . . . . 0.0 113.388 -178.127 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.3 t -74.12 -25.29 59.69 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 179.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 17.5 pttt -66.55 -18.71 65.51 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 119.371 0.987 . . . . 0.0 113.005 174.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -101.51 -12.25 18.66 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.211 1.005 . . . . 0.0 113.16 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 156.27 -144.37 10.76 Favored Glycine 0 CA--C 1.529 0.957 0 CA-C-N 118.467 0.576 . . . . 0.0 112.525 -176.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 26.1 tptt -131.67 128.38 38.91 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.929 1.292 . . . . 0.0 108.766 175.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.519 HD11 ' HB2' ' A' ' 42' ' ' PHE . 2.0 mp -84.14 131.34 34.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 177.19 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.0 t -100.76 -31.74 11.04 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 178.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 51.1 m-80 -108.22 163.78 12.88 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 119.329 0.968 . . . . 0.0 112.171 178.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -170.05 116.74 0.54 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.306 1.042 . . . . 0.0 112.307 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -132.97 126.52 32.18 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 121.877 0.846 . . . . 0.0 111.591 -179.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -119.5 86.04 33.28 Favored Pre-proline 0 CA--C 1.542 0.656 0 C-N-CA 126.464 1.906 . . . . 0.0 108.32 -178.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -69.53 174.78 8.81 Favored 'Trans proline' 0 C--N 1.355 0.881 0 C-N-CA 123.346 2.697 . . . . 0.0 110.95 177.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -145.53 172.35 13.35 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.235 1.414 . . . . 0.0 111.494 176.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -113.58 110.85 20.9 Favored 'General case' 0 C--O 1.223 -0.324 0 C-N-CA 125.096 1.358 . . . . 0.0 110.24 175.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 54.24 21.19 2.97 Favored 'General case' 0 CA--C 1.554 1.131 0 N-CA-C 114.884 1.439 . . . . 0.0 114.884 179.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 86.33 17.1 61.23 Favored Glycine 0 CA--C 1.539 1.579 0 O-C-N 121.259 -0.9 . . . . 0.0 113.485 -173.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 27.7 mmmt -117.22 176.34 5.19 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 127.65 2.38 . . . . 0.0 110.091 -177.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.422 HG22 ' HB3' ' A' ' 25' ' ' GLN . 76.2 p -50.6 117.39 2.42 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 126.739 2.016 . . . . 0.0 112.86 -176.233 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -69.71 177.41 3.04 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.922 0.889 . . . . 0.0 112.769 175.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -138.98 -1.63 2.01 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 125.503 1.525 . . . . 0.0 115.254 173.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -146.93 155.27 42.15 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 119.627 1.713 . . . . 0.0 109.098 -174.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.1 pp -138.99 166.44 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 125.233 1.413 . . . . 0.0 110.424 173.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 26.7 t80 -135.43 126.91 28.66 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.141 0.976 . . . . 0.0 109.827 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -130.51 139.42 50.5 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.444 1.498 . . . . 0.0 110.186 179.216 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -127.3 125.81 41.5 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.858 1.263 . . . . 0.0 111.034 177.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -86.05 169.22 13.37 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 122.199 0.999 . . . . 0.0 111.769 176.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -77.51 -5.96 51.89 Favored 'General case' 0 CA--C 1.549 0.918 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 175.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -154.51 156.19 31.37 Favored Pre-proline 0 N--CA 1.473 0.721 0 C-N-CA 125.059 1.344 . . . . 0.0 112.83 -176.096 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -65.38 -48.67 3.13 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 123.646 2.897 . . . . 0.0 111.478 179.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -53.29 -18.32 2.36 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.387 1.875 . . . . 0.0 114.284 177.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 22.3 m170 -85.81 -48.29 8.92 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 119.146 0.884 . . . . 0.0 110.494 175.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -64.29 -54.7 29.09 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.892 1.277 . . . . 0.0 112.335 177.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 11.8 m -59.51 -31.73 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 123.034 0.533 . . . . 0.0 111.438 -177.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -73.28 -57.67 3.85 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.59 1.156 . . . . 0.0 111.286 172.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -50.22 -44.09 53.12 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.637 1.175 . . . . 0.0 113.595 -178.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.604 HG23 HG22 ' A' ' 18' ' ' ILE . 54.8 t -58.48 -43.03 85.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 174.126 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.0 -0.52 51.94 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.616 1.566 . . . . 0.0 112.852 -179.415 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -113.86 -44.68 3.15 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 124.189 0.996 . . . . 0.0 112.436 178.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -94.91 18.78 11.27 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 -178.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -56.87 83.21 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 126.271 1.828 . . . . 0.0 113.053 177.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 102.99 87.0 1.98 Allowed Glycine 0 CA--C 1.527 0.806 0 C-N-CA 124.852 1.215 . . . . 0.0 113.401 171.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -66.47 143.51 57.05 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 -176.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.195 0 O-C-N 120.241 -1.537 . . . . 0.0 114.932 -176.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 . . . . . 0 N--CA 1.463 0.188 0 N-CA-C 110.151 -0.314 . . . . 0.0 110.151 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 15.8 mmm-85 -138.52 98.62 3.63 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.165 0.986 . . . . 0.0 109.603 -177.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 40.4 t -87.77 119.8 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 178.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 52.6 m-80 . . . . . 0 CA--C 1.545 0.765 0 C-N-CA 125.553 1.541 . . . . 0.0 110.852 -179.976 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . 0.323 4.7 p-10 . . . . . 0 CA--C 1.553 1.077 0 N-CA-C 117.81 2.522 . . . . 0.0 117.81 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 50.6 m -115.33 4.1 14.35 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 129.424 3.09 . . . . 0.0 114.001 -174.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.2 m -137.75 161.74 32.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 125.098 1.359 . . . . 0.0 111.985 -172.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.546 HG22 HG23 ' A' ' 78' ' ' VAL . 19.1 pt -130.76 152.88 38.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 CA-C-O 122.338 1.066 . . . . 0.0 110.256 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 61.3 t -137.8 142.28 36.64 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.334 0 C-N-CA 125.482 1.513 . . . . 0.0 108.751 176.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -122.44 151.37 26.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 125.002 1.321 . . . . 0.0 108.679 178.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -127.65 167.3 16.61 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.204 1.402 . . . . 0.0 110.897 178.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 38.4 m-20 59.04 31.53 21.42 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 126.64 1.976 . . . . 0.0 114.212 -173.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . 0.254 7.6 p -102.01 81.29 0.34 Allowed Pre-proline 0 N--CA 1.479 1.011 0 C-N-CA 125.847 1.659 . . . . 0.0 111.835 -179.169 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -67.51 159.65 51.53 Favored 'Trans proline' 0 C--N 1.356 0.952 0 C-N-CA 122.004 1.803 . . . . 0.0 110.895 175.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -75.83 167.57 21.63 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.785 170.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.421 HG21 ' HG2' ' A' ' 30' ' ' ARG . 31.8 m -136.99 166.45 25.72 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 C-N-CA 126.521 1.928 . . . . 0.0 109.272 -177.33 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -75.78 -173.24 34.21 Favored Glycine 0 CA--C 1.539 1.59 0 C-N-CA 124.341 0.972 . . . . 0.0 114.523 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.548 ' HA ' HD22 ' A' ' 31' ' ' LEU . 68.2 Cg_endo -61.39 169.07 7.02 Favored 'Trans proline' 0 CA--C 1.536 0.614 0 C-N-CA 123.568 2.845 . . . . 0.0 111.019 177.607 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 61.69 9.6 2.91 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.843 1.657 . . . . 0.0 114.046 -178.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.421 ' HG2' HG21 ' A' ' 26' ' ' VAL . 43.4 ttt85 -150.66 -29.61 0.2 Allowed 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 127.031 2.132 . . . . 0.0 114.601 -178.229 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.548 HD22 ' HA ' ' A' ' 28' ' ' PRO . 1.7 pt? -51.7 -33.22 33.33 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 115.263 1.579 . . . . 0.0 115.263 177.117 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -66.29 -50.77 62.53 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 125.613 1.565 . . . . 0.0 109.315 178.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 5.8 mptt -49.76 -37.83 31.35 Favored 'General case' 0 C--N 1.345 0.408 0 C-N-CA 127.627 2.371 . . . . 0.0 110.379 175.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -47.36 -64.71 0.71 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.135 1.374 . . . . 0.0 111.361 177.047 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.91 -28.47 58.06 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.687 0.795 . . . . 0.0 112.472 176.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -60.33 -59.69 5.01 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 117.773 -1.108 . . . . 0.0 111.437 176.305 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 32.3 m -53.94 -33.78 24.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 125.1 1.36 . . . . 0.0 111.746 -177.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.2 mp -50.09 -48.49 23.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 124.381 1.072 . . . . 0.0 111.137 169.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.418 ' HA ' HD13 ' A' ' 48' ' ' ILE . 19.4 m-70 -67.55 -20.33 65.39 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 119.446 1.021 . . . . 0.0 113.544 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.28 -49.64 5.12 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.02 1.328 . . . . 0.0 111.498 -177.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -55.17 -43.87 72.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 124.581 1.152 . . . . 0.0 111.129 175.179 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.517 ' HB2' HD11 ' A' ' 48' ' ' ILE . 36.5 m-85 -87.22 -0.14 56.25 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 113.04 0.755 . . . . 0.0 113.04 -177.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -70.09 -35.29 74.07 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.094 1.358 . . . . 0.0 112.05 178.333 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.442 ' HE3' ' CZ ' ' A' ' 45' ' ' PHE . 20.7 pttt -61.82 -17.36 55.96 Favored 'General case' 0 N--CA 1.478 0.941 0 O-C-N 120.948 -1.095 . . . . 0.0 113.647 177.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.442 ' CZ ' ' HE3' ' A' ' 44' ' ' LYS . 9.2 m-85 -101.17 -10.99 19.91 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.881 1.272 . . . . 0.0 113.346 178.29 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 149.55 -149.31 21.24 Favored Glycine 0 CA--C 1.532 1.125 0 CA-C-N 119.182 0.901 . . . . 0.0 112.663 -174.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 21.3 tptt -127.47 124.64 38.86 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 124.405 1.082 . . . . 0.0 108.945 178.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.517 HD11 ' HB2' ' A' ' 42' ' ' PHE . 2.4 mp -79.61 130.37 36.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 123.672 0.789 . . . . 0.0 109.066 175.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 2.8 t -100.7 -30.62 11.63 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.754 1.222 . . . . 0.0 113.516 177.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 42.7 m-80 -113.15 154.11 27.18 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 119.647 1.112 . . . . 0.0 111.548 179.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -159.46 123.91 3.94 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.665 0.786 . . . . 0.0 110.759 176.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -134.83 129.81 35.07 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 123.678 0.791 . . . . 0.0 111.905 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -121.65 86.17 44.69 Favored Pre-proline 0 CA--C 1.538 0.508 0 C-N-CA 127.449 2.3 . . . . 0.0 108.442 -177.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -68.67 174.49 8.44 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 122.736 2.291 . . . . 0.0 110.929 174.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -146.04 172.53 13.25 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 126.548 1.939 . . . . 0.0 110.416 174.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -113.33 110.29 20.1 Favored 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 125.674 1.59 . . . . 0.0 109.049 175.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 57.18 20.17 5.44 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 124.686 1.194 . . . . 0.0 113.784 177.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 85.04 14.62 68.98 Favored Glycine 0 CA--C 1.537 1.467 0 O-C-N 121.025 -1.047 . . . . 0.0 114.002 -172.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 5.8 mmmt -114.64 171.1 7.84 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 128.368 2.667 . . . . 0.0 109.976 -178.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 4.0 t -40.85 115.5 0.59 Allowed 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 127.228 2.211 . . . . 0.0 112.632 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.0 pttp -62.91 -179.11 0.25 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.339 1.056 . . . . 0.0 112.628 168.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -142.69 0.19 1.39 Allowed Glycine 0 CA--C 1.531 1.086 0 C-N-CA 126.51 2.005 . . . . 0.0 115.441 170.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -146.6 154.52 41.58 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 119.957 1.879 . . . . 0.0 108.999 -174.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.1 pp -137.09 165.3 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 126.274 1.83 . . . . 0.0 110.834 172.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -135.66 126.2 26.95 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.2 1.4 . . . . 0.0 109.507 -177.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -131.1 141.12 50.11 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.816 1.646 . . . . 0.0 110.706 -178.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -129.69 127.29 40.21 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.635 0.774 . . . . 0.0 109.908 -179.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -88.99 167.21 13.37 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.968 0.89 . . . . 0.0 111.693 177.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.2 -4.0 36.33 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.099 0.959 . . . . 0.0 113.499 174.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -157.3 153.86 24.47 Favored Pre-proline 0 N--CA 1.474 0.727 0 C-N-CA 124.973 1.309 . . . . 0.0 112.717 -177.036 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -63.07 -47.69 7.81 Favored 'Trans proline' 0 C--N 1.354 0.816 0 C-N-CA 123.862 3.041 . . . . 0.0 110.877 177.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -55.69 -14.72 2.38 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.735 2.014 . . . . 0.0 114.624 178.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 54.2 m170 -88.46 -46.37 9.18 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 119.669 1.122 . . . . 0.0 110.609 171.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -66.42 -54.31 25.72 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 124.03 0.932 . . . . 0.0 111.465 -179.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 10.7 m -61.28 -26.16 38.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 124.013 0.925 . . . . 0.0 112.076 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -78.25 -56.91 4.08 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.823 1.249 . . . . 0.0 110.299 172.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -50.65 -43.73 57.31 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 119.705 1.139 . . . . 0.0 113.411 -179.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.546 HG23 HG22 ' A' ' 18' ' ' ILE . 61.2 t -57.91 -39.82 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 123.63 0.772 . . . . 0.0 112.907 175.276 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 7.2 mttt -90.18 4.69 49.75 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 126.095 1.758 . . . . 0.0 113.088 179.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -124.8 -20.5 5.0 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 115.147 1.536 . . . . 0.0 115.147 178.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -120.94 21.74 11.28 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 125.479 1.511 . . . . 0.0 112.287 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -56.54 79.74 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 127.586 2.354 . . . . 0.0 113.797 178.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 98.11 91.29 1.95 Allowed Glycine 0 C--N 1.341 0.86 0 C-N-CA 124.202 0.906 . . . . 0.0 111.955 174.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -67.33 150.13 49.4 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.449 1.1 . . . . 0.0 113.704 -177.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . 0.273 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.219 0 N-CA-C 115.266 1.58 . . . . 0.0 115.266 -178.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 . . . . . 0 N--CA 1.464 0.227 0 CA-C-O 121.0 0.429 . . . . 0.0 111.293 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 23.3 mmm180 -137.59 89.88 2.46 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.21 1.404 . . . . 0.0 110.705 -177.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 33.3 t -77.9 118.78 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 123.616 0.766 . . . . 0.0 109.43 176.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 55.6 m-80 . . . . . 0 CA--C 1.544 0.722 0 C-N-CA 125.768 1.627 . . . . 0.0 110.563 178.964 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 . . . . . 0 CA--C 1.55 0.943 0 N-CA-C 116.036 1.865 . . . . 0.0 116.036 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.6 m -121.53 1.52 10.09 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 126.532 1.933 . . . . 0.0 113.348 -174.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 26.8 m -144.89 167.72 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 124.386 1.075 . . . . 0.0 111.772 -169.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.535 HG22 HG23 ' A' ' 78' ' ' VAL . 21.0 pt -130.96 156.03 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 CA-C-O 121.401 0.619 . . . . 0.0 111.472 178.191 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 98.2 t -136.0 152.93 31.23 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.029 0 C-N-CA 125.286 1.434 . . . . 0.0 109.964 175.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -130.43 149.78 33.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 N-CA-C 108.312 -0.995 . . . . 0.0 108.312 177.061 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -124.86 162.37 24.5 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 124.357 1.063 . . . . 0.0 110.59 176.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 12.9 t30 65.76 34.02 7.78 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.709 1.604 . . . . 0.0 113.405 -177.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.7 p -104.53 81.7 0.56 Allowed Pre-proline 0 N--CA 1.476 0.866 0 C-N-CA 125.572 1.549 . . . . 0.0 112.612 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -68.31 144.85 63.7 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.108 1.872 . . . . 0.0 111.84 177.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.426 ' HB3' HG22 ' A' ' 60' ' ' THR . 0.0 OUTLIER -64.93 163.55 14.28 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 120.915 0.388 . . . . 0.0 111.193 169.79 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 31.3 m -138.55 161.37 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 C-N-CA 125.294 1.438 . . . . 0.0 109.935 -174.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -70.47 -173.25 12.75 Favored Glycine 0 CA--C 1.546 2.021 0 N-CA-C 115.286 0.875 . . . . 0.0 115.286 -179.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.559 ' HA ' HD22 ' A' ' 31' ' ' LEU . 59.3 Cg_endo -62.21 167.97 10.09 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 123.527 2.818 . . . . 0.0 111.493 179.247 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 19.2 t70 64.4 7.75 3.82 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.055 1.342 . . . . 0.0 113.126 -178.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.2 ttt-85 -150.36 -27.38 0.23 Allowed 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.566 1.546 . . . . 0.0 114.142 -179.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.559 HD22 ' HA ' ' A' ' 28' ' ' PRO . 1.6 pt? -52.02 -33.09 36.9 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 114.713 1.375 . . . . 0.0 114.713 176.386 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -65.34 -53.14 48.06 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 125.077 1.351 . . . . 0.0 108.844 177.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.79 -38.52 48.83 Favored 'General case' 0 C--O 1.219 -0.541 0 C-N-CA 126.623 1.969 . . . . 0.0 111.003 176.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -46.65 -59.59 2.92 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 119.406 1.003 . . . . 0.0 111.879 175.263 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -75.17 -32.79 61.37 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.762 0.825 . . . . 0.0 112.824 175.232 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.99 -55.42 25.85 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 117.659 -1.163 . . . . 0.0 111.835 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 15.6 m -55.14 -37.55 43.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 124.25 1.02 . . . . 0.0 110.838 179.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.1 mp -53.18 -47.62 55.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 124.81 1.244 . . . . 0.0 111.495 170.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 13.5 m-70 -65.37 -39.7 92.6 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 119.29 0.95 . . . . 0.0 112.644 178.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -72.77 -49.14 32.65 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 119.233 0.924 . . . . 0.0 112.669 177.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -57.03 -39.86 69.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 CA-C-N 119.378 0.99 . . . . 0.0 111.878 -177.468 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.537 ' HB2' HD11 ' A' ' 48' ' ' ILE . 35.3 m-85 -86.64 -1.03 57.35 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -178.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -75.78 -22.94 55.92 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 -179.369 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 3.4 pttm -68.56 -24.94 64.68 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 119.488 1.04 . . . . 0.0 112.367 175.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -92.16 -14.24 29.42 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.977 0.911 . . . . 0.0 112.825 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 156.59 -148.35 18.11 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 123.982 0.801 . . . . 0.0 112.361 -176.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 12.3 tptm -128.08 123.16 33.88 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.455 1.102 . . . . 0.0 109.463 176.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.537 HD11 ' HB2' ' A' ' 42' ' ' PHE . 1.7 mp -79.71 123.55 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 177.436 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.8 t -102.18 -11.57 18.69 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 117.697 -1.144 . . . . 0.0 114.061 -178.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 32.0 m-80 -121.91 165.7 15.55 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.057 1.343 . . . . 0.0 110.917 175.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.505 ' HA ' HD23 ' A' ' 66' ' ' LEU . 0.2 OUTLIER -166.79 126.21 1.48 Allowed 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.811 0.845 . . . . 0.0 111.928 173.689 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -137.02 122.37 19.42 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.833 0.825 . . . . 0.0 111.478 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -119.92 86.58 36.69 Favored Pre-proline 0 CA--C 1.538 0.504 0 C-N-CA 126.086 1.754 . . . . 0.0 108.835 -178.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -70.33 174.79 9.49 Favored 'Trans proline' 0 CA--C 1.536 0.612 0 C-N-CA 123.069 2.513 . . . . 0.0 111.043 178.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -145.54 171.97 13.91 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.482 1.113 . . . . 0.0 111.753 173.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -111.97 109.87 19.88 Favored 'General case' 0 C--O 1.223 -0.309 0 C-N-CA 124.734 1.213 . . . . 0.0 109.639 176.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 54.26 24.96 5.4 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 125.054 1.342 . . . . 0.0 114.462 179.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 83.7 12.89 76.78 Favored Glycine 0 CA--C 1.539 1.534 0 O-C-N 121.494 -0.754 . . . . 0.0 113.666 -174.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.9 mtpp -114.79 179.32 3.98 Favored 'General case' 0 C--N 1.343 0.297 0 C-N-CA 126.604 1.961 . . . . 0.0 110.857 -177.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.426 HG22 ' HB3' ' A' ' 25' ' ' GLN . 65.6 p -54.46 110.92 0.69 Allowed 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.675 1.59 . . . . 0.0 113.556 -173.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.6 pttt -59.23 174.12 0.42 Allowed 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.86 1.664 . . . . 0.0 113.291 173.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -136.38 -3.38 2.44 Favored Glycine 0 CA--C 1.534 1.272 0 C-N-CA 125.265 1.412 . . . . 0.0 115.484 173.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -144.7 154.77 43.11 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 126.116 1.766 . . . . 0.0 109.009 -176.109 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.1 pp -137.06 168.66 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 125.671 1.588 . . . . 0.0 110.74 172.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -138.65 132.68 31.31 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.748 1.219 . . . . 0.0 110.102 -178.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.505 HD23 ' HA ' ' A' ' 51' ' ' ASP . 31.8 mt -136.45 147.1 47.03 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 125.04 1.336 . . . . 0.0 110.684 179.186 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -132.31 122.17 24.7 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 124.149 0.98 . . . . 0.0 109.848 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -83.29 170.86 14.16 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 121.933 0.873 . . . . 0.0 111.245 175.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -74.01 -3.53 29.82 Favored 'General case' 0 CA--C 1.549 0.904 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 173.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.3 p -161.1 156.08 20.41 Favored Pre-proline 0 CA--C 1.54 0.567 0 CA-C-N 119.561 1.073 . . . . 0.0 112.997 -175.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -65.73 -45.41 6.56 Favored 'Trans proline' 0 C--N 1.355 0.919 0 C-N-CA 123.363 2.708 . . . . 0.0 111.632 -178.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -55.42 -15.51 2.73 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.295 1.838 . . . . 0.0 114.028 177.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -90.44 -46.57 8.27 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 119.729 1.15 . . . . 0.0 110.817 174.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -60.2 -57.18 13.91 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.338 1.055 . . . . 0.0 112.452 173.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 10.4 m -61.69 -28.48 44.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -176.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -74.82 -56.29 4.93 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.455 1.102 . . . . 0.0 110.66 173.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.77 -41.55 61.72 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.165 0.986 . . . . 0.0 112.969 -176.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.535 HG23 HG22 ' A' ' 18' ' ' ILE . 78.8 t -58.02 -39.44 72.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 124.018 0.927 . . . . 0.0 113.167 174.375 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 3.2 mptt -88.32 3.75 48.58 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.075 1.35 . . . . 0.0 113.348 178.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -120.67 -31.11 4.34 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 179.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -110.12 21.18 17.09 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 119.251 0.932 . . . . 0.0 113.039 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -57.21 85.61 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.768 1.627 . . . . 0.0 113.076 178.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 97.56 79.28 1.45 Allowed Glycine 0 CA--C 1.53 0.989 0 C-N-CA 124.308 0.956 . . . . 0.0 113.304 173.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -57.49 128.66 38.14 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.805 1.242 . . . . 0.0 112.941 -177.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.477 0.895 0 O-C-N 119.941 -1.724 . . . . 0.0 115.283 -176.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 . . . . . 0 N--CA 1.466 0.328 0 CA-C-O 120.648 0.261 . . . . 0.0 110.746 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 22.1 mmt180 -137.08 87.04 2.25 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.985 0.914 . . . . 0.0 110.673 -178.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 39.2 t -78.82 118.7 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 177.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 54.7 m-80 . . . . . 0 CA--C 1.538 0.493 0 C-N-CA 125.686 1.594 . . . . 0.0 110.006 -178.319 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 CA--C 1.547 0.829 0 N-CA-C 116.427 2.01 . . . . 0.0 116.427 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 68.4 m -118.73 8.41 11.85 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.859 1.664 . . . . 0.0 113.722 -177.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.5 m -142.62 164.6 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 C-N-CA 123.517 0.727 . . . . 0.0 111.432 -174.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.578 HG22 HG23 ' A' ' 78' ' ' VAL . 18.4 pt -129.63 148.4 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 123.063 0.545 . . . . 0.0 110.976 179.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 40.7 t -134.01 137.13 52.71 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.121 0 CA-C-O 122.318 1.056 . . . . 0.0 109.173 174.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.489 HG22 HG13 ' A' ' 64' ' ' ILE . 0.9 OUTLIER -109.61 154.23 11.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.054 -0.975 . . . . 0.0 109.27 179.371 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -129.77 158.38 39.58 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 123.263 0.625 . . . . 0.0 111.792 174.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 63.5 t30 61.58 40.1 13.9 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 126.009 1.724 . . . . 0.0 113.056 -178.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.7 m -99.82 83.28 0.34 Allowed Pre-proline 0 N--CA 1.483 1.18 0 C-N-CA 126.032 1.733 . . . . 0.0 112.434 174.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -65.21 140.14 63.47 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 121.759 1.64 . . . . 0.0 110.002 171.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.67 177.36 1.62 Allowed 'General case' 0 CA--C 1.541 0.596 0 CA-C-O 121.385 0.612 . . . . 0.0 112.136 170.363 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.532 HG21 ' HG2' ' A' ' 30' ' ' ARG . 27.3 m -135.47 162.77 36.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 C-N-CA 125.183 1.393 . . . . 0.0 110.557 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -66.56 -174.15 5.86 Favored Glycine 0 CA--C 1.544 1.849 0 C-N-CA 124.069 0.842 . . . . 0.0 114.989 -179.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.5 ' HA ' HD22 ' A' ' 31' ' ' LEU . 61.0 Cg_endo -63.81 166.19 16.67 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 123.051 2.501 . . . . 0.0 111.661 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.6 t0 62.33 11.72 4.73 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 123.876 0.87 . . . . 0.0 112.725 -177.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.532 ' HG2' HG21 ' A' ' 26' ' ' VAL . 7.2 ttt180 -151.52 -26.55 0.19 Allowed 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.431 1.492 . . . . 0.0 113.922 177.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.5 HD22 ' HA ' ' A' ' 28' ' ' PRO . 1.7 pt? -51.6 -32.9 30.57 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 114.694 1.368 . . . . 0.0 114.694 179.56 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -66.98 -49.24 66.02 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 125.46 1.504 . . . . 0.0 109.694 179.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 8.3 mptt -49.65 -34.17 17.6 Favored 'General case' 0 C--O 1.219 -0.551 0 C-N-CA 126.601 1.961 . . . . 0.0 111.279 173.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -50.42 -63.49 1.1 Allowed 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 120.264 1.393 . . . . 0.0 110.875 177.269 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.91 -28.89 61.76 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 121.444 -0.785 . . . . 0.0 112.687 175.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.8 -56.7 15.07 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 118.016 -0.992 . . . . 0.0 112.164 177.108 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 19.0 m -55.61 -34.84 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 124.004 0.922 . . . . 0.0 110.983 -178.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.1 mp -49.41 -46.89 19.83 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 124.528 1.131 . . . . 0.0 111.462 171.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 18.8 m-70 -68.68 -16.73 63.92 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 113.542 0.942 . . . . 0.0 113.542 179.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -94.04 -51.44 4.85 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.528 1.131 . . . . 0.0 111.19 178.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -56.08 -37.23 48.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 CA-C-N 118.831 0.741 . . . . 0.0 111.742 177.165 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.54 ' HB2' HD11 ' A' ' 48' ' ' ILE . 37.2 m-85 -91.12 -0.93 57.81 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -179.292 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -74.31 -27.01 60.51 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 178.441 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.487 ' HE3' ' CZ ' ' A' ' 45' ' ' PHE . 16.9 pttt -66.67 -22.08 66.09 Favored 'General case' 0 N--CA 1.48 1.071 0 O-C-N 120.536 -1.353 . . . . 0.0 113.188 176.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.487 ' CZ ' ' HE3' ' A' ' 44' ' ' LYS . 9.6 m-85 -94.95 -12.89 25.94 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.68 0.792 . . . . 0.0 113.001 -179.266 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 151.03 -152.18 24.03 Favored Glycine 0 CA--C 1.53 1.024 0 N-CA-C 111.668 -0.573 . . . . 0.0 111.668 -173.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 24.6 tptt -126.26 123.61 38.52 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.506 1.122 . . . . 0.0 110.067 177.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.546 HG21 HD22 ' A' ' 66' ' ' LEU . 2.4 mp -76.37 129.72 36.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 176.369 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.592 HG23 HD22 ' A' ' 50' ' ' ASN . 2.6 t -100.83 -30.48 11.66 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.551 0.74 . . . . 0.0 112.826 179.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.592 HD22 HG23 ' A' ' 49' ' ' THR . 8.8 m-80 -109.88 162.73 14.22 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.39 1.076 . . . . 0.0 110.843 -179.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.536 ' HA ' HD23 ' A' ' 66' ' ' LEU . 0.3 OUTLIER -165.52 125.67 1.82 Allowed 'General case' 0 N--CA 1.468 0.439 0 O-C-N 121.424 -0.797 . . . . 0.0 111.785 174.39 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -136.83 122.87 20.27 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.941 0.876 . . . . 0.0 111.577 -179.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -119.72 86.1 34.63 Favored Pre-proline 0 CA--C 1.537 0.461 0 C-N-CA 125.892 1.677 . . . . 0.0 109.11 -176.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -70.75 171.08 16.24 Favored 'Trans proline' 0 CA--C 1.534 0.511 0 C-N-CA 122.99 2.46 . . . . 0.0 111.426 178.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -145.67 173.78 11.77 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.282 1.033 . . . . 0.0 111.705 175.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -116.22 111.34 20.04 Favored 'General case' 0 C--O 1.223 -0.3 0 C-N-CA 124.771 1.228 . . . . 0.0 110.096 176.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 50.86 30.08 4.87 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 125.768 1.627 . . . . 0.0 113.911 -178.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 79.66 12.96 83.06 Favored Glycine 0 CA--C 1.534 1.24 0 O-C-N 121.163 -0.96 . . . . 0.0 113.042 -176.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 26.7 mtpt -111.41 -178.35 3.43 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.689 1.995 . . . . 0.0 109.85 -178.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 64.4 p -57.72 115.37 2.76 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 126.818 2.047 . . . . 0.0 112.98 -172.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.8 pttp -69.46 171.81 8.19 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.605 1.162 . . . . 0.0 113.96 171.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -138.29 3.77 3.05 Favored Glycine 0 CA--C 1.536 1.385 0 C-N-CA 126.848 2.166 . . . . 0.0 115.638 175.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -147.38 152.57 38.38 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 119.961 1.88 . . . . 0.0 109.542 -178.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.489 HG13 HG22 ' A' ' 20' ' ' VAL . 1.0 OUTLIER -135.84 166.72 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 125.643 1.577 . . . . 0.0 111.098 172.331 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -134.72 126.09 28.31 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.223 1.409 . . . . 0.0 109.985 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.546 HD22 HG21 ' A' ' 48' ' ' ILE . 73.9 mt -127.72 149.62 50.14 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 124.593 1.157 . . . . 0.0 110.722 175.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -136.34 132.56 35.78 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-O 122.364 1.078 . . . . 0.0 110.253 178.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -94.82 167.97 11.1 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 114.762 -1.108 . . . . 0.0 111.186 177.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -80.51 10.24 4.97 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.944 0.898 . . . . 0.0 112.339 176.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 9.7 m -169.78 153.04 4.79 Favored Pre-proline 0 CA--C 1.54 0.592 0 CA-C-N 120.005 1.275 . . . . 0.0 112.583 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -64.09 -46.12 8.79 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 124.818 3.679 . . . . 0.0 111.865 -178.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -53.98 -20.8 6.78 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.725 1.61 . . . . 0.0 113.509 176.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 33.0 m170 -84.99 -47.87 9.81 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 119.778 1.172 . . . . 0.0 110.534 176.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -65.06 -51.86 59.08 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.099 0.96 . . . . 0.0 112.287 178.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 15.9 m -60.47 -34.06 56.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 122.664 0.386 . . . . 0.0 111.149 -179.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -68.36 -57.39 5.97 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 123.593 0.757 . . . . 0.0 110.463 172.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -55.7 -39.66 71.33 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 119.101 0.864 . . . . 0.0 112.748 -173.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.578 HG23 HG22 ' A' ' 18' ' ' ILE . 49.2 t -59.43 -42.2 86.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 123.971 0.908 . . . . 0.0 112.713 173.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.56 2.33 37.71 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.354 1.061 . . . . 0.0 113.463 177.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -115.67 -53.63 2.57 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 119.036 0.835 . . . . 0.0 111.409 179.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -88.11 19.18 3.79 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.021 0.928 . . . . 0.0 113.327 -176.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -52.33 86.44 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.518 1.927 . . . . 0.0 113.374 -179.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.64 95.49 0.77 Allowed Glycine 0 CA--C 1.531 1.075 0 C-N-CA 124.557 1.075 . . . . 0.0 111.495 -178.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 23.6 m-85 -59.59 156.25 13.88 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 122.14 0.972 . . . . 0.0 112.397 177.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.467 0.418 0 C-N-CA 124.445 1.098 . . . . 0.0 110.08 -172.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 . . . . . 0 N--CA 1.467 0.392 0 CA-C-O 120.408 0.147 . . . . 0.0 111.087 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 21.0 mmm180 -136.43 94.76 3.05 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.606 0.762 . . . . 0.0 110.648 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 60.4 t -89.55 109.88 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 123.64 0.776 . . . . 0.0 109.849 179.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.433 ' HA ' HG13 ' A' ' 78' ' ' VAL . 49.1 m-80 . . . . . 0 CA--C 1.546 0.796 0 C-N-CA 125.004 1.321 . . . . 0.0 111.356 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . 0.272 3.6 p30 . . . . . 0 N--CA 1.477 0.875 0 N-CA-C 115.955 1.835 . . . . 0.0 115.955 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 59.7 m -130.83 5.68 4.62 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 127.21 2.204 . . . . 0.0 113.132 -171.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.6 m -142.3 162.7 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 C-N-CA 125.211 1.404 . . . . 0.0 111.785 -173.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.662 HG22 HG23 ' A' ' 78' ' ' VAL . 16.7 pt -131.42 150.09 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 C-N-CA 123.874 0.87 . . . . 0.0 110.243 -178.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 44.5 t -136.08 132.44 50.04 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.175 0 C-N-CA 124.954 1.302 . . . . 0.0 109.004 175.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -107.01 151.55 8.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 124.544 1.138 . . . . 0.0 109.51 176.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -127.23 166.32 17.97 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.229 1.012 . . . . 0.0 111.309 175.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 66.4 t30 60.2 39.62 19.06 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 126.593 1.957 . . . . 0.0 113.057 -176.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . 0.26 7.2 p -109.0 80.44 1.31 Allowed Pre-proline 0 N--CA 1.476 0.865 0 C-N-CA 125.63 1.572 . . . . 0.0 112.019 179.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -66.89 142.29 62.08 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 121.986 1.791 . . . . 0.0 110.975 175.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.31 163.02 13.72 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 122.981 0.512 . . . . 0.0 111.62 170.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.575 HG22 HD11 ' A' ' 34' ' ' LEU . 33.2 m -133.42 173.0 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 124.913 1.285 . . . . 0.0 110.953 -174.123 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -74.22 -176.58 35.4 Favored Glycine 0 CA--C 1.543 1.783 0 N-CA-C 114.478 0.551 . . . . 0.0 114.478 178.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.533 ' HA ' HD22 ' A' ' 31' ' ' LEU . 61.8 Cg_endo -62.34 168.98 8.67 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 123.49 2.794 . . . . 0.0 111.205 176.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.1 t70 64.07 2.63 1.47 Allowed 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.425 1.49 . . . . 0.0 113.53 -177.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.501 ' HG2' HG21 ' A' ' 26' ' ' VAL . 4.4 ttp180 -142.71 -28.6 0.58 Allowed 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 126.525 1.93 . . . . 0.0 113.77 179.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.533 HD22 ' HA ' ' A' ' 28' ' ' PRO . 1.6 pt? -51.46 -33.4 30.82 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 115.146 1.536 . . . . 0.0 115.146 179.19 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -68.81 -43.22 76.04 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 124.929 1.292 . . . . 0.0 110.474 178.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -51.52 -38.52 54.48 Favored 'General case' 0 C--O 1.221 -0.424 0 C-N-CA 126.052 1.741 . . . . 0.0 110.659 174.238 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.575 HD11 HG22 ' A' ' 26' ' ' VAL . 80.6 mt -52.71 -43.42 65.63 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 120.142 1.337 . . . . 0.0 113.692 178.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.1 tmtt? -91.88 -28.07 17.53 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.726 0.811 . . . . 0.0 112.103 176.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -62.12 -61.79 2.23 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 118.864 -0.588 . . . . 0.0 111.557 173.501 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 28.0 m -54.04 -34.95 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 124.936 1.294 . . . . 0.0 111.42 -174.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.402 HD13 ' O ' ' A' ' 34' ' ' LEU . 1.1 mp -46.92 -55.74 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.335 0 C-N-CA 125.582 1.553 . . . . 0.0 109.955 169.415 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 29.2 m-70 -63.39 -34.08 76.93 Favored 'General case' 0 C--O 1.223 -0.295 0 CA-C-O 118.203 -0.903 . . . . 0.0 112.275 -178.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.7 -54.12 11.35 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 118.877 0.762 . . . . 0.0 111.366 178.234 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -58.28 -42.13 82.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-N 118.42 0.555 . . . . 0.0 111.441 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.548 ' HB2' HD11 ' A' ' 48' ' ' ILE . 34.0 m-85 -84.43 -1.31 55.41 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 113.626 0.972 . . . . 0.0 113.626 -177.144 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.77 -27.32 61.09 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.534 1.133 . . . . 0.0 113.174 179.038 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 2.7 pttm -67.69 -24.78 65.44 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 119.794 1.179 . . . . 0.0 112.892 177.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -93.33 -10.39 35.55 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.28 1.032 . . . . 0.0 113.014 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 149.15 -142.67 10.05 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.046 0.831 . . . . 0.0 112.356 -176.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.5 tppt? -134.69 130.91 37.02 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 124.574 1.15 . . . . 0.0 109.766 177.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.573 HG21 HD22 ' A' ' 66' ' ' LEU . 2.9 mp -81.9 127.09 39.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 124.686 1.194 . . . . 0.0 108.46 175.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.578 HG23 HD22 ' A' ' 50' ' ' ASN . 3.2 t -97.86 -33.28 11.3 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.472 1.109 . . . . 0.0 113.089 178.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.578 HD22 HG23 ' A' ' 49' ' ' THR . 8.7 m-80 -104.26 165.13 11.26 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.928 1.291 . . . . 0.0 111.162 179.39 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.54 ' HA ' HD23 ' A' ' 66' ' ' LEU . 0.3 OUTLIER -167.78 126.16 1.24 Allowed 'General case' 0 N--CA 1.469 0.494 0 O-C-N 121.244 -0.91 . . . . 0.0 111.915 174.124 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -137.0 118.43 14.73 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-O 121.566 0.698 . . . . 0.0 111.366 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -116.46 86.75 18.73 Favored Pre-proline 0 CA--C 1.539 0.553 0 C-N-CA 126.136 1.774 . . . . 0.0 108.583 -179.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -69.29 174.61 8.85 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 123.249 2.632 . . . . 0.0 111.234 178.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -145.38 172.68 12.83 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.855 1.262 . . . . 0.0 111.94 174.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -113.76 108.25 16.85 Favored 'General case' 0 C--O 1.224 -0.275 0 C-N-CA 125.339 1.456 . . . . 0.0 109.508 178.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 53.96 26.73 6.58 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.289 1.435 . . . . 0.0 114.021 -179.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.58 11.69 82.73 Favored Glycine 0 CA--C 1.532 1.14 0 O-C-N 121.352 -0.842 . . . . 0.0 113.493 -174.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.5 mtpp -111.56 178.86 4.19 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 126.648 1.979 . . . . 0.0 110.252 178.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 44.0 p -48.71 106.43 0.1 Allowed 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 127.68 2.392 . . . . 0.0 115.013 -176.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.7 pttt -58.77 172.03 0.58 Allowed 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.026 1.33 . . . . 0.0 112.127 173.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -132.01 -2.81 4.16 Favored Glycine 0 CA--C 1.538 1.53 0 C-N-CA 127.364 2.412 . . . . 0.0 116.149 173.157 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -145.82 155.15 42.72 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 119.796 1.798 . . . . 0.0 109.249 -175.057 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -136.52 164.6 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 125.672 1.589 . . . . 0.0 111.34 170.574 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -134.32 127.81 32.47 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 125.671 1.588 . . . . 0.0 109.917 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.573 HD22 HG21 ' A' ' 48' ' ' ILE . 69.8 mt -130.22 149.78 51.77 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 124.775 1.23 . . . . 0.0 110.658 176.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -134.74 134.87 41.45 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 124.93 1.292 . . . . 0.0 110.148 178.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -94.93 169.67 9.97 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 121.979 0.895 . . . . 0.0 111.461 176.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -74.81 -3.69 33.28 Favored 'General case' 0 CA--C 1.55 0.968 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 174.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.4 p -163.06 155.47 15.84 Favored Pre-proline 0 CA--C 1.541 0.6 0 C-N-CA 124.222 1.009 . . . . 0.0 113.369 -173.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -65.5 -47.95 3.71 Favored 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 123.848 3.032 . . . . 0.0 111.482 -176.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -53.08 -21.76 5.18 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.411 1.884 . . . . 0.0 113.776 178.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 24.6 m170 -83.5 -46.13 12.81 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 119.338 0.972 . . . . 0.0 110.799 175.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -68.05 -50.93 52.17 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.014 0.926 . . . . 0.0 112.846 179.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 17.9 m -60.9 -31.09 48.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 123.7 0.8 . . . . 0.0 111.734 -178.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -70.44 -62.8 1.25 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.795 1.638 . . . . 0.0 109.402 169.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -50.65 -41.76 55.68 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.177 1.391 . . . . 0.0 114.052 -175.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.662 HG23 HG22 ' A' ' 18' ' ' ILE . 23.6 t -52.86 -49.53 47.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 123.492 0.717 . . . . 0.0 111.806 173.03 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -91.95 19.94 6.21 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 126.45 1.9 . . . . 0.0 112.124 178.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -132.54 -3.22 3.36 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 125.459 1.504 . . . . 0.0 114.228 174.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -137.65 19.34 2.88 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.381 1.072 . . . . 0.0 112.623 178.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -61.36 79.47 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 126.109 1.764 . . . . 0.0 112.308 -178.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 103.06 87.29 2.0 Allowed Glycine 0 CA--C 1.527 0.841 0 C-N-CA 125.08 1.324 . . . . 0.0 113.758 172.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -66.08 145.09 56.25 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.833 1.253 . . . . 0.0 114.35 -179.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.474 0.749 0 C-N-CA 124.863 1.265 . . . . 0.0 114.198 177.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 . . . . . 0 N--CA 1.468 0.47 0 CA-C-O 120.579 0.228 . . . . 0.0 110.871 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 16.1 mmm180 -136.45 95.55 3.19 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.677 1.191 . . . . 0.0 109.717 -178.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 40.6 t -89.38 116.13 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 123.679 0.792 . . . . 0.0 109.411 178.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.467 ' HA ' HG13 ' A' ' 78' ' ' VAL . 35.9 m-80 . . . . . 0 CA--C 1.545 0.766 0 C-N-CA 124.423 1.089 . . . . 0.0 110.429 178.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 . . . . . 0 CA--C 1.548 0.889 0 N-CA-C 115.551 1.685 . . . . 0.0 115.551 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -121.26 2.2 10.3 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 127.42 2.288 . . . . 0.0 113.839 -175.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.1 m -139.78 162.58 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 124.203 1.001 . . . . 0.0 110.456 -172.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.445 HG22 HG23 ' A' ' 78' ' ' VAL . 14.7 pt -133.19 155.28 40.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 124.438 1.095 . . . . 0.0 110.718 -178.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -144.47 162.39 14.43 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.483 0 C-N-CA 125.207 1.403 . . . . 0.0 110.011 178.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.465 HG22 HG22 ' A' ' 94' ' ' VAL . 27.1 t -137.8 127.38 35.11 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.192 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 -176.114 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -96.26 163.13 13.22 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.313 1.045 . . . . 0.0 112.032 169.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 16.0 m-20 62.12 43.79 8.44 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 129.059 2.944 . . . . 0.0 114.199 -178.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.784 HG11 HG23 ' A' ' 64' ' ' ILE . 7.4 p -111.34 84.25 4.68 Favored Pre-proline 0 N--CA 1.485 1.286 0 C-N-CA 124.973 1.309 . . . . 0.0 111.957 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -66.69 145.88 77.09 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 122.064 1.843 . . . . 0.0 110.796 172.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.451 ' HB3' HG22 ' A' ' 60' ' ' THR . 15.6 tt0 -65.1 159.62 22.95 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 121.51 0.672 . . . . 0.0 110.941 169.386 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.421 HG21 ' HG3' ' A' ' 30' ' ' ARG . 35.0 m -130.95 166.01 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 C-N-CA 126.373 1.869 . . . . 0.0 109.043 -176.224 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -74.62 -173.6 31.03 Favored Glycine 0 CA--C 1.543 1.794 0 C-N-CA 124.175 0.893 . . . . 0.0 114.493 -179.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.558 ' HA ' HD22 ' A' ' 31' ' ' LEU . 63.0 Cg_endo -62.23 168.15 9.82 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 123.435 2.757 . . . . 0.0 110.839 177.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.3 t70 65.93 2.63 2.28 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 125.385 1.474 . . . . 0.0 113.448 -177.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.421 ' HG3' HG21 ' A' ' 26' ' ' VAL . 9.6 tpt180 -145.83 -28.83 0.43 Allowed 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.661 1.584 . . . . 0.0 114.555 -177.002 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.558 HD22 ' HA ' ' A' ' 28' ' ' PRO . 1.6 pt? -52.31 -32.68 38.94 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 114.861 1.43 . . . . 0.0 114.861 177.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -69.58 -50.32 45.75 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.991 1.316 . . . . 0.0 109.542 179.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -47.84 -41.07 23.06 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 127.127 2.171 . . . . 0.0 109.827 175.206 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.6 tp -47.79 -47.9 30.6 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.567 1.547 . . . . 0.0 114.147 179.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -91.32 -31.48 16.07 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.478 1.111 . . . . 0.0 112.086 173.466 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -57.91 -59.17 5.67 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 118.102 -0.951 . . . . 0.0 111.461 175.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 15.4 m -53.38 -35.9 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 124.826 1.25 . . . . 0.0 110.829 178.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.1 mp -53.1 -44.99 52.99 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-N 118.859 0.754 . . . . 0.0 111.408 171.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.462 ' HA ' HD13 ' A' ' 48' ' ' ILE . 22.5 m-70 -66.8 -36.15 81.73 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 120.9 -1.125 . . . . 0.0 112.138 178.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -76.21 -50.24 15.02 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 118.716 0.689 . . . . 0.0 111.803 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -55.43 -40.04 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 124.404 1.082 . . . . 0.0 112.032 -179.112 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.66 ' HB2' HD11 ' A' ' 48' ' ' ILE . 31.6 m-85 -88.38 -6.04 57.93 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -177.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -68.1 -26.34 65.76 Favored 'General case' 0 C--N 1.343 0.305 0 C-N-CA 124.687 1.195 . . . . 0.0 111.96 -178.163 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 9.6 pttt -68.43 -19.34 64.58 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 175.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -100.2 -12.67 19.37 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.144 0.978 . . . . 0.0 112.79 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 153.14 -144.82 11.83 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 123.971 0.796 . . . . 0.0 111.722 -175.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 21.0 tptt -130.55 125.66 34.81 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.375 1.47 . . . . 0.0 109.082 178.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.66 HD11 ' HB2' ' A' ' 42' ' ' PHE . 4.2 mp -72.94 141.39 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 123.376 0.67 . . . . 0.0 109.802 173.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.6 t -114.51 -28.99 6.99 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 125.453 1.501 . . . . 0.0 113.235 178.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 24.1 m-80 -132.56 136.09 46.37 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 119.071 0.851 . . . . 0.0 109.338 -176.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -152.03 122.45 7.3 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.706 1.602 . . . . 0.0 112.195 -176.019 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -139.74 136.17 33.89 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.97 1.308 . . . . 0.0 111.084 -178.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -119.96 76.02 21.73 Favored Pre-proline 0 N--CA 1.47 0.569 0 C-N-CA 124.715 1.206 . . . . 0.0 109.453 -175.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -68.17 141.52 52.64 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.582 2.188 . . . . 0.0 111.531 -174.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -117.24 168.66 10.11 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.652 1.581 . . . . 0.0 111.512 -177.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -113.18 117.17 31.17 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 125.168 1.387 . . . . 0.0 109.397 179.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 51.45 24.26 2.13 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.034 1.333 . . . . 0.0 114.479 -177.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 79.84 17.77 74.25 Favored Glycine 0 CA--C 1.542 1.763 0 O-C-N 121.101 -1.0 . . . . 0.0 113.758 -176.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 5.4 mtpp -112.83 -178.04 3.29 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 127.647 2.379 . . . . 0.0 110.098 -176.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.451 HG22 ' HB3' ' A' ' 25' ' ' GLN . 82.3 p -49.33 114.5 1.04 Allowed 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.496 1.119 . . . . 0.0 111.158 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.9 170.5 0.42 Allowed 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.293 1.037 . . . . 0.0 113.571 171.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -133.71 -8.97 2.08 Favored Glycine 0 CA--C 1.529 0.935 0 CA-C-O 117.87 -1.517 . . . . 0.0 114.52 173.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -143.43 161.73 37.64 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 119.939 1.87 . . . . 0.0 109.98 175.323 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.784 HG23 HG11 ' A' ' 23' ' ' VAL . 1.1 pp -124.41 161.2 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 C-N-CA 125.533 1.533 . . . . 0.0 111.224 169.477 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -134.01 119.01 18.46 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.053 1.741 . . . . 0.0 110.358 179.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -123.69 147.09 47.75 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.589 1.555 . . . . 0.0 110.293 177.344 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -131.51 135.95 47.49 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 122.486 1.136 . . . . 0.0 110.271 175.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -96.33 163.76 12.94 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 122.536 1.16 . . . . 0.0 111.587 175.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.28 -8.92 57.95 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.521 1.128 . . . . 0.0 113.001 177.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -153.66 152.1 26.52 Favored Pre-proline 0 CA--C 1.542 0.663 0 C-N-CA 125.759 1.624 . . . . 0.0 113.127 -177.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -63.7 -45.41 11.13 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 123.927 3.085 . . . . 0.0 111.258 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -53.83 -21.56 7.79 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.064 1.745 . . . . 0.0 113.505 177.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 21.8 m170 -84.38 -49.04 9.06 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 119.465 1.03 . . . . 0.0 110.229 175.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -60.14 -55.21 36.7 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.584 1.154 . . . . 0.0 111.689 177.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 15.2 m -60.76 -31.42 49.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 123.831 0.852 . . . . 0.0 111.892 -176.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -76.06 -55.46 5.57 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.587 1.155 . . . . 0.0 110.854 174.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -53.24 -42.88 66.87 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.639 1.176 . . . . 0.0 112.641 -177.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.445 HG23 HG22 ' A' ' 18' ' ' ILE . 50.2 t -55.62 -48.64 77.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 C-N-CA 123.861 0.865 . . . . 0.0 111.504 175.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -76.48 2.82 12.69 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 126.635 1.974 . . . . 0.0 114.368 178.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -117.53 -45.91 2.69 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.685 0.794 . . . . 0.0 112.337 177.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -93.74 23.0 5.03 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.066 0.946 . . . . 0.0 113.204 -178.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -49.11 80.95 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 127.941 2.496 . . . . 0.0 113.785 178.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 84.75 106.24 0.63 Allowed Glycine 0 CA--C 1.533 1.193 0 C-N-CA 125.641 1.591 . . . . 0.0 111.796 -179.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -67.95 161.28 26.86 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 121.65 -0.912 . . . . 0.0 111.985 176.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.845 0 C-N-CA 124.943 1.297 . . . . 0.0 113.995 -170.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 . . . . . 0 CA--C 1.537 0.477 0 CA-C-O 120.827 0.346 . . . . 0.0 111.579 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 38.2 mmm-85 -135.73 88.13 2.38 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.774 0.83 . . . . 0.0 112.639 -178.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.465 HG22 HG22 ' A' ' 20' ' ' VAL . 24.2 t -75.74 116.21 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 124.12 0.968 . . . . 0.0 110.96 178.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 44.3 m-80 . . . . . 0 CA--C 1.549 0.92 0 C-N-CA 125.122 1.369 . . . . 0.0 111.392 -179.872 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . 0.301 5.4 p-10 . . . . . 0 N--CA 1.478 0.935 0 N-CA-C 116.639 2.089 . . . . 0.0 116.639 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -124.38 7.05 8.36 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 127.209 2.204 . . . . 0.0 113.93 -170.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.4 m -132.04 166.02 30.27 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 O-C-N 120.576 -1.328 . . . . 0.0 113.469 -171.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.63 HG22 HG23 ' A' ' 78' ' ' VAL . 16.0 pt -136.23 153.66 31.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 C-N-CA 124.498 1.119 . . . . 0.0 110.84 178.21 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 73.7 t -137.7 151.37 25.89 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.227 0 C-N-CA 125.957 1.703 . . . . 0.0 108.672 175.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -131.08 154.32 40.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 C-N-CA 124.73 1.212 . . . . 0.0 108.481 177.351 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -127.69 169.55 13.68 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.662 1.585 . . . . 0.0 110.719 176.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 13.8 m-20 59.08 29.82 19.47 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 126.284 1.834 . . . . 0.0 114.393 -174.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . 0.265 6.9 p -100.59 84.98 0.5 Allowed Pre-proline 0 N--CA 1.481 1.096 0 C-N-CA 125.156 1.382 . . . . 0.0 112.113 -177.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -69.45 160.08 51.18 Favored 'Trans proline' 0 C--N 1.354 0.864 0 C-N-CA 122.235 1.956 . . . . 0.0 111.345 175.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.56 ' HB3' HG22 ' A' ' 60' ' ' THR . 0.0 OUTLIER -78.5 168.1 20.3 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.649 170.763 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.405 HG21 ' HG2' ' A' ' 30' ' ' ARG . 30.9 m -140.25 168.42 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 125.743 1.617 . . . . 0.0 110.119 -175.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -76.85 -173.37 37.88 Favored Glycine 0 CA--C 1.544 1.891 0 C-N-CA 123.722 0.677 . . . . 0.0 114.244 178.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.539 ' HA ' HD22 ' A' ' 31' ' ' LEU . 67.0 Cg_endo -61.54 172.05 3.88 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 123.307 2.672 . . . . 0.0 111.406 177.486 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 62.17 6.24 1.75 Allowed 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 126.116 1.766 . . . . 0.0 114.353 -178.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.405 ' HG2' HG21 ' A' ' 26' ' ' VAL . 2.1 ttt85 -151.58 -25.82 0.19 Allowed 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 126.985 2.114 . . . . 0.0 114.184 -177.199 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.539 HD22 ' HA ' ' A' ' 28' ' ' PRO . 1.8 pt? -49.69 -36.24 24.48 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 114.97 1.47 . . . . 0.0 114.97 175.011 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -64.7 -54.23 34.79 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 125.019 1.327 . . . . 0.0 108.747 178.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.9 -38.88 17.42 Favored 'General case' 0 C--O 1.219 -0.545 0 C-N-CA 127.344 2.258 . . . . 0.0 110.705 174.221 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -48.99 -55.52 11.68 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 119.744 1.156 . . . . 0.0 112.309 177.199 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.2 tmtt? -84.62 -27.29 27.3 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.753 0.821 . . . . 0.0 112.499 175.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -63.84 -53.65 47.34 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 117.286 -1.34 . . . . 0.0 111.597 176.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 30.2 m -52.32 -32.22 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 125.36 1.464 . . . . 0.0 112.768 -177.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.2 mp -50.58 -51.82 18.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 C-N-CA 124.482 1.113 . . . . 0.0 110.685 169.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 33.4 m-70 -64.67 -40.89 96.21 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 119.658 1.117 . . . . 0.0 112.098 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.403 ' HD3' ' H ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -67.39 -51.23 54.54 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.044 0.938 . . . . 0.0 111.087 179.699 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -61.4 -43.95 97.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-N 118.552 0.614 . . . . 0.0 111.154 179.069 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.486 ' HB2' HD11 ' A' ' 48' ' ' ILE . 37.8 m-85 -82.47 -6.36 59.26 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -176.1 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.57 -29.66 70.88 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.053 1.341 . . . . 0.0 113.337 177.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.4 pttm -65.95 -23.07 66.53 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 119.709 1.14 . . . . 0.0 112.952 177.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -96.97 -10.09 26.97 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.501 1.12 . . . . 0.0 113.069 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 149.46 -137.8 6.46 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 124.309 0.957 . . . . 0.0 112.623 -178.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.9 tppt? -135.83 137.8 41.88 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 124.655 1.182 . . . . 0.0 109.105 177.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.486 HD11 ' HB2' ' A' ' 42' ' ' PHE . 2.5 mp -95.53 128.13 46.97 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 C-N-CA 124.171 0.988 . . . . 0.0 108.717 179.175 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.9 t -96.17 -29.19 14.19 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.798 1.239 . . . . 0.0 113.911 178.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 47.2 m-80 -112.13 158.03 20.12 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.468 1.107 . . . . 0.0 111.562 178.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -163.16 125.33 2.57 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.761 0.824 . . . . 0.0 111.249 173.247 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -134.55 126.78 30.0 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 123.704 0.802 . . . . 0.0 111.843 -178.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.408 ' CE2' HG21 ' A' ' 64' ' ' ILE . 15.8 m-85 -120.5 86.48 39.53 Favored Pre-proline 0 CA--C 1.542 0.641 0 C-N-CA 127.266 2.226 . . . . 0.0 108.909 -177.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -70.26 173.1 11.91 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 123.129 2.552 . . . . 0.0 111.033 175.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -145.41 172.89 12.54 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.55 1.54 . . . . 0.0 111.24 175.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -113.71 109.56 18.77 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 125.488 1.515 . . . . 0.0 109.276 177.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 22.2 t0 53.07 26.53 4.93 Favored 'General case' 0 CA--C 1.552 1.033 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 178.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 82.52 12.41 80.36 Favored Glycine 0 CA--C 1.537 1.463 0 O-C-N 120.998 -1.064 . . . . 0.0 113.957 -175.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 29.6 mtpt -112.17 -179.74 3.77 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 127.4 2.28 . . . . 0.0 110.148 -178.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.56 HG22 ' HB3' ' A' ' 25' ' ' GLN . 39.2 p -54.29 119.02 4.59 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.927 1.691 . . . . 0.0 113.517 -174.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.8 pttt -67.6 178.3 1.7 Allowed 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.399 1.08 . . . . 0.0 113.417 175.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -139.36 -4.82 1.4 Allowed Glycine 0 CA--C 1.537 1.415 0 C-N-CA 125.502 1.525 . . . . 0.0 115.561 172.039 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -145.88 156.17 43.37 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 119.444 1.622 . . . . 0.0 109.647 -174.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.408 HG21 ' CE2' ' A' ' 53' ' ' TYR . 1.1 pp -138.62 166.59 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 C-N-CA 125.674 1.59 . . . . 0.0 110.851 173.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 29.1 t80 -136.75 129.71 30.9 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.549 1.14 . . . . 0.0 110.114 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.426 ' CD2' HG21 ' A' ' 48' ' ' ILE . 0.8 OUTLIER -131.94 146.56 52.17 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.791 1.636 . . . . 0.0 110.284 179.5 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -132.87 127.21 33.91 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.846 1.258 . . . . 0.0 110.577 177.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -86.87 168.16 13.68 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.826 0.851 . . . . 0.0 111.73 175.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -74.07 -5.71 43.19 Favored 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 124.42 1.088 . . . . 0.0 113.539 173.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -161.57 153.21 15.95 Favored Pre-proline 0 N--CA 1.473 0.703 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 -171.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -67.45 -48.27 1.73 Allowed 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 123.224 2.616 . . . . 0.0 111.072 -173.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -53.45 -18.24 2.56 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.373 1.869 . . . . 0.0 114.244 176.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 20.6 m170 -85.8 -48.32 8.9 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 119.49 1.041 . . . . 0.0 110.348 175.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -65.06 -54.42 30.47 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.482 1.113 . . . . 0.0 112.826 176.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 12.9 m -57.66 -35.29 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 123.131 0.572 . . . . 0.0 111.344 -177.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -66.92 -63.84 0.98 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 126.046 1.739 . . . . 0.0 110.045 170.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -50.02 -41.03 46.5 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.892 1.277 . . . . 0.0 114.308 -176.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.63 HG23 HG22 ' A' ' 18' ' ' ILE . 40.4 t -56.21 -50.46 70.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 123.548 0.739 . . . . 0.0 111.854 173.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 11.4 tmtt? -82.87 -4.93 58.72 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.501 1.92 . . . . 0.0 112.599 -177.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -112.75 -19.78 11.89 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.558 1.543 . . . . 0.0 113.901 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -118.65 18.75 13.39 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 120.756 1.617 . . . . 0.0 113.22 177.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -54.96 85.19 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 126.222 1.809 . . . . 0.0 112.773 178.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 96.46 91.26 1.82 Allowed Glycine 0 C--N 1.338 0.662 0 C-N-CA 125.0 1.286 . . . . 0.0 112.9 174.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -66.55 147.47 53.24 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.477 0.893 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 178.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 . . . . . 0 N--CA 1.465 0.309 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 2.8 mmm180 -136.35 96.03 3.29 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.754 0.822 . . . . 0.0 110.179 -179.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 39.1 t -85.15 119.36 33.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 57.5 m-80 . . . . . 0 CA--C 1.54 0.56 0 C-N-CA 125.148 1.379 . . . . 0.0 110.269 178.254 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . 0.258 3.8 p30 . . . . . 0 CA--C 1.549 0.93 0 N-CA-C 117.668 2.47 . . . . 0.0 117.668 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.3 m -114.73 2.38 14.42 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 129.335 3.054 . . . . 0.0 113.034 -175.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.0 m -136.53 168.39 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 O-C-N 121.471 -0.768 . . . . 0.0 111.517 -174.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.552 HG22 HG23 ' A' ' 78' ' ' VAL . 21.0 pt -134.31 155.12 38.71 Favored 'Isoleucine or valine' 0 C--O 1.24 0.572 0 CA-C-O 121.797 0.808 . . . . 0.0 111.478 176.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 29.6 t -137.84 154.07 28.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 125.962 1.705 . . . . 0.0 109.036 177.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -131.69 156.33 42.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 C-N-CA 125.116 1.366 . . . . 0.0 109.05 177.38 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -128.94 165.87 20.24 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 124.338 1.055 . . . . 0.0 110.077 175.625 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 19.4 m-20 58.56 35.99 24.91 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 126.333 1.853 . . . . 0.0 113.776 -174.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.3 p -102.74 83.91 0.59 Allowed Pre-proline 0 N--CA 1.48 1.044 0 C-N-CA 124.886 1.275 . . . . 0.0 112.287 178.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -68.92 155.72 67.64 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 122.675 2.25 . . . . 0.0 111.774 175.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.413 ' HB3' HG22 ' A' ' 60' ' ' THR . 8.9 tt0 -76.67 166.75 22.95 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.355 170.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.436 HG21 ' HG2' ' A' ' 30' ' ' ARG . 27.8 m -135.64 166.36 27.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 C-N-CA 126.61 1.964 . . . . 0.0 109.687 -177.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -75.77 -171.08 30.23 Favored Glycine 0 CA--C 1.539 1.594 0 C-N-CA 123.267 0.461 . . . . 0.0 114.097 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.542 ' HA ' HD22 ' A' ' 31' ' ' LEU . 59.5 Cg_endo -63.67 169.03 10.62 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 123.549 2.833 . . . . 0.0 111.692 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.1 t0 62.12 11.39 4.31 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.295 1.038 . . . . 0.0 113.12 -178.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.436 ' HG2' HG21 ' A' ' 26' ' ' VAL . 5.7 ttt180 -153.64 -28.34 0.13 Allowed 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 126.362 1.865 . . . . 0.0 113.426 -178.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.542 HD22 ' HA ' ' A' ' 28' ' ' PRO . 1.7 pt? -51.33 -33.17 28.1 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 177.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -66.86 -47.54 71.6 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 125.019 1.327 . . . . 0.0 109.696 178.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 8.5 mmtm -52.9 -36.06 58.92 Favored 'General case' 0 C--O 1.218 -0.563 0 C-N-CA 125.381 1.472 . . . . 0.0 110.235 176.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.9 tp -48.31 -49.48 33.81 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.875 1.27 . . . . 0.0 113.086 178.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.27 -28.71 17.6 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.955 0.902 . . . . 0.0 112.37 175.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -59.42 -57.54 12.55 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 118.289 -0.862 . . . . 0.0 111.534 174.016 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 17.9 m -51.4 -36.83 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 125.049 1.34 . . . . 0.0 110.998 -179.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.1 mp -54.43 -47.88 69.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 124.603 1.161 . . . . 0.0 110.681 173.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.448 ' HA ' HD13 ' A' ' 48' ' ' ILE . 20.8 m-70 -65.36 -31.04 71.95 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 118.16 -0.924 . . . . 0.0 113.079 178.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.19 -49.75 9.14 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 118.865 0.757 . . . . 0.0 112.025 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -56.76 -37.88 55.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 CA-C-N 118.832 0.742 . . . . 0.0 112.4 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.551 ' HB2' HD11 ' A' ' 48' ' ' ILE . 41.8 m-85 -91.16 0.76 57.47 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -178.632 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.9 t -70.12 -37.72 75.4 Favored 'General case' 0 C--N 1.342 0.265 0 C-N-CA 125.957 1.703 . . . . 0.0 111.569 178.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.57 -24.54 63.83 Favored 'General case' 0 N--CA 1.478 0.951 0 O-C-N 121.047 -1.033 . . . . 0.0 112.856 179.188 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -92.37 -7.22 48.39 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.443 1.097 . . . . 0.0 112.795 177.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 139.52 -144.93 15.83 Favored Glycine 0 CA--C 1.537 1.423 0 C-N-CA 124.92 1.247 . . . . 0.0 112.876 -177.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 13.9 tptt -120.63 138.2 54.04 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 120.781 -1.423 . . . . 0.0 111.193 175.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.551 HD11 ' HB2' ' A' ' 42' ' ' PHE . 2.7 mp -90.75 135.83 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 124.085 0.954 . . . . 0.0 109.253 174.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.9 t -108.02 -16.66 14.23 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 116.603 -1.665 . . . . 0.0 114.837 178.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 52.2 m-80 -125.9 157.33 37.97 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 120.385 1.448 . . . . 0.0 111.137 176.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -165.1 115.68 1.12 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.263 0.625 . . . . 0.0 112.499 -177.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 51.4 m-85 -131.43 129.25 41.0 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 121.894 0.854 . . . . 0.0 111.792 -179.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -120.38 86.42 38.8 Favored Pre-proline 0 CA--C 1.539 0.552 0 C-N-CA 126.148 1.779 . . . . 0.0 108.914 -178.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -69.79 173.73 10.57 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 122.692 2.262 . . . . 0.0 111.196 177.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -144.59 173.75 11.54 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.285 1.434 . . . . 0.0 111.583 175.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -115.4 107.91 15.83 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 124.453 1.101 . . . . 0.0 110.65 177.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 19.0 t70 55.48 24.46 6.83 Favored 'General case' 0 CA--C 1.549 0.917 0 N-CA-C 113.777 1.028 . . . . 0.0 113.777 -178.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 85.5 11.3 75.16 Favored Glycine 0 CA--C 1.539 1.563 0 CA-C-O 118.815 -0.992 . . . . 0.0 113.284 -174.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 30.1 mtpt -114.09 171.31 7.68 Favored 'General case' 0 C--N 1.345 0.398 0 C-N-CA 126.788 2.035 . . . . 0.0 110.763 -178.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.413 HG22 ' HB3' ' A' ' 25' ' ' GLN . 70.8 p -44.98 116.84 1.17 Allowed 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 126.954 2.102 . . . . 0.0 112.387 -176.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 3.7 pttt -67.78 178.02 1.87 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 126.601 1.96 . . . . 0.0 112.743 174.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -139.99 -1.77 1.74 Allowed Glycine 0 CA--C 1.542 1.739 0 C-N-CA 125.875 1.702 . . . . 0.0 115.317 174.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -148.4 151.66 35.66 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 126.622 1.969 . . . . 0.0 109.14 -173.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -135.44 164.61 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 125.714 1.605 . . . . 0.0 110.907 174.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -134.98 125.27 26.28 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.208 1.003 . . . . 0.0 109.686 -178.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -129.82 139.88 51.13 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.283 1.433 . . . . 0.0 110.453 -179.399 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -128.62 124.72 36.52 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.218 0.607 . . . . 0.0 110.584 -179.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -88.23 173.86 8.54 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 122.072 0.939 . . . . 0.0 111.53 178.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -84.38 -0.84 54.2 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.661 0.784 . . . . 0.0 113.031 176.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.2 p -158.2 161.26 29.02 Favored Pre-proline 0 CA--C 1.541 0.63 0 CA-C-N 120.037 1.29 . . . . 0.0 112.88 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -68.05 -49.86 0.92 Allowed 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 123.086 2.524 . . . . 0.0 111.276 176.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -51.88 -30.17 22.85 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.764 1.226 . . . . 0.0 112.602 178.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -74.11 -47.11 38.45 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.19 0.996 . . . . 0.0 112.112 176.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -64.71 -54.34 33.14 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.772 1.229 . . . . 0.0 112.195 176.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 10.3 m -59.41 -35.95 61.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 122.881 0.473 . . . . 0.0 111.486 -177.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -66.05 -56.47 11.38 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 118.415 -0.802 . . . . 0.0 111.174 172.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.97 -43.99 63.81 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 119.274 0.943 . . . . 0.0 112.681 -177.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.552 HG23 HG22 ' A' ' 18' ' ' ILE . 79.5 t -59.65 -33.0 50.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 175.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.75 6.87 46.94 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.052 1.341 . . . . 0.0 112.039 -179.2 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 8.2 m-80 -125.94 -28.33 3.2 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 179.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -114.62 23.02 13.06 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.597 0.759 . . . . 0.0 112.15 -176.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -59.91 54.95 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 130.609 3.564 . . . . 0.0 115.771 -178.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 124.91 82.82 0.52 Allowed Glycine 0 CA--C 1.533 1.172 0 C-N-CA 125.182 1.372 . . . . 0.0 113.125 174.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -58.01 148.03 27.46 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.921 1.688 . . . . 0.0 113.865 -176.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.84 0 O-C-N 120.546 -1.346 . . . . 0.0 113.797 -177.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 . . . . . 0 N--CA 1.466 0.34 0 CA-C-O 120.743 0.306 . . . . 0.0 110.754 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 5.3 mmm180 -136.25 84.99 2.12 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.704 0.802 . . . . 0.0 111.932 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 27.4 t -72.94 121.78 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 122.772 0.429 . . . . 0.0 109.888 177.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 58.0 m-80 . . . . . 0 CA--C 1.545 0.772 0 C-N-CA 125.834 1.653 . . . . 0.0 111.09 -179.838 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 . . . . . 0 N--CA 1.477 0.924 0 N-CA-C 115.669 1.729 . . . . 0.0 115.669 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.3 m -121.42 5.63 10.16 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 126.683 1.993 . . . . 0.0 113.676 -177.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.1 m -139.55 165.27 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 C-N-CA 124.342 1.057 . . . . 0.0 111.684 -172.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.59 HG22 HG23 ' A' ' 78' ' ' VAL . 22.7 pt -132.17 154.56 40.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-O 122.215 1.007 . . . . 0.0 110.497 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 60.9 t -139.96 144.74 27.6 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.482 0 C-N-CA 125.318 1.447 . . . . 0.0 108.764 178.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -124.96 152.66 31.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 124.756 1.223 . . . . 0.0 108.807 178.404 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -127.07 164.06 22.39 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.362 1.465 . . . . 0.0 110.41 178.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 30.5 m-20 60.24 35.26 20.9 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 126.471 1.908 . . . . 0.0 113.101 -175.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . 0.261 7.3 p -104.14 81.92 0.55 Allowed Pre-proline 0 N--CA 1.479 0.989 0 C-N-CA 125.966 1.707 . . . . 0.0 111.589 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_endo -69.96 158.36 56.96 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 122.044 1.83 . . . . 0.0 111.152 175.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.89 170.08 14.46 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 121.611 -0.681 . . . . 0.0 111.72 167.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.436 HG21 ' HG2' ' A' ' 30' ' ' ARG . 30.9 m -138.57 167.65 20.88 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 126.81 2.044 . . . . 0.0 109.719 176.097 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -71.48 -175.81 23.42 Favored Glycine 0 CA--C 1.544 1.882 0 C-N-CA 124.733 1.158 . . . . 0.0 114.578 178.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.549 ' HA ' HD22 ' A' ' 31' ' ' LEU . 64.9 Cg_endo -62.2 168.32 9.51 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 123.595 2.863 . . . . 0.0 111.043 179.027 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 13.5 t70 62.66 7.14 2.34 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 125.151 1.381 . . . . 0.0 113.926 -178.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.436 ' HG2' HG21 ' A' ' 26' ' ' VAL . 6.1 ttt180 -148.25 -29.38 0.31 Allowed 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 127.203 2.201 . . . . 0.0 114.136 -178.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.549 HD22 ' HA ' ' A' ' 28' ' ' PRO . 1.6 pt? -51.29 -32.62 25.47 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 177.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -67.81 -49.04 64.45 Favored 'General case' 0 C--O 1.231 0.1 0 C-N-CA 125.639 1.576 . . . . 0.0 109.356 179.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -45.11 -41.27 7.72 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 127.37 2.268 . . . . 0.0 110.5 174.024 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -47.53 -56.21 7.57 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.067 1.347 . . . . 0.0 112.422 178.093 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.17 -30.11 28.07 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.493 1.117 . . . . 0.0 112.163 176.11 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -60.88 -57.84 10.96 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 118.397 -0.811 . . . . 0.0 111.803 177.293 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 19.0 m -54.27 -36.96 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 124.899 1.28 . . . . 0.0 110.987 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.1 mp -47.85 -52.68 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 125.347 1.459 . . . . 0.0 109.971 170.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 19.9 m-70 -63.83 -39.31 93.93 Favored 'General case' 0 N--CA 1.466 0.331 0 O-C-N 121.211 -0.93 . . . . 0.0 111.892 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.48 -51.02 39.9 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 119.062 0.846 . . . . 0.0 111.609 179.272 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -60.04 -42.34 89.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 CA-C-N 118.528 0.604 . . . . 0.0 111.785 179.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.589 ' HB2' HD11 ' A' ' 48' ' ' ILE . 33.6 m-85 -86.07 -2.94 58.79 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -175.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.73 -27.27 63.84 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.754 1.222 . . . . 0.0 112.97 178.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.32 -24.16 65.71 Favored 'General case' 0 N--CA 1.484 1.262 0 O-C-N 120.661 -1.274 . . . . 0.0 113.178 177.298 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -92.65 -16.02 26.09 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.437 1.095 . . . . 0.0 113.125 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 155.38 -147.82 17.25 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 124.505 1.05 . . . . 0.0 112.51 -174.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 23.4 tptt -128.64 124.17 35.11 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.93 1.292 . . . . 0.0 109.938 177.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.589 HD11 ' HB2' ' A' ' 42' ' ' PHE . 3.6 mp -71.8 135.02 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 123.801 0.84 . . . . 0.0 109.897 175.094 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.3 t -111.54 -25.61 9.49 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.611 1.564 . . . . 0.0 113.462 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 28.5 m-80 -129.97 138.68 50.97 Favored 'General case' 0 C--N 1.339 0.117 0 C-N-CA 125.108 1.363 . . . . 0.0 110.31 -178.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -152.7 121.15 6.35 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.554 1.142 . . . . 0.0 111.657 -176.147 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -134.37 132.07 39.0 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.519 1.128 . . . . 0.0 111.338 -178.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -121.02 83.48 37.93 Favored Pre-proline 0 CA--C 1.542 0.644 0 C-N-CA 126.3 1.84 . . . . 0.0 108.728 -177.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -68.69 168.36 20.27 Favored 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 122.995 2.463 . . . . 0.0 111.096 178.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -144.7 172.72 12.6 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.434 1.493 . . . . 0.0 111.357 177.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -114.12 108.93 17.65 Favored 'General case' 0 C--O 1.221 -0.411 0 C-N-CA 125.753 1.621 . . . . 0.0 109.803 178.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.1 t70 54.44 29.12 10.55 Favored 'General case' 0 CA--C 1.555 1.161 0 C-N-CA 124.424 1.09 . . . . 0.0 113.065 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 76.84 12.61 84.4 Favored Glycine 0 CA--C 1.537 1.468 0 O-C-N 120.748 -1.22 . . . . 0.0 114.205 -174.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 26.2 mtpt -109.2 180.0 4.0 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 127.008 2.123 . . . . 0.0 109.949 -178.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 20.5 p -53.02 117.09 2.73 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 127.072 2.149 . . . . 0.0 112.651 -173.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.9 pttt -68.64 176.42 2.97 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.139 0.976 . . . . 0.0 113.387 170.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -140.61 -0.35 1.81 Allowed Glycine 0 CA--C 1.54 1.631 0 C-N-CA 126.908 2.194 . . . . 0.0 115.48 171.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -146.8 154.08 40.94 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 119.586 1.693 . . . . 0.0 108.875 -174.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -136.6 165.18 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 125.535 1.534 . . . . 0.0 111.063 173.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 19.3 t80 -132.27 123.67 27.38 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.479 1.112 . . . . 0.0 109.385 -179.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -126.46 137.97 53.46 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.867 1.667 . . . . 0.0 109.862 179.055 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -125.12 134.08 52.59 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 122.133 0.968 . . . . 0.0 109.744 176.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -94.53 164.55 12.94 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 122.202 1.001 . . . . 0.0 111.44 175.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -76.23 -4.9 44.37 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.667 1.187 . . . . 0.0 112.699 175.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -153.4 151.51 25.74 Favored Pre-proline 0 CA--C 1.546 0.81 0 O-C-N 121.052 -1.03 . . . . 0.0 111.874 -176.165 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -63.54 -47.05 8.07 Favored 'Trans proline' 0 C--N 1.355 0.88 0 C-N-CA 123.542 2.828 . . . . 0.0 111.096 177.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -55.19 -16.83 3.52 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.428 1.891 . . . . 0.0 113.938 178.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 14.5 m-70 -86.93 -48.53 8.07 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 119.902 1.228 . . . . 0.0 111.263 173.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -61.87 -56.86 14.94 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.387 1.075 . . . . 0.0 111.882 176.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 11.3 m -61.35 -26.68 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 123.331 0.652 . . . . 0.0 112.016 -177.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -77.64 -56.19 4.73 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.531 1.133 . . . . 0.0 110.641 172.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.64 -44.25 62.89 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.609 1.164 . . . . 0.0 112.881 -177.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.59 HG23 HG22 ' A' ' 18' ' ' ILE . 54.4 t -56.84 -37.72 55.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 123.897 0.879 . . . . 0.0 113.071 175.024 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.2 mttm -89.83 4.22 50.5 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 126.102 1.761 . . . . 0.0 113.445 179.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -121.36 -32.97 3.76 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 178.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -109.75 17.75 20.92 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.254 1.021 . . . . 0.0 113.294 -177.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -53.59 88.52 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.952 2.101 . . . . 0.0 112.306 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 89.66 106.31 1.17 Allowed Glycine 0 C--N 1.339 0.738 0 N-CA-C 110.736 -0.945 . . . . 0.0 110.736 -178.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.429 ' CD2' ' CZ2' ' B' ' 52' ' ' TRP . 10.8 m-85 -80.06 146.87 31.7 Favored 'General case' 0 CA--C 1.548 0.889 0 O-C-N 121.3 -1.118 . . . . 0.0 112.15 177.514 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 1.1 pttt -98.88 59.64 1.21 Allowed 'General case' 0 N--CA 1.483 1.179 0 O-C-N 120.644 -1.285 . . . . 0.0 114.111 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.14 -10.28 14.26 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 178.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 26.1 t70 55.84 65.27 1.5 Allowed 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 125.156 1.383 . . . . 0.0 112.896 -178.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -128.25 -76.26 0.56 Allowed 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 -177.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -146.14 -69.86 0.26 Allowed 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.296 1.438 . . . . 0.0 111.14 179.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 -116.01 146.69 41.94 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.007 1.323 . . . . 0.0 110.371 -177.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.54 162.74 28.91 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 124.328 1.051 . . . . 0.0 111.66 176.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -90.54 172.42 8.72 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 126.285 1.834 . . . . 0.0 110.163 176.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 27.0 mmm-85 -139.04 91.46 2.52 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.107 0.963 . . . . 0.0 110.99 -178.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 27.0 t -78.41 118.9 26.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 54.9 m-80 . . . . . 0 CA--C 1.545 0.753 0 C-N-CA 126.111 1.764 . . . . 0.0 111.04 178.801 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 24.2 t70 . . . . . 0 CA--C 1.537 0.461 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -112.1 -178.9 3.54 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.397 1.479 . . . . 0.0 111.14 -178.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 47' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -68.55 73.51 0.24 Allowed 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.491 1.516 . . . . 0.0 112.444 174.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 12.5 m -138.44 177.95 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 126.771 2.028 . . . . 0.0 110.974 173.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 2.5 ttmt -50.15 133.76 23.02 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 126.553 1.941 . . . . 0.0 110.075 172.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -68.31 57.34 0.08 Allowed 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 125.835 1.654 . . . . 0.0 111.933 173.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -73.29 47.91 0.22 Allowed 'General case' 0 CA--C 1.549 0.913 0 O-C-N 119.957 -1.714 . . . . 0.0 112.888 177.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 52' ' ' TRP . . . . . 0.429 ' CZ2' ' CD2' ' A' ' 84' ' ' TYR . 64.4 t-105 -154.62 27.74 0.44 Allowed 'General case' 0 CA--C 1.557 1.238 0 C-N-CA 125.068 1.347 . . . . 0.0 112.949 -178.151 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -168.36 94.52 0.37 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 119.834 -1.791 . . . . 0.0 113.395 177.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -71.47 117.3 12.85 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 121.469 -0.77 . . . . 0.0 110.871 -178.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 . . . . . 0 CA--C 1.541 0.617 0 C-N-CA 126.098 1.759 . . . . 0.0 112.643 -177.803 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 . . . . . 0 CA--C 1.546 0.808 0 N-CA-C 116.347 1.98 . . . . 0.0 116.347 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.9 t -125.81 9.3 7.58 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 126.673 1.989 . . . . 0.0 113.351 -175.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.9 m -141.99 165.46 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 124.125 0.97 . . . . 0.0 111.99 -174.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.563 HG22 HG23 ' A' ' 78' ' ' VAL . 21.1 pt -130.59 154.95 41.38 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 C-N-CA 124.206 1.003 . . . . 0.0 111.258 178.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 57.9 t -137.79 144.67 30.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 125.257 1.423 . . . . 0.0 109.266 176.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -125.66 150.03 30.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 123.948 0.899 . . . . 0.0 108.924 178.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -125.17 172.9 9.13 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.848 1.259 . . . . 0.0 110.405 178.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 54.08 32.55 15.89 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.634 1.574 . . . . 0.0 113.97 -174.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.3 p -103.73 81.09 0.44 Allowed Pre-proline 0 N--CA 1.475 0.807 0 C-N-CA 124.352 1.061 . . . . 0.0 111.202 -179.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -66.82 145.76 75.94 Favored 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 121.735 1.623 . . . . 0.0 111.368 176.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.71 163.63 13.59 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 120.82 0.343 . . . . 0.0 111.462 172.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 35.0 m -134.55 165.2 32.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 124.089 0.955 . . . . 0.0 110.822 -173.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -76.4 -171.3 32.67 Favored Glycine 0 CA--C 1.543 1.785 0 CA-C-O 121.417 0.454 . . . . 0.0 113.853 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.536 ' HA ' HD22 ' A' ' 31' ' ' LEU . 61.4 Cg_endo -64.17 168.05 13.24 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 123.032 2.488 . . . . 0.0 112.291 177.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 65.52 9.28 5.7 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.423 1.089 . . . . 0.0 112.341 -178.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 27.0 ttt180 -150.61 -29.64 0.2 Allowed 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.391 1.476 . . . . 0.0 113.902 -177.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.536 HD22 ' HA ' ' A' ' 28' ' ' PRO . 1.6 pt? -52.83 -30.45 33.55 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 178.15 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -69.49 -45.45 68.91 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 122.927 0.491 . . . . 0.0 110.708 177.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.47 -39.25 67.3 Favored 'General case' 0 C--O 1.215 -0.748 0 C-N-CA 125.877 1.671 . . . . 0.0 110.776 175.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -45.84 -54.31 8.31 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.871 1.269 . . . . 0.0 112.544 178.18 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.3 tmtt? -84.89 -27.38 26.68 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.096 0.958 . . . . 0.0 113.144 175.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -64.36 -56.01 17.26 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 117.942 -1.028 . . . . 0.0 112.629 174.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 32.8 m -52.84 -34.2 19.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-N 119.507 1.049 . . . . 0.0 111.38 -178.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.1 mp -49.54 -52.21 12.77 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 C-N-CA 124.707 1.203 . . . . 0.0 111.325 170.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.429 ' HA ' HD13 ' A' ' 48' ' ' ILE . 33.1 m-70 -66.59 -18.33 65.31 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 119.03 0.832 . . . . 0.0 113.082 177.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.73 -52.36 5.17 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 119.318 0.963 . . . . 0.0 111.351 178.083 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -59.09 -41.98 85.15 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-N 118.408 0.549 . . . . 0.0 111.874 177.102 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.608 ' HB2' HD11 ' A' ' 48' ' ' ILE . 46.9 m-85 -84.6 -3.03 58.27 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 112.794 0.664 . . . . 0.0 112.794 -178.121 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -67.17 -30.75 70.8 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 119.618 1.099 . . . . 0.0 113.909 177.171 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.481 ' HE3' ' CZ ' ' A' ' 45' ' ' PHE . 18.2 pttt -65.56 -23.01 66.75 Favored 'General case' 0 N--CA 1.48 1.039 0 O-C-N 120.74 -1.225 . . . . 0.0 112.853 179.128 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.481 ' CZ ' ' HE3' ' A' ' 44' ' ' LYS . 9.8 m-85 -92.49 -14.96 27.67 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.446 0.699 . . . . 0.0 112.826 -179.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 149.59 -146.26 15.33 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 124.034 0.826 . . . . 0.0 111.93 -173.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 19.0 tptt -129.61 126.61 38.85 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.271 1.028 . . . . 0.0 110.72 178.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.608 HD11 ' HB2' ' A' ' 42' ' ' PHE . 4.5 mp -72.2 138.56 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 123.701 0.8 . . . . 0.0 110.193 177.097 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.0 t -112.72 -22.95 10.46 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.819 1.247 . . . . 0.0 113.539 179.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 28.9 m-80 -135.08 134.13 40.0 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 119.487 1.039 . . . . 0.0 109.801 -176.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -147.98 124.58 11.08 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.253 1.021 . . . . 0.0 111.844 -176.428 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -135.84 130.95 34.72 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.255 1.022 . . . . 0.0 111.449 -177.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -122.46 85.85 48.28 Favored Pre-proline 0 CA--C 1.536 0.44 0 C-N-CA 125.68 1.592 . . . . 0.0 109.196 -175.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -70.66 169.71 19.4 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.6 2.2 . . . . 0.0 110.933 179.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -145.27 172.74 12.71 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.186 0.995 . . . . 0.0 111.688 175.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -112.39 109.9 19.8 Favored 'General case' 0 C--O 1.222 -0.369 0 C-N-CA 124.155 0.982 . . . . 0.0 110.611 177.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 17.7 t70 54.32 21.23 3.06 Favored 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 -179.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 85.86 13.39 69.6 Favored Glycine 0 CA--C 1.536 1.353 0 O-C-N 121.045 -1.034 . . . . 0.0 113.832 -174.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 10.2 mmtm -108.07 -179.94 4.04 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 127.039 2.136 . . . . 0.0 110.342 -178.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 79.9 p -58.84 115.58 3.19 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.235 1.414 . . . . 0.0 113.149 -176.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 3.2 pttt -64.17 174.85 1.43 Allowed 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.802 1.641 . . . . 0.0 114.508 172.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -136.31 -2.95 2.54 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 125.902 1.715 . . . . 0.0 115.314 174.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -145.36 154.81 42.7 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.945 1.698 . . . . 0.0 109.744 -175.325 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.1 pp -135.96 163.45 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 124.812 1.245 . . . . 0.0 110.205 172.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -130.4 125.38 34.4 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.568 1.147 . . . . 0.0 109.688 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -128.58 139.8 52.1 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 124.486 1.114 . . . . 0.0 109.993 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -125.59 134.28 51.99 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 121.898 0.856 . . . . 0.0 110.51 176.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -95.84 162.5 13.56 Favored 'General case' 0 CA--C 1.528 0.118 0 CA-C-O 122.185 0.993 . . . . 0.0 111.587 176.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.56 -1.83 26.26 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.24 1.016 . . . . 0.0 113.287 176.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -157.52 150.46 18.39 Favored Pre-proline 0 CA--C 1.541 0.612 0 C-N-CA 124.643 1.177 . . . . 0.0 111.877 -178.267 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -62.97 -44.37 16.17 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 123.41 2.74 . . . . 0.0 111.981 177.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -57.74 -20.99 38.63 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.844 1.258 . . . . 0.0 113.36 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 20.1 m-70 -82.05 -46.2 14.24 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 119.29 0.95 . . . . 0.0 111.735 173.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -66.44 -52.72 43.38 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.43 0.692 . . . . 0.0 112.387 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 11.3 m -61.32 -28.79 44.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 122.623 0.369 . . . . 0.0 111.861 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -75.54 -55.96 5.16 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.894 0.878 . . . . 0.0 111.155 173.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -52.85 -42.0 64.79 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.296 1.038 . . . . 0.0 112.772 -176.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.563 HG23 HG22 ' A' ' 18' ' ' ILE . 53.8 t -60.6 -35.77 65.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 123.859 0.863 . . . . 0.0 112.94 175.109 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 6.7 mttp -89.17 2.65 53.88 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.192 1.397 . . . . 0.0 113.241 178.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -123.83 -23.79 4.6 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 113.723 1.008 . . . . 0.0 113.723 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -114.63 18.7 16.54 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.531 1.132 . . . . 0.0 113.008 -177.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -61.8 74.5 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.964 2.106 . . . . 0.0 114.34 -177.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 105.72 78.85 1.22 Allowed Glycine 0 CA--C 1.527 0.793 0 C-N-CA 124.592 1.091 . . . . 0.0 113.107 174.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.403 ' HB3' ' HA ' ' B' ' 52' ' ' TRP . 11.0 m-85 -51.89 148.59 5.68 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.979 2.112 . . . . 0.0 113.226 179.426 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 7.2 mmmt -94.19 60.79 2.8 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 120.904 -1.122 . . . . 0.0 112.7 -171.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -39.91 -49.04 2.42 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 124.711 1.204 . . . . 0.0 112.901 -170.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -145.72 -66.49 0.3 Allowed 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 127.993 2.517 . . . . 0.0 109.268 169.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -159.27 -56.79 0.06 Allowed 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.647 0.779 . . . . 0.0 112.252 -178.207 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.41 -32.29 22.43 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.134 0.974 . . . . 0.0 112.894 -174.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -75.63 111.68 11.2 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.73 1.612 . . . . 0.0 109.864 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.9 m -127.13 149.51 49.92 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.248 1.019 . . . . 0.0 110.73 -177.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -114.62 176.54 5.0 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 124.982 1.313 . . . . 0.0 110.284 -174.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -135.0 95.97 3.42 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 122.999 0.52 . . . . 0.0 110.198 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 40.9 t -85.45 122.28 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 178.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 52.7 m-80 . . . . . 0 CA--C 1.542 0.653 0 C-N-CA 125.255 1.422 . . . . 0.0 110.715 -179.174 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 . . . . . 0 CA--C 1.535 0.366 0 CA-C-O 121.373 0.606 . . . . 0.0 111.769 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -80.57 64.15 5.26 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.836 0.854 . . . . 0.0 111.738 -179.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 47' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -123.41 -35.38 2.95 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 -178.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 15.8 m -110.11 -174.48 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 124.61 1.164 . . . . 0.0 110.806 178.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 11.1 mtpp -52.71 161.8 0.68 Allowed 'General case' 0 C--N 1.346 0.433 0 CA-C-O 122.101 0.953 . . . . 0.0 111.143 171.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -76.79 58.74 1.48 Allowed 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.685 1.194 . . . . 0.0 112.056 -172.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -61.33 6.86 0.05 OUTLIER 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 126.319 1.847 . . . . 0.0 114.519 176.165 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 52' ' ' TRP . . . . . 0.403 ' HA ' ' HB3' ' A' ' 84' ' ' TYR . 62.0 t-105 -138.83 17.52 2.67 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 125.375 1.47 . . . . 0.0 112.713 177.129 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -128.11 118.24 23.08 Favored 'General case' 0 N--CA 1.478 0.95 0 O-C-N 120.226 -1.546 . . . . 0.0 113.632 -177.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -50.08 139.39 14.28 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 122.313 1.054 . . . . 0.0 113.683 178.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.533 0.303 0 C-N-CA 125.805 1.642 . . . . 0.0 110.55 -177.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . 0.259 1.9 m-20 . . . . . 0 CA--C 1.546 0.807 0 N-CA-C 116.779 2.141 . . . . 0.0 116.779 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -124.09 5.79 8.57 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 126.758 2.023 . . . . 0.0 113.472 -177.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.0 m -137.2 165.65 27.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 124.015 0.926 . . . . 0.0 112.395 -173.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.604 HG22 HG23 ' A' ' 78' ' ' VAL . 17.5 pt -132.64 154.15 39.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 C-N-CA 124.526 1.13 . . . . 0.0 110.476 179.217 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 60.8 t -137.98 144.74 30.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 C-N-CA 125.676 1.59 . . . . 0.0 108.678 176.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -122.98 156.04 28.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 C-N-CA 123.56 0.744 . . . . 0.0 109.372 174.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -130.32 169.65 15.16 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.34 1.456 . . . . 0.0 110.677 176.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 31.2 m-20 56.12 34.02 23.06 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 126.38 1.872 . . . . 0.0 113.91 -174.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . 0.255 7.5 p -102.18 81.15 0.34 Allowed Pre-proline 0 N--CA 1.484 1.252 0 C-N-CA 124.92 1.288 . . . . 0.0 112.158 179.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -66.62 149.25 84.06 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 122.058 1.839 . . . . 0.0 110.961 174.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.422 ' HB3' HG22 ' A' ' 60' ' ' THR . 38.2 tt0 -67.72 163.74 20.92 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 121.634 0.731 . . . . 0.0 110.635 169.153 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.425 HG21 ' HG2' ' A' ' 30' ' ' ARG . 31.2 m -135.88 165.79 28.82 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 126.835 2.054 . . . . 0.0 109.482 -177.296 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -73.51 -172.54 24.83 Favored Glycine 0 CA--C 1.539 1.572 0 C-N-CA 123.833 0.73 . . . . 0.0 114.505 -178.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.578 ' HA ' HD22 ' A' ' 31' ' ' LEU . 66.3 Cg_endo -62.49 169.76 7.79 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 123.353 2.702 . . . . 0.0 111.256 178.291 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 42.9 m-20 60.24 8.42 1.55 Allowed 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 125.451 1.501 . . . . 0.0 114.316 -177.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.425 ' HG2' HG21 ' A' ' 26' ' ' VAL . 0.2 OUTLIER -148.31 -29.57 0.3 Allowed 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 126.046 1.739 . . . . 0.0 113.063 -179.56 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.578 HD22 ' HA ' ' A' ' 28' ' ' PRO . 1.7 pt? -51.36 -32.9 27.36 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 115.324 1.601 . . . . 0.0 115.324 177.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -68.59 -47.32 67.04 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.454 1.102 . . . . 0.0 109.502 179.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.4 mptt -51.08 -34.91 32.28 Favored 'General case' 0 C--O 1.219 -0.503 0 C-N-CA 126.601 1.96 . . . . 0.0 111.395 173.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 13.0 tp -51.99 -51.18 58.96 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 119.804 1.184 . . . . 0.0 113.134 177.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.8 tmtt? -83.35 -32.27 26.34 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.767 0.827 . . . . 0.0 112.79 172.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -60.84 -57.26 13.42 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 118.042 -0.98 . . . . 0.0 112.107 177.254 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 16.8 m -53.94 -37.91 35.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 CA-C-N 119.405 1.002 . . . . 0.0 111.257 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.2 mp -53.54 -45.27 58.76 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 124.525 1.13 . . . . 0.0 111.676 170.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.404 ' HA ' HD13 ' A' ' 48' ' ' ILE . 15.5 m-70 -65.51 -40.43 92.98 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 120.052 1.296 . . . . 0.0 112.623 176.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -74.29 -49.53 22.67 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 118.857 0.753 . . . . 0.0 112.647 -179.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -55.26 -42.68 67.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-N 118.759 0.709 . . . . 0.0 111.807 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.519 ' HB2' HD11 ' A' ' 48' ' ' ILE . 30.8 m-85 -83.19 -2.08 54.61 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 113.388 0.885 . . . . 0.0 113.388 -178.127 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.3 t -74.12 -25.29 59.69 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 179.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 17.5 pttt -66.55 -18.71 65.51 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 119.371 0.987 . . . . 0.0 113.005 174.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -101.51 -12.25 18.66 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.211 1.005 . . . . 0.0 113.16 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 156.27 -144.37 10.76 Favored Glycine 0 CA--C 1.529 0.957 0 CA-C-N 118.467 0.576 . . . . 0.0 112.525 -176.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 26.1 tptt -131.67 128.38 38.91 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.929 1.292 . . . . 0.0 108.766 175.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.519 HD11 ' HB2' ' A' ' 42' ' ' PHE . 2.0 mp -84.14 131.34 34.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 177.19 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.0 t -100.76 -31.74 11.04 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 178.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 51.1 m-80 -108.22 163.78 12.88 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 119.329 0.968 . . . . 0.0 112.171 178.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -170.05 116.74 0.54 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.306 1.042 . . . . 0.0 112.307 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -132.97 126.52 32.18 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 121.877 0.846 . . . . 0.0 111.591 -179.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -119.5 86.04 33.28 Favored Pre-proline 0 CA--C 1.542 0.656 0 C-N-CA 126.464 1.906 . . . . 0.0 108.32 -178.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -69.53 174.78 8.81 Favored 'Trans proline' 0 C--N 1.355 0.881 0 C-N-CA 123.346 2.697 . . . . 0.0 110.95 177.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -145.53 172.35 13.35 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.235 1.414 . . . . 0.0 111.494 176.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -113.58 110.85 20.9 Favored 'General case' 0 C--O 1.223 -0.324 0 C-N-CA 125.096 1.358 . . . . 0.0 110.24 175.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 54.24 21.19 2.97 Favored 'General case' 0 CA--C 1.554 1.131 0 N-CA-C 114.884 1.439 . . . . 0.0 114.884 179.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 86.33 17.1 61.23 Favored Glycine 0 CA--C 1.539 1.579 0 O-C-N 121.259 -0.9 . . . . 0.0 113.485 -173.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 27.7 mmmt -117.22 176.34 5.19 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 127.65 2.38 . . . . 0.0 110.091 -177.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.422 HG22 ' HB3' ' A' ' 25' ' ' GLN . 76.2 p -50.6 117.39 2.42 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 126.739 2.016 . . . . 0.0 112.86 -176.233 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -69.71 177.41 3.04 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.922 0.889 . . . . 0.0 112.769 175.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -138.98 -1.63 2.01 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 125.503 1.525 . . . . 0.0 115.254 173.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -146.93 155.27 42.15 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 119.627 1.713 . . . . 0.0 109.098 -174.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.1 pp -138.99 166.44 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 125.233 1.413 . . . . 0.0 110.424 173.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 26.7 t80 -135.43 126.91 28.66 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.141 0.976 . . . . 0.0 109.827 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -130.51 139.42 50.5 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.444 1.498 . . . . 0.0 110.186 179.216 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -127.3 125.81 41.5 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.858 1.263 . . . . 0.0 111.034 177.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -86.05 169.22 13.37 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 122.199 0.999 . . . . 0.0 111.769 176.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -77.51 -5.96 51.89 Favored 'General case' 0 CA--C 1.549 0.918 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 175.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -154.51 156.19 31.37 Favored Pre-proline 0 N--CA 1.473 0.721 0 C-N-CA 125.059 1.344 . . . . 0.0 112.83 -176.096 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -65.38 -48.67 3.13 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 123.646 2.897 . . . . 0.0 111.478 179.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -53.29 -18.32 2.36 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.387 1.875 . . . . 0.0 114.284 177.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 22.3 m170 -85.81 -48.29 8.92 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 119.146 0.884 . . . . 0.0 110.494 175.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -64.29 -54.7 29.09 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.892 1.277 . . . . 0.0 112.335 177.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 11.8 m -59.51 -31.73 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 123.034 0.533 . . . . 0.0 111.438 -177.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -73.28 -57.67 3.85 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.59 1.156 . . . . 0.0 111.286 172.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -50.22 -44.09 53.12 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.637 1.175 . . . . 0.0 113.595 -178.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.604 HG23 HG22 ' A' ' 18' ' ' ILE . 54.8 t -58.48 -43.03 85.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 174.126 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.0 -0.52 51.94 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.616 1.566 . . . . 0.0 112.852 -179.415 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -113.86 -44.68 3.15 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 124.189 0.996 . . . . 0.0 112.436 178.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -94.91 18.78 11.27 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 -178.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -56.87 83.21 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 126.271 1.828 . . . . 0.0 113.053 177.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 102.99 87.0 1.98 Allowed Glycine 0 CA--C 1.527 0.806 0 C-N-CA 124.852 1.215 . . . . 0.0 113.401 171.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -66.47 143.51 57.05 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 -176.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.26 49.12 1.37 Allowed 'General case' 0 N--CA 1.483 1.195 0 O-C-N 120.241 -1.537 . . . . 0.0 114.932 -176.215 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -58.85 -29.99 67.37 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.711 1.205 . . . . 0.0 113.915 -179.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 30.6 t70 67.56 91.84 0.08 Allowed 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 127.997 2.519 . . . . 0.0 113.671 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -149.28 -78.37 0.14 Allowed 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.383 1.073 . . . . 0.0 112.115 179.494 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -142.16 -69.14 0.36 Allowed 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 125.723 1.609 . . . . 0.0 110.384 -173.04 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 23.4 m80 -118.41 144.88 45.62 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 125.605 1.562 . . . . 0.0 110.4 177.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -73.34 166.74 22.61 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 125.11 1.364 . . . . 0.0 111.526 176.378 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -91.13 172.1 8.79 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 125.92 1.688 . . . . 0.0 110.151 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 15.8 mmm-85 -138.52 98.62 3.63 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.165 0.986 . . . . 0.0 109.603 -177.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 40.4 t -87.77 119.8 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 178.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 52.6 m-80 . . . . . 0 CA--C 1.545 0.765 0 C-N-CA 125.553 1.541 . . . . 0.0 110.852 -179.976 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 11.8 p30 . . . . . 0 CA--C 1.537 0.45 0 N-CA-C 115.039 1.496 . . . . 0.0 115.039 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 63.29 5.97 2.22 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 126.159 1.784 . . . . 0.0 114.486 -174.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 47' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -103.58 -63.05 1.22 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.59 1.156 . . . . 0.0 112.01 -175.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 35.0 m -97.8 -172.44 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 123.249 0.62 . . . . 0.0 111.013 -177.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.74 159.25 0.39 Allowed 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.418 1.087 . . . . 0.0 111.548 168.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -76.6 65.7 2.45 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-O 121.393 0.616 . . . . 0.0 112.197 -176.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -64.24 10.77 0.05 Allowed 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 126.036 1.734 . . . . 0.0 114.926 176.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 52' ' ' TRP . . . . . . . . . . . . . 58.4 t-105 -122.67 -50.89 1.95 Allowed 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 126.883 2.073 . . . . 0.0 110.65 176.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -146.94 127.24 13.91 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 122.613 2.461 . . . . 0.0 113.76 171.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -150.18 172.5 15.21 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.85 1.66 . . . . 0.0 108.771 -178.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 6.2 t0 . . . . . 0 CA--C 1.545 0.779 0 C-N-CA 125.549 1.539 . . . . 0.0 111.98 -175.583 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . 0.323 4.7 p-10 . . . . . 0 CA--C 1.553 1.077 0 N-CA-C 117.81 2.522 . . . . 0.0 117.81 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 50.6 m -115.33 4.1 14.35 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 129.424 3.09 . . . . 0.0 114.001 -174.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.2 m -137.75 161.74 32.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 125.098 1.359 . . . . 0.0 111.985 -172.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.546 HG22 HG23 ' A' ' 78' ' ' VAL . 19.1 pt -130.76 152.88 38.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 CA-C-O 122.338 1.066 . . . . 0.0 110.256 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 61.3 t -137.8 142.28 36.64 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.334 0 C-N-CA 125.482 1.513 . . . . 0.0 108.751 176.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -122.44 151.37 26.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 125.002 1.321 . . . . 0.0 108.679 178.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -127.65 167.3 16.61 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.204 1.402 . . . . 0.0 110.897 178.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 38.4 m-20 59.04 31.53 21.42 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 126.64 1.976 . . . . 0.0 114.212 -173.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . 0.254 7.6 p -102.01 81.29 0.34 Allowed Pre-proline 0 N--CA 1.479 1.011 0 C-N-CA 125.847 1.659 . . . . 0.0 111.835 -179.169 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -67.51 159.65 51.53 Favored 'Trans proline' 0 C--N 1.356 0.952 0 C-N-CA 122.004 1.803 . . . . 0.0 110.895 175.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -75.83 167.57 21.63 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.785 170.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.421 HG21 ' HG2' ' A' ' 30' ' ' ARG . 31.8 m -136.99 166.45 25.72 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 C-N-CA 126.521 1.928 . . . . 0.0 109.272 -177.33 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -75.78 -173.24 34.21 Favored Glycine 0 CA--C 1.539 1.59 0 C-N-CA 124.341 0.972 . . . . 0.0 114.523 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.548 ' HA ' HD22 ' A' ' 31' ' ' LEU . 68.2 Cg_endo -61.39 169.07 7.02 Favored 'Trans proline' 0 CA--C 1.536 0.614 0 C-N-CA 123.568 2.845 . . . . 0.0 111.019 177.607 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 61.69 9.6 2.91 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.843 1.657 . . . . 0.0 114.046 -178.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.421 ' HG2' HG21 ' A' ' 26' ' ' VAL . 43.4 ttt85 -150.66 -29.61 0.2 Allowed 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 127.031 2.132 . . . . 0.0 114.601 -178.229 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.548 HD22 ' HA ' ' A' ' 28' ' ' PRO . 1.7 pt? -51.7 -33.22 33.33 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 115.263 1.579 . . . . 0.0 115.263 177.117 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -66.29 -50.77 62.53 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 125.613 1.565 . . . . 0.0 109.315 178.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 5.8 mptt -49.76 -37.83 31.35 Favored 'General case' 0 C--N 1.345 0.408 0 C-N-CA 127.627 2.371 . . . . 0.0 110.379 175.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -47.36 -64.71 0.71 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.135 1.374 . . . . 0.0 111.361 177.047 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.91 -28.47 58.06 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.687 0.795 . . . . 0.0 112.472 176.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -60.33 -59.69 5.01 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 117.773 -1.108 . . . . 0.0 111.437 176.305 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 32.3 m -53.94 -33.78 24.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 125.1 1.36 . . . . 0.0 111.746 -177.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.2 mp -50.09 -48.49 23.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 124.381 1.072 . . . . 0.0 111.137 169.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.418 ' HA ' HD13 ' A' ' 48' ' ' ILE . 19.4 m-70 -67.55 -20.33 65.39 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 119.446 1.021 . . . . 0.0 113.544 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.28 -49.64 5.12 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.02 1.328 . . . . 0.0 111.498 -177.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -55.17 -43.87 72.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 124.581 1.152 . . . . 0.0 111.129 175.179 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.517 ' HB2' HD11 ' A' ' 48' ' ' ILE . 36.5 m-85 -87.22 -0.14 56.25 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 113.04 0.755 . . . . 0.0 113.04 -177.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -70.09 -35.29 74.07 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.094 1.358 . . . . 0.0 112.05 178.333 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.442 ' HE3' ' CZ ' ' A' ' 45' ' ' PHE . 20.7 pttt -61.82 -17.36 55.96 Favored 'General case' 0 N--CA 1.478 0.941 0 O-C-N 120.948 -1.095 . . . . 0.0 113.647 177.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.442 ' CZ ' ' HE3' ' A' ' 44' ' ' LYS . 9.2 m-85 -101.17 -10.99 19.91 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.881 1.272 . . . . 0.0 113.346 178.29 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 149.55 -149.31 21.24 Favored Glycine 0 CA--C 1.532 1.125 0 CA-C-N 119.182 0.901 . . . . 0.0 112.663 -174.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 21.3 tptt -127.47 124.64 38.86 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 124.405 1.082 . . . . 0.0 108.945 178.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.517 HD11 ' HB2' ' A' ' 42' ' ' PHE . 2.4 mp -79.61 130.37 36.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 123.672 0.789 . . . . 0.0 109.066 175.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 2.8 t -100.7 -30.62 11.63 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.754 1.222 . . . . 0.0 113.516 177.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 42.7 m-80 -113.15 154.11 27.18 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 119.647 1.112 . . . . 0.0 111.548 179.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -159.46 123.91 3.94 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.665 0.786 . . . . 0.0 110.759 176.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -134.83 129.81 35.07 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 123.678 0.791 . . . . 0.0 111.905 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -121.65 86.17 44.69 Favored Pre-proline 0 CA--C 1.538 0.508 0 C-N-CA 127.449 2.3 . . . . 0.0 108.442 -177.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -68.67 174.49 8.44 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 122.736 2.291 . . . . 0.0 110.929 174.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -146.04 172.53 13.25 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 126.548 1.939 . . . . 0.0 110.416 174.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -113.33 110.29 20.1 Favored 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 125.674 1.59 . . . . 0.0 109.049 175.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 57.18 20.17 5.44 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 124.686 1.194 . . . . 0.0 113.784 177.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 85.04 14.62 68.98 Favored Glycine 0 CA--C 1.537 1.467 0 O-C-N 121.025 -1.047 . . . . 0.0 114.002 -172.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 5.8 mmmt -114.64 171.1 7.84 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 128.368 2.667 . . . . 0.0 109.976 -178.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 4.0 t -40.85 115.5 0.59 Allowed 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 127.228 2.211 . . . . 0.0 112.632 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.0 pttp -62.91 -179.11 0.25 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.339 1.056 . . . . 0.0 112.628 168.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -142.69 0.19 1.39 Allowed Glycine 0 CA--C 1.531 1.086 0 C-N-CA 126.51 2.005 . . . . 0.0 115.441 170.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -146.6 154.52 41.58 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 119.957 1.879 . . . . 0.0 108.999 -174.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.1 pp -137.09 165.3 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 126.274 1.83 . . . . 0.0 110.834 172.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -135.66 126.2 26.95 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.2 1.4 . . . . 0.0 109.507 -177.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -131.1 141.12 50.11 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.816 1.646 . . . . 0.0 110.706 -178.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -129.69 127.29 40.21 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.635 0.774 . . . . 0.0 109.908 -179.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -88.99 167.21 13.37 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.968 0.89 . . . . 0.0 111.693 177.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.2 -4.0 36.33 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.099 0.959 . . . . 0.0 113.499 174.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -157.3 153.86 24.47 Favored Pre-proline 0 N--CA 1.474 0.727 0 C-N-CA 124.973 1.309 . . . . 0.0 112.717 -177.036 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -63.07 -47.69 7.81 Favored 'Trans proline' 0 C--N 1.354 0.816 0 C-N-CA 123.862 3.041 . . . . 0.0 110.877 177.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -55.69 -14.72 2.38 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.735 2.014 . . . . 0.0 114.624 178.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 54.2 m170 -88.46 -46.37 9.18 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 119.669 1.122 . . . . 0.0 110.609 171.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -66.42 -54.31 25.72 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 124.03 0.932 . . . . 0.0 111.465 -179.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 10.7 m -61.28 -26.16 38.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 124.013 0.925 . . . . 0.0 112.076 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -78.25 -56.91 4.08 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.823 1.249 . . . . 0.0 110.299 172.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -50.65 -43.73 57.31 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 119.705 1.139 . . . . 0.0 113.411 -179.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.546 HG23 HG22 ' A' ' 18' ' ' ILE . 61.2 t -57.91 -39.82 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 123.63 0.772 . . . . 0.0 112.907 175.276 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 7.2 mttt -90.18 4.69 49.75 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 126.095 1.758 . . . . 0.0 113.088 179.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -124.8 -20.5 5.0 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 115.147 1.536 . . . . 0.0 115.147 178.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -120.94 21.74 11.28 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 125.479 1.511 . . . . 0.0 112.287 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -56.54 79.74 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 127.586 2.354 . . . . 0.0 113.797 178.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 98.11 91.29 1.95 Allowed Glycine 0 C--N 1.341 0.86 0 C-N-CA 124.202 0.906 . . . . 0.0 111.955 174.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.426 ' CE2' ' CZ2' ' B' ' 52' ' ' TRP . 11.2 m-85 -67.33 150.13 49.4 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.449 1.1 . . . . 0.0 113.704 -177.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . 0.273 0.0 OUTLIER -93.58 51.57 1.6 Allowed 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 115.266 1.58 . . . . 0.0 115.266 -178.977 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.52 22.26 0.06 Allowed 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 125.69 1.596 . . . . 0.0 114.171 176.589 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 24.6 t70 56.37 -88.91 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 125.519 1.528 . . . . 0.0 111.579 -168.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 45.2 -142.9 0.23 Allowed 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 127.985 2.514 . . . . 0.0 113.478 -177.32 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -115.49 -41.59 3.24 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 126.311 1.844 . . . . 0.0 112.187 172.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 8.1 m80 -126.41 139.23 53.42 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.99 1.716 . . . . 0.0 108.911 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.04 166.41 18.14 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.6 1.56 . . . . 0.0 111.726 177.532 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -88.39 170.77 10.65 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 126.665 1.986 . . . . 0.0 111.293 176.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 23.3 mmm180 -137.59 89.88 2.46 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.21 1.404 . . . . 0.0 110.705 -177.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 33.3 t -77.9 118.78 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 123.616 0.766 . . . . 0.0 109.43 176.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 55.6 m-80 . . . . . 0 CA--C 1.544 0.722 0 C-N-CA 125.768 1.627 . . . . 0.0 110.563 178.964 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 . . . . . 0 CA--C 1.539 0.521 0 N-CA-C 114.152 1.167 . . . . 0.0 114.152 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 50.5 mm-40 47.29 59.61 3.97 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 126.04 1.736 . . . . 0.0 113.01 -170.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.76 74.72 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.852 0 CA-C-O 122.412 1.101 . . . . 0.0 112.529 174.004 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 2.4 p -165.54 -49.98 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 127.764 2.425 . . . . 0.0 111.104 -178.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 1.8 ttpt -172.95 -176.48 1.42 Allowed 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 125.84 1.656 . . . . 0.0 111.447 -171.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -98.03 42.61 1.09 Allowed 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 127.52 2.328 . . . . 0.0 112.046 -169.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 12.4 t30 -55.3 -6.71 0.17 Allowed 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 126.666 1.986 . . . . 0.0 114.884 176.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 52' ' ' TRP . . . . . 0.426 ' CZ2' ' CE2' ' A' ' 84' ' ' TYR . 72.2 t-105 -130.84 3.83 4.49 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.345 1.458 . . . . 0.0 113.152 173.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -80.13 -165.48 0.85 Allowed 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 120.876 1.671 . . . . 0.0 111.272 177.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 32.1 t0 -140.59 33.06 1.83 Allowed 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 127.867 2.467 . . . . 0.0 112.267 172.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 28.8 t70 . . . . . 0 N--CA 1.469 0.488 0 C-N-CA 124.982 1.313 . . . . 0.0 109.275 175.821 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 . . . . . 0 CA--C 1.55 0.943 0 N-CA-C 116.036 1.865 . . . . 0.0 116.036 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.6 m -121.53 1.52 10.09 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 126.532 1.933 . . . . 0.0 113.348 -174.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 26.8 m -144.89 167.72 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 124.386 1.075 . . . . 0.0 111.772 -169.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.535 HG22 HG23 ' A' ' 78' ' ' VAL . 21.0 pt -130.96 156.03 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 CA-C-O 121.401 0.619 . . . . 0.0 111.472 178.191 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 98.2 t -136.0 152.93 31.23 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.029 0 C-N-CA 125.286 1.434 . . . . 0.0 109.964 175.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -130.43 149.78 33.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 N-CA-C 108.312 -0.995 . . . . 0.0 108.312 177.061 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -124.86 162.37 24.5 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 124.357 1.063 . . . . 0.0 110.59 176.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 12.9 t30 65.76 34.02 7.78 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.709 1.604 . . . . 0.0 113.405 -177.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.7 p -104.53 81.7 0.56 Allowed Pre-proline 0 N--CA 1.476 0.866 0 C-N-CA 125.572 1.549 . . . . 0.0 112.612 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -68.31 144.85 63.7 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.108 1.872 . . . . 0.0 111.84 177.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.426 ' HB3' HG22 ' A' ' 60' ' ' THR . 0.0 OUTLIER -64.93 163.55 14.28 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 120.915 0.388 . . . . 0.0 111.193 169.79 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 31.3 m -138.55 161.37 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 C-N-CA 125.294 1.438 . . . . 0.0 109.935 -174.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -70.47 -173.25 12.75 Favored Glycine 0 CA--C 1.546 2.021 0 N-CA-C 115.286 0.875 . . . . 0.0 115.286 -179.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.559 ' HA ' HD22 ' A' ' 31' ' ' LEU . 59.3 Cg_endo -62.21 167.97 10.09 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 123.527 2.818 . . . . 0.0 111.493 179.247 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 19.2 t70 64.4 7.75 3.82 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.055 1.342 . . . . 0.0 113.126 -178.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.2 ttt-85 -150.36 -27.38 0.23 Allowed 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.566 1.546 . . . . 0.0 114.142 -179.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.559 HD22 ' HA ' ' A' ' 28' ' ' PRO . 1.6 pt? -52.02 -33.09 36.9 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 114.713 1.375 . . . . 0.0 114.713 176.386 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -65.34 -53.14 48.06 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 125.077 1.351 . . . . 0.0 108.844 177.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.79 -38.52 48.83 Favored 'General case' 0 C--O 1.219 -0.541 0 C-N-CA 126.623 1.969 . . . . 0.0 111.003 176.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -46.65 -59.59 2.92 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 119.406 1.003 . . . . 0.0 111.879 175.263 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -75.17 -32.79 61.37 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.762 0.825 . . . . 0.0 112.824 175.232 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.99 -55.42 25.85 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 117.659 -1.163 . . . . 0.0 111.835 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.406 HG12 ' CB ' ' B' ' 45' ' ' ASP . 15.6 m -55.14 -37.55 43.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 124.25 1.02 . . . . 0.0 110.838 179.345 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.1 mp -53.18 -47.62 55.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 124.81 1.244 . . . . 0.0 111.495 170.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 13.5 m-70 -65.37 -39.7 92.6 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 119.29 0.95 . . . . 0.0 112.644 178.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -72.77 -49.14 32.65 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 119.233 0.924 . . . . 0.0 112.669 177.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -57.03 -39.86 69.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 CA-C-N 119.378 0.99 . . . . 0.0 111.878 -177.468 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.537 ' HB2' HD11 ' A' ' 48' ' ' ILE . 35.3 m-85 -86.64 -1.03 57.35 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -178.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -75.78 -22.94 55.92 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 -179.369 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 3.4 pttm -68.56 -24.94 64.68 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 119.488 1.04 . . . . 0.0 112.367 175.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -92.16 -14.24 29.42 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.977 0.911 . . . . 0.0 112.825 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 156.59 -148.35 18.11 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 123.982 0.801 . . . . 0.0 112.361 -176.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 12.3 tptm -128.08 123.16 33.88 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.455 1.102 . . . . 0.0 109.463 176.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.537 HD11 ' HB2' ' A' ' 42' ' ' PHE . 1.7 mp -79.71 123.55 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 177.436 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.8 t -102.18 -11.57 18.69 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 117.697 -1.144 . . . . 0.0 114.061 -178.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 32.0 m-80 -121.91 165.7 15.55 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.057 1.343 . . . . 0.0 110.917 175.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.505 ' HA ' HD23 ' A' ' 66' ' ' LEU . 0.2 OUTLIER -166.79 126.21 1.48 Allowed 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.811 0.845 . . . . 0.0 111.928 173.689 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -137.02 122.37 19.42 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.833 0.825 . . . . 0.0 111.478 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -119.92 86.58 36.69 Favored Pre-proline 0 CA--C 1.538 0.504 0 C-N-CA 126.086 1.754 . . . . 0.0 108.835 -178.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -70.33 174.79 9.49 Favored 'Trans proline' 0 CA--C 1.536 0.612 0 C-N-CA 123.069 2.513 . . . . 0.0 111.043 178.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -145.54 171.97 13.91 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.482 1.113 . . . . 0.0 111.753 173.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -111.97 109.87 19.88 Favored 'General case' 0 C--O 1.223 -0.309 0 C-N-CA 124.734 1.213 . . . . 0.0 109.639 176.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 54.26 24.96 5.4 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 125.054 1.342 . . . . 0.0 114.462 179.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 83.7 12.89 76.78 Favored Glycine 0 CA--C 1.539 1.534 0 O-C-N 121.494 -0.754 . . . . 0.0 113.666 -174.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.9 mtpp -114.79 179.32 3.98 Favored 'General case' 0 C--N 1.343 0.297 0 C-N-CA 126.604 1.961 . . . . 0.0 110.857 -177.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.426 HG22 ' HB3' ' A' ' 25' ' ' GLN . 65.6 p -54.46 110.92 0.69 Allowed 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.675 1.59 . . . . 0.0 113.556 -173.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.6 pttt -59.23 174.12 0.42 Allowed 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.86 1.664 . . . . 0.0 113.291 173.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -136.38 -3.38 2.44 Favored Glycine 0 CA--C 1.534 1.272 0 C-N-CA 125.265 1.412 . . . . 0.0 115.484 173.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -144.7 154.77 43.11 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 126.116 1.766 . . . . 0.0 109.009 -176.109 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.1 pp -137.06 168.66 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 125.671 1.588 . . . . 0.0 110.74 172.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -138.65 132.68 31.31 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.748 1.219 . . . . 0.0 110.102 -178.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.505 HD23 ' HA ' ' A' ' 51' ' ' ASP . 31.8 mt -136.45 147.1 47.03 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 125.04 1.336 . . . . 0.0 110.684 179.186 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -132.31 122.17 24.7 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 124.149 0.98 . . . . 0.0 109.848 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -83.29 170.86 14.16 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 121.933 0.873 . . . . 0.0 111.245 175.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -74.01 -3.53 29.82 Favored 'General case' 0 CA--C 1.549 0.904 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 173.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.3 p -161.1 156.08 20.41 Favored Pre-proline 0 CA--C 1.54 0.567 0 CA-C-N 119.561 1.073 . . . . 0.0 112.997 -175.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -65.73 -45.41 6.56 Favored 'Trans proline' 0 C--N 1.355 0.919 0 C-N-CA 123.363 2.708 . . . . 0.0 111.632 -178.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -55.42 -15.51 2.73 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.295 1.838 . . . . 0.0 114.028 177.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -90.44 -46.57 8.27 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 119.729 1.15 . . . . 0.0 110.817 174.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -60.2 -57.18 13.91 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.338 1.055 . . . . 0.0 112.452 173.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 10.4 m -61.69 -28.48 44.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -176.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -74.82 -56.29 4.93 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.455 1.102 . . . . 0.0 110.66 173.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.77 -41.55 61.72 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.165 0.986 . . . . 0.0 112.969 -176.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.535 HG23 HG22 ' A' ' 18' ' ' ILE . 78.8 t -58.02 -39.44 72.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 124.018 0.927 . . . . 0.0 113.167 174.375 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 3.2 mptt -88.32 3.75 48.58 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.075 1.35 . . . . 0.0 113.348 178.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -120.67 -31.11 4.34 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 179.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -110.12 21.18 17.09 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 119.251 0.932 . . . . 0.0 113.039 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -57.21 85.61 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.768 1.627 . . . . 0.0 113.076 178.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 97.56 79.28 1.45 Allowed Glycine 0 CA--C 1.53 0.989 0 C-N-CA 124.308 0.956 . . . . 0.0 113.304 173.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -57.49 128.66 38.14 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.805 1.242 . . . . 0.0 112.941 -177.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.65 55.81 2.09 Favored 'General case' 0 N--CA 1.477 0.895 0 O-C-N 119.941 -1.724 . . . . 0.0 115.283 -176.371 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 50.6 tp -57.02 -26.92 61.11 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.927 1.291 . . . . 0.0 113.797 178.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 14.0 t70 60.52 75.36 0.41 Allowed 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.739 1.616 . . . . 0.0 111.475 -177.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 7.8 ttmt -142.3 -64.94 0.41 Allowed 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 -174.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -151.68 -74.38 0.15 Allowed 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.077 1.351 . . . . 0.0 110.966 178.221 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 56.8 m80 -114.64 145.5 41.94 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.119 1.368 . . . . 0.0 110.761 178.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.91 163.96 27.37 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 125.249 1.42 . . . . 0.0 111.818 177.1 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -90.42 173.42 8.11 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 125.061 1.345 . . . . 0.0 110.746 177.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 22.1 mmt180 -137.08 87.04 2.25 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.985 0.914 . . . . 0.0 110.673 -178.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 39.2 t -78.82 118.7 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 177.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 54.7 m-80 . . . . . 0 CA--C 1.538 0.493 0 C-N-CA 125.686 1.594 . . . . 0.0 110.006 -178.319 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . 0.406 ' CB ' HG12 ' A' ' 37' ' ' VAL . 16.1 t0 . . . . . 0 CA--C 1.55 0.971 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -67.75 53.21 0.06 Allowed 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 128.062 2.545 . . . . 0.0 113.7 -179.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 47' ' ' ASP . . . . . . . . . . . . . 31.8 t0 53.72 63.15 2.3 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 127.821 2.448 . . . . 0.0 113.329 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 15.8 m -130.29 59.02 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 124.891 1.276 . . . . 0.0 113.003 -174.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.26 -161.07 0.3 Allowed 'General case' 0 N--CA 1.473 0.679 0 O-C-N 121.458 -0.776 . . . . 0.0 110.262 -174.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -114.61 41.28 2.37 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.999 1.319 . . . . 0.0 111.505 -177.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -61.05 12.19 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 116.34 1.978 . . . . 0.0 116.34 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 52' ' ' TRP . . . . . . . . . . . . . 66.2 t-105 -141.27 2.83 1.71 Allowed 'General case' 0 CA--C 1.555 1.156 0 C-N-CA 127.289 2.235 . . . . 0.0 112.222 177.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -112.18 109.21 18.77 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-N 121.214 1.824 . . . . 0.0 112.471 178.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -48.12 133.38 15.18 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.817 1.247 . . . . 0.0 111.477 172.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 . . . . . 0 CA--C 1.538 0.502 0 C-N-CA 124.153 0.981 . . . . 0.0 111.779 -176.825 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 CA--C 1.547 0.829 0 N-CA-C 116.427 2.01 . . . . 0.0 116.427 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 68.4 m -118.73 8.41 11.85 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.859 1.664 . . . . 0.0 113.722 -177.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.5 m -142.62 164.6 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 C-N-CA 123.517 0.727 . . . . 0.0 111.432 -174.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.578 HG22 HG23 ' A' ' 78' ' ' VAL . 18.4 pt -129.63 148.4 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 123.063 0.545 . . . . 0.0 110.976 179.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 40.7 t -134.01 137.13 52.71 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.121 0 CA-C-O 122.318 1.056 . . . . 0.0 109.173 174.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.489 HG22 HG13 ' A' ' 64' ' ' ILE . 0.9 OUTLIER -109.61 154.23 11.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.054 -0.975 . . . . 0.0 109.27 179.371 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -129.77 158.38 39.58 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 123.263 0.625 . . . . 0.0 111.792 174.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 63.5 t30 61.58 40.1 13.9 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 126.009 1.724 . . . . 0.0 113.056 -178.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.7 m -99.82 83.28 0.34 Allowed Pre-proline 0 N--CA 1.483 1.18 0 C-N-CA 126.032 1.733 . . . . 0.0 112.434 174.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -65.21 140.14 63.47 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 121.759 1.64 . . . . 0.0 110.002 171.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.67 177.36 1.62 Allowed 'General case' 0 CA--C 1.541 0.596 0 CA-C-O 121.385 0.612 . . . . 0.0 112.136 170.363 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.532 HG21 ' HG2' ' A' ' 30' ' ' ARG . 27.3 m -135.47 162.77 36.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 C-N-CA 125.183 1.393 . . . . 0.0 110.557 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -66.56 -174.15 5.86 Favored Glycine 0 CA--C 1.544 1.849 0 C-N-CA 124.069 0.842 . . . . 0.0 114.989 -179.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.5 ' HA ' HD22 ' A' ' 31' ' ' LEU . 61.0 Cg_endo -63.81 166.19 16.67 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 123.051 2.501 . . . . 0.0 111.661 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.6 t0 62.33 11.72 4.73 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 123.876 0.87 . . . . 0.0 112.725 -177.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.532 ' HG2' HG21 ' A' ' 26' ' ' VAL . 7.2 ttt180 -151.52 -26.55 0.19 Allowed 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.431 1.492 . . . . 0.0 113.922 177.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.5 HD22 ' HA ' ' A' ' 28' ' ' PRO . 1.7 pt? -51.6 -32.9 30.57 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 114.694 1.368 . . . . 0.0 114.694 179.56 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -66.98 -49.24 66.02 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 125.46 1.504 . . . . 0.0 109.694 179.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 8.3 mptt -49.65 -34.17 17.6 Favored 'General case' 0 C--O 1.219 -0.551 0 C-N-CA 126.601 1.961 . . . . 0.0 111.279 173.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -50.42 -63.49 1.1 Allowed 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 120.264 1.393 . . . . 0.0 110.875 177.269 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.91 -28.89 61.76 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 121.444 -0.785 . . . . 0.0 112.687 175.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.8 -56.7 15.07 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 118.016 -0.992 . . . . 0.0 112.164 177.108 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.444 HG12 ' N ' ' B' ' 45' ' ' ASP . 19.0 m -55.61 -34.84 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 124.004 0.922 . . . . 0.0 110.983 -178.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.1 mp -49.41 -46.89 19.83 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 124.528 1.131 . . . . 0.0 111.462 171.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 18.8 m-70 -68.68 -16.73 63.92 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 113.542 0.942 . . . . 0.0 113.542 179.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -94.04 -51.44 4.85 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.528 1.131 . . . . 0.0 111.19 178.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -56.08 -37.23 48.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 CA-C-N 118.831 0.741 . . . . 0.0 111.742 177.165 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.54 ' HB2' HD11 ' A' ' 48' ' ' ILE . 37.2 m-85 -91.12 -0.93 57.81 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -179.292 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -74.31 -27.01 60.51 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 178.441 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.487 ' HE3' ' CZ ' ' A' ' 45' ' ' PHE . 16.9 pttt -66.67 -22.08 66.09 Favored 'General case' 0 N--CA 1.48 1.071 0 O-C-N 120.536 -1.353 . . . . 0.0 113.188 176.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.487 ' CZ ' ' HE3' ' A' ' 44' ' ' LYS . 9.6 m-85 -94.95 -12.89 25.94 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.68 0.792 . . . . 0.0 113.001 -179.266 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 151.03 -152.18 24.03 Favored Glycine 0 CA--C 1.53 1.024 0 N-CA-C 111.668 -0.573 . . . . 0.0 111.668 -173.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 24.6 tptt -126.26 123.61 38.52 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.506 1.122 . . . . 0.0 110.067 177.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.546 HG21 HD22 ' A' ' 66' ' ' LEU . 2.4 mp -76.37 129.72 36.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 176.369 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.592 HG23 HD22 ' A' ' 50' ' ' ASN . 2.6 t -100.83 -30.48 11.66 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.551 0.74 . . . . 0.0 112.826 179.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.592 HD22 HG23 ' A' ' 49' ' ' THR . 8.8 m-80 -109.88 162.73 14.22 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.39 1.076 . . . . 0.0 110.843 -179.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.536 ' HA ' HD23 ' A' ' 66' ' ' LEU . 0.3 OUTLIER -165.52 125.67 1.82 Allowed 'General case' 0 N--CA 1.468 0.439 0 O-C-N 121.424 -0.797 . . . . 0.0 111.785 174.39 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -136.83 122.87 20.27 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.941 0.876 . . . . 0.0 111.577 -179.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -119.72 86.1 34.63 Favored Pre-proline 0 CA--C 1.537 0.461 0 C-N-CA 125.892 1.677 . . . . 0.0 109.11 -176.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -70.75 171.08 16.24 Favored 'Trans proline' 0 CA--C 1.534 0.511 0 C-N-CA 122.99 2.46 . . . . 0.0 111.426 178.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -145.67 173.78 11.77 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.282 1.033 . . . . 0.0 111.705 175.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -116.22 111.34 20.04 Favored 'General case' 0 C--O 1.223 -0.3 0 C-N-CA 124.771 1.228 . . . . 0.0 110.096 176.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 50.86 30.08 4.87 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 125.768 1.627 . . . . 0.0 113.911 -178.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 79.66 12.96 83.06 Favored Glycine 0 CA--C 1.534 1.24 0 O-C-N 121.163 -0.96 . . . . 0.0 113.042 -176.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 26.7 mtpt -111.41 -178.35 3.43 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.689 1.995 . . . . 0.0 109.85 -178.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 64.4 p -57.72 115.37 2.76 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 126.818 2.047 . . . . 0.0 112.98 -172.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.8 pttp -69.46 171.81 8.19 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.605 1.162 . . . . 0.0 113.96 171.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -138.29 3.77 3.05 Favored Glycine 0 CA--C 1.536 1.385 0 C-N-CA 126.848 2.166 . . . . 0.0 115.638 175.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -147.38 152.57 38.38 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 119.961 1.88 . . . . 0.0 109.542 -178.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.489 HG13 HG22 ' A' ' 20' ' ' VAL . 1.0 OUTLIER -135.84 166.72 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 125.643 1.577 . . . . 0.0 111.098 172.331 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -134.72 126.09 28.31 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.223 1.409 . . . . 0.0 109.985 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.546 HD22 HG21 ' A' ' 48' ' ' ILE . 73.9 mt -127.72 149.62 50.14 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 124.593 1.157 . . . . 0.0 110.722 175.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -136.34 132.56 35.78 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-O 122.364 1.078 . . . . 0.0 110.253 178.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -94.82 167.97 11.1 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 114.762 -1.108 . . . . 0.0 111.186 177.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -80.51 10.24 4.97 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.944 0.898 . . . . 0.0 112.339 176.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 9.7 m -169.78 153.04 4.79 Favored Pre-proline 0 CA--C 1.54 0.592 0 CA-C-N 120.005 1.275 . . . . 0.0 112.583 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -64.09 -46.12 8.79 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 124.818 3.679 . . . . 0.0 111.865 -178.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -53.98 -20.8 6.78 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.725 1.61 . . . . 0.0 113.509 176.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 33.0 m170 -84.99 -47.87 9.81 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 119.778 1.172 . . . . 0.0 110.534 176.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -65.06 -51.86 59.08 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.099 0.96 . . . . 0.0 112.287 178.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 15.9 m -60.47 -34.06 56.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 122.664 0.386 . . . . 0.0 111.149 -179.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -68.36 -57.39 5.97 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 123.593 0.757 . . . . 0.0 110.463 172.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -55.7 -39.66 71.33 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 119.101 0.864 . . . . 0.0 112.748 -173.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.578 HG23 HG22 ' A' ' 18' ' ' ILE . 49.2 t -59.43 -42.2 86.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 123.971 0.908 . . . . 0.0 112.713 173.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.56 2.33 37.71 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.354 1.061 . . . . 0.0 113.463 177.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -115.67 -53.63 2.57 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 119.036 0.835 . . . . 0.0 111.409 179.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -88.11 19.18 3.79 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.021 0.928 . . . . 0.0 113.327 -176.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -52.33 86.44 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.518 1.927 . . . . 0.0 113.374 -179.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.64 95.49 0.77 Allowed Glycine 0 CA--C 1.531 1.075 0 C-N-CA 124.557 1.075 . . . . 0.0 111.495 -178.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 23.6 m-85 -59.59 156.25 13.88 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 122.14 0.972 . . . . 0.0 112.397 177.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.7 64.77 0.61 Allowed 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.445 1.098 . . . . 0.0 110.08 -172.089 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 44.5 tp -62.89 -4.19 2.02 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 126.18 1.792 . . . . 0.0 113.369 173.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.1 t0 61.68 32.11 18.47 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.44 1.096 . . . . 0.0 111.677 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.0 171.11 7.8 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 127.54 2.336 . . . . 0.0 111.523 -177.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 5.2 mp0 -69.85 -27.77 65.12 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -175.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 7.0 m80 -116.6 132.12 56.77 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.241 1.416 . . . . 0.0 109.615 -178.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.2 m -97.65 164.96 12.2 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.383 1.073 . . . . 0.0 110.911 -178.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -95.71 173.02 7.68 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 125.563 1.545 . . . . 0.0 111.087 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 21.0 mmm180 -136.43 94.76 3.05 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.606 0.762 . . . . 0.0 110.648 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 60.4 t -89.55 109.88 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 123.64 0.776 . . . . 0.0 109.849 179.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.433 ' HA ' HG13 ' A' ' 78' ' ' VAL . 49.1 m-80 . . . . . 0 CA--C 1.546 0.796 0 C-N-CA 125.004 1.321 . . . . 0.0 111.356 179.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . 0.444 ' N ' HG12 ' A' ' 37' ' ' VAL . 18.8 t70 . . . . . 0 CA--C 1.535 0.397 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 66.5 mm-40 -153.05 -73.08 0.14 Allowed 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 119.418 1.008 . . . . 0.0 109.446 176.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 47' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -81.56 -179.5 7.4 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.278 1.031 . . . . 0.0 111.459 175.17 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 8.6 t 79.47 160.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 127.523 2.329 . . . . 0.0 110.354 -174.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.91 179.01 0.3 Allowed 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 122.796 1.284 . . . . 0.0 111.482 168.373 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -67.42 59.73 0.06 Allowed 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 125.989 1.716 . . . . 0.0 112.233 173.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -64.46 -7.91 11.7 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.586 1.554 . . . . 0.0 113.168 174.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 52' ' ' TRP . . . . . . . . . . . . . 57.1 t-105 -137.77 -21.57 1.12 Allowed 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.074 1.35 . . . . 0.0 112.752 176.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -97.54 168.6 10.27 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.359 1.864 . . . . 0.0 112.141 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 -65.74 119.61 11.52 Favored 'General case' 0 C--N 1.327 -0.396 0 O-C-N 120.792 -1.193 . . . . 0.0 110.418 174.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 27.5 t70 . . . . . 0 CA--C 1.533 0.305 0 C-N-CA 124.613 1.165 . . . . 0.0 112.619 -173.075 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . 0.272 3.6 p30 . . . . . 0 N--CA 1.477 0.875 0 N-CA-C 115.955 1.835 . . . . 0.0 115.955 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 59.7 m -130.83 5.68 4.62 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 127.21 2.204 . . . . 0.0 113.132 -171.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.6 m -142.3 162.7 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 C-N-CA 125.211 1.404 . . . . 0.0 111.785 -173.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.662 HG22 HG23 ' A' ' 78' ' ' VAL . 16.7 pt -131.42 150.09 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 C-N-CA 123.874 0.87 . . . . 0.0 110.243 -178.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 44.5 t -136.08 132.44 50.04 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.175 0 C-N-CA 124.954 1.302 . . . . 0.0 109.004 175.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -107.01 151.55 8.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 124.544 1.138 . . . . 0.0 109.51 176.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -127.23 166.32 17.97 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.229 1.012 . . . . 0.0 111.309 175.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 66.4 t30 60.2 39.62 19.06 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 126.593 1.957 . . . . 0.0 113.057 -176.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . 0.26 7.2 p -109.0 80.44 1.31 Allowed Pre-proline 0 N--CA 1.476 0.865 0 C-N-CA 125.63 1.572 . . . . 0.0 112.019 179.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -66.89 142.29 62.08 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 121.986 1.791 . . . . 0.0 110.975 175.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.31 163.02 13.72 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 122.981 0.512 . . . . 0.0 111.62 170.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.575 HG22 HD11 ' A' ' 34' ' ' LEU . 33.2 m -133.42 173.0 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 124.913 1.285 . . . . 0.0 110.953 -174.123 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -74.22 -176.58 35.4 Favored Glycine 0 CA--C 1.543 1.783 0 N-CA-C 114.478 0.551 . . . . 0.0 114.478 178.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.533 ' HA ' HD22 ' A' ' 31' ' ' LEU . 61.8 Cg_endo -62.34 168.98 8.67 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 123.49 2.794 . . . . 0.0 111.205 176.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.1 t70 64.07 2.63 1.47 Allowed 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.425 1.49 . . . . 0.0 113.53 -177.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.501 ' HG2' HG21 ' A' ' 26' ' ' VAL . 4.4 ttp180 -142.71 -28.6 0.58 Allowed 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 126.525 1.93 . . . . 0.0 113.77 179.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.533 HD22 ' HA ' ' A' ' 28' ' ' PRO . 1.6 pt? -51.46 -33.4 30.82 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 115.146 1.536 . . . . 0.0 115.146 179.19 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -68.81 -43.22 76.04 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 124.929 1.292 . . . . 0.0 110.474 178.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -51.52 -38.52 54.48 Favored 'General case' 0 C--O 1.221 -0.424 0 C-N-CA 126.052 1.741 . . . . 0.0 110.659 174.238 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.575 HD11 HG22 ' A' ' 26' ' ' VAL . 80.6 mt -52.71 -43.42 65.63 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 120.142 1.337 . . . . 0.0 113.692 178.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.1 tmtt? -91.88 -28.07 17.53 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.726 0.811 . . . . 0.0 112.103 176.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -62.12 -61.79 2.23 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 118.864 -0.588 . . . . 0.0 111.557 173.501 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 28.0 m -54.04 -34.95 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 124.936 1.294 . . . . 0.0 111.42 -174.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.402 HD13 ' O ' ' A' ' 34' ' ' LEU . 1.1 mp -46.92 -55.74 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.335 0 C-N-CA 125.582 1.553 . . . . 0.0 109.955 169.415 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 29.2 m-70 -63.39 -34.08 76.93 Favored 'General case' 0 C--O 1.223 -0.295 0 CA-C-O 118.203 -0.903 . . . . 0.0 112.275 -178.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.7 -54.12 11.35 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 118.877 0.762 . . . . 0.0 111.366 178.234 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.402 HG13 ' HA ' ' B' ' 53' ' ' ASP . 0.0 OUTLIER -58.28 -42.13 82.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-N 118.42 0.555 . . . . 0.0 111.441 179.723 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.548 ' HB2' HD11 ' A' ' 48' ' ' ILE . 34.0 m-85 -84.43 -1.31 55.41 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 113.626 0.972 . . . . 0.0 113.626 -177.144 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.77 -27.32 61.09 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.534 1.133 . . . . 0.0 113.174 179.038 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 2.7 pttm -67.69 -24.78 65.44 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 119.794 1.179 . . . . 0.0 112.892 177.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -93.33 -10.39 35.55 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.28 1.032 . . . . 0.0 113.014 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 149.15 -142.67 10.05 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.046 0.831 . . . . 0.0 112.356 -176.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.5 tppt? -134.69 130.91 37.02 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 124.574 1.15 . . . . 0.0 109.766 177.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.573 HG21 HD22 ' A' ' 66' ' ' LEU . 2.9 mp -81.9 127.09 39.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 124.686 1.194 . . . . 0.0 108.46 175.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.578 HG23 HD22 ' A' ' 50' ' ' ASN . 3.2 t -97.86 -33.28 11.3 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.472 1.109 . . . . 0.0 113.089 178.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.578 HD22 HG23 ' A' ' 49' ' ' THR . 8.7 m-80 -104.26 165.13 11.26 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.928 1.291 . . . . 0.0 111.162 179.39 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.54 ' HA ' HD23 ' A' ' 66' ' ' LEU . 0.3 OUTLIER -167.78 126.16 1.24 Allowed 'General case' 0 N--CA 1.469 0.494 0 O-C-N 121.244 -0.91 . . . . 0.0 111.915 174.124 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -137.0 118.43 14.73 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-O 121.566 0.698 . . . . 0.0 111.366 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -116.46 86.75 18.73 Favored Pre-proline 0 CA--C 1.539 0.553 0 C-N-CA 126.136 1.774 . . . . 0.0 108.583 -179.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -69.29 174.61 8.85 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 123.249 2.632 . . . . 0.0 111.234 178.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -145.38 172.68 12.83 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.855 1.262 . . . . 0.0 111.94 174.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -113.76 108.25 16.85 Favored 'General case' 0 C--O 1.224 -0.275 0 C-N-CA 125.339 1.456 . . . . 0.0 109.508 178.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 53.96 26.73 6.58 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.289 1.435 . . . . 0.0 114.021 -179.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.58 11.69 82.73 Favored Glycine 0 CA--C 1.532 1.14 0 O-C-N 121.352 -0.842 . . . . 0.0 113.493 -174.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.5 mtpp -111.56 178.86 4.19 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 126.648 1.979 . . . . 0.0 110.252 178.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 44.0 p -48.71 106.43 0.1 Allowed 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 127.68 2.392 . . . . 0.0 115.013 -176.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.7 pttt -58.77 172.03 0.58 Allowed 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.026 1.33 . . . . 0.0 112.127 173.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -132.01 -2.81 4.16 Favored Glycine 0 CA--C 1.538 1.53 0 C-N-CA 127.364 2.412 . . . . 0.0 116.149 173.157 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -145.82 155.15 42.72 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 119.796 1.798 . . . . 0.0 109.249 -175.057 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -136.52 164.6 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 125.672 1.589 . . . . 0.0 111.34 170.574 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -134.32 127.81 32.47 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 125.671 1.588 . . . . 0.0 109.917 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.573 HD22 HG21 ' A' ' 48' ' ' ILE . 69.8 mt -130.22 149.78 51.77 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 124.775 1.23 . . . . 0.0 110.658 176.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -134.74 134.87 41.45 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 124.93 1.292 . . . . 0.0 110.148 178.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -94.93 169.67 9.97 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 121.979 0.895 . . . . 0.0 111.461 176.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -74.81 -3.69 33.28 Favored 'General case' 0 CA--C 1.55 0.968 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 174.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.4 p -163.06 155.47 15.84 Favored Pre-proline 0 CA--C 1.541 0.6 0 C-N-CA 124.222 1.009 . . . . 0.0 113.369 -173.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -65.5 -47.95 3.71 Favored 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 123.848 3.032 . . . . 0.0 111.482 -176.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -53.08 -21.76 5.18 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.411 1.884 . . . . 0.0 113.776 178.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 24.6 m170 -83.5 -46.13 12.81 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 119.338 0.972 . . . . 0.0 110.799 175.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -68.05 -50.93 52.17 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.014 0.926 . . . . 0.0 112.846 179.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 17.9 m -60.9 -31.09 48.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 123.7 0.8 . . . . 0.0 111.734 -178.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -70.44 -62.8 1.25 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.795 1.638 . . . . 0.0 109.402 169.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -50.65 -41.76 55.68 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.177 1.391 . . . . 0.0 114.052 -175.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.662 HG23 HG22 ' A' ' 18' ' ' ILE . 23.6 t -52.86 -49.53 47.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 123.492 0.717 . . . . 0.0 111.806 173.03 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -91.95 19.94 6.21 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 126.45 1.9 . . . . 0.0 112.124 178.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -132.54 -3.22 3.36 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 125.459 1.504 . . . . 0.0 114.228 174.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -137.65 19.34 2.88 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.381 1.072 . . . . 0.0 112.623 178.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -61.36 79.47 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 126.109 1.764 . . . . 0.0 112.308 -178.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 103.06 87.29 2.0 Allowed Glycine 0 CA--C 1.527 0.841 0 C-N-CA 125.08 1.324 . . . . 0.0 113.758 172.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -66.08 145.09 56.25 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.833 1.253 . . . . 0.0 114.35 -179.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.64 65.12 8.32 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.863 1.265 . . . . 0.0 114.198 177.253 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 64.2 tp -58.83 -10.76 2.61 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 172.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.3 t70 75.55 25.38 1.22 Allowed 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 126.311 1.844 . . . . 0.0 112.226 -178.048 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -105.64 172.42 6.81 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 128.047 2.539 . . . . 0.0 111.734 -178.187 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 5.7 mp0 -70.41 -28.39 65.02 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 114.241 1.201 . . . . 0.0 114.241 -177.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 3.6 m80 -123.14 143.97 49.64 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.321 1.448 . . . . 0.0 109.329 -178.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -95.14 170.04 9.68 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.543 1.137 . . . . 0.0 111.063 -177.323 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -91.28 172.08 8.78 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 125.368 1.467 . . . . 0.0 110.871 176.163 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 16.1 mmm180 -136.45 95.55 3.19 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.677 1.191 . . . . 0.0 109.717 -178.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 40.6 t -89.38 116.13 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 123.679 0.792 . . . . 0.0 109.411 178.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.467 ' HA ' HG13 ' A' ' 78' ' ' VAL . 35.9 m-80 . . . . . 0 CA--C 1.545 0.766 0 C-N-CA 124.423 1.089 . . . . 0.0 110.429 178.157 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 . . . . . 0 CA--C 1.546 0.803 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -174.99 -177.54 1.1 Allowed 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 128.046 2.538 . . . . 0.0 109.055 -178.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 47' ' ' ASP . . . . . . . . . . . . . 18.5 t70 57.82 21.65 7.73 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.923 1.689 . . . . 0.0 114.388 175.106 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 7.9 p -146.39 156.65 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 128.117 2.567 . . . . 0.0 109.092 -178.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 41.6 mtmt -56.65 -70.74 0.11 Allowed 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.873 1.269 . . . . 0.0 110.607 171.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 4.9 p30 177.86 77.73 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.827 2.051 . . . . 0.0 110.51 -173.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 11.6 t30 -68.01 2.69 1.93 Allowed 'General case' 0 CA--C 1.55 0.967 0 O-C-N 120.635 -1.291 . . . . 0.0 112.569 168.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 52' ' ' TRP . . . . . . . . . . . . . 48.0 t-105 -154.03 89.48 1.3 Allowed 'General case' 0 N--CA 1.451 -0.387 0 O-C-N 120.24 -1.538 . . . . 0.0 108.572 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . 0.402 ' HA ' HG13 ' A' ' 41' ' ' ILE . 0.6 OUTLIER -166.84 -172.22 2.04 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 127.892 2.477 . . . . 0.0 111.579 170.036 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -144.25 155.88 44.05 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.005 0.922 . . . . 0.0 109.094 163.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 . . . . . 0 N--CA 1.466 0.369 0 C-N-CA 124.847 1.259 . . . . 0.0 110.899 178.423 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 . . . . . 0 CA--C 1.548 0.889 0 N-CA-C 115.551 1.685 . . . . 0.0 115.551 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -121.26 2.2 10.3 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 127.42 2.288 . . . . 0.0 113.839 -175.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.1 m -139.78 162.58 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 124.203 1.001 . . . . 0.0 110.456 -172.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.445 HG22 HG23 ' A' ' 78' ' ' VAL . 14.7 pt -133.19 155.28 40.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 124.438 1.095 . . . . 0.0 110.718 -178.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -144.47 162.39 14.43 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.483 0 C-N-CA 125.207 1.403 . . . . 0.0 110.011 178.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.465 HG22 HG22 ' A' ' 94' ' ' VAL . 27.1 t -137.8 127.38 35.11 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.192 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 -176.114 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -96.26 163.13 13.22 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.313 1.045 . . . . 0.0 112.032 169.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 16.0 m-20 62.12 43.79 8.44 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 129.059 2.944 . . . . 0.0 114.199 -178.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.784 HG11 HG23 ' A' ' 64' ' ' ILE . 7.4 p -111.34 84.25 4.68 Favored Pre-proline 0 N--CA 1.485 1.286 0 C-N-CA 124.973 1.309 . . . . 0.0 111.957 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -66.69 145.88 77.09 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 122.064 1.843 . . . . 0.0 110.796 172.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.451 ' HB3' HG22 ' A' ' 60' ' ' THR . 15.6 tt0 -65.1 159.62 22.95 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 121.51 0.672 . . . . 0.0 110.941 169.386 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.421 HG21 ' HG3' ' A' ' 30' ' ' ARG . 35.0 m -130.95 166.01 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 C-N-CA 126.373 1.869 . . . . 0.0 109.043 -176.224 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -74.62 -173.6 31.03 Favored Glycine 0 CA--C 1.543 1.794 0 C-N-CA 124.175 0.893 . . . . 0.0 114.493 -179.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.558 ' HA ' HD22 ' A' ' 31' ' ' LEU . 63.0 Cg_endo -62.23 168.15 9.82 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 123.435 2.757 . . . . 0.0 110.839 177.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.3 t70 65.93 2.63 2.28 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 125.385 1.474 . . . . 0.0 113.448 -177.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.421 ' HG3' HG21 ' A' ' 26' ' ' VAL . 9.6 tpt180 -145.83 -28.83 0.43 Allowed 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.661 1.584 . . . . 0.0 114.555 -177.002 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.558 HD22 ' HA ' ' A' ' 28' ' ' PRO . 1.6 pt? -52.31 -32.68 38.94 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 114.861 1.43 . . . . 0.0 114.861 177.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -69.58 -50.32 45.75 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.991 1.316 . . . . 0.0 109.542 179.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -47.84 -41.07 23.06 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 127.127 2.171 . . . . 0.0 109.827 175.206 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.6 tp -47.79 -47.9 30.6 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.567 1.547 . . . . 0.0 114.147 179.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -91.32 -31.48 16.07 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.478 1.111 . . . . 0.0 112.086 173.466 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -57.91 -59.17 5.67 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 118.102 -0.951 . . . . 0.0 111.461 175.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 15.4 m -53.38 -35.9 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 124.826 1.25 . . . . 0.0 110.829 178.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.1 mp -53.1 -44.99 52.99 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-N 118.859 0.754 . . . . 0.0 111.408 171.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.462 ' HA ' HD13 ' A' ' 48' ' ' ILE . 22.5 m-70 -66.8 -36.15 81.73 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 120.9 -1.125 . . . . 0.0 112.138 178.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -76.21 -50.24 15.02 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 118.716 0.689 . . . . 0.0 111.803 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -55.43 -40.04 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 124.404 1.082 . . . . 0.0 112.032 -179.112 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.66 ' HB2' HD11 ' A' ' 48' ' ' ILE . 31.6 m-85 -88.38 -6.04 57.93 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -177.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -68.1 -26.34 65.76 Favored 'General case' 0 C--N 1.343 0.305 0 C-N-CA 124.687 1.195 . . . . 0.0 111.96 -178.163 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 9.6 pttt -68.43 -19.34 64.58 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 175.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -100.2 -12.67 19.37 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.144 0.978 . . . . 0.0 112.79 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 153.14 -144.82 11.83 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 123.971 0.796 . . . . 0.0 111.722 -175.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 21.0 tptt -130.55 125.66 34.81 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.375 1.47 . . . . 0.0 109.082 178.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.66 HD11 ' HB2' ' A' ' 42' ' ' PHE . 4.2 mp -72.94 141.39 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 123.376 0.67 . . . . 0.0 109.802 173.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.6 t -114.51 -28.99 6.99 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 125.453 1.501 . . . . 0.0 113.235 178.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 24.1 m-80 -132.56 136.09 46.37 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 119.071 0.851 . . . . 0.0 109.338 -176.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -152.03 122.45 7.3 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.706 1.602 . . . . 0.0 112.195 -176.019 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -139.74 136.17 33.89 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.97 1.308 . . . . 0.0 111.084 -178.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -119.96 76.02 21.73 Favored Pre-proline 0 N--CA 1.47 0.569 0 C-N-CA 124.715 1.206 . . . . 0.0 109.453 -175.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -68.17 141.52 52.64 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.582 2.188 . . . . 0.0 111.531 -174.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -117.24 168.66 10.11 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.652 1.581 . . . . 0.0 111.512 -177.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -113.18 117.17 31.17 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 125.168 1.387 . . . . 0.0 109.397 179.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 51.45 24.26 2.13 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.034 1.333 . . . . 0.0 114.479 -177.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 79.84 17.77 74.25 Favored Glycine 0 CA--C 1.542 1.763 0 O-C-N 121.101 -1.0 . . . . 0.0 113.758 -176.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 5.4 mtpp -112.83 -178.04 3.29 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 127.647 2.379 . . . . 0.0 110.098 -176.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.451 HG22 ' HB3' ' A' ' 25' ' ' GLN . 82.3 p -49.33 114.5 1.04 Allowed 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.496 1.119 . . . . 0.0 111.158 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.9 170.5 0.42 Allowed 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.293 1.037 . . . . 0.0 113.571 171.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -133.71 -8.97 2.08 Favored Glycine 0 CA--C 1.529 0.935 0 CA-C-O 117.87 -1.517 . . . . 0.0 114.52 173.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -143.43 161.73 37.64 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 119.939 1.87 . . . . 0.0 109.98 175.323 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.784 HG23 HG11 ' A' ' 23' ' ' VAL . 1.1 pp -124.41 161.2 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 C-N-CA 125.533 1.533 . . . . 0.0 111.224 169.477 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -134.01 119.01 18.46 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.053 1.741 . . . . 0.0 110.358 179.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -123.69 147.09 47.75 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.589 1.555 . . . . 0.0 110.293 177.344 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -131.51 135.95 47.49 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 122.486 1.136 . . . . 0.0 110.271 175.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -96.33 163.76 12.94 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 122.536 1.16 . . . . 0.0 111.587 175.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.28 -8.92 57.95 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.521 1.128 . . . . 0.0 113.001 177.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -153.66 152.1 26.52 Favored Pre-proline 0 CA--C 1.542 0.663 0 C-N-CA 125.759 1.624 . . . . 0.0 113.127 -177.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -63.7 -45.41 11.13 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 123.927 3.085 . . . . 0.0 111.258 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -53.83 -21.56 7.79 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.064 1.745 . . . . 0.0 113.505 177.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 21.8 m170 -84.38 -49.04 9.06 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 119.465 1.03 . . . . 0.0 110.229 175.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -60.14 -55.21 36.7 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.584 1.154 . . . . 0.0 111.689 177.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 15.2 m -60.76 -31.42 49.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 123.831 0.852 . . . . 0.0 111.892 -176.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -76.06 -55.46 5.57 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.587 1.155 . . . . 0.0 110.854 174.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -53.24 -42.88 66.87 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.639 1.176 . . . . 0.0 112.641 -177.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.445 HG23 HG22 ' A' ' 18' ' ' ILE . 50.2 t -55.62 -48.64 77.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 C-N-CA 123.861 0.865 . . . . 0.0 111.504 175.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -76.48 2.82 12.69 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 126.635 1.974 . . . . 0.0 114.368 178.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -117.53 -45.91 2.69 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.685 0.794 . . . . 0.0 112.337 177.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -93.74 23.0 5.03 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.066 0.946 . . . . 0.0 113.204 -178.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -49.11 80.95 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 127.941 2.496 . . . . 0.0 113.785 178.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 84.75 106.24 0.63 Allowed Glycine 0 CA--C 1.533 1.193 0 C-N-CA 125.641 1.591 . . . . 0.0 111.796 -179.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -67.95 161.28 26.86 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 121.65 -0.912 . . . . 0.0 111.985 176.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.416 ' HE3' ' HA ' ' B' ' 54' ' ' ASP . 0.0 OUTLIER -117.23 48.73 1.28 Allowed 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.943 1.297 . . . . 0.0 113.995 -170.835 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 39.9 tp -38.46 -61.55 0.68 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 128.353 2.661 . . . . 0.0 112.817 -171.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 19.6 t70 162.91 -49.53 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 130.003 3.321 . . . . 0.0 111.11 -176.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.84 166.09 22.79 Favored 'General case' 0 N--CA 1.479 1.007 0 O-C-N 121.362 -0.836 . . . . 0.0 112.358 -178.182 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 5.9 mp0 -61.66 -42.64 99.19 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.318 1.447 . . . . 0.0 111.565 -176.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 74.4 m80 -62.97 102.15 0.33 Allowed 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 127.075 2.15 . . . . 0.0 110.845 -177.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.85 154.42 19.51 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 122.841 1.305 . . . . 0.0 112.439 -179.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -86.44 169.06 13.21 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 126.623 1.969 . . . . 0.0 111.579 -178.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 38.2 mmm-85 -135.73 88.13 2.38 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.774 0.83 . . . . 0.0 112.639 -178.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.465 HG22 HG22 ' A' ' 20' ' ' VAL . 24.2 t -75.74 116.21 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 124.12 0.968 . . . . 0.0 110.96 178.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 44.3 m-80 . . . . . 0 CA--C 1.549 0.92 0 C-N-CA 125.122 1.369 . . . . 0.0 111.392 -179.872 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 1.1 p30 . . . . . 0 N--CA 1.469 0.512 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 168.69 -42.96 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 128.929 2.892 . . . . 0.0 111.236 -177.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 47' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -126.94 -169.7 2.08 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.201 1.4 . . . . 0.0 110.785 -177.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 2.7 t 69.67 44.13 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 125.637 1.575 . . . . 0.0 110.861 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 43.6 mtmt 55.87 -147.27 0.53 Allowed 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.996 1.318 . . . . 0.0 109.456 -177.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 60.0 m-20 -111.72 59.91 0.62 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.577 1.551 . . . . 0.0 109.582 -179.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -63.0 -0.53 0.71 Allowed 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 114.795 1.406 . . . . 0.0 114.795 177.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 52' ' ' TRP . . . . . . . . . . . . . 26.2 t-105 -136.87 -14.76 1.59 Allowed 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 126.113 1.765 . . . . 0.0 113.518 176.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -103.88 111.27 23.73 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 120.111 1.323 . . . . 0.0 110.535 -169.211 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . 0.416 ' HA ' ' HE3' ' A' ' 85' ' ' LYS . 17.2 t70 -91.88 152.65 19.98 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 121.743 0.782 . . . . 0.0 111.371 174.602 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 . . . . . 0 CA--C 1.541 0.599 0 C-N-CA 127.592 2.357 . . . . 0.0 109.044 171.936 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . 0.301 5.4 p-10 . . . . . 0 N--CA 1.478 0.935 0 N-CA-C 116.639 2.089 . . . . 0.0 116.639 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -124.38 7.05 8.36 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 127.209 2.204 . . . . 0.0 113.93 -170.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.4 m -132.04 166.02 30.27 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 O-C-N 120.576 -1.328 . . . . 0.0 113.469 -171.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.63 HG22 HG23 ' A' ' 78' ' ' VAL . 16.0 pt -136.23 153.66 31.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 C-N-CA 124.498 1.119 . . . . 0.0 110.84 178.21 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 73.7 t -137.7 151.37 25.89 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.227 0 C-N-CA 125.957 1.703 . . . . 0.0 108.672 175.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -131.08 154.32 40.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 C-N-CA 124.73 1.212 . . . . 0.0 108.481 177.351 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -127.69 169.55 13.68 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.662 1.585 . . . . 0.0 110.719 176.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 13.8 m-20 59.08 29.82 19.47 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 126.284 1.834 . . . . 0.0 114.393 -174.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . 0.265 6.9 p -100.59 84.98 0.5 Allowed Pre-proline 0 N--CA 1.481 1.096 0 C-N-CA 125.156 1.382 . . . . 0.0 112.113 -177.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -69.45 160.08 51.18 Favored 'Trans proline' 0 C--N 1.354 0.864 0 C-N-CA 122.235 1.956 . . . . 0.0 111.345 175.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.56 ' HB3' HG22 ' A' ' 60' ' ' THR . 0.0 OUTLIER -78.5 168.1 20.3 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.649 170.763 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.405 HG21 ' HG2' ' A' ' 30' ' ' ARG . 30.9 m -140.25 168.42 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 125.743 1.617 . . . . 0.0 110.119 -175.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -76.85 -173.37 37.88 Favored Glycine 0 CA--C 1.544 1.891 0 C-N-CA 123.722 0.677 . . . . 0.0 114.244 178.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.539 ' HA ' HD22 ' A' ' 31' ' ' LEU . 67.0 Cg_endo -61.54 172.05 3.88 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 123.307 2.672 . . . . 0.0 111.406 177.486 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 62.17 6.24 1.75 Allowed 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 126.116 1.766 . . . . 0.0 114.353 -178.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.405 ' HG2' HG21 ' A' ' 26' ' ' VAL . 2.1 ttt85 -151.58 -25.82 0.19 Allowed 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 126.985 2.114 . . . . 0.0 114.184 -177.199 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.539 HD22 ' HA ' ' A' ' 28' ' ' PRO . 1.8 pt? -49.69 -36.24 24.48 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 114.97 1.47 . . . . 0.0 114.97 175.011 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -64.7 -54.23 34.79 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 125.019 1.327 . . . . 0.0 108.747 178.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.9 -38.88 17.42 Favored 'General case' 0 C--O 1.219 -0.545 0 C-N-CA 127.344 2.258 . . . . 0.0 110.705 174.221 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -48.99 -55.52 11.68 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 119.744 1.156 . . . . 0.0 112.309 177.199 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.2 tmtt? -84.62 -27.29 27.3 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.753 0.821 . . . . 0.0 112.499 175.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -63.84 -53.65 47.34 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 117.286 -1.34 . . . . 0.0 111.597 176.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 30.2 m -52.32 -32.22 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 125.36 1.464 . . . . 0.0 112.768 -177.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.2 mp -50.58 -51.82 18.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 C-N-CA 124.482 1.113 . . . . 0.0 110.685 169.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 33.4 m-70 -64.67 -40.89 96.21 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 119.658 1.117 . . . . 0.0 112.098 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.449 ' HZ1' ' N ' ' B' ' 45' ' ' ASP . 0.0 OUTLIER -67.39 -51.23 54.54 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.044 0.938 . . . . 0.0 111.087 179.699 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.427 HG13 ' HA ' ' B' ' 53' ' ' ASP . 0.0 OUTLIER -61.4 -43.95 97.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-N 118.552 0.614 . . . . 0.0 111.154 179.069 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.486 ' HB2' HD11 ' A' ' 48' ' ' ILE . 37.8 m-85 -82.47 -6.36 59.26 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -176.1 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.57 -29.66 70.88 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.053 1.341 . . . . 0.0 113.337 177.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.4 pttm -65.95 -23.07 66.53 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 119.709 1.14 . . . . 0.0 112.952 177.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -96.97 -10.09 26.97 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.501 1.12 . . . . 0.0 113.069 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 149.46 -137.8 6.46 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 124.309 0.957 . . . . 0.0 112.623 -178.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.9 tppt? -135.83 137.8 41.88 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 124.655 1.182 . . . . 0.0 109.105 177.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.486 HD11 ' HB2' ' A' ' 42' ' ' PHE . 2.5 mp -95.53 128.13 46.97 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 C-N-CA 124.171 0.988 . . . . 0.0 108.717 179.175 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.9 t -96.17 -29.19 14.19 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.798 1.239 . . . . 0.0 113.911 178.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 47.2 m-80 -112.13 158.03 20.12 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.468 1.107 . . . . 0.0 111.562 178.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -163.16 125.33 2.57 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.761 0.824 . . . . 0.0 111.249 173.247 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -134.55 126.78 30.0 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 123.704 0.802 . . . . 0.0 111.843 -178.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.408 ' CE2' HG21 ' A' ' 64' ' ' ILE . 15.8 m-85 -120.5 86.48 39.53 Favored Pre-proline 0 CA--C 1.542 0.641 0 C-N-CA 127.266 2.226 . . . . 0.0 108.909 -177.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -70.26 173.1 11.91 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 123.129 2.552 . . . . 0.0 111.033 175.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -145.41 172.89 12.54 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.55 1.54 . . . . 0.0 111.24 175.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -113.71 109.56 18.77 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 125.488 1.515 . . . . 0.0 109.276 177.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 22.2 t0 53.07 26.53 4.93 Favored 'General case' 0 CA--C 1.552 1.033 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 178.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 82.52 12.41 80.36 Favored Glycine 0 CA--C 1.537 1.463 0 O-C-N 120.998 -1.064 . . . . 0.0 113.957 -175.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 29.6 mtpt -112.17 -179.74 3.77 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 127.4 2.28 . . . . 0.0 110.148 -178.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.56 HG22 ' HB3' ' A' ' 25' ' ' GLN . 39.2 p -54.29 119.02 4.59 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.927 1.691 . . . . 0.0 113.517 -174.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.8 pttt -67.6 178.3 1.7 Allowed 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.399 1.08 . . . . 0.0 113.417 175.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -139.36 -4.82 1.4 Allowed Glycine 0 CA--C 1.537 1.415 0 C-N-CA 125.502 1.525 . . . . 0.0 115.561 172.039 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -145.88 156.17 43.37 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 119.444 1.622 . . . . 0.0 109.647 -174.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.408 HG21 ' CE2' ' A' ' 53' ' ' TYR . 1.1 pp -138.62 166.59 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 C-N-CA 125.674 1.59 . . . . 0.0 110.851 173.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 29.1 t80 -136.75 129.71 30.9 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.549 1.14 . . . . 0.0 110.114 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.426 ' CD2' HG21 ' A' ' 48' ' ' ILE . 0.8 OUTLIER -131.94 146.56 52.17 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.791 1.636 . . . . 0.0 110.284 179.5 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -132.87 127.21 33.91 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.846 1.258 . . . . 0.0 110.577 177.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -86.87 168.16 13.68 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.826 0.851 . . . . 0.0 111.73 175.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -74.07 -5.71 43.19 Favored 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 124.42 1.088 . . . . 0.0 113.539 173.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -161.57 153.21 15.95 Favored Pre-proline 0 N--CA 1.473 0.703 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 -171.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -67.45 -48.27 1.73 Allowed 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 123.224 2.616 . . . . 0.0 111.072 -173.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -53.45 -18.24 2.56 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.373 1.869 . . . . 0.0 114.244 176.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 20.6 m170 -85.8 -48.32 8.9 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 119.49 1.041 . . . . 0.0 110.348 175.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -65.06 -54.42 30.47 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.482 1.113 . . . . 0.0 112.826 176.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 12.9 m -57.66 -35.29 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 123.131 0.572 . . . . 0.0 111.344 -177.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -66.92 -63.84 0.98 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 126.046 1.739 . . . . 0.0 110.045 170.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -50.02 -41.03 46.5 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.892 1.277 . . . . 0.0 114.308 -176.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.63 HG23 HG22 ' A' ' 18' ' ' ILE . 40.4 t -56.21 -50.46 70.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 123.548 0.739 . . . . 0.0 111.854 173.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 11.4 tmtt? -82.87 -4.93 58.72 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.501 1.92 . . . . 0.0 112.599 -177.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -112.75 -19.78 11.89 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.558 1.543 . . . . 0.0 113.901 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -118.65 18.75 13.39 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 120.756 1.617 . . . . 0.0 113.22 177.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -54.96 85.19 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 126.222 1.809 . . . . 0.0 112.773 178.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 96.46 91.26 1.82 Allowed Glycine 0 C--N 1.338 0.662 0 C-N-CA 125.0 1.286 . . . . 0.0 112.9 174.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -66.55 147.47 53.24 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.524 ' HE3' ' O ' ' B' ' 54' ' ' ASP . 0.0 OUTLIER -92.58 69.31 4.86 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 178.674 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 56.3 tp -44.88 -45.24 10.19 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.716 1.206 . . . . 0.0 113.096 -177.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -148.13 -66.46 0.25 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 127.327 2.251 . . . . 0.0 109.138 171.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -158.65 -58.39 0.07 Allowed 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.677 1.191 . . . . 0.0 112.192 -178.107 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -87.92 -29.61 20.7 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 125.488 1.515 . . . . 0.0 114.209 -174.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 10.4 m80 -82.84 110.61 18.0 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 125.162 1.385 . . . . 0.0 109.568 -178.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.32 160.3 29.63 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.967 1.307 . . . . 0.0 111.366 -175.035 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 -126.93 176.44 7.31 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 125.969 1.708 . . . . 0.0 109.661 -171.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 2.8 mmm180 -136.35 96.03 3.29 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.754 0.822 . . . . 0.0 110.179 -179.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 39.1 t -85.15 119.36 33.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 57.5 m-80 . . . . . 0 CA--C 1.54 0.56 0 C-N-CA 125.148 1.379 . . . . 0.0 110.269 178.254 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . 0.449 ' N ' ' HZ1' ' A' ' 40' ' ' LYS . 44.2 m-20 . . . . . 0 CA--C 1.543 0.688 0 N-CA-C 112.786 0.661 . . . . 0.0 112.786 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 62.78 10.55 4.32 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.987 1.315 . . . . 0.0 113.475 178.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 47' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -63.68 -24.71 67.89 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 126.533 1.933 . . . . 0.0 114.458 -174.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 6.0 m -118.28 62.68 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 125.874 1.67 . . . . 0.0 110.962 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? 54.41 -86.17 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 126.672 1.989 . . . . 0.0 109.867 -164.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -175.07 63.74 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 126.081 1.753 . . . . 0.0 113.649 -169.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -65.11 24.4 0.02 OUTLIER 'General case' 0 CA--C 1.562 1.424 0 C-N-CA 125.817 1.647 . . . . 0.0 115.411 174.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 52' ' ' TRP . . . . . . . . . . . . . 54.7 t-105 -146.99 4.39 0.83 Allowed 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 126.916 2.086 . . . . 0.0 113.553 176.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . 0.427 ' HA ' HG13 ' A' ' 41' ' ' ILE . 0.5 OUTLIER -66.97 -165.79 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.253 0 CA-C-N 121.24 1.836 . . . . 0.0 114.305 174.818 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . 0.524 ' O ' ' HE3' ' A' ' 85' ' ' LYS . 2.1 p-10 -100.79 153.6 19.33 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 121.186 -0.946 . . . . 0.0 112.498 170.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.539 0.556 0 C-N-CA 124.148 0.979 . . . . 0.0 110.942 172.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . 0.258 3.8 p30 . . . . . 0 CA--C 1.549 0.93 0 N-CA-C 117.668 2.47 . . . . 0.0 117.668 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.3 m -114.73 2.38 14.42 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 129.335 3.054 . . . . 0.0 113.034 -175.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.0 m -136.53 168.39 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 O-C-N 121.471 -0.768 . . . . 0.0 111.517 -174.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.552 HG22 HG23 ' A' ' 78' ' ' VAL . 21.0 pt -134.31 155.12 38.71 Favored 'Isoleucine or valine' 0 C--O 1.24 0.572 0 CA-C-O 121.797 0.808 . . . . 0.0 111.478 176.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 29.6 t -137.84 154.07 28.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 125.962 1.705 . . . . 0.0 109.036 177.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -131.69 156.33 42.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 C-N-CA 125.116 1.366 . . . . 0.0 109.05 177.38 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -128.94 165.87 20.24 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 124.338 1.055 . . . . 0.0 110.077 175.625 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 19.4 m-20 58.56 35.99 24.91 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 126.333 1.853 . . . . 0.0 113.776 -174.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.3 p -102.74 83.91 0.59 Allowed Pre-proline 0 N--CA 1.48 1.044 0 C-N-CA 124.886 1.275 . . . . 0.0 112.287 178.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -68.92 155.72 67.64 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 122.675 2.25 . . . . 0.0 111.774 175.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.413 ' HB3' HG22 ' A' ' 60' ' ' THR . 8.9 tt0 -76.67 166.75 22.95 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.355 170.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.436 HG21 ' HG2' ' A' ' 30' ' ' ARG . 27.8 m -135.64 166.36 27.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 C-N-CA 126.61 1.964 . . . . 0.0 109.687 -177.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -75.77 -171.08 30.23 Favored Glycine 0 CA--C 1.539 1.594 0 C-N-CA 123.267 0.461 . . . . 0.0 114.097 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.542 ' HA ' HD22 ' A' ' 31' ' ' LEU . 59.5 Cg_endo -63.67 169.03 10.62 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 123.549 2.833 . . . . 0.0 111.692 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.1 t0 62.12 11.39 4.31 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.295 1.038 . . . . 0.0 113.12 -178.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.436 ' HG2' HG21 ' A' ' 26' ' ' VAL . 5.7 ttt180 -153.64 -28.34 0.13 Allowed 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 126.362 1.865 . . . . 0.0 113.426 -178.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.542 HD22 ' HA ' ' A' ' 28' ' ' PRO . 1.7 pt? -51.33 -33.17 28.1 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 177.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -66.86 -47.54 71.6 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 125.019 1.327 . . . . 0.0 109.696 178.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 8.5 mmtm -52.9 -36.06 58.92 Favored 'General case' 0 C--O 1.218 -0.563 0 C-N-CA 125.381 1.472 . . . . 0.0 110.235 176.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.9 tp -48.31 -49.48 33.81 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.875 1.27 . . . . 0.0 113.086 178.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.27 -28.71 17.6 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.955 0.902 . . . . 0.0 112.37 175.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -59.42 -57.54 12.55 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 118.289 -0.862 . . . . 0.0 111.534 174.016 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.423 HG12 ' CB ' ' B' ' 45' ' ' ASP . 17.9 m -51.4 -36.83 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 125.049 1.34 . . . . 0.0 110.998 -179.195 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.1 mp -54.43 -47.88 69.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 124.603 1.161 . . . . 0.0 110.681 173.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.448 ' HA ' HD13 ' A' ' 48' ' ' ILE . 20.8 m-70 -65.36 -31.04 71.95 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 118.16 -0.924 . . . . 0.0 113.079 178.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.19 -49.75 9.14 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 118.865 0.757 . . . . 0.0 112.025 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.417 HG13 ' HA ' ' B' ' 53' ' ' ASP . 0.0 OUTLIER -56.76 -37.88 55.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 CA-C-N 118.832 0.742 . . . . 0.0 112.4 179.725 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.551 ' HB2' HD11 ' A' ' 48' ' ' ILE . 41.8 m-85 -91.16 0.76 57.47 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -178.632 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.9 t -70.12 -37.72 75.4 Favored 'General case' 0 C--N 1.342 0.265 0 C-N-CA 125.957 1.703 . . . . 0.0 111.569 178.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.57 -24.54 63.83 Favored 'General case' 0 N--CA 1.478 0.951 0 O-C-N 121.047 -1.033 . . . . 0.0 112.856 179.188 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -92.37 -7.22 48.39 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.443 1.097 . . . . 0.0 112.795 177.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 139.52 -144.93 15.83 Favored Glycine 0 CA--C 1.537 1.423 0 C-N-CA 124.92 1.247 . . . . 0.0 112.876 -177.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 13.9 tptt -120.63 138.2 54.04 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 120.781 -1.423 . . . . 0.0 111.193 175.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.551 HD11 ' HB2' ' A' ' 42' ' ' PHE . 2.7 mp -90.75 135.83 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 124.085 0.954 . . . . 0.0 109.253 174.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.9 t -108.02 -16.66 14.23 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 116.603 -1.665 . . . . 0.0 114.837 178.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 52.2 m-80 -125.9 157.33 37.97 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 120.385 1.448 . . . . 0.0 111.137 176.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -165.1 115.68 1.12 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.263 0.625 . . . . 0.0 112.499 -177.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 51.4 m-85 -131.43 129.25 41.0 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 121.894 0.854 . . . . 0.0 111.792 -179.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -120.38 86.42 38.8 Favored Pre-proline 0 CA--C 1.539 0.552 0 C-N-CA 126.148 1.779 . . . . 0.0 108.914 -178.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -69.79 173.73 10.57 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 122.692 2.262 . . . . 0.0 111.196 177.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -144.59 173.75 11.54 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.285 1.434 . . . . 0.0 111.583 175.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -115.4 107.91 15.83 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 124.453 1.101 . . . . 0.0 110.65 177.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 19.0 t70 55.48 24.46 6.83 Favored 'General case' 0 CA--C 1.549 0.917 0 N-CA-C 113.777 1.028 . . . . 0.0 113.777 -178.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 85.5 11.3 75.16 Favored Glycine 0 CA--C 1.539 1.563 0 CA-C-O 118.815 -0.992 . . . . 0.0 113.284 -174.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 30.1 mtpt -114.09 171.31 7.68 Favored 'General case' 0 C--N 1.345 0.398 0 C-N-CA 126.788 2.035 . . . . 0.0 110.763 -178.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.413 HG22 ' HB3' ' A' ' 25' ' ' GLN . 70.8 p -44.98 116.84 1.17 Allowed 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 126.954 2.102 . . . . 0.0 112.387 -176.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 3.7 pttt -67.78 178.02 1.87 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 126.601 1.96 . . . . 0.0 112.743 174.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -139.99 -1.77 1.74 Allowed Glycine 0 CA--C 1.542 1.739 0 C-N-CA 125.875 1.702 . . . . 0.0 115.317 174.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -148.4 151.66 35.66 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 126.622 1.969 . . . . 0.0 109.14 -173.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -135.44 164.61 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 125.714 1.605 . . . . 0.0 110.907 174.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -134.98 125.27 26.28 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.208 1.003 . . . . 0.0 109.686 -178.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -129.82 139.88 51.13 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.283 1.433 . . . . 0.0 110.453 -179.399 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -128.62 124.72 36.52 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.218 0.607 . . . . 0.0 110.584 -179.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -88.23 173.86 8.54 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 122.072 0.939 . . . . 0.0 111.53 178.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -84.38 -0.84 54.2 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.661 0.784 . . . . 0.0 113.031 176.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.2 p -158.2 161.26 29.02 Favored Pre-proline 0 CA--C 1.541 0.63 0 CA-C-N 120.037 1.29 . . . . 0.0 112.88 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -68.05 -49.86 0.92 Allowed 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 123.086 2.524 . . . . 0.0 111.276 176.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -51.88 -30.17 22.85 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.764 1.226 . . . . 0.0 112.602 178.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -74.11 -47.11 38.45 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.19 0.996 . . . . 0.0 112.112 176.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -64.71 -54.34 33.14 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.772 1.229 . . . . 0.0 112.195 176.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 10.3 m -59.41 -35.95 61.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 122.881 0.473 . . . . 0.0 111.486 -177.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -66.05 -56.47 11.38 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 118.415 -0.802 . . . . 0.0 111.174 172.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.97 -43.99 63.81 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 119.274 0.943 . . . . 0.0 112.681 -177.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.552 HG23 HG22 ' A' ' 18' ' ' ILE . 79.5 t -59.65 -33.0 50.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 175.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.75 6.87 46.94 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.052 1.341 . . . . 0.0 112.039 -179.2 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 8.2 m-80 -125.94 -28.33 3.2 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 179.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -114.62 23.02 13.06 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.597 0.759 . . . . 0.0 112.15 -176.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -59.91 54.95 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 130.609 3.564 . . . . 0.0 115.771 -178.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 124.91 82.82 0.52 Allowed Glycine 0 CA--C 1.533 1.172 0 C-N-CA 125.182 1.372 . . . . 0.0 113.125 174.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -58.01 148.03 27.46 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.921 1.688 . . . . 0.0 113.865 -176.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.05 72.33 2.93 Favored 'General case' 0 N--CA 1.476 0.84 0 O-C-N 120.546 -1.346 . . . . 0.0 113.797 -177.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 26.1 tp -69.81 7.49 0.89 Allowed 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 125.443 1.497 . . . . 0.0 114.384 175.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.1 t70 67.09 47.69 1.33 Allowed 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.043 1.337 . . . . 0.0 112.117 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 18.9 mmtm -142.41 172.91 12.05 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.7 1.6 . . . . 0.0 112.407 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.55 -38.01 62.84 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.638 1.975 . . . . 0.0 113.333 179.327 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 27.6 m-70 -90.98 133.58 35.17 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 124.458 1.103 . . . . 0.0 109.443 177.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.7 m -112.02 162.63 15.17 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.331 1.053 . . . . 0.0 110.566 -176.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -86.26 170.96 11.62 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.139 0.976 . . . . 0.0 110.754 -178.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 5.3 mmm180 -136.25 84.99 2.12 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.704 0.802 . . . . 0.0 111.932 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 27.4 t -72.94 121.78 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 122.772 0.429 . . . . 0.0 109.888 177.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 58.0 m-80 . . . . . 0 CA--C 1.545 0.772 0 C-N-CA 125.834 1.653 . . . . 0.0 111.09 -179.838 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . 0.423 ' CB ' HG12 ' A' ' 37' ' ' VAL . 10.8 t0 . . . . . 0 CA--C 1.537 0.457 0 CA-C-O 121.624 0.726 . . . . 0.0 111.191 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -169.55 174.42 5.9 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 128.598 2.759 . . . . 0.0 107.371 -176.186 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 47' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -65.94 -8.43 22.46 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 178.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 11.1 p -48.3 -45.02 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 125.94 1.696 . . . . 0.0 113.441 178.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 3.1 mtpp 169.43 170.97 0.05 OUTLIER 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 127.899 2.48 . . . . 0.0 110.883 -173.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -110.35 45.13 1.15 Allowed 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 126.699 2.0 . . . . 0.0 112.079 -169.28 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 17.7 t30 -58.75 2.62 0.04 OUTLIER 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 125.754 1.622 . . . . 0.0 114.744 176.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 52' ' ' TRP . . . . . . . . . . . . . 69.6 t-105 -139.25 7.41 2.4 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.084 1.354 . . . . 0.0 112.933 176.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . 0.417 ' HA ' HG13 ' A' ' 41' ' ' ILE . 0.4 OUTLIER -97.06 -138.86 0.28 Allowed 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 120.611 1.55 . . . . 0.0 111.119 -173.793 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -149.82 171.07 17.34 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 124.337 1.055 . . . . 0.0 110.679 173.145 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 3.9 t70 . . . . . 0 CA--C 1.545 0.754 0 C-N-CA 124.242 1.017 . . . . 0.0 110.16 170.728 . . . . . . . . 0 0 . 1 stop_ save_